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001 [Oral 022]
Anti-Idiotype Vaccination Induces T Cell Responses Against Conserved Framework
Sequences Rather than the Hypervariable CDR3 Region
R. Demine and P. Walden
Department of Dermatology and Allergy, ChariteÂ, Humboldt University, Berlin, Germany
The idiotype region of the T cell receptor (TCR), because of its restriction to the malignant T cell
clone, is generally seen as an ideal tumour antigen for vaccination therapy of T cell lymphomas.
Similarly, the variable regions of immunoglobulins are preferred targets for antitumour
vaccinations in B cell lymphomas. Consequently, anti-idiotype vaccination is the major strategy
for therapeutic vaccination in cases of cutaneous and systemic lymphomas. To identify likely targets
of these strategies, we have subjected all 74 completely sequenced TCRVb to computational
analyses for T cell epitopes taking into consideration the protein chemical constitution of these
molecules, and algorithms for the prediction of proteasome cleavage (HolzhuÈtter, 1999) and for
MHC binding (SYFPEITHI). To include epitopes that are generated from proteasome products by
subsequent trimming, octa to deca peptides were predicted from the protein sequences and
analysed further for peptides that conform to the MHC allele-speci®c anchor motifs of HLA-A1, -
A2.1, -A3, -B7, -B8 as the most frequent HLA alleles in the middle European populations.
Overall, these analyses yielded a predictably large number of potential epitopes. However, only a
relatively small number of these epitopes scored highly for MHC binding thus indicating that the
variable domain of T cell receptors is not an ef®cient T cell antigen. Most strikingly, the
hypervariable idiotype regions are almost completely devoid of potential T cell epitopes which
almost all reside in conserved framework sequences. This out-come is in good agreement with the
protein chemistry of the proteins and of MHC-binding peptides. Hydrophobic amino acids are
preferred in MHC-binding peptides. Such amino acids are abandon in the framework regions that
constitute protein cores but are largely lacking in the exposed hypervariable loops, in particular in
the CDR3 sequences. These ®ndings might explain why almost all veri®ed TCR T cell epitopes
are framework sequences. In conclusion, vaccinations with TCR sequences will preferentially
induce TCR family speci®c and not tumour-speci®c immune responses.
002 [Oral 025]
Induction of a Caffeine-Sensitive S-Phase Cell Cycle Checkpoint by Psoralen Plus
Ultraviolet A Radiation
I. Kuntze, C. Joerges, and T. Herzinger
Munich, Germany
Induction of interstrand crosslinks (ICLs) in chromosomal DNA is considered a major reason for
the antiproliferative effect of psoralen plus ultraviolet A (PUVA). It is unclear as to whether PUVA
induced cell cycle arrest is caused by ICLs mechanically stalling replication forks or by triggering
cell cycle checkpoints. Cell cycle checkpoints serve to maintain genomic stability by halting cell
cycle progression to prevent replication of damaged DNA templates or segregation of broken
chromosomes. In response to DNA damage, the caffeine-sensitive kinases ATM or ATR
phosphorylate and thereby activate the checkpoint kinase Chk1. Activated Chk1 phosphorylates
Cdc25 dual-speci®city protein phosphatases which promote cell cycle transitions by depho-
sphorylating cyclin-dependent kinases. Phosphorylation of Cdc25 phosphatases inhibits their
function or targets them for degradation. Here we show that HaCaT keratinocytes treated with
PUVA arrest with S-phase DNA content. Cells that had completed DNA replication were not
perturbed by PUVA and passed through mitosis. PUVA induced rapid phosphorylation of the
Chk1 checkpoint kinase at Ser345 and a concomitant decrease in Cdc25A levels. The decrease of
Cdc25A levels and the S-phase arrest were both abolished by caffeine, suggesting that active
checkpoint signaling rather than mechanical blockage by ICLs causes the PUVA induced
replication arrest.
003 [Oral 026]
Drebrin ± an Actin-Binding Protein Involved in Regulations of Cellular Protrusions and
Cell Motility
W. K. Peitsch, I. Hofmann, S. PraÈtzel, C. Kuhn, P. Houdeck, I. Moll, S. Goerdt, and
W. W. Franke
Heidelberg, Mannheim and Hamburg, Germany
Drebrins are actin-binding proteins initially identi®ed in ± and thought to be speci®c for ±
neuronal cells. Recently, we detected the drebrin isoform E2 as a widespread, although not
ubiquitous, component of the actin cytoskeletal system of various cell types. In cells forming
adhering junctions drebrin is associated with the submembranous actin micro®lament system
whereas in motile cells it is accumulated in lamellipodia, ®lopodia and other cellular protrusions.
Here we present results indicating that drebrin accumulation at adhering junctions and in cellular
processes plays a role in the physiology and pathophysiology of human skin. Using
immunocytochemistry and immunoblotting, we have identi®ed drebrin in a number of skin-
speci®c cell types, including keratinocytes, melanocytes and Merkel cells. Certain skin tumors,
notably basal cell carcinomas and melanoma metastases, seem to contain more drebrin. In vitro
wound healing models show enhanced drebrin immunostaining in keratinocytes migrating into the
wound. Analysis of the physical state of drebrin by sucrose gradient fractionation and
immunoprecipitation has revealed drebrin-containing particles (``drebrosomes'') including some
in which drebrin is associated with actin and partly also with certain membrane-associated actin
binding proteins. We conclude that drebrin is involved in the regulation of the actin cytoskeleton
in cellular processes and at membranes, possibly serving as a membrane-cytoskeleton linker.
Drebrin is recruited to sites of protrusions in situations of increased cellular motility, suggesting a
role in the regulation of actin during cell migration.
004 [Oral 027]
Cx26 Null Mutation Affects the Development of Human Epidermis In Vitro
L. Wiszniewski,§ M. H. Cao, F. Denoyelle,* C. Petit,* G. Walksman,² J. Lamartine,² P. Meda,
and D. Salomon³
Department of Morphology, Geneva University Hospital, Switzerland; *Pasteur Institute, Paris, France;
²Functional Genomic Service, University of Evry/CEA, Paris, France; ³Department of Dermatology,
Geneva University Hospital, Switzerland; §Department of Otology, Geneva University Hospital,
Switzerland
Recently, connexin (Cx) mutations of Cx26 have been identi®ed in hereditary deafness associated
or not to abnormal epidermal differentiation. Among this mutation, the most frequent, is the Cx26
null mutation (35delG homozygous). The Cx26 is highly expressed in epidermal hyperproliferative
state (psoriasis, reepithelialisation), in hair follicles or in mucosa. Surprisingly, the patients bearing
the Cx26 null mutation did not have an abnormal skin phenotype. To study this paradox, we have
analysed the proliferation and migration of keratinocytes from 5 patients bearing a Cx26 null
mutation (35delG homozygous) and studied their ability to form In vitro a so called epidermal
equivalents. The absence of Cx26 resulted in a reduced thickness of epidermal equivalents (n = 60,
p < 0,0001), an alteration, which was not observed in 5 healthy volunteers (n = 75). The colony
forming ef®ciency of keratinocytes from homozygous 35delG (n = 40) is reduced (p < 0,0001) as
compared to 4 heterozygous (n = 50) and control patients (n = 50). By time lapse videomicroscopy,
we demonstrated that the migration of the mutated keratinocytes was dramatically reduced as
compared to normal keratinocytes. By ¯uorescent dye microinjection and scrape loading, we were
unable to demonstrate a difference in gap junction intercellular communication. The mRNA
coding for Cx30, 30.3, 31, 31.1, 43 was detected by RTPCR. In vivo, the surprising aspect of the
35delG mutation is that apart a neurological deafness, the absence of Cx26 seems not to cause gross
functional abnormalities in others organs, where this connexin is normally expressed. In contrast,
we demonstrated that, in an In vitro controlled environment, the absence of Cx26 reduced the
colony forming ef®ciency and migration of keratinocytes, which could be involved in the impaired
strati®cation of the epidermal equivalents. We can speculate that, even if the repithelialisation is
perturbed In vivo, these alterations revealed In vitro are not measurable by clinical observations.
005 [Oral 032]
Keratin5-Cre/lox-P Mediated Deletion of Vascular Endothelial Cell Growth Factor
Severely Compromises Mammary Gland Development and Function
H. Rossiter, C. Barresi, C.-I. Wu, E. F. Wagner, and E. Tschachler
Vienna, Austria and Neuilly, France
VEGF is essential for embryonic blood vessel development, and in the adult remains the major
regulator of angiogenesis not only during patho-physiological processes, but also during the female
reproductive cycle. We have previously shown that keratin5 driven, Cre/lox-P mediated deletion
of VEGF in epidermal keratinocytes delays wound healing and prevents tumor growth. As an
appendage of the skin, mammary gland epithelium also expresses keratin 5, and VEGF is also
deleted in this tissue in K5-Cre VEGF ¯ox/¯ox mice. Such females bear few live young, probably
due to genomic deletion of the VEGF gene caused by Cre activation during fertilization,
con®rming the necessity for VEGF during embryonic development. Mammary gland ducts of
pubescent virgin K5-Cre VEGF ¯ox/¯ox mice are shorter, have fewer branches and a smaller
diameter compared to controls, and pups which are reared by mutant adult females are growth
retarded, and display reduced amounts of milk in their stomachs. Immunohistochemistry of
mammary glands from mutant lactating females reveals a reduced number of mammary alveoli,
lined by droplet-containing cells that are not present in control mice. We conclude that lack of
VEGF production in mammary epithelium results in severely compromised development and
function.
006
Seborrheic Keratoses Contain Higher Levels of Lipid Peroxides and Less a-Tocopherol
than Normal Epidermis
C. Antille, O. Sorg, and J. H. Saurat
Department of Dermatology, Geneva University Hospital, Geneva, Switzerland
Background: Seborrheic keratosis is a common and benign lesion of the epidermis; its aetiology is
still unknown. The skin is constantly exposed to various environmental factors (UV, oxidants) and
is therefore susceptible to suffer from oxidative stress. a-tocopherol (vitamin E) plays an important
role in the antioxidant defence system of the epidermis and functions In vivo as a protector against
lipid peroxidation. Objectives: We assessed the oxidative stress by comparing a-tocopherol and
lipid peroxide concentrations of seborrheic keratosis with those of the epidermis of healthy
volunteers. Methods: 32 Seborrheic keratoses were collected by vaporisation with liquid nitrogen
followed by shaving, and 17 epidermal samples were collected from plastic surgery for controls. a-
tocopherol was analysed by high-pressure liquid chromatography, and lipid peroxides were assayed
by ferrous oxidation followed by xylenol orange complexometry. Results: Seborrheic keratoses
showed a lower concentration of a-tocopherol (13.2 6 2.4 nmol per g) as compared to healthy
control epidermis (38.3 6 5.9 nmol per g) (p<0.001), as well as a higher concentration of lipid
peroxides (504.1 6 73.4 and 212.0 6 27.0 nmol per g for seborrheic keratosis and healthy control
epidermis, respectively) (p<0.001). The mean DNA content was comparable between seborrheic
keratosis and the epidermis (4.05 6 0.46 mg per g and 4.17 6 0.35 mg per g respectively).
Conclusion: Seborrheic keratoses were shown to exhibit a higher oxidative state than the
epidermis of healthy volunteers. We don't know whether this is a cause or a consequence of the
lesions, but this can be added to the growing list of the pathologies associated with an oxidative
stress.
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Macrophage Metalloelastse (MMP-12) and 92-kDa Gelatinase are Overexpressed in
Nodular Kaposi's Sarcoma
U. Impola, M. A. Cuccuru, M. V. Masala, F. Cottoni, and U. Saarialho-Kere
Helsinki, Finland, Sassari, Italy
Kaposi's sarcoma (KS) is an angioproliferative tumor that exists in several clinical and
epidemiological forms. They all share same histological features and are associated with infection
by human herpesvirus 8 (HHV8). Histologically KS is characterized by growth of spindle cells and
a lymphomononuclear in®ltration. The classic KS shows tendency to skin lesions while AIDS ±
associated KS can widely disseminate to other organs. Matrix metalloproteinases (MMPs) are a
family of zinc-dependent proteolytic enzymes, most of which have been implicated in cancer
growth and angiogenesis. Their role in KS is not well studied except that MMP-2 and MMP-9
have been reported in KS cell cultures by Northern and Western analysis. In fact synthetic MMP
inhibitors are currently in clinical trials as a therapy for KS. Our initial aim was to study putative
expression of macrophage metalloelastase (MMP-12) in KS. We have previously shown that in
skin cancer the amount of MMP-12 positive macrophages correlates with good prognosis while
that produced by epithelial cancer cells implicates aggressive phenotype. Expression of other
MMPs was also studied by immunohistochemistry or in situ hybridization in 28 classical and 4
HIV-associated Kaposi's sarcoma. 11 specimens represented patch stage, 6 plaque lesions and 15
nodular tumor stage. MMP-12 was expressed in 12/32 specimens by CD-68 positive correlating
with nodular stage. MMP-2 was found in ®broblasts surrounding the tumor nodules but not in
spindle cells. MMP-9 was expressed by neutrophils in®ltrating into tumor and by macrophages and
endothelial cells inside the tumor nodule. MMP-19 was detected in endothelial cells of the tumor
nodule and occasionally in ®broblasts and macrophage-like cells. Our results suggest that selective
inhibitors of MMP-12 and MMP-9 could be bene®cial for treating Kaposi's sarcoma
008
Expression of 4a Carbinolamine Dehydratase and Hepatocyte Nuclear Factor 1a and
Transcription of Albumin in the Human Epidermis
S. Kothari, S. Hasse, S. Kauser, L. K. Marles, H. Rokos, and K. U. Schallreuter
University of Bradford,UK
Recently protein expression as well as enzymatic function of 4a carbinolamine dehydratase (PCD)
has been demonstrated in the human epidermis in situ and in cell extracts from suction blister roofs.
Since this enzyme also acts as a dimersation cofactor of hepatocyte nuclear factor 1a (DCoH), it
was tempting to look for this function of PCD/DCoH. DCoH and hepatocyte nuclear factors 1a
(HNF-1a) transcribe a number of genes, including albumin. Using immunohistochemistry with
antibodies directed against human PCD/DCoH, HNF-1a and human albumin, we were able to
demonstrate the presence of PCD/DCoH, HNF-1a and albumin in human melanocytes and
keratinocytes In vitro and in situ. Applying the double immuno¯uorescence technique, we
demonstrated colocalisation of PCD/DCoH and HNF-1a in the nucleus and in the cytosol of
melanocytes and keratinocytes. Furthermore, we demonstrated also the colocalisation of HNF-1a
and albumin in both cell types and in situ. The presence of albumin was con®rmed by
electrophoresis and Western Blots. The results of this study show for the ®rst time the expression of
HNF-1a in the human epidermis together with DCoH and albumin, supporting transcription of
the albumin gene in melanocytes and keratinocytes.
009
Regulation of the Lipoprotein Lipase Activity in 3T3-L1 Adipocytes Using an
Oxazolidinone Derivative
F. Pellicier, J. Franchi, P. AndreÂ, and B. FeÁve*
Laboratoires R et D, LVMH Branche Parfums et CosmeÂtiques, Saint Jean de Braye; *UMR CNRS 7079,
Institut des Cordeliers, Paris, France
The Lipoprotein Lipase (LPL) which is present in the adipose tissue is an enzyme which plays a
main role in the the adipocyte's lipid storage. The LPL is synthesized by the adipocyte, secreted in
the interstitial space and carried to the capillary endothelial cells where it binds with
glycoaminoglycans. It thus becomes responsible for the hydrolysis of endogeneous triglycerides
(VLDL) and exogeneous triglycerides (chylomicrons) and generates free fatty acids and
monoacylglycerol during circulation. As soon as they are released, the fatty acids can be caught
by the adipoctye, re-ester®ed and stored in triglyceride form. As the series phenomena suggests that
the LPL plays a role in the development of the adipose tissue, we thought it would be interesting to
identify the potential regulators of this enzyme. Amongst the components tested, one molecule
(sphingosine biomimetics: oxazolidinone) was selected for its ability to modulate the activity of the
LPL secreted by the 3T3-L1 adipocytes in culture. The secretion level of the LPL was measured by
radioisotopic dosage of the enzymatic activity. It clearly showed that the molecule has an obvious
dose-dependant inhibiting effect on the LPL activity. This effect reaches its height after 48 h of
treatment by the molecule. Furthermore, this molecule is a moderate inhibitor of the adipocyte
differentiation process (dosage of the speci®c G3PDH activity) and slightly reduces the cellular
triglyceride content. The molecule thus appears to be of potential interest in modulating the
importance of subcutaneous adipose deposits.
010
Tight Junctions and New Compositionally Related Structures in Epidermis and Other
Strati®ed Epithelia
L. Langbein, C. Grund, C. Kuhn, S. Praetzel, J. Kartenbeck, J. M. Brandner, I. Moll, and W. W.
Franke
Heidelberg and Hamburg, Germany
The occurrence of tight junction (TJ) structures and the spatial arrangement of TJ proteins in
strati®ed epithelia have long been controversial. Therefore, we have systematically examined the
localization of TJ proteins (occludin, claudins 1 and 4, ZO-1, cingulin and symplekin) in diverse
strati®ed epithelial tissues, including skin and cell cultures by electron microscopy and
immunocytochemistry at both the light- and the electron microscopic level. We have found an
unexpected diversity of TJ-related structures of which only those showing colocalization with
occludin, the most restricted transmembrane TJ-protein, are presented here. While in the
epidermis as in all the other epithelia a true, probably continuous occluding TJ zone is restricted to
the uppermost living cell layer(s), TJ-related junctions are abundant in several or even the majority
of the suprabasal cells. Interfollicular epidermis contains in the str. granulosum extended TJ
structures, which can also be traced, at least, through the Henle cell layer of hair follicles. Besides
``classical'' TJs, however, we have noticed TJ protein-positive junctional structures, represented
mostly by broad, ribbon-like membrane contacts that often appear pentalaminar, with an electron-
dense middle lamella (``lamellated TJs'', coniunctiones laminosae) and numerous junctions with a 10±
30 nm dense intermembraneous lamina (``sandwich junctions''; iuncturae structae). Corresponding
TJs and compositionally related junctions are also formed in cell cultures during strati®cation.
These junctions are mostly in close vicinity to and in their amount next to desmosomes and
obviously part of the epithelial barrier.
011
Diversity of Desmoplakin Expression in Basal Palm Keratinocytes: A Possible Clue to
the Identi®cation of Epidermal Stem Cells
H. Wan, J. Marshall,* L. E. Reynolds,* M. G. Stone,* J. A. McGrath, K. M. Hodivala-Dilke,*
and R. A. J. Eady
Department of Cell and Molecular Pathology, St John's Institute of Dermatology, *Cancer Research UK,
Guy's, King's and St Thomas' School of Medicine, London, UK
Desmosomes are the most abundant intercellular junctions in skin and play a pivotal role in
epithelial sheet formation and maintenance of tissue integrity and function. The expression of
desmosomal proteins in skin varies according to the body site and differentiation status of the
epidermis. Using immuno¯uorescence and in situ hybridisation, we found that desmoplakin
expression varied in the basal layer of normal palm skin In vivo as well as in the cultured
keratinocytes of the same phenotype. Cells located at the bottom of deep rete ridges, the region of
putative stem cells, showed a low level of desmoplakin expression, while those at the side of rete
ridges or above the dermal papillae, expressed abundant desmoplakin. Small keratinocytes also
expressed less desmoplakin In vitro, compared with larger cells. We hypothesized that putative
epidermal stem/progenitor cells express fewer desmosomes. To test this, we separated trypsin-
dissociated basal palm keratinocytes into two populations according to their rapid (20 min) or slow
(20 min+) ability to adhere to type IV collagen, a selection procedure corresponding to the cell's
b1 integrin level. We used unseparated cells as the control. We further examined desmoplakin
expression between these two populations by Western blotting and immuno¯uorescence and
found that cells with a high b1 expression appeared to have a low desmoplakin expression, and vice
versa. Similar expression pro®les between the two cell populations were also observed for other
major desmosome proteins including desmoglein, desmocollin, plakoglobin and plakophilin1. In
conclusion, keratinocytes with a high b1 integrin expression, the putative stem cell enriched
population, express a low level of desmosomal proteins, and, by inference, are ``desmosome
sparse''. This ®nding may provide a novel marker for the puri®cation of putative epidermal stem
cells.
012
Dynamic Characterisation of the Molecular Events Controlling Dermal Fibroblasts
Proliferation During Wound Healing
A.-A. Chassot, L. Turchi, J.-P. Ortonne, V. Dulic,* and G. Ponzio
Inserm U385, Nice, France; *CRBM CNRS, Montpellier, France
Skin wound healing is a complex process allowing the reconstruction of epidermal and dermal
lesions caused by mechanical, chemical or thermal agents. Many genetic or acquired defects can
perturb the normal wound healing process, leading to skin pathologies like hypertrophic scars or
keloõÈds, in which ®broblasts are characterised by an important abnormal proliferation. However,
the molecular abnormalities at the origin of these pathologies are still unknown notably because the
experimental systems used to study wound healing do not allow a molecular approach of the
process. To circumvent this hurdle, we have developed an original device that performs calibrated
injuries of great length within con¯uent cell cultures or reconstructed dermis and skins and thus
enables the detection of a wide range of molecular events activated during In vitro wound healing.
Using this system we demonstrate that mechanical lesions performed within dermal ®broblast
cultures lead to the phosphorylation of pRb and p107, the stimulation of CDK4 and CDK2 kinase
activity and the cells commitment into S phase. Two major events play a key role in these different
processes: (1) the stimulation of cyclin D1 expression, and (2) the decrease in the expression of the
CDKs inhibitor p27KIP1. First, we propose that the stimulation of cyclin D1 expression could
trigger p27KIP1 relocalisation from cyclin E/CDK2 to cyclin D1/CDK4 complexes, leading to
cyclin E/CDK2 complexes activation and induction of genes necessary to the cell commitment in
S phase. On the other hand, we bring evidences indicating that p27KIP1 is phosphorylated by cyclin
A/CDK2 complexes and degraded via a proteasome-dependent pathway. In conclusion, we
propose here a coherent scheme describing, for the ®rst time, the cascade of events that initiate and
regulate the ®broblasts proliferation during the dermal repair In vitro.
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013
Induction of Cytochrome P450 Enzyme Activity by UVB and Xenobiotics in Normal
Human Keratinocytes and Melanocytes
L. Benassi, G. Bertazzoni, C. Magnoni, M. Caselli,* and S. Seidenari
Department of Dermatology, University of Modena and Reggio Emilia, Italy; *Department of Chemistry,
University of Modena and Reggio Emilia, Italy
Cytochrome P450 (CYP450) plays a major role in the bioactivation of procarcenogenesis in target
tissues and the expression of this enzyme is an important determinant of human susceptibility to
cancer. Relatively little is known about the overall role of CYP450 in the metabolism of
xenobiotics or endogenous cellular compounds in the skin. The aim of this study was to analyse the
expression of cytochrome enzymes in proliferating human keratinocytes and melanocytes after
exposure to UVB radiation and to three classical cytochrome inducers such as: b-naphtho¯avone
(BNF), 3-methylcholanthrene (MC), phenobarbital (PB). We investigated 7-ethoxyresoru®n O-
deethylase (EROD) (which is CYPP450 1A1 dependent) and 7-pentoxyresoru®n O-depenthylase
(PROD: CYP450 2B1 dependent) activities. Normal human keratinocytes were cultivated in
Dulbecco's modi®ed Eagle's medium/Ham's F12 or with KGM serum-free medium. Melanocytes
were grown in Medium 154. At con¯uency cells were incubated with inducers or irradiated with
different doses UVB. At different times after treatments, cells were harvested for In vitro
measurement of CYP450 induction. The microsomal fraction was studied by Western blot
analysis. Low, but measurable levels of CYP activity were detected in both basal and differentiating
keratinocytes. The MC- induced EROD activity was up to 4 fold higher when compared with
BNF induced activity. UVB exposure resulted in a dose-dependent (10±75 mJ) and time
dependent (4±24 h) induction of CYP450 1A1 for keratinocytes and CYP450 2B1 for
melanocytes. Immunoblotting assay showed expression for CYP450 1B1 for both keratinocytes
and melanocytes. Proadifen, an inhibitor of CYP450-monooxygenase, led to a signi®cant decrease
in EROD activity. The results of the present study clearly show that irradiation with UVB is
capable of modifying the activity of CYP450 isoenzymes not only in keratinocytes but also in
melanocytes. These experimental ®ndings stress the value of epidermal cell culture for
parmacotoxicological studies of topical agents used in dermatology.
014
Gap Junctions and Wound Healing
J. M. Brandner, C. Kaiser, P. Houdek, and I. Moll
Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, Germany
Gap-junctions (GJ) are cell-cell junctions allowing the communication and coordination of
adjacent cells by the exchange of small molecules, e.g. second messengers. They play important
roles in proliferation, migration and differentiation of many cells, processes which are all included
in wound healing. We have examined the fate of various gap junction-proteins, i.e. connexins 26,
30 and 43, during spontaneous wound healing and after the transplantation of keratinocytes by
using a wound healing model. Moreover we investigated the in¯uence of gap junction-inhibitors
on wound healing. We show the lack of all three GJ proteins at the wound edges at the beginning
of wound healing and an up-regulation of Cx 26 and 30 in the course of reepithelialisation.
Transplanted keratinocytes are positive for Cxs already at very early time points after
transplantation. The inhibition of GJ communication by inhibitors resulted in a delay in wound
healing. These results argue for an important role of the coordinated synthesis and function of GJ
proteins and channels during wound healing. The putative implication on nonhealing wounds is
discussed.
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Biological Effects of Hormonal Aging on Human Sebocytes In Vitro
E. Makrantonaki, H. Seltmann, S. Fimmel, and Ch. C. Zouboulis
Berlin, Germany
Hormones have been suggested to exhibit a profound in¯uence on sebaceous gland aging. In order
to elucidate this hypothesis, we investigated the biological activity of hormones at levels
representative for different age groups in females on SZ95 sebocytes In vitro. First, growth hormone
receptor (GHR), insulin receptor (IR), insulin-like growth factor I receptor (IGF-IR), androgen
receptor (AR), estrogen receptor±a and -b (ERa and ERb) were examined by highly sensitive
RT-PCR and Western blotting in SZ95 sebocytes and were found to be expressed. SZ95
sebocytes incubated with several hormones at levels similar to those found in postmenopausal
women showed signi®cantly lower content of neutral lipids (±10%), as detected with the nile red
¯uorescent lipid microassay, compared to the lipids detected in sebocytes incubated with hormones
at levels representing 20-year-old-women after a 2-d treatment. Polar lipids, cell proliferation
estimated with the MUH ¯uorescent assay, and toxicity measured by the lactate dehydrogenase
colorimetric assay remained unchanged. SZ95 sebocytes also responded to IGF-I, as a single agent,
at the lower concentrations of postmenopausal vs. young women with a marked reduction of
neutral (±20%) and polar (±8%) lipids. Cell proliferation rates were similar after 4 d of treatment.
Postmenopausal levels of testosterone also reduced neutral lipids compared to the levels of young
women (±12%). In contrast, GH, 17b-estradiol, progesterone and DHEA, as single agents, in
concentrations of postmenopausal women did not change lipid synthesis or proliferation of SZ95
sebocytes under hormone concentrations of young women. These results suggest that human
sebocytes express several hormone receptors, especially GHR, IR, IGF-IR, AR, ERa and ERb
and are therefore susceptible to multiple hormonal effects. Among these hormones, IGF-I, and at a
lower magnitude testosterone, maintained as single agents the effects of age-relevant hormone
mixtures on sebaceous lipids.
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The Role of Postmitotic Differentiated Fibroblasts in Retinoic Acid Induced Synthesis
of Procollagen I in Photodamaged Skin
M. Donovan, H. Muir-Howie, P. Kealaher, L. Watson, and M. R. Green
Unilever Research, Colworth Laboratory, Sharnbrook, Beds, UK
This study investigated the role of differentiated ®broblasts in the production of newly synthesised
collagen during the repair of photodamaged skin by retinoic acid. A clinical study showed that
daily application of 0.05% retinoic acid, for 14 or 28 weeks, to moderately photodamaged forearms
of healthy volunteers increased the dermal levels of procollagen I (PCI). A heterogeneous pattern
of expression for PCI was observed surrounding papillary dermal ®broblasts. It has also been
reported that a heterogeneous population of mitotic (de®ned as type 1) and postmitotic (de®ned as
types 2 & 3) differentiated cells exists in ®broblast cultures (Alaluf et al Differentiation 2000,
66:147) and in human dermal ®broblasts derived from photodamaged skin. Using a dot blot
protein assay to measure PCI secretion, we found that cultures with elevated proportions of type 3
®broblasts closely associated with increased levels of PCI production (r2 = 0.73, p < 0.002).
Immuno¯uorescence and Western blot analysis showed that type 3 ®broblasts express
approximately 3 fold higher levels of PCI and higher levels of the TGFb receptor type II
compared to type 1 ®broblasts. Treatment of cultured dermal ®broblasts with retinoic acid
increased the proportion of type 3 ®broblasts. Treatment of photodamaged skin with retinoic acid
also led to increased TGFb1 protein expression in the epidermis and dermis compared to placebo
as measured using immunohistochemistry. Taken together these results suggest that retinoic acid
may stimulate the repair of photodamaged skin by promoting ®broblast differentiation to post
mitotic collagen producing (type 3) cells and by stimulating PCI synthesis in these ®broblasts
through a TGFb1 pathway.
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Semiquantitative Detection of Lipids by a Quick Fluorescence Assay and Their
Regulation Through Androgens, the PPAR-Ligand Linoleic Acid and Hydrocortisone
in Human Sebocytes
H. Seltmann and Ch. C. Zouboulis
Berlin, Germany
A major characteristic of sebaceous gland cell (sebocyte) differentiation is the intracellular
accumulation of neutral lipids. To detect these lipids, several techniques are available which are
either time consuming or expensive. A second important matter is the distinction between neutral
and polar lipids. While the ¯uorescent dye nile red is capable to detect both lipid classes, detection
of lipids by ¯ow cytometry using nile red staining is limited by the fact that adherent growing
mature sebocytes are destroyed after cell dissociation and proliferating, undifferentiated and early
differentiated sebocytes can only be evaluated. Labelling the cells on chamber slides eliminates this
technical disadvantage but does not allow quanti®cation of lipids. To resolve this problem, SZ95
sebocytes were directly labelled with nile red (1 mg per ml) in 96-well plates after 24 and 48 h of
treatment and the resulting ¯uorescence was detected by a spectro¯uorometer at different
wavelengths for neutral (excitation 485 nm, emission 565 nm) and polar lipids (excitation 540 nm,
emission 620 nm). SZ95 sebocytes were treated 2 d after seeding with testosterone (10-5±10-4 M),
dihydrotestosterone (DHT, 10-6±10-4 M), the PPAR-ligand linoleic acid (LA, 5 3 10-5±10-4 M)
and hydrocortisone (HC, 10-9±10-6 M) under serum-containing conditions. Fluorescence values
were referred to cell numbers per well measured by the MUH-assay; cytotoxicity was evaluated by
the lactate dehydrogenase assay. Similar cell numbers and no signi®cant cytotoxicity were detected
after 24 and 48 h of treatment with all compounds. In contrast, a dose-dependent increase of
neutral lipids was found after cell incubation with testosterone and DHT (~ 10±50%) and a
dramatical increase with LA (~ 50±600%). A decrease of neutral lipids occurred after incubation
with HC (~ ±15% at 10-7 M) for 48 h. LA which was the strongest enhancer of neutral lipids, also
increased slightly the polar ones (~ 10±60%). In conclusion, we developed a simple and fast method
to screen different drugs for their capacity to regulate synthesis of total, neutral and polar lipids in
adherent cell cultures.
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Regulation of Apoptosis of Human Mast Cells by Anticancer Drugs
J. Funke, L. M. Preussner, and K. Hartmann
Cologne, Germany
Agressive mastocytosis and mast cell leukemia usually fail to respond to conventional anticancer
drugs and are therefore associated with a poor prognosis. To gain further insight into
chemoresistance of human mast cells, the effect of etoposide, hydroxyurea, methotrexate, and
cyclophosphamide on proliferation, viability, and apoptosis of the human leukemic mast cell line
HMC-1 and primary cord blood-derived mast cells (CBMC) was evaluated. Proliferation was
measured by microscopic counting of trypan blue-negative cells. To assess the number of viable
and apoptotic cells, the uptake of PI and binding of annexin-V was investigated by ¯ow cytometry.
Immunoblotting was additionally performed to investigate the expression of bcl-2, bax, and bcl-xL
after incubation with anticancer drugs. Whereas etoposide (0.01±1 mg per ml), hydroxyurea (1±
100 mg per ml), and methotrexate (1±100 mg per ml), but not cyclophosphamide (1±100 mg per ml),
were able to inhibit proliferation and viability and to induce apoptosis of HMC-1 cells in a dose-
and time-dependent manner (24±72 h), CBMC were at ®rst resistant to anticancer drug-induced
apoptosis. However, preliminary results showed that after the addition of dexamethasone (0.4 mg
per ml) or TRAIL (500 ng per ml), CBMC also exhibited apoptosis in response to anticancer drugs
after 48 h. In HMC-1 cells, apoptosis following treatment with etoposide and methotrexate was
associated with an increased expression of the pro-apoptotic protein bax and a decreased expression
of antiapoptotic bcl-2 and bcl-xL. Thus, etoposide, hydroxyurea, and methotrexate are able to
regulate proliferation and apoptosis of human mast cells In vitro and may therefore be further
explored for the treatment of aggressive forms of mastocytosis.
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The Stimulation of the Dermal and Epidermal Metabolisms: A New Antiaging
Approach
B. Closs, S. Bordes, P. AndreÂ,* J.-C. Archambault,* and J.-F. Franchi*
SILAB, Brive, France; *LVMH ± Fragrances and Cosmetics, Saint Jean de Braye, France
When the skin is young and sensitive to its environment, the epidermal cells are able to produce
the proteins which are in charge of the cutaneous structure and organisation, as well as small
peptides and growth factors which send out signals of synthesis or reparation to the surrrounding
cells. The regulation of this biosynthesis represents the speci®c molecular keys of a youthful skin
and ensures the ®rness, elasticity and protective role of this young skin. As the skin becomes older,
the cellular renewal slows down and there are more and more biosynthesis abnormalities which are
responsible for the decrease of the endogeneous production of proteins and growth factors. Our
reseach Laboratories have isolated and puri®ed an oligosaccharide fraction rich in galacturonic acids
from the ¯owery heads of Malva sylvestris. This extract is able to ®ght against the reduced
metabolism of senescent and de®cient epidermal and dermal cells and can biologically ``wake up''
certain metabolic activities. Therefore, via in vitro studies using monolayer cell cultures, our
oligosaccharide fraction in¯uences the epidermal cells' metabolism by on the one hand restoring
the proliferation capacities of senescent human keratinocytes and on the other hand favorising
keratinocyte synthesis such as the production of ®laggrine, a structural protein of the corneocyte
envelope or the synthesis of perlecan type proteoglycanes. In parallel, our molecular complex plays
an important role in the activity of dermal cells by stimulating the ®broblasts proliferation capacity
particularly in drastic culture conditions (culture medium de®cient in nutriments and growth
factors) and by increasing collagen synthesis. This effective cellular activity can be compared with a
typical Retinoic acid response pro®le, recognised as the cutaneous antiage molecule reference.
These results may prove to be an answer to the armful effects of aging on the skin and invite us to
consider our oligosaccharide fraction as a potentiel candidate for antiaging program.
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FXIII-Mediated Down-Regulation of the Urokinase-Type Plasminogen Activator (uPA)
and Its Receptor (CD87) in Venous Ulcers
M. O. Hellstern, J. Norgauer, E. SchoÈpf, and Y. Herouy
Department of Dermatology, University-Hospital, Freiburg
Pattern of expression and state of activity of ®brinolytic factors after treatment of venous ulcers
with the ®brin stabilizing factor XIII. The plasminogen activation system involving the urokinase-
type plasminogen activator (uPA) and the urokinase-type plasminogen activator receptor (CD87)
have been studied in tissue specimen on the mRNA- and protein expression by using reverse
transcription followed by polymerase chain reaction, Western blot, immunohistochemistry and
®brin zymography after topical application of ®brin stabilizing factor XIII on venous ulcers. The
®brin stabilizing factor XIII displays accelerated wound healing, when applied on venous ulcers.
Our results shows that local application of the ®brin stabilizing factor XIII reduces the mRNA- and
protein expression of uPA and its receptor (CD87) as well as the functional ®brinolytic activity.
These data strongly suggest, that wound healing in venous ulcers requires down-regulation of the
®brinolytic activity and characterizes the pharmacological effect of the ®brin stabilizing factor XIII
on molecular level.
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The In¯uence of Lysophosphatidic Acid on the Functions of Human Dendritic Cells
J. Norgauer, E. Panther, M. Idzko, S. Corinti,* Y. Herouy, and G. Girolomoni*
Department of Experimental Dermatology, University of Freiburg, Freiburg, Germany; *Laboratory of
Immunology, Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy
Lysophosphatidic acid (LPA) is a bioactive lipid mediator generated by secretory phospholipase A2,
which accumulates in extracellular ¯uids of in¯ammatory sites. Here we studied the biological
activity of LPA on human dendritic cells (DC), which are specialized antigen presenting cells
characterized by their ability to migrate into target sites and secondary lymphoid organs in order to
process antigens and activate naive T cells. We show that immature and mature DC express the
mRNA for different LPA receptors such as EDG-2, EDG-4 and EDG-7. In immature DC, LPA
stimulated pertussis toxin-sensitive Ca2+ increase, actin-polymerization and chemotaxis. During
the maturation process, DC lost their ability to respond towards LPA with Ca2+ transients, actin
polymerization and chemotaxis. However, LPA inhibited in a pertussis toxin-insensitive manner
the secretion of interleukin 12 and tumor necrosis factor a as well as enhanced secretion of IL-10
from mature DC. Moreover, it increased the allostimulatory function of mature DC and favored
the emergence of a Th2 immune response. In summary, our study implicates that LPA might
regulate the traf®cking, cytokine production, T cell activating functions of DC and ulimately favor.
Th2 lymphocyte-dominated immunity.
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HETE and F2-Isoprostanes in UV-Irradiated Human Skin and HaCaT-Cultures After
Administration of Diclofenac and Acetylsalicylicacid Using Microdialysis Technique
J.-U. Grundmann, I. Wiswedel, D. Hirsch, R. BoÈckelmann, C. C. MuÈller-Goymann, B.
Bonnekoh, and H. P. Gollnick
Department of Dermatology and Venereology and Department of Pathobiochemistry, Otto-von-Guericke-
University, Magdeburg, TU Braunschweig, Pharma. Technology, Germany
UV-irradiation of the human skin leads to induction of oxidative stress and in¯ammation mediated
by reactive oxygen radicals, lipid peroxidation, liberation of arachidonic acid from membrane
phospholipids and formation of prostaglandins and leucotrienes. Therefore, we investigated ``lipid
mediators'', such as 8-epi-PGF2a, 9a11a-PGF2a, HETEs and LTB4 in the dermal interstitial ¯uid
obtained In vivo by cutaneous microdialysis technique and In vitro from keratinocyte (HaCaT)
cultures after UV-irradiation and application of diclofenac, a nonsteroidal anti-in¯ammatory drug.
De®ned areas on the volar forearm of 10 healthy volunteers were exposed to UVB irradiation (20±
60 mJ per cm2). After 24 h, microdialysis membranes were cutaneously inserted beneath the
irriadiated area and diclofenac was administered topically. The probes were perfused with isotonic
saline solution and microdialysate samples were collected at 20 min intervals over up to 6 h.
Analysis of oxidized arachidonic acid derivatives using sensitive NICI-GC-MS showed enhanced
amounts of 2-, 3-, 5-,12- and 15-HETE, LTB4, 8-epi-PGF2a and 9a11a-PGF2a in the picomol
range after UV irradiation, which were suppressed by topical diclofenac and acetylsalicylacid.
Further investigations may show whether these new ®ndings may also be relevant to validate
therapeutical strategies for other in¯ammatory skin conditions.
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Adaptation Response in Human Skin Barrier to a Hot and Dry Environment
L. Declercq, N. Muizzuddin,* L. Hellemans, L. Van Overloop, R. Sparacio,* K. Marenus,* and
D. Maes*
Estee Lauder Coordination Center, Oevel, Belgium; *Estee Lauder Companies, Melville, USA
The epidermal permeability barrier, which resides in the stratum corneum (SC), is considered to be a
biosensor that regulates epidermal responses to various exogenous insults. In order to investigate
the effect of prolonged exposure to an environment with low relative humidity (RH) we
compared the barrier strength and SC structure of panelists living in Arizona (USA, 27% RH in
June) to panelists living in New York (USA) and Oevel (Belgium) (both 80% RH in July). We
have previously reported that the SC of dry, xerotic skin showed lower levels of active proteases,
e.g. the stratum corneum chymotryptic enzyme (SCCE), and a decrease in ratio of ceramides to
proteins. Tape strippings from xerotic skin contained more protein, which has been correlated to
increasing corneocyte density by image analysis. Skin chronically exposed to a hot, dry
environment exhibited stronger skin barrier functions and lower basal transepidermal water loss.
Fewer proteins were removed by tape stripping, suggesting less xerosis. RH may affect the rate of
desquamation by modulating the in situ activity of desquamatory enzymes. The amount of active
SCCE was higher in the skin of panelists exposed to low RH, suggesting that up-regulation of the
amount of active proteases may be part of an adaptation response to ensure proper desquamation at
low humidity. Calcium ions modulate barrier formation by inducing terminal differentiation,
formation of the corni®ed envelope and regulating lipid secretion. Higher calcium levels were
found in the upper SC of the Arizona panel, which might induce sustained lamellar body secretion.
Taken together these data suggest that human skin can adapt to a low humidity environment by
increasing epidermal barrier function and modulating desquamation. The distribution of calcium
ions may constitute an internal signal for this adaptation response.
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Bioconversion of Topical b-Carotene to Retinyl Esters in Ex Vivo Human Skin
C. Antille, O. Sorg, C. Tran, and J-H. Saurat
Department of Dermatology, University Hospital, Geneva, Switzerland
Background: The human epidermis contains endogenous retinoids (retinol, retinyl esters) and
carotenoids (b-carotene). Several studies have shown that the enzymes involved in retinoid
metabolism are present in human epidermis. There is still a controversy about the presence in the
skin of the enzymes able to convert b-carotene into vitamin A (retinol). Andersson and coll.
demonstrated recently that b-carotene can be converted into vitamin A in human cultured
keratinocytes and melanocytes. Objective: We applied b-carotene and natural retinoids on the
surface of ex vivo human skin to study their penetration into the epidermis and their bioconversion
into vitamin A. Methods: Fresh surgically excised human abdominal skin was mounted in modi®ed
Franz perfusion chambers. Retinal, retinol, retinoic acid (0.05%, 2.5 mg per cm2) or b-carotene
(228 nmol per cm2) were applied in the donor chamber; the receptor chamber was ®lled with a
culture medium. The skin was incubated for 24 hours at 37°C, then epidermis was separated from
dermis by heat (30 seconds at 56°C). High pressure liquid chromatography was used for the
quantitative determinations of retinoids and carotenoids. Results: 24 hours following topical
application with b-carotene, human skin was highly loaded with b-carotene (57 nmol per g), and
epidermal retinyl ester concentration was increased to 2240 pmol per g, as compared to 124 pmol
per g in untreated skin, whereas epidermal retinol was under the limit of detection of 10 pmol per
g (untreated skin: 117 pmol per g). Topical retinal increased epidermal retinol and retinyl esters to
1635 and 353 pmol per g, respectively; after topical retinol, these values were 8311 and 697 pmol
per g, respectively. Topical retinoic acid penetrated the epidermis (8124 pmol per g), and showed
no metabolism. No retinoic acid was shown after topical retinal, retinol or b-carotene. Conclusion:
Our results demonstraed that topical b-carotene is converted into retinol by human epidermis in an
ex vivo model, and that retinol is then esteri®ed with fatty acids. Since retinyl esters can be
converted by the epidermis into the biologically active retinoic acids, topical b-carotene appears as
a precursor of epidermal vitamin A.
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Acute UVB Irradiation Does Not Modify the Penetration of Topical Retinoids in Ex Vivo
Mouse Skin, But Alters their Metabolism
C. Tran,*² F. Pirot,² O. Sorg,* L. Didierjean,* F. Falson,² and J-H. Saurat*
*Department of Dermatology, University Hospital, Geneva, Switzerland; ²Department of Pharmacology,
University of Lyon, France
In the present study, we assessed the effects of a single UVB exposure on the percutaneous
absorption of retinal (RAL) and retinol (ROL), as well as their metabolism by the skin, in ex vivo
mouse skin, using a tape-stripping method (Pirot et al PNAS 94:1562±1567 (1997)). Hairless mice
were exposed to single UVB dose of 1 J per cm2 under a ¯ux of 0.28 mW per cm2. One hour
following UVB irradiation, the mice were sacri®ced, and the skin was taken off and mounted onto
Franz diffusion cells in which receptor compartment was ®lled with saline solution supplemented
with PEG 400. Ex vivo retinoid metabolism and skin absorption. Donor compartment of Franz
diffusion cell was ®lled with either 0.05% RAL or 0.05% ROL preparation (2 mg per cm2).
Receptor ¯uid was withdrawn at regular intervals on a period of time of 6 h. The epidermis was
then removed by successive tape-stripping. After chemical extraction, RAL, ROL, retinoic acid
(RA) and 13-cis RA (13cRA) content into tape strips, dermis and receptor ¯uid solutions were
assayed by HPLC. No retinoid was detected in the receptor ¯uid solutions. The epidermal
concentration pro®les of ROL and RAL, following topical ROL and RAL, respectively, were not
altered by a pre-exposure to UVB. In nonirradiated skin, epidermal ROL was the only retinoid
found after topical ROL, whereas topical RAL produced sizeable amount of RA, 13cRA and
ROL in the upper layers, respectively, 200.8, 172.8 and 33.4 nmol per g of epidermis. RAL
applied to synthetic membranes showed no formation of RA or ROL. RAL applied on ex vivo skin
one hour after UVB exposure produced less RA (58.5 nmol per g) and 13cRA (53.4 nmol per g),
and no ROL. This indicates that a single UVB irradiation do not modify the penetration of topical
retinoids in ex vivo mouse epidermis. However the capacity of the upper layers to metabolise
retinoids has been signi®cantly altered.
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Involvement of Prostaglandins in Sebocytic Lipogenesis In Vivo and In Vitro:
Indomethacin Augments the Production of Prostaglandin J2 by Cyclooxygenase-
Independent Pathways
N. Akimoto, C. Iwata, T. Sato, and A. Ito
Department of Biochemistry, Tokyo University of Pharmacy and Life Science, Hachioji, Tokyo, Japan
Sebaceous glands are important skin appendages and sebum excretion is considered to be associated
with the functional maintenance of the surface of skin as a biological barrier. Sebaceous gland cells
(sebocytes) differentiate and sequentially form intracellular lipid droplets. Recently, it has been
reported that overexpression of cyclooxygenase-2 (COX-2) in epidermis of transgenic mouse skin
has caused hyperplasia of sebaceous glands and augmented the accumulation of lipid droplets. In
the present study, to clarify the involvement of prostaglandins (PGs) in sebocytic lipogenesis, we
examined the effect of PGs and a COX inhibitor, indomethacin on the formation of lipid droplets
and the function of sebaceous glands of hamster in vitro and in vivo. Various PGs such as PGE2,
PGF2a and PGJ2 were detected in the culture medium of hamster sebocytes and the levels of PGF2a
and PGJ2 were increased along with the insulin-induced augmentation of lipogenesis. In addition,
exogenous PGF2a and PGJ2 augmented the accumulation of lipid droplets, which mainly consisted
of triglycerides. When the sebocytes were treated with indomethacin, the production of PGF2a
and PGE2 decreased, but the level of PGJ2 in the medium increased. Furthermore, the augmented
formation of intracellular lipid droplets was observed in the indomethacin-treated sebocytes. When
indomethacin was applied to auricles of 5-week-old male golden hamsters, the development of
sebaceous glands was also observed. Therefore, these results suggest that PGs such as PGJ2 and
PGF2a may play roles as endogenous regulators for stimulating lipogenesis in hamster sebaceous
glands. Moreover, we suggest novel evidence that a by-pass to synthesize PGJ2 from arachidonic
acid may be evoked by intercepting the COX pathways in hamster sebocytes.
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Intercellular Lipid Lamellar Structure in Hairless Mouse Stratum Corneum at Various
Water Contents
N. Ohta, S. Ban, H. Tanaka, S. Nakata, and I. Hatta
Department of Applied Physics, Nagoya University, Nagoya; Nippon Menard Cosmetic Co., Ltd, Nagoya;
Fukui University of Technology, Fukui, Japan
Lamellar structures of intercellular lipids in stratum corneum of hairless mouse were investigated at
various water contents by small-angle X-ray diffraction. At water content 21 wt%, we observed
long and short lamellar structures with repeat distances of 13.6 nm and 6.0 nm at room
temperature, respectively. The spacing of the long lamellar structure is almost constant over the
water content from 0 wt% to 80 wt%. This result is consistent with the previously reported one.
For the short lamellar structure, we found that with increasing the water content the lamellar
spacing becomes large, that is, from 12 wt% to 50 wt% the short lamellar spacing increases from
5.8 nm to 6.6 nm. In addition to the previously reported result that at the water content of about 20
wt% the X-ray diffraction peak for the long lamellar structure becomes sharp, we found that this is
also the case for the short lamellar structure. Below the water content of about 12 wt% the X-ray
diffraction peak for the short lamellar structure disappers. On the other hand, above the water
content of about 50 wt%, it becomes weak and ®nally merges into the second-order diffraction
peak for the long lamellar structure. From the behavior of the lamellar spacings and sharpness of
diffraction peak as a function of the water content, it is speculated that an anhydrous long lamellar
structure correlates with double short lamellar spacing with water layer. It is likely that the long and
short lamellar structures of the intercellular lipid play an important role in the regulation of water
stored in stratum corneum.
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Reduced Activity of Ceramide Generating Acid Sphingomyelinase in Atopic Dermatitis
J.-M. Jensen, I. Kreiselmaier, P. Grosse HuÈttmann, C. Neumann, S. SchuÈtze, R. FoÈlster-Holst,
and E. Proksch
University of Kiel, Kiel, Germany
A defect in permeability barrier function, leading to the penetration of environmental allergens
into the skin is crucially involved in the pathogenesis of atopic dermatitis. Allergens induce
immunological reactions leading to in¯ammation. Previous studies showed that the decreased level
of stratum corneum ceramides may be the cause for the defect in permeability barrier function in
atopic dermatitis. We recently described that acid sphingomyelinase (A-SMase) generates speci®c
ceramides for permeability barrier function. A-SMase is localized predominantly in the endosomal
epidermal lamellar bodies of the upper stratum spinosum/stratum granulosum, from which the
lipids are delivered to the intercellular lipid bilayers of the stratum corneum. The aim of the present
study was to determine whether A-SMase activity is impaired in atopic dermatitis. We performed
5 mm punch biopsies from lesional and nonlesional skin in patients with atopic dermatitis and got
skin samples from healthy controls. The epidermis was separated from the dermis and speci®c
enzyme assay was performed. We found a signi®cant decrease in epidermal A-SMase activity in
lesional (±48%) and nonlesional skin (±73%) of patients with atopic dermatitis compared to healthy
controls. In contrast, preliminary studies in allergic patch test reactions revealed an increase in
SMase activity. Recently, it was shown that epidermal A-SMase speci®cally generates stratum
corneum ceramides 2 and 5 subtypes. Ceramide 2 is quantitatively the most important ceramide in
the epidermis. Therefore, it is most likely that the speci®cally reduced A-SMase activity in atopic
dermatitis, as we found here, is responsible for the decrease in stratum corneum ceramide and the
reduced barrier function. In summary, we found a reduced epidermal A-SMase activity correlating
with the reduced ceramide content known in atopic dermatitis.
029 [Oral 004]
Injection of a Soluble Form of Ectodysplasin A (EDA) Stably Reverts the Murine
Equivalent of X-Linked Hypohydrotic Ectodermal Dyslasia (XL-HED)
O. Gaide, J. Tschopp, and P. Schneider
Institute of Biochemistry, University of Lausanne, Switzerland
Hypohidrotic Ectodermal Dysplasias are characterized by defects in the development of structure
of ectodermal origin such as hair, teeth and sweat glands. Most forms of the disease have been
shown to implicate defects of the signaling pathway of the TNF family ligand Ectodysplasin A
(EDA). Absence or de®cient expression of EDA itself give rise to X-Linked HED type I, the most
common form of the disease. In mice, absence of EDA results in the Tabby phenotype, which
resembles human HED in many aspects, thus providing an excellent animal model for this
condition. Based on functional analysis of point mutations found in patients, we could show that
EDA activity depends on ligand shedding from the membrane as well as ligand aggregation by its
collagen domain. This prompted us to engineer a soluble and aggregated form of EDA that can
cross the placental barrier and reach the developing embryo. This treatment stably reverts most of
the Tabby defects and represents one of the rare examples where a genetic disorder can be treated
by administration of a recombinant protein. Our results indicate that this recombinant EDA holds
interesting promises for both therapy and fundamental research.
030 [Oral 054]
Interactions Between HIV and Dendritic Cells: Turning the Pathogen Into a DC-
Speci®c Vector
V. Piguet, J. F. Arrighi, S. Abraham, F. Leuba, S. Zarei, A. Engering, C. Hauser, and Y. Van
Kooyk
Geneva, Switzerland and Amsterdam, the Netherlands
Since new HIV infections occur primarily through sexual transmission, small amounts of virus have
to cross the mucosal barrier and reach replication-competent sites. Evidence has accumulated that a
speci®c subtype of cells, called Langerhans/dendritic (DC) cells, plays a crucial role in the early
events of entry of the virus in the host. HIV can avoid digestion by the DC and uses their
migratory properties in order to gain access to the lymph nodes, where maximal viral replication
occurs. We provide evidence of how HIV escapes degradation and processing in DC and replicates
actively in DC-T cell clusters, which contributes to HIV pathogenesis. However, HIV not only
prevails as a dangerous parasite, but can be modi®ed into a useful vector for DC-based therapies.
Attenuated variants of HIV/SIV are promising tools to genetically modify DC, usually resistant to
physical transfection methods. Lentiviral vectors ef®ciently transduce human CD34+ stem cell
derived DC, monocyte derived DC, as well as murine bone marrow derived DC, with
transduction rates up to 90%. Furthermore, we will demonstrate that targeting of dendritic cells by
LCMV antigen-encoding lentiviral vectors permits antigen processing and MHC class I dependant
presentation. Our results point to lentivectors as promising candidates for DC-based
immunotherapy purposes due to high transduction ability, targeting properties via DC-speci®c
promoters and capacity of inducing Ag-speci®c immune responses. Together, these studies
illustrate the complex interactions between dendritic cells and HIV and their potential implications
for immunotherapy strategies.
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A Functional Knockout of Human Keratin 10: A New Clinical Entity of Bullous
Congenital Ichthyosis
F. B. MuÈller, M. Huber,* T. Kinaciyan,² D. Hohl,* I. Hauber,³ and B. P. Korge
University of Cologne, Cologne, Germany; *CHUV, Lausanne, Switzerland; ²AKH, Vienna, Austria;
³University of Heidelberg, Heidelberg, Germany
Epidermolytic hyperkeratosis (EHK) is generally inherited as an autosomal dominant trait and
caused by mutations in keratin 1 and 10 (K1 AND K10). In the here described family two children
from consanguineous clinically unaffected parents exhibited typical clinical features of severe EHK
such as generalized exfoliative scaling erythroderma. Palms and soles were not affected. The
diagnosis was con®rmed by electron microscopy demonstrating abundant keratin tono®lament
aggregates in the suprabasal epidermal layers in both affected children. Surprisingly these keratin
clumps did not show ®lamentous, striped aspects as in autosomal dominant EHK but were
completely amorphous. Perinuclear shells of keratin clumps were absent. Sequence analysis of PCR
ampli®ed DNA fragments from both affected children using speci®c primers for keratin genes 1
and 10 (KRT1 AND KRT10) revealed a homozygous CAA to TAA base pair exchange at
position 1276 in exon 6 of the KRT10. Both parents were heterozygous carriers of this mutation.
The mutation results in a premature stop codon (Q426X) 25 amino acid residues before the end of
the 2B rod domain of K10. Immunohistochemistry applying a speci®c polyclonal antibody against
the C-terminus of K10 failed to detect K10 in keratin extracts of cultured keratinocytes of the
affected children. Semiquantitative rT-PCR showed almost complete reduction of speci®c
KRT10 mRNA levels in cultured keratinocytes. These results suggest that the mutant KRT10
mRNA is mostly degraded due to nonsense mediated RNA decay and is not translated in a stable
truncated K10. In the heterozygous parents this defect is obviously compensated by the remaining
unaffected KRT10 allele. The absence of K10 in the epidermis of our patients resulted in a disease
phenotype resembling autosomal dominant EHK where the expression of a mutated K10 exerts a
dominant negative effect on keratin intermediate ®lament formation. This observation is in
contrast to a recently established KRT10 knockout mouse model that developed an intact
epidermis without signs of increased skin fragility. In these mice the lack of K10 seems to be
compensated by decreased proteolysis of the basal keratins K5 and K14 and there persistence into
suprabasal epidermal layers. Current investigations aim to establish the molecular correlate for this
pronounced differences between the mouse model and the human KRT10 knockout.
032 [Oral 056]
Tissue and Cell Characterization of Lympho-Epithelial Kazal-Type Related Inhibitor
(LEKTI) Provides Evidence for Defective Expression in Netherton Syndrome
E. Bitoun,* A. Micheloni,² L. Lamant,³ A. Tartaglia-Polcini,² C. Bodemer,§ J. Mazereeuw-
Hautier,³ J. Harper,¶ G. Delsol,³ M. D'Alessio,² and A. Hovnanian*³
*Oxford and ¶London, UK; ²Rome, Italy; ³Toulouse and §Paris, France
LEKTI is a predicted 120 kDa serine protease inhibitor organised in 15 potential inhibitory Kazal-
type domains (D1-D15). It is produced as the precursor of at least 3 proteolytic fragments: D1
(6.5 kDa), D6 (7.5 kDa) and D8-D11 (30 kDa) among which D6 was demonstrated to inhibit
trypsin activity In vitro. LEKTI is encoded by SPINK5 which we recently identi®ed as the
defective gene in Netherton Syndrome (NS), a severe autosomal recessive ichthyosis characterised
by congenital erythroderma, a speci®c hair-shaft abnormality and atopic manifestations. In order to
study LEKTI tissue and cell expression, we developed rabbit polyclonal antibodies raised against
recombinant N-terminal (D1-D6) and C-terminal (D13-D15) parts of the molecule produced as
GST-fusion proteins in E. coli. Immunohistochemical analysis showed strong and speci®c labelling
in the granular layer of the epidermis, in the hair follicle and sebaceous gland epithelium. Localised
expression of LEKTI was found in epithelial cells of the thymus, suggestive of Hassal bodies. Oral
mucosa, tonsil and genital epithelia also showed strong expression of the protein. In contrast,
LEKTI expression was not detectable in skin sections of NS patients. Lysates from sub- and
postcon¯uent normal vs. NS human primary keratinocyte (HPK) cultures were analysed by
Western blotting. The presence of a 120-kDa protein, consistent with the expected relative
molecular weight of LEKTI, was detected in normal postcon¯uent HPK and not in NS HPK.
Western blot analysis of conditioned media from transfected COS cells over-expressing the C-
terminal myc-tagged protein con®rmed the expression of the 120 kDa LEKTI precursor and
allowed the identi®cation of a 75-kDa C-terminal proteolytic fragment predicted to correspond to
polypeptide D7-D15. Additional fragments of smaller size were also detected with antibodies to
D1-D6 and may correspond to N-terminal proteolytic products. The antisera against LEKTI
which we have developed represent powerful tools for rapid diagnosis of NS. They will also prove
useful for further analysis of LEKTI expression and identi®cation of its interacting molecules.
033 [Oral 059]
Spectrum of Mutations in the ECM1 Gene in Lipoid Proteinosis
T. Hamada, V. Wessagowit, A. P. South, I. Chan, A. Siriwattana,* P. Jewhasuchin,* S.
Charuwichitratana,* D. M. Thappa,² B. Jeevankumar,² and J. McGrath
St John's Institute of Dermatology, London, UK; *Ramathibodi Hospital, Mahidol University, Bangkok,
Thailand; ²JIPMER, Pondicherry, India
We recently identi®ed homozygous nonsense mutations in the extracellular matrix protein 1 gene,
ECM1, in the autosomal recessive disorder lipoid proteinosis (Hamada T et al Hum Mol Genet
2002; 11: 833±40). In the present study, we sequenced ECM1 in 4 further patients to extend
genotype-phenotype correlation and to add to the mutation database. The patients comprised two
Thai brothers (aged 38 and 19 years) with severe laryngeal hoarseness and scarring; the third patient
was an unrelated 30-year-old Thai woman with very mild hoarseness and a few eyelid papules; the
fourth patient was a 23-year-old Indian man with moderately severe skin changes, hoarseness and
temporal lobe calci®cation. Sequencing of genomic DNA disclosed novel homozygous single base-
pair deletions: 507delT in the Thai brothers, 243delG in the other Thai patient and 785delA in the
Indian patient. The latter mutation occurs in the normally differentially spliced exon 7 and is
predicted to ablate the ECM1a isoform but not the shorter ECM1b transcript. Conversely, the
mutations in the Thai patients (exons 4 and 6) are expected to completely ablate both ECM1a and
ECM1b. To explain phenotypic diversity in the Thai patients, RT-PCR using cDNA from
cultured keratinocytes provided evidence for partial rescue of the mutant transcripts with
restoration of the open reading frame through in-frame skipping of exons 3 and 4 in the patient
with mild disease, but no such changes in the more severely affected brothers. In summary, 9
different homozygous ECM1 mutations in lipoid proteinosis have now been reported, most of
which occur in exon 7. However, lipoid proteinosis is clinically heterogeneous and accurate
clinicopathological correlation also requires RNA and protein analysis.
034 [Oral 060]
A Canine Model for Somatic Gene Therapy of Junctional Epidermolysis Bullosa
F. Spirito, A. Capt, E. Guaguere,* J.-P. Ortonne, and G. Meneguzzi
INSERM U385, Faculty of Medicine, Nice, France; *Clinique St Bernard, Lomme, France
Our study is aimed at the perfection of somatic gene therapy of junctional epidermolysis bullosa
(JEB), a heterogeneous group of skin blistering diseases associated with genetic mutations in the
genes for the adhesion ligand laminin 5. Since the full phenotypic reversion of human JEB
keratinocytes has been achieved ex vivo, we have established a spontaneous animal model of JEB
suitable for the preclinical validation of the gene therapy approach. Genetic analysis of German
Shorthaired Pointers with mild JEB demonstrated that the affected animals carry the homozygous
missense mutation 1514C-to-T in the laminin-5 a3 chain. Transfer of the wild-type canine a3
cDNA (5,1 kb) into the dog JEB keratinocytes using a retroviral MMLV-based vector enhanced
the secretion of laminin 5 in the extracellular matrix and restored the adhesion and proliferation
capacity of the transduced cells. The clonogenic potential of the reverted keratinocytes was also
fully recovered, which demonstrates that the dominant positive effect of the wild-type laminin a3
chain results in the assembly of functional laminin-5 molecules. The reverted dog keratinocytes
have been used to reconstruct autologous transplantable epithelia that have been grafted onto three
JEB dogs. This approach will provide information on the tolerance that immune competent hosts
have for genetically engineered JEB epithelia expressing recombinant laminin 5 molecules and will
provide the proof of ef®cacy for the genetic therapy of inherited skin blistering diseases.
035
Uptake, Traf®cking and Expression of Naked Plasmid DNA in Human Keratinocytes
E. Basner-Tschakarjan, A. Mirmohammadsadegh, J. Maschke, and U. R. Hengge
Deptartment of Dermatology, University of Essen, Germany
The skin is an interesting organ for human gene therapy due to its easy accessibility, immunologic
potential and synthesis capabilities. Therefore, it is important to understand the uptake and
transport mechanisms of DNA in keratinocytes with the goal to optimize therapeutic approaches in
skin gene therapy. In previous work we have shown that naked plasmid DNA is taken up and
expressed by human keratinocytes upon in vivo intradermal injection. Yet, the mechanism by
which plasmids surmount the cell membrane and enter keratinocytes as well as their intracellular
traf®cking still remain unknown. We measured uptake of FITC-labeled plasmid by FACS analysis
after 24 h incubation detecting 5±10% internalization in a dose- and time-dependent manner.
Furthermore, we demonstrate that cycloheximide treatment inhibited uptake by > 90%, suggesting
a protein-mediated uptake. Next, we attempted to inhibit selected alternative internalization
pathways such as macropinocytosis (by dimethylamylorid), clathrin-coated pits (by chlorproma-
zine) and caveolae (by nystatin/®lipin). Most prominently, blocking macropinocytosis reduced the
uptake by > 85%, while chlorpromazine and nystatin had no inhibitory effect. Finally,
colocalization studies by confocal laser microscopy revealed a time-dependent accumulation of
plasmid DNA in endosomes (FITC-dextran) and lysosomes (LysoTracker Greenq). To detect
potential DNA receptors on the keratinocyte surface, two DNA-binding proteins, ezrin and
moesin, were identi®ed in 2-D South-Western blots and MALDI-mass spectrometry using
linearized calf thymus and l phage DNA. Although these actin-membrane linker proteins are
localized intracellularly, they are functionally associated with a number of transmembrane receptors
such as the EGF- or ICAM-1-receptor. Taken together naked plasmid DNA seems to enter
human keratinocytes through different pathways. Compared with linear calf thymus DNA, plasmid
DNA seems to be less abundant in endosomes and lysosomes, making it particularly suitable for
skin gene therapy.
036
Dyschromatosis Symmetric Hereditaria: Analyses of Clinical and Genetic Features
P. He, X. Zhang, G. Lin, M. Gao, Y. Song, and S. Yang
Institute of Dermatology, Hefei, China
Objective: To study clinical and genetic features of Dyschromatosis Symmetric Hereditaria (DSH)
in Chinese. Methods we studied the clinical and genetic features of DSH by reviewing 8 families
reported in China since 1980. Results: The pattern of inheritance was autosomal dominant. The
patients showed a mixed of hyperpigmented and hypopigmented macules symmetrically
distributed on the extremities ,which are typical DSH. A few of DSH patients showed freckle-
like pigmented macules on the face or spreaded on the trunk. DSH occured in infancy or
childhood. There was different expressity in different patients of the same family. The patients with
DSH in Family IV were also affected by Ichthyosis Vulgaris. Patients with DSH in other families
were not affected by other diseases. Family V showed a irregular dominance. Conclusions: DSH
generally shows an autosomal dominant pattern of inheritance with high penetrance and it is not a
rare disease in Chinese. The typical DSH is characterized by a mixed of hyperpigmented and
hypopigmented macules on the extremities. There are differences in the expressity of patients.
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Collagen Type VII (COL7A1) Mutation Survey and Genotype-Phenotype Correlation in
Italian Patients Affected by Dystrophic Epidermolysis Bullosa
C. Castiglia, R. Gardella,* P. Posteraro, G. Tadini,² S. Barlati,* J. McGrath,² M. Colombi,* and
G. Zambruno
IDI-IRCCS, Rome, Italy; *University of Brescia, Brescia, Italy; ²IRCCS Policlinico of Milano, Milan,
Italy; Guy's King's College and St Thomas' Hospital, London, UK
Dystrophic epidermolysis bullosa (DEB) is a rare skin disorder showing clinical heterogeneity and
transmitted either in dominant (DDEB) or recessive (RDEB) mode. All variants of DEB have been
associated to mutations in type VII collagen gene (COL7A1). We report the survey of COL7A1
mutations in 51 Italian DEB patients, 27 affected by Hallopeau-Siemens RDEB (HS-RDEB), 19
by non HS-RDEB, 2 by DDEB, 2 by pretibial DEB (Pt-DEB) and 1 by inversa RDEB (I-RDEB).
42 mutations were identi®ed, 18 of which are novel. Mutation consequences were analyzed at the
mRNA and protein level and genotype-phenotype correlation drawn. The recessive inheritance of
2 cases of Pt-DEB was also established. In RDEB patients, 6 recurrent mutations were identi®ed:
7344G®A, 425 A®G, 8441±14del21, 4783±1G®A, 497insA and G1664A, the last three being
found only in Italian patients. Haplotype analysis and patient geographic origin attested the
propagation of ancestral mutated alleles within the Italian population. Altogether recurrent
mutations cover about 43% of RDEB alleles in Italian patients and therefore new DEB patients
should ®rst be screened for the presence of these mutations.
038
Expression of the Psoriasis Candidate Gene, HCR, Located in the PSORS1, is
In¯uenced by Proliferation and Cytokines
S. Suomela, K. Asumalahti, O. Elomaa, S.-L. Karvonen, J. Peltonen, J. Kere, and U. Saarialho-
Kere
Helsinki and Oulu, Finland; Huddinge, Sweden
The genetic susceptibility to psoriasis is most clearly linked and associated to the PSORS1 region
near HLA-C in chromosome 6p. We are studying the genes located in this region as candidates for
the biological effect with a role in the pathogenesis of psoriasis. A strong candidate gene, HCR (for
a-helical coiled-coil rod protein), is located 115 kb away from HLA-C. Our initial analyses
showed that the HCR gene is highly polymorphic and that it has speci®c coding SNPs that
associate strongly with psoriasis. In order to re®ne the possible role of HCR in psoriasis, we
undertook to study (1) whether the same alleles associate with psoriasis in different populations; (2)
how strong the associations are in comparison with other genes in the PSORS1 region; (3)
whether HCR expression changes in psoriasis and other differential diagnostic skin disorders; and
(4) whether cytokines and regulators of keratinocyte function affect HCR expression. In addition,
we are in the process of developing cell culture models to study HCR function. Our results have
shown that the same set of coding SNPs form a speci®c susceptibility allele that is a genetic risk
factor for psoriasis in at least 7 distinct populations from Europe and Asia. The genetic association
parallels that observed for HLA-Cw6 and surpasses CDSN (corneodesmosin) associations. No
other known genes in the region have allele frequencies that would offer stronger associations.
HCR expression is qualitatively changed in psoriatic lesions as compared to normal skin with an
altered pro®le in rete ridges. HCR is also expressed in certain epithelial cancers suggesting that
proliferation or cell cycle can in¯uence its expression. Finally, biologically active cytokines regulate
HCR expression levels. We conclude that HCR is a good candidate for an effector gene in the
PSORS1 region.
039
Identi®cation and Characterization of an RNA Gene Related to Psoriasis Susceptibility
M. SzeÂll, Zs Bata-CsoÈrgoÄ, A. Pivarcsi, L. KemeÂny, and A. Dobozy
Szeged, Hungary
In order to identify transcriptional level differences between psoriatic noninvolved and healthy
epidermis contributing to psoriasis susceptibility, differential display (DD) experiments were carried
out. Beside several genes with already well characterized functions (®bronectin, RAB10),
differentially regulated cDNAs with yet unknown functions were identi®ed. One of these cDNAs
showed 100% homology to a transcribed gene sequenced from a human 10-week-old foetal cDNA
library, with GeneBank accession number AK022045. The gene is localized on chromosome 10
and in silico translation resulted in no translatable protein product on its nucleotide sequence. The 5¢
end of the gene harbours an Sq subtype Alu element and two conserved RNA polymerase III
promoter elements but no small nuclear RNA conservative elements. These characteristics reveal a
high level simirality to the BC200 RNA gene that encodes a neural small cytoplasmic RNA and
shows abnormal expression in non-neuronal tumors. Reverse-Southern and RT-PCR experi-
ments on numerous independent samples proved that AK022045 is up-regulated in the
noninvolved epidermis of psoriatic patients compared to healthy epidermis and shows even
higher expression in the psoriatic plaques. In vitro expression studies on HaCaT cells and
keratinocytes demonstrated the expression of AK022045 in both cell types and its up-regulation
under certain stress conditions (contact inhibition, serum-starvation, UV-B irradiation, heat shock,
LPS combined with in¯ammatory cytokines). Cultured melanocytes, an immortalized melanocyte
cell line and a melanoma cell line also expressed the AK022045 RNA. The level of expression was
signi®cantly higher in the immortalized cell line and in the melanoma cell line compared to normal
cultured melanocytes.
040
Role of the Autoimmune Regulator (AIRE) Gene in Alopecia Areata: Strong
Association of a Potentially Functional AIRE Polymorphism with Alopecia Universalis
R. Tazi-Ahnini, M. J. Cork, D. Gawkrodger,* D. Wengraf, A. G. Messenger,* and A. J. G.
McDonagh*
University of Shef®eld, Shef®eld, UK; *Royal Hallamshire Hospital, Shef®eld, UK
Alopecia areata (AA) is a chronic in¯ammatory disease characterised by patchy hair loss with T cell
in®ltration of hair follicles. The lifetime risk of AA is approximately 1% in the general population,
but this is increased to 30% or more in the autoimmune polyendocrinopathy candidiasis
ectodermal dysplasia syndrome (APECED), a recessive disorder due to mutation of the
autoimmune regulator (AIRE) gene on chromosome 21q22.3. We have therefore studied the
possible involvement of AIRE in the pathogenesis of AA. On screening the AIRE coding
sequence, we identi®ed 22 variants in the AIRE gene sequence. Two variants at positions G961C
and T1029C gave amino acid changes S278R and V301A located in the DNA-binding segment
(SAND) and PHD1 zinc ®nger motif, respectively. We have developed genotyping assays for both
G961C and T1029C variants. The AIRE T1029C variant was not informative and the frequency
of the rare allele (961C) of the AIRE G961C variant was 0.08 in our control group. We developed
differential double enzyme assays to discriminate the AIRE G961C alleles and genotyped 202 AA
patients and 175 matched Caucasian controls. There was a signi®cant increase in the frequency of
the 961C allele in AA patients overall to 0.13. This increase was higher in severe disease (alopecia
universalis) 0.21. We found no association between the AIRE G961C variant and mild (patchy)
AA or alopecia totalis. However, the AIRE 961C allele presents a strong risk factor (more than
three times) for development of the most severe form of AA [(OR) = 3.27 (1.56,6.88) p = 0.0012].
Early age of onset (< 30 year) is also a risk factor for disease [OR 2.22 (1.22,4.03) p = 0.0082]. The
amino acid change from serine to arginine in the SAND domain of Aire protein may have a
signi®cant effect on Aire DNA-binding activity. Moreover, our results could provide a rational
explanation of the unusually high frenquency of AA in APECED patients which also supports the
concept of AA as an autoimmune disease.
041
Ef®cient Transgene Expression in Skin Equivalent Model Using Replication-De®cient
Adenovirus Vector System
Y. Shirakata, Y. Hanakawa, K. Yamasaki, S. Tokumaru, L. Yang, X. D. Dai, Y. Yahata, M.
Tohyama, K. Sayama, and K. Hashimoto
Ehime University School of Medicine, Ehime, Japan
It has been reported that skin equivalent model might be an effective means to treat genetic skin
diseases such as epidermolysis bullosa, which can be treated by skin gene therapy in future. For ex
vivo gene therapy, we investigated gene transfer into skin equivalent model. The adenovirus vector
system is a highly effective tool of expressing foreign genes in various tissues. Therefore, we
examined whether the adenovirus vector system could introduce foreign gene into skin equivalent
model. We constructed Cre-loxP adenovirus vector carrying enhanced green ¯uorescence protein
(EGFP) gene. First we examined EGFP expression in monolayer keratinocytes by coinfection of
adenovirus carrying cre-recombinase and loxP-EGFP. EGFP was detected 6 h after infection in
almost all of the cells, and its expression was observed in a time and dose dependent manner until
36 h. Next we examined the gene expression in skin equivalent model. When keratinocytes were
infected with the adenovirus vector before seeding on collagen gels, EGFP expression was limited
to the corni®ed cell layer. So, we changed the infection method. Skin equivalent was produced by
air exposure, followed by direct injection between epidermis and dermis. Using this approach,
EGFP was expressed prominently in the basal and suprabasal layers con®rmed by confocal laser
microscopy and graft model. These results demonstrate that the Cre-loxP adenovirus vector system
is a useful vector for exogenous gene expression in skin equivalent model as well as in monolayer
keratinocytes, and leads to an ex vivo gene therapy of skin diseases.
042
A Homozygous In-Frame Deletion in the Largest Collagenous Domain Decreases the
Thermal Stability of Collagen XVII
L. VaÈisaÈnen, K. Tasanen, P. Nykvist, J. Heino, M. Daamen, and L. Bruckner-Tuderman
Oulu and JyvaÈskylaÈ, Finland, and MuÈnster, Germany
Collagen XVII is a transmembrane hemidesmosomal component which is associated with
epidermal detachment in junctional epidermolysis bullosa (JEB). Most COL17A1 mutations
described lead to a premature termination codon and cause absence of collagen XVII in skin. Here
we analyzed the biological consequences of a COL17A1 in-frame deletion by studying the stability
and integrin binding of wild-type and mutated collagen XVII domains. The mutation occurred in
a newborn patient with JEB who was homozygous for the splice site mutation 2441±2 A to G. It
results in an in-frame skipping of the entire exon 32 and causes a deletion of 9 amino acids in the
largest collagenous domain of collagen XVII. Ultrastructural and immuno¯uoresence investiga-
tions revealed absence of collagen XVII and junctional blistering with intact keratinocytes in blister
roof and normal lamina densa and anchoring ®brils in blister base. Site-directed mutagenesis was
used to generate the deletion in an expression vector coding for the largest collagenous domain,
Col15 and the mutated collagen was expressed in an eukaryotic episomal expression system.
Trypsin digestions as probes for protein folding indicated that the stability of the mutated Col15
fragment was signi®cantly reduced. The midpoint of the helix-to-coil transition, Tm, was 7°C
lower than that of wild-type Col15 fragment. In cell spreading assays, HaCaT cells migrated
similarly on cell culture wells precoated with wild-type or mutated Col15. Thus this deletion
causes abnormal triple-helix folding and susceptibility to unspeci®c proteolysis of the ectodomain
but has no effect on keratinocyte binding of collagen XVII.
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Recessive Palmoplantar Keratoderma: Mapping and Candidate Gene Exclusion
L. M. Wennerstrand, M. H. Klingberg, G. Holmgren, A. LundstroÈm, and L. K. Lind
UmeaÊ, Sweden
In the northern part of Sweden two types of hereditary nonepidermolytic palmoplantar
keratodermas (PPKs) are present, one with autosomal dominant mode of inheritance (PPK type
Bothnia) and one with autosomal recessive mode of inheritance (rPPK). PPK type Bothnia is the
predominant disorder with a reported prevalence of 0.3±0.5%, whereas the prevalence of rPPK is
about 2.7 3 10±5. The phenotype of rPPK includes a sharply demarcated waxy diffuse palmoplantar
hyperkeratosis usually accompanied by hyperkeratosis on dorsal aspects of ®ngers and toes.
Additional features of the rPPK phenotype are dermatophyte infections and hyperhidrosis of
palmoplantar skin, conical tapering of ®ngertips and maceration between toes. There are no
associated ectodermal defects. We have collected DNA from the 13 known rPPK patients in
Sweden and their unaffected relatives and performed a genome wide search for the disease locus.
Linkage was found to microsatellite markers on chromosome 8qter, with a maximum LOD score
of 5.64. Within the region all affected individuals shared a common haplotype, indicating a founder
effect. The rPPK region on is approximately 2.3 Mb accordning to the USCS map and contains
about 35 genes. The genodermatose Mal de Maleda has a similar phenotype to rPPK and maps to
the same region. A recent report concludes that Mal de Maleda is caused by mutations in the ARS
gene. We therefore analysed both intron and exon sequence of the ARS gene in our family
material using denaturing-high-performance-chromatography (DHPLC). No polymorphims
segregating with rPPK was found, leading to exclusion of ARS as a candidate for rPPK.
Coding regions of 5 additional candidate genes have been analysed, however, no polymorphism
segregating with rPPK has been detected so far.
044
Real Time Quantitative RT-PCR: A New Approach for Studying Expression of Markers
for Ageing in Human Skin
M. Bonnet-Duquennoy, S. Bosset,* A. Chalon,* K. Lazou, F. BonteÂ, S. Schnebert, F. Disant,² J.
F. Nicolas,* and R. KurfuÈrst
Laboratoires R & D, LVMH Branche Parfums et CosmeÂtiques, St Jean de Braye, France; *INSERM
U503, UniversiteÂ Claude Bernard et Hospices Civils de Lyon, Lyon, France; ²Service ORL, HoÃpital E.
Herriot, Lyon, France
Skin aging can be divided into two simultaneous processes: intrinsic and extrinsic ageing due to
environmental factors as chronic sun exposure (photoaging). Several studies were focused on
molecular dermis features in photo-aged skin. Very little is known about epidermal markers and
structural modi®cations due to ageing has been reported in basal cell keratinocytes. To investigate
epidermal markers of the photo-ageing process for the face skin, we studied in wrinkled sun-
exposed and in nonexposed control skin, transcripts coding for b1A integrin, a marker of basal
keratinocytes and for involucrin, a marker of differenciation for keratinocytes. We developed a
real-time quantitative RT-PCR assays to quantify these two transcripts in human skin biopsies.
The RT-PCR were performed on isolated epidermis in conditions to obtain a detection level of
50 copies and an ef®cacy up to 90% with standard curves and samples. These two transcripts were
detected and quanti®ed in all biopsies studied. Our data showed that in 8 out of 10 patients, b1A-
integrin transcripts were decreased in sun-exposed skin compared to control biopsies. For
involucrin, variation of transcript between sun-exposed and control skin is proper to each patient.
These data indicate that at mRNA level, b1A integrin is a marker of the photoaging process and
could be considered for studying the effect of potential active compounds.
045
A Missense Mutation in CDH3, Encoding P-Cadherin, Causes Hypotrichosis with
Juvenile Macular Dystrophy
E. Sprecher, M. Indelman, R. Lurie,* G. Richard,² B. Miller,³ D. Petronius, R. Leibu,³ I.
Perlman,§ and R. Bergman
Departments of Dermatology, and ³Ophtalmology, Rambam Medical Center, Haifa, Israel; *Pediatric
Dermatology Unit, Schneider Children's Hospital, Petach-Tikva, Israel; ²Department of Dermatology and
Cutaneous Biology, Thomas Jefferson Institute of Molecular Medicine, Thomas Jefferson Medical College,
Philadelphia, Pennsylvania, United States of America; Department §Physiology and Biophysics, Bruce
Rappaport Faculty of Medicine, Technion ± Israel Institute of Technology, Haifa, Israel
Hypotrichosis with juvenile macular dystrophy (HJMD) is a rare autosomal recessive disorder
characterized by early hair loss heralding the occurrence of severe degenerative changes affecting
the retinal macula and culminating in blindness during the second to third decade of life. We
recently reported a frameshift mutation in the CDH3 gene encoding p-cadherin, as the proximal
cause of HJMD in 4 families. We identi®ed an additional consanguineous family affected with
HJMD and comprising 4 affected individuals. Light and scanning electron microscopy revealed
morphological hair abnormalities consistent with pili torti in all patients. Fundus examination
disclosed in all patients marked degenerative changes in the macular pigment epithelium.
Electrophysiological studies were diagnostic of severe retinal dysfunction. Using haplotype analysis,
we found out that all affected family members were homozygous for a polymorphic marker located
in the vicinity of the CDH3 gene. We establish the entire coding sequence of CDH3 in a patient
and identi®ed a missense mutation in this gene resulting in a substitution at position 503 of P-
cadherin amino acid sequence (R503H). The mutation was found in an homozygous state in all
affected individuals, in an heterozygous state in obligatory carriers and in none of 83 healthy
unrelated individuals. The mutation was shown to affect a highly conserved residue, considered to
be involved in Ca+2 binding. This is the ®rst missense mutation reported in CDH3 and the second
mutation found to underlie HJMD. These ®ndings establish mutations in CDH3 as the cause of
HJMD and expand our understanding of the pathophysiology of this fascinating disorder.
046
Novel Mutation of Keratin 9 in a Hungarian Pedigree with Epidermolytic Palmoplantar
Keratoderma
M. CsikoÂs, P. HolloÂ , K. Becker, E. RaÂcz, A. HorvaÂth, and S. KaÂrpaÂti
Budapest, Hungary
Epidermolytic palmoplantar keratoderma (EPPK, MIM#144200) is an autosomal dominant
disorder with hyperkeratosis con®ned to the palms and soles. It is characterized histologically by
cytolysis within the stratum spinosum and granulosum. Mutations in the keratin 9 gene (KRT 9)
encoding this type I keratin, expressed exclusively in the suprabasal keratinocytes of the
palmoplantar epidermis, have previously been demonstrated in this disorder. We studied a large
Hungarian pedigree presenting with EPPK and reviewed the literature. The diagnosis was
con®rmed by skin ultrastructural studies. A novel heterozygous missense mutation, 545 A®T,
N160I in exon 1 of KRT 9, was detected. This new mutation located in the helix initiation motif
at the start of the central coiled-coil rod domain of keratin 9. These ®ndings provide further
evidence for mutational heterogeneity in EPPK and underline the functional importance of the 1 A
rod domain segment in the structural integrity of keratin intermediate ®laments.
047
Mutation Analysis of the ATP2A2 Gene in Five Hungarian Patients with Darier's Disease
E. RaÂcz, M. CsikoÂs, Z. KornseÂe, A. HorvaÂth, and S. KaÂrpaÂti
Budapest, Hungary
Mutations in the ATP2A2 gene, encoding SERCA2, a P-type ATPase had been identi®ed as the
cause of Darier's disease (DD), an autosomal dominantly inherited skin disease. Mutation analysis
in ®ve Hungarian DD patients had been performed, to get more information about phenotype-
genopyte relations. All of them had moderate to severe skin symptoms. PCR ampli®cation of the
entire coding region of ATP2A2 was performed. Mutation detection strategies included
heteroduplex scanning by conformation-sensitive gel electrophoresis and direct nucleotid
sequencing. We found distinct, heterozygous mutations (2 missense, 1 nonsense, 1 deletion and
1 insertion), 3 of which was novel. In a 31-year-old DD woman with learning dif®culties we
disclosed a previously described missense mutation (D702N) in exon 15, however, in that other
patient no neuropsychiatric symptoms had been indicated. A 44-year-old mentally mildly
handicapped DD woman had a T insertion at nucleotid 559 in exon 7 of the ATP2A2 gene, which
resulted in a premature stop codon at codon 192. A woman, whose skin symptoms developed
unusually late, at the age 50, had a T deletion (1320delT) in exon 11 resulting in a premature stop
codon at codon 448. Our most severe case had a known missense mutation N39T, resulting in a
nonconservative amino acid change at the upstream stalk region. A further new nonsense mutation
(C909Z) was detected in the M8 transmembrane domain. International comparative genotype-
phenotype analyses can be only performed from exact clinical databases.
048
Fluconazole Down-Regulates Metallothionein Gene in Dermatophyte (M. canis)
A. Uthman,*² M. Dockal,* S. Rezaie,* J. Ban,* J. SoÈ ltz-SzoÈts,² and E. Tschachler*
*Department of Dermatology, University of Vienna Medical School; ²Ludwig Boltzmann-Institute for
Investigation of Infectious Venerodermatological Diseases, Vienna, Austria
Azole antifungals are widely used to treat infections with dermatophyte fungi. Whereas it is
commonly accepted that this class of drugs interferes with fungal sterol synthesis, little is known
about their potential other biological effects. To investigate M. canis genes regulated by ¯uconazole
we cultured M. canis in the present of 50 mg ¯uconazole and subjected the RNA to differential
display analysis. Differently expressed genes were isolated and sequenced. Here we demonstrate
that ¯uconazole is able to down-regulate the baseline as well as copper-induced expression of
Metallothionein by M. canis. Since this effect occurred within 30 min after exposure of the fungus
to ¯uconazole, it is unlikely that it represents a secondary effect of cell wall destabilisation due to
impaired sterol synthesis. Our additional demonstration that ¯uconazole enhances copper toxicity
for M. canis suggest that inhibition of metallothionein expression by ¯uconazole is biologically
relevant and may represent an important mode of the antifungal action of this drug. Therefore our
data indicate that antifungal effects of azoles derivatives might not only be due to interference with
cell wall synthesis but may affect other biological circuits within the fungal cells.
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Targeted Inhibition of Human Collagenase-3 (MMP-13) Expression by Antisense
Ribozyme Inhibits Squamous Cell Carcinoma Growth In Vivo
R. Ala-aho, M. Ahonen, S. J. George, J. HeikkilaÈ, R. GreÂnman, M. Kallajoki, and V.-M. KaÈhaÈri
Turku, Finland and Bristol, UK
Squamous cell carcinomas (SCCs) of the head and neck are characterized by high tendency to
invade locally and metastasize. Collagenase-3 (matrix metalloproteinase-13, MMP-13) is expressed
by tumor cells of SCCs and it is associated with high invasion capacity. To speci®cally examine the
role of MMP-13 in the growth and invasion of SCC, we constructed a hammerhead ribozyme
speci®cally targeted against human MMP-13 mRNA. The MMP-13 antisense ribozyme
effectively cleaved MMP-13 transcripts In vitro. We also constructed a recombinant adenovirus,
RAdMMP-13ASRz, to express MMP-13 antisense hammerhead ribozyme in living cells.
Adenoviral delivery of MMP-13 antisense ribozyme into cutaneous SCC cells resulted in potent
and speci®c inhibition in production of proMMP-13 and suppressed invasion of SCC cells through
Matrigel by 80%. TUNEL positive cells were detected 72 h after the adenoviral delivery of MMP-
13 antisense ribozyme into SCC cells, and Hoechst staining of SCC cells showed condensated
nuclei within 96 h. SCC tumors established in SCID mice were injected with RAdMMP-13ASRz
intratumorally 2±3 times a week (109pfu per dose) for three weeks. In vivo injection of RAdMMP-
13ASRz into SCC tumors inhibited tumor growth by 50±75%. The gelatinolytic activity was
inhibited in RAdMMP-13ASRz injected tumors as a result of inhibition of MMP-13 expression.
In addition, the amount of proliferating Ki67 positive cells in the tumors injected with MMP-13
antisense ribozyme was reduced by 30%. These results show, that MMP-13 antisense ribozyme
potently inhibits expression of MMP-13 by SCC cells and suppresses SCC tumor growth in vivo. In
conclusion, these results show, that MMP-13 plays an important role in invasion, and survival of
SCC cells in vivo.
050
Increased Levels of Phosphorylated Small Heat Shock Protein (Hsp27-p82) in the
Epidermis of Patients with Keratin Genodermatoses
S. C. L. Tan, R. A. Quinlan,* and P. Bowden
Uinversity of Wales College of Medicine, Dermatology, Cardiff, UK; *Durham University, Durham, UK
Keratin gene mutations cause genetic disorders that produce phenotypes in various epithelia
including the skin, hair and nail. Generally, mutations are located in the structurally sensitive a-
helical core of the protein, which weakens the intermediate ®lament (IF) network. Subsequent
stress placed on the epithelia then causes ®lament collapse and initiates a cellular ``stress'' response.
It is the response of the damaged cells that characterises the resulting clinical phenotype. To further
understand how these phenotypes develop and how similar mutations in the same gene can give
rise to different phenotypes, we have studied several patients with different genodermatoses. We
examined expression of inducible keratins (K6, K16 and K17) and two small heat-shock proteins
(Hsp27 and aB-crystallin). In addition, we used an antibody speci®c for the phosphorylated
``active'' form of Hsp27 (Hsp27-p82). Skin biopsies from 5 normal volunteers, 3 patients with
psoriasis (lesional and peri-lesional skin) and 8 patients with genodermatoses (1 EBS, 2 EHK, 1
EPPK, 2 IBS and 2 LEN) were studied. Keratin mutations were de®ned in all 8 patients. Fixed
biopsies processed and sectioned at 5 mm, incubated with primary antibody (or control buffer) and
the antigens visualised by immunohistochemistry with DAB. Sections were treated with primary
monoclonal or polyclonal antibodies to K16, K17, Hsp27, Hsp27-p82 and aB-crystallin. In all
eight genodermatosis cases examined, a large increase in the expression of K16, NF-IL6 and Hsp27
was observed at the site of cellular damage. In addition, levels of activated Hsp27-p82 were
increased. There was more variable up-regulation of K17 and little effect on aB-crystallin. Thus,
keratin mutations weaken the IF network and subsequent cellular stress collapses the ®lament
network and invokes a stress response typi®ed by increased expression of K16 and speci®c
phosphorylation of the small heat-shock protein, Hsp27.
051
Differential Regulation of Apoptosis by Bcl-X Proteins in Human Melanoma Cell Lines
A. M. Hossini, J. Eberle, L. F. Fecker, C. E. Orfanos, and C. C. Geilen
Department of Dermatology, University Medical Center Benjamin Franklin, The Free University of Berlin,
Germany
Bcl-X, a member of the Bcl-2 gene family is expressed in two known splice variants, Bcl-XS
(proapoptotic) and Bcl-XL (antiapoptotic) which regulate cell death in eukaryotic cells. Bcl-X
proteins can form homo- and heterodimers with other Bcl-2-related proteins, their active form
being localized in the outer mitochondrial membrane. Until now the mechanism of Bcl-XS
induced apoptosis is not clear. Expression analyses of Bcl-2-related proteins in melanoma cell lines
by Western blotting revealed high levels of Bcl-XL and Bcl-2 protein in melanoma cell lines,
whereas Bcl-XS was only weakly expressed. In order to investigate the role of Bcl-XS and Bcl-XL
for apoptotic processes in human melanoma cell lines, we subcloned full-length cDNA fragments
by RT-PCR. Identity of the clones was con®rmed by sequence analysis. For overexpression, both
cDNAs were further subcloned in sense and in antisense-orientation downstream of a tetracyclin-
regulatable promoter and were transfected into established Tet-On (SK-Mel-13, Bro) and Tet-Off
(Mel-2a) melanoma cell lines. Expression of Bcl-XL/XS after transient transfection was veri®ed on
the mRNA level by Northern and on the protein level by Western analysis, and apoptosis was
quanti®ed by the cell death detection ELISA (Roche). Induction of Bcl-XS by doxycyclin led to
signi®cantly increased apoptosis as compared to noninduced cultures (1.2±1.7-fold), whereas
induction of Bcl-XL resulted in reduced apoptosis. Sensitivity to Fas ligand-induced apoptosis was
strongly reduced in cell clones, stably transfected with Bcl-XL. These ®ndings suggest that
exogenous Bcl-XS may provide a novel tool for initiating cell death in human melanoma cells. Bcl-
XL is equipotent to Bcl-2 in prohibiting FasL-induced apoptosis in melanoma cells.
052 [Oral 007]
The Released Collagen XVII Ectodomain Inhibits Human Keratinocyte Migration
C.-W. Franzke, K. Tasanen, K. Brandt, F. Echtermeyer, and L. Bruckner-Tuderman
MuÈnster, Germany and Oulu, Finland
Collagen XVII is a structural component of the hemidesmosomes and exists in two forms, as a 180-
kDa type II transmembrane protein and as a soluble 120 kDa form, which corresponds to the
extracellular collagenous domain of collagen XVII. We have previously shown that the release of
the ectodomain from keratinocyte surface was generated by at least three members of the ADAM
family. Until now, only little is known about the physiological and pathological relevance of the
shed ectodomain. Time chase experiments with biotinylated keratinocytes revealed that the
ectodomain was detectable within minutes and showed high stability in the medium for more than
48 h. The use of domain speci®c antibodies demonstrates that the authentic shedding product
contains at least a part of the NC16A domain and the full C-terminus of the collagen XVII
molecule. To get more information about the involvement of collagen XVII-shedding in the
reepithelialization of healing wounds, we investigated the haptotactic migration of COS-7 cells on
®bronectin. Collagen XVII transfected COS-7 cells showed a 2.5-fold increased motility
compared to control cells, which were transfected with the empty vector. Transfection with a
NC16a deletion construct of collagen XVII, which was not shed from the cell surface leads to a
35% increased migration rate compared to collagen XVII transfected cells. Addition of af®nity
puri®ed collagen XVII-ectodomain (100 nM) to the lower chamber of the transwell plates leads to
40% reduced motility of both, full-length collagen XVII and NC16a deleted collagen XVII
transfected cells. In addition, In vitro scratch assays with normal human keratinocytes were
performed. Correspondingly, the addition of soluble collagen XVII ectodomain caused a
signi®cantly decreased rate of wound closure. The amino acid sequence of the ectodomain includes
no putative integrin RGD-binding sites, but numerous, highly related KGD sequences, which
have found in snake venom poisons and show similar integrin binding ability. These results suggests
that the collagen XVII ectodomain includes integrin binding motifs for ®bronectin, like the a5b1
and aV integrins. Recent studies revealed that these integrins were only expressed in migrating
wound keratinocytes, but not in normal keratinocytes. Therefore, it is possible that the shed
collagen XVII ectodomain plays a role in regulation of keratinocyte migration in wound healing
processes.
053 [Oral 008]
Towards Gene Therapy of Recessive Dystrophic Epidermolysis Bullosa
Y. Gache, C. Baldeschi, A. Rattenholl,* A. Spadafora, F. BouilleÂ,² J.-P. Ortonne, L. Bruckner-
Tuderman,* and G. Meneguzzi
Inserm, U385, Nice, France; *University of MuÈnster, MuÈnster, Germany; ²Genethon III, Evry, France
Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited skin disorder caused by
mutations in the gene for collagen type VII. No conventional therapy is available for this disease,
which justi®es the perfection of treatments based on gene therapy. To this purpose, we have
investigated the capacity of viral vectors to ef®ciently transduce a full-length collagen VII cDNA
(> 9 kb) into human collagen VII-null RDEB keratinocytes ex vivo. Recombinant MoMuLV- and
MSCV-based vectors ef®ciently transduced the keratinocyte cultures which led to the synthesis and
secretion of collagen VII molecules of the expected size. Limited proteolysis of the recombinant
collagen VII using pepsin or collagenase con®rmed that the recombinant molecules are secreted as
correctly folded helical trimers preserving their functional domains. Tri-dimensional skin
equivalents (SE) were constructed using wild type or RDEB ®broblasts embedded substrates
overlaid with wild-type, RDEB or reverted RDEB keratinocytes. After 15 days exposure of the
organotypic cultures to the air±liquid interface, immunohistochemical analysis detected a strong
linear staining of collagen VII along the BM in the SE formed by the RDEB ®broblasts and the
reverted RDEB keratinocytes. After a 30-day exposure to air, the immuno¯uorescence signals was
restricted to the BM and was indistinguishable from that obtained in the SE made with the wild-
type cells. Our results show that (i) retroviral vectors ef®ciently express the large collagen VII
cDNA, (ii) the recombinant collagen VII is ef®ciently synthesized, matured and secreted by the
transduced cells; (ii) phenotypically reverted skin can be produced by the RDEB transduced
keratinocytes. These ®ndings pave the way to a preclinical validation of a gene therapy approach
for the treatment of RDEB.
054 [Oral 047]
Matrix Metalloproteinase-19 Expression in Wound Healing and in Dermal Fibroblasts
N. Reunanen, U. Impola, C. LoÂpez-OtõÂn, U. Saarialho-Kere, and V.-M. KaÈhaÈri
Turku, Finland, Helsinki, Finland, and Oviedo, Spain
We have examined the expression of matrix metalloproteinase-19 (MMP-19) in cutaneous wound
healing and the roles of mitogen-activated protein kinase (MAPK) signaling pathways in the
regulation of MMP-19 expression in normal dermal ®broblasts. MMP-19 was expressed in human
cutaneous wounds, in venous and decubitus chronic ulcers as well as in well granulating ulcers.
MMP-19 protein was detected in wound stroma in endothelial cells and ®broblasts, often in the
vicinity of in¯ammatory cells. Expression of MMP-19 in human skin ®broblasts was enhanced by
IL-1, PDGF, TGF-b, and most potently by TNF-a. TNF-a activated extracellular signal-
regulated kinase (ERK)1,2, Jun ± N-terminal kinase (JNK) and p38 MAPK in dermal ®broblasts.
Induction of MMP-19 mRNA expression by TNF-a was in part (by 50%) prevented either by
blocking p38 activity by SB203580 or by blocking the activation of ERK1/2 by PD98059.
Activation of endogenous ERK1/2 by adenovirus-mediated delivery of constitutively active
MEK1 resulted in induction of MMP-19 expression. Activation of endogenous p38 alone by
adenovirally delivered expression of constitutively active MKK3b and MKK6b also enhanced
MMP-19 expression and augmented the up-regulatory effect of constitutively active MEK1 on the
expression of MMP-19. Activation of JNK by adenovirus-mediated expression of constitutively
active MKK7 also augmented the enhancement of MMP-19 expression by constitutively active
MEK1, but had no effect alone. The abundant proMMP-19 production induced by simultaneous
activation of ERK1/2 together with JNK or p38 was associated with proteolytic processing of
proMMP-19. These results show, that MMP-19 is speci®cally expressed during cutaneous wound
healing, and identify two distinct mechanisms for inducing MMP-19 expression in ®broblasts: AP-
1-dependent activation via ERK1/2 pathway, and AP-1-independent activation via p38 pathway,
both of which apparently control the proteolytic activity of normal ®broblasts, e.g. in wound repair
and tumor invasion.
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055 [Oral 057]
Proteinases of the BMP-1 Family Convert Procollagen VII to Mature Anchoring Fibril
Collagen
A. Rattenholl, W. N. Pappano, M. Koch, D. R. Keene, K. E. Kadler, T. Sasaki, R. Timpl, R. E.
Burgeson, D. S. Greenspan, and L. Bruckner-Tuderman
MuÈnster, Germany, Madison, USA, Charlestown, USA, Portland, USA, Manchester, UK and
Martinsried, Germany
Collagen VII is located at the basement membrane zone of the skin. Here it is the major structural
component of the anchoring ®brils which ensure the cohesion between the epidermis and the
dermis. Collagen VII is secreted into the extracellular matrix as a precursor, procollagen VII. A C-
terminal propeptide is cleaved during maturation of the anchoring ®brils. However, the
mechanisms of anchoring ®bril maturation, including the cleavage site and the enzyme processing
procollagen VII have remained elusive. Genetic evidence has suggested the involvement of BMP-1
in this process, since a naturally occurring deletion in the COL7A1 gene, 8523del14, which
eliminates a putative cleavage site for BMP-1, prevents processing of procollagen VII in the skin.
Here we show that recombinant BMP-1 cleaves full-length human procollagen VII in vitro,
yielding a cleavage product of the same size as mature collagen VII in the dermis. In order to
determine the cleavage site, a truncated recombinant procollagen VII containing an intact C-
terminus was produced. This construct was cleaved by both BMP-1 and the related proteinases
mammalian tolloid-like-1 and ±2 (mTLL-1 and mTLL-2) at the predicted site In vitro. Analysis of
collagen VII in the skin of BMP-1 de®cient mouse embryos demonstrated that procollagen VII
was processed to the same extent compared to wild type embryos. This suggests that in situ the
collagen VII precursor can be cleaved by at least three metalloproteases including BMP-1, mTLL-1
and mTLL-2.
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Dystroglycan, a Transmembrane Component in Cutaneous Cells, is Proteolytically
Processed
C. Herzog, C. Has, C. W. Franzke, S. KroÈger, E. Gustafsson,* R. Faessler,* and L. Bruckner-
Tuderman
Department of Dermatology, University Hospital, MuÈnster, Germany; *University of Lund, Lund, Sweden
Dystroglycan (DG) is a membrane spanning complex composed of two subunits, a and b
dystroglycan. Originally, DG was identi®ed as an integral component of the dystrophin
glycoprotein complex (DGC) which provides a tight link between the cytoskeleton and the
basement membrane (BM) in muscle. Dysfunction of the DGC has commonly been implicated in
the pathogenesis of severe forms of neuromuscular diseases. More recent work showed that DG is
also expressed in a variety of nonmuscle tissues like skin, peripheral nerve, kidney and lung.
Despite of expanding knowledge about the function of DG in nonmuscle tissues a number of
questions remained to be answered. Therefore we analyzed the biological function of DG in skin
and cutaneous cells in more detail. In order to study the expression and localization of DG in skin
and cutaneous cells on the protein level we generated domain-speci®c antibodies for a and b DG
and used them for immuno¯uorescence studies and Western blotting (WB). In parallel DG was
analyzed on the mRNA level by in situ hybridization. DG is present at the skin BM and is
synthesized by keratinocytes and ®broblasts, In vitro. WB of cell extracts and media of keratinocytes
revealed that the transmembrane protein b DG is localized in the cell extracts whereas a DG was
only detected in the media. In recent studies the existence of a truncated form of b DG was
described and it was suggested that this truncated 30 kDa fragment of b DG is generated by
proteolytic processing of the extracellular domain of b DG. We showed that in keratinocytes this
processing of b DG takes place and can be stimulated by PMA, EGF and Il-1 b. Furhtermore, this
process is sensitive to hydroxamate inhibitors which indicates that the cleavage is mediated by
matrix metalloproteinases or ADAM's. In order to analyze the effect of ligand interaction on the
shedding process we examined perlecan ±/± ®broblasts. In these cells, which lack a strong binding
partner for a DG, the processing of b DG was strongly enhanced. This study shows that DG is
constitutively shed from the cell surface in keratinocytes and ®broblasts. The shedding has a great
impact on the integrity of the epithelial DG complex.
058
A Role of Dermatopontin in Wound Healing
U. Takeda, N. Fujita, and H. Shinkai
Graduate School of Medicine, Chiba University, Chiba City, Japan
Dermatopontin (DPT) knockout (KO) mice, generated by targeted disruption of Dpt gene, display
abnormal collagen ®brillogenesis and increased elasticity in skin. We have also shown the lack of
DPT may cause decreased collagen accumulation in skin. We think DPT-KO mice could
represent a useful animal model to investigate the wound healing, ®brosis, and tumorogenesis.
DPT and ®bril-associated genes expression levels and distributions during skin wound healing were
assessed by RT-PCR and in situ hybridization. Samples were collected from wild-type mice
wounds at 1 day, 4 day, 1 week, 2 week, and 3 week after full-thickness skin injury with 6 mm
punches. Whereas very little expression was noted in unwounded skin, Dpt expression was up-
regulated at 1 week after injury. Expressing cells were localized in ®broblastic cells throughout the
granulation tissue. The pattern of Dpt expression was correlated with that of ®bril-associated genes
and type 1 collagen expression. Healing wounds were comparable between wild-type and DPT-
KO mice during the repair process when analyzed using light microscopy. However, electron
microscopic studies displayed alterations in collagen ®bril formation of dermal wound in DPT-KO
mice. These results suggest that DPT may function in remodeling wound matrix in a process that
involves ®brillar collagen organization.
059
Modulation of Collagen Synthesis and Messenger RNA by Continuous and Intermittent
Use of Topical Glucocorticoid
A. Oikarinen, P. Nuutinen, R. Riekki, M. Parikka, T. Salo, J. Risteli, and P. Autio
Oulu and Helsinki, Finland
Glucocorticoids have been shown to down-regulate collagen synthesis in human skin in vivo,
thereby contributing to skin atrophy. The aim of the present study was to compare the effects of
continuous and intermittent use of topical hydrocortisone on skin collagen synthesis and,
furthermore, to elucidate the mechanism of collagen synthesis reduction induced by
hydrocortisone. Collagen propeptides re¯ecting the synthesis rate of type I and III collagens
were studied from suction blister ¯uids in nine healthy subjects after three weeks of continuous
(twice daily) or intermittent (on three consecutive days weekly) topical hydrocortisone treatment
and two weeks after the termination of treatment. Type I collagen mRNA was studied in the same
subjects from skin biopsies by using in situ hybridization after three weeks' treatment. Three weeks'
continuous treatment decreased the types I and III collagen propeptides in suction blister ¯uid by
89% and 82%, while intermittent treatment resulted in a corresponding decrease of 53% and 50%.
In situ hybridization (ISH) studies from skin biopsies showed type I collagen mRNA to be
markedly reduced in ®broblasts after continuous and intermittent steroid treatment. After a two-
week drug-free interval, the synthesis rate was completely restored in both areas, and some subjects
even showed up-regulation of synthesis in previously steroid-treated skin. As a conclusion
continuous hydrocortisone for 3 weeks decreases markedly collagen propeptides and corresponding
mRNA in human skin. Intermittent hydrocortisone has a less marked effect on the collagen
synthesis rate.
060
Minocycline Does Not Alter Collagen Type I Metabolism of Dermal Fibroblasts in
Culture
U. Anderegg, J. Prieb, and U.-F. Haustein
Department of Dermatology, Leipzig University and Saxon Academy of Science, Leipzig
Antibiotic drugs such as Penicillamine, Penicillin G and Minocycline are used in the treatment of
Systemic Sclerosis (SSc). However, there is little knowledge on the mechanism of anti®brotic
action of these drugs. In general, excluding cell proliferation data, the in¯uence of antibiotics on
the metabolism of eukaryotic cells is poorly investigated. Penicillin G that may improve skin status
of SSc-patients signi®cantly did not in¯uence collagen metabolism In vitro during previous
investigations. Minocycline is another drug that may improve the clinical phenotype of SSc. We
studied the effects of Minocycline by analysing the in¯uence of various concentrations of
Minocycline on cell proliferation, synthesis and degradation of collagen by human dermal
®broblast from healthy donors and SSc-patients (collagen high producer). More detailed, collagen
metabolism of cultured dermal ®broblasts was studied by Northern Hybridisation for mRNA of
collagen I, proline-4-hydroxylase, lysyl-hydroxylase, matrix metalloproteinase I and determination
of collagen content in culture supernatants. Minocycline did not alter the expression of the
investigated mRNA, independently on the dosage and the incubation times used. The amount of
collagen I protein was not in¯uenced. In conclusion, there is no evidence of a direct anti®brotic
effect of Minocycline on dermal ®broblasts. Therefore, other mechanisms might be responsible for
its effect in the treatment of SSc-patients. In the case of Minocycline, the anti-in¯ammatory action
might be relevant for the positive effects known from SSc therapy.
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Vasoactive Intestinal Peptide Stimulates Nitric Oxide Production by Mastocytosis
Fibroblasts
A. Zalewska, J. Wyczolkowska,* and A. Sysa-Jedrzejowska
Department of Dermatology, Medical University of Lodz, *Department of Biogenic Amines, Polish Academy
of Sciences, Lodz, Poland
Nitric oxide (NO) and stress have been implicated in the pathogenesis of manyin¯ammatory and
hyperproliferative disorders. It is also suggested that ®broblast±mast cell interactions, via their
numerous mediators, play some role in cutaneous mastocytosis course. So, the aim of our study was
to evaluate NO production by mono- and cocultures of ®broblasts and mast cells upon vasoactive
intestinal peptide (VIP) stimulation. The following cells were used: skin ®broblasts from the lesions
of urticaria pigmantosa patients with con®rmed diagnosis of systemic mastocytosis, normal skin
®broblasts (controls), human leukaemic mast cell line (HMC-1) as either mono-cultures or
cocultures of mast cells and ®broblasts (third passage). Cells were stimulated with different
concentrations of VIP (10±6, 10±7, 10±8, 10±9 M). NO production was assessed by Griess method.
Measurements were performed in quadruplicate. We observed that VIP stimulated NO production
by mastosytosis ®broblasts and exert rather inhibitory effect on control ones in a dose-dependent
manner. With increasing VIP concentrations ± NO production was as follows: 0.97 vs. 1.46 mM,
1.36 vs. 1.82 mM, 1.46 vs. 1.94 mM, 1.46 vs. 1.99 mM, respectively. NO synthesis by HMC-1 cells
was also inhibited by VIP and ranged from 1.44 to 1.64 mM and did not reach spontaneous
production levels (mean 1.79 mM). As for cocultures, in control experiments NO production
oscillated around levels observed on spontaneous NO production (no VIP stimulation) ± mean
1.77 vs. 1.84 mM, respectively. However, in cocultures of mastocytosis ®broblasts and HMC-1 line
NO production was signi®cantly higher when comparing to control experiments and ranged from
2.04 to 4.02 mM (mean 3.33 mM). It seems that VIP is involved in modulatory processes of NO
production by mastocytosis skin ®broblasts.
062
Inhibitory Effect of Substance P and Vasoactive Intestinal Peptide on Psoriasis Vulgaris
Fibroblasts
A. Zalewska, J. Dastych,* and A. Sysa-Jedrzejowska
Department of Dermatology, Medical University of Lodz, *Department of Biogenic Amines, Polish Academy
of Sciences, Lodz, Poland
It is known that neuropeptides are involved in pathomechanism of psoriasis vulgaris. It is also
suggested that mast cell±®broblast interactions play a role in psoriatic lesions development. So, the
aim of our study was to examine in¯uence of substance p (SP) and vasoactive intestinal peptide
(VIP) on the proliferation of ®broblasts obtained from the psoriatic lesions (PsLF), their close
surroundings (PsSF), normal healthy skin of the control subjects and human leukaemic mast cell
line (HMC-1). After 72-h stimulation of already selected concentrations of neuropeptides (VIP ±
10±8, 10±6 M and SP 10±13, 10±8 M), proliferation assays were performed. In cocultures HMC-1
were preincubated with mitomycin C. Experiments were performed in quadruplicate. Fibroblasts
from the fourth passage were used. We observed that spontaneous proliferation of PsLF was
considerably higher than proliferation of PsSF and control ones ± mean 2907 DPM vs. 2371 and
964 DPM, respectively. We also noticed that both VIP and SP inhibited proliferation of all the
studied ®broblasts in an inversely dose-depandent manner. As for ®broblast-mast cell cocultures,
inhibitory effect of neuropeptides was preserved when HMC-1 line cells were pretreated with
mitomycin C. In cocultures, both neuropeptides exhibited slightly less inhibitory effect on cell
proliferation. However, diseased ®broblasts (both PsLF and PsSF ones) were more susceptible to
VIP and SP inhibition than control ones. HMC-1 presence seems to diminish the inhibitory effect
of neuropeptides on control ®broblasts. However, as regards PsLF and PsSF ones, HMC-1 cells are
unable to abolish this inhibitory effect. These observations suggest that in psoriasis vulgaris
interactions between mast cells and ®broblasts seem to be somewhat disturbed, maybe by the
previous (in vivo) nerve-mast cell in¯uence.
063
Role of Boron and Manganese in Wound Healing Through Induction of MMP-2 and
MMP-9
N. Chebassier, E. J. Ouijja,* I. Viegas,* A. C. Knol, and B. Dreno
INSERM U463, Nantes, France; *Laboratoires Rivadis, Thouars, France
Synthesis of new tissue and maturation of the wound by the remodelling of extracellular matrix
(ECM) are two phases of wound healing which involved matrix metalloproteinases (MMPs).
Clinical studies aim to demonstrate the bene®cial effect of trace-elements in cutaneous wound
healing. Thus, boron compounds would enhance wound healing by their action on extracellular
matrix. In the same way, previous studies lead in our laboratory demonstrated an induction of
integrin expression by keratinocytes after a treatment with manganese. Leif R Lund et al have
demonstrated the presence as well as the localisation of MMP-2 and MMP-9 mRNA which play
an important role during cutaneous wound healing. In our study, we observed the effect of boron
and manganese on MMP-2 and MMP-9 keratinocyte expression. Human normal keratinocytes
were cultured in monolayers and incubated during 24 h with boron (Labcatal, France) (0,5±1 ± 5±
6,46±10 mg per ml) or manganese (Labcatal) (0,1±0,2±0,3±0,6±1,5 mg per ml). MMP-2 and MMP-
9 extracellular expression was studied using zymography on culture supernatants and Western blot
on cell lysates and culture supernatants. RT-PCR was used for the study of mRNAs. After 24 h of
incubation a signi®cant increase of MMP-2 and MMP-9 secretion by keratinocytes incubated
either with boron or manganese was obtained. In a similar manner, an increase of intracellular
expression of pro-MMP9 using Western blot was noted associated with an increase of MMP-9
mRNA expression in keratinocytes cultured with boron or manganese. In regard of MMP-2
mRNA localisation in dermis underlying the wound and knowing that MMP-9 is involved in
keratinocyte migration from the wound edges (Leif R Lund et al), our results demonstrate that one
mechanism of wound healing of boron and manganese observed in vivo is the induction of MMP-2
and MMP-9 production in situ.
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Age-Related Decrease of L-Ascorbate Uptake by Human Skin Fibroblasts: Regulation
by a Bertholletia Excelsa Pericarp Extract
M. Dumas, S. Chastrusse, C. Gondran, A. Saunois, and F. BonteÂ
LVMH R & D Perfumes and Cosmetics, Saint-Jean de Braye, France
Cellular L-ascorbate (LA) homeostasis plays a determinant role in neutralizing free radicals formed
during oxidative metabolism or UV exposure of human skin, radicals suspected to trigger oxidative
stress-related disorders and ageing at the molecular, cellular and tissue levels. LA is also the main
cofactor for the prolyl- and lysyl-hydroxlases involved in co- and post-translational collagen
modi®cations and stimulates collagen biosynthesis at the protein and mRNA levels. It has been
previously shown that ®broblasts from a sun exposed area, where wrinkles appear easily, present a
decreased of collagen type I and III synthesis and a lower response to LA stimulation. Primary
cultures of normal human skin ®broblasts were obtained from face lifts (12 healthy caucasian
women from 37 to 74 years old) and grown in an E-199 medium containing 2 mM L±glutamine
and 10% v/v foetal calf serum. LA uptake was carried out using a 2-h incubation with 150 mM 14C-
LA (speci®c activity 14.1 Ci per mM) then quanti®ed by liquid scintillation after separation by NH2
phase HPLC. Cellular proteins were measured using the bicinchoninic acid reagent. An age-related
decrease of LA uptake was observed on ®broblast cultures (from 4 to 1.5 pmol LA per mg protein).
Furthermore, a Bertholletia excelsa pericarp extract, enriched in ellagic acid and O-methylellagic
acid, was found to increase the ®broblast input of LA (+ 55% at 1 mg per ml to + 78% at 5 mg
per ml) and thus appears to be of potential interest in aging treatment.
065
Retinoid Regulation of Collagen Synthesis by TGF-b1, CTGF, and Cyr61 in
Chronologically Aged and Photoaged Human Skin In Vivo
G. J. Fisher, T. H. Quan, T. Y. He, Y. Shao, and J. J. Voorhees
Department of Dermatology, University of Michigan, Ann Arbor, MI, USA
Synthesis of type I procollagen (COL), the major structural protein in skin, is reduced in aged and
photoaged human skin. TGF-b is a major regulator of COL biosynthesis. Recently, two related
proteins, CTGF and Cyr61, have been demonstrated to modulate TGF-b regulation of COL
synthesis. CTGF is directly regulated by TGF-b, and like TGF-b promotes COL synthesis. Cry61
acts in opposition to TGF-b and CTGF to reduce COL synthesis. We have examined TGF-b,
CTGF, and Cyr61 expression, and their regulation by retinoid, in aged and photoaged human
skin. Quantitative real-time RT-PCR analysis demonstrated that TGF-b1 (but not TGF-b2 or b3)
and CTGF mRNA levels, normalized to total RNA or housekeeping gene 36B4, were reduced in
sun-protected aged (80+ years) skin by 65% and 45%, respectively, compared to young skin (20±
30 years, n = 6, p < 0.05). In photoaged forearm skin, TGF-b1 and CTGF mRNA were reduced
by 60% and 50%, respectively, compared to subject-matched sun-protected skin (n = 6, p < 0.05).
In contrast, Cyr61 mRNA levels were increased 3.9-fold in aged skin (n = 5, p < 0.05), and 2.9-
fold in photoaged skin (n = 3, p < 0.05). Immunohistology revealed that TGF-b1 and CTGF
proteins were expressed throughout the epidermis and dermis, while Cyr61 was expressed mainly
in dermal cells. Topical application of retinol (1%) for seven days markedly increased TGF-b1 (2.3-
fold), CTGF (2.6-fold), and COL (2.6-fold) gene expression, compared to vehicle (n = 5, p < 0.05)
in aged skin. In contrast, retinol treatment reduced Cyr61 gene expression by 65% (n = 6, p
< 0.05). Similarly, retinol increased TGF-b1 (2.1-fold), CTGF (2.2-fold), and COL (3.0-fold)
(n = 4±6, p < 0.05), and reduced Cyr61 gene expression by 70% (n = 3, p < 0.05) in photoaged
skin. In situ hybridization revealed increased TGF-b1 and CTGF mRNA in the dermis and
epidermis of aged and photoaged skin. These data reveal that molecular mechanisms that mediate
reduced COL synthesis are strikingly similar in aged and photoaged skin. These molecular
mechanisms involve aberrant expression of both positive (TGF-b, CTGF) and negative (Cyr61)
regulators, whose expression is normalized by topical retinoid treatment.
066
Chemokines: Key Regulators in the Dynamic Process of Cutaneous Wound Healing
E. BuÈnemann, M. Zepeda, A. MuÈller, A. Zlotnik, and B. Homey
DuÈsseldorf, Germany; San Diego, USA and South San Francisco, USA
Wound healing represents a dynamic process involving directional migration of leukocytes and
structural cells such as keratinocytes, ®broblasts, and endothelial cells. Recently, it has been shown
that chemokines regulate leukocyte traf®cking. We performed a comprehensive analysis of
cytokine, adhesion molecule, matrix metalloproteinase (MMPs), growth factor and chemokine
expression in murine cutaneous wound healing using real time quantitative PCR (n = 162 different
genes). Compared to other cytokines, growth factors and MMPs, chemokines were the most
highly regulated genes. Chemokine expression coincided with the appearence of matching
receptors. Within hours after injury, chemokines such as MIP-2, LIX, MIP-1a, MIP-1b, MIP-1 g,
eotaxin, MCP-1, MCP-3, and IP-10 showed peak levels of expression. However, MCP-6, SDF-1
and RANTES dominated chemokine expression on day 2±5; while MIG and CCR6 were up-
regulated on day 5±10. Next to leukocytes, we could show that resting as well as activated human
primary keratinocytes (CXCR1, CXCR2, CCR6), dermal ®broblasts (CCR7) and dermal
microvascular endothelial cells (CXCR3, CCR3) express a distinct and functionally active
repertoire of chemokine receptors. Taken together, our results indicate that chemokines may
regulate the directional migration of both leukocytes and structural cells in the dynamic process of
wound healing. These ®ndings may have impact on the development of novel therapeutic
strategies for the treatment of chronic ulcers.
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Increase of Melanoma Cells Invasion by Elastin Derived Peptides Through Up-
Regulation of MMP-2 Activation
C. Ntayi, W. Hornebeck,* and P. Bernard
Department of Dermatology and *Department of Biochemistry, CNRS FRE 3524; IFR 53-Biomolecules,
Faculty of Medicine, Reims, France
Elastin, as a main constituent of elastin ®bers, plays an important role in skin biology. Its
degradation by gelatinases (MMP-2, MMP-9) generates elastin peptides (E.P.) which exhibit
several biological functions. Particularly, interaction between E.P. and a truncated b galactosidase
elastin/laminin receptor present at the plasma membrane of various cell types was shown to trigger
MMP-expression. Here, we studied the effects of a soluble elastin-derived peptides (EDPs) from
alkaline or elastase hydrolyses of insoluble elastin, on melanoma cells invasion and MMP
expression. When melanoma cells were cultured on EDPs coated dishes, the expression of MMP-
2, MT1-MMP, TIMP-2, but not MMP-1, were enhanced. The stimulatory effect of MMP-2
production could be reproduced when melanoma cells were grown on dishes coated with Val-
Gly-Val-Ala-Pro-Gly (VGVAPG) peptide, an elastin derived hydrophobic hexapeptide which
represented the elastin receptor binding sequence of tropoelastin. Furthermore, EDPs did not
altered nor melanoma cells adhesion nor their proliferation, suggesting that the observed
phenomenon required transcriptional or post-transcriptional mechanisms. In a previous work, we
have shown that the activation of MMP-1 and MMP-2 occurred within a three dimensional type I
collagen matrix, thus allowing melanoma cells invasiveness. In presence of EDPs, MMP-2
activation was strikingly exacerbated, related to a decrease of TIMP-2 production. In the same
manner, invasion of type I collagen matrix by melanoma cells was signi®cantly increased. These
results, in keeping with our previous data suggest that the main ®brillar matrix macromolecules of
human dermis i.e collagen and elastin, actively contribute to melanoma cells invasion, through
modulation of MMP-2 activation.
068
5-Fluorouracil Blocks TGF-b-Induced a((2)) Type I Collagen (COL1A2) Gene
Expression in Human Fibroblasts: Role of JNK/AP-1
J. Wendling, C. Tacheau, A. Mauviel, and F. Verrecchia
INSERM U532, Skin Research Institute, Saint-Louis Hospital, Paris, France
5-¯uorouracil (5-FU), a pyrimidine analog, is widely used in cancer chemotherapy and for its
anti®brotic effect in the glaucoma surgery. Recently its interest in the treatment of keloids, scars
which overgrow the boundaries of original wounds, has been suggested. Given the
physiopathological importance of TGF-b in keloid formation, we focussed our attention on the
molecular events underlying the effect of this drug on TGF-b-induced type I collagen gene
expression. Western blot analysis and transient transfections experiments demonstrated that short-
term 5-FU applications (10 mM, 24 h) antagonize TGF-b driven COL1A2 transcription, in human
dermal and lung ®broblasts. EMSA experiments showed that 5-FU inhibit the formation of Smad/
DNA complexes upon TGF-b stimulation. Given the critical role of of c-Jun in mediating the
antagonistic effect of TNF-a on the up-regulation of type I collagen gene expression by TGF-b,
we investigated the effect of 5-FU on cJun/AP-1 signaling pathway. Transient transfection
experiments demonstrated that 5-FU (10 mM, 24 h) is able to transactivate the AP-1 speci®c
promoter construct pAP1-lux. In EMSA, a strong band identi®ed as an AP-1-containing complex
was detected with nuclear extracts from 5-FU-treated ®broblasts, which was supershifted with a
cJun antibody. On the other hand, we demonstrate that in a cellular context devoid of JNK activity
(i.e. JNK±/± ®broblasts), 5-FU do not inhibit the formation of Smad/DNA complexes and resulting
Smad-driven COL1A2 transcription in response to TGF-b. Together, these results suggest a
critical role for JNK-mediated c-Jun phosphorylation in mediating the inhibitory effect of 5-FU on
TGF-b/Smad signaling and subsequent up-regulation of COL1A2 gene expression by TGF-b. In
addition to the effect of 5-FU long-term exposures on cellular metabolism, the antagonistic activity
of 5-FU against TGF-b/Smad-driven COL1A2 gene transcription could explain the clinical effect
of 5-FU in keloids.
069 [Oral 058]
An Amino Acid Substitution in Integrin a6 Causes Junctional Epidermolysis Bullosa
with Pyloric Atresia
L. Gagnoux-Palacios, M. Allegra, Y. Gache, G. Lestringant,* and G. Meneguzzi
U385 INSERM, Nice, France; *Tawam Medical Center, Al Ain, United Arab Emirates
Mutations in the genes for integrin a6b4 cause junctional epidermolysis bullosa associated with
pyloric atresia (PA-JEB), an inherited disorder characterized by severe blistering of the skin, pyloric
occlusion and aplasia cutis. In this study, we report the characterization of a consanguineous PA-
JEB family with a member affected by a lethal form of the condition. The proband's skin was not
reactive with the antibodies speci®c to integrin a6b4. Western blot and immunoprecipitation
analysis of cellular extracts obtained from cultures of the patient's keratinocytes revealed expression
of integrin b4 and failed to detect the mature form of integrin a6. The steady-state level of the a6
and b4 transcripts in the PA-JEB keratinocytes resulted comparable to that of wild type controls.
Genetic analysis of the a6 cDNA revealed a homozygous base pair substitution at position 286 that
results in the substitution of a serine to a leucine residue (286 S-to-L). Analysis at genomic level
assessed the mendelian transmission of the DNA sequence variation in the PA-JEB kindred. The
286 S-to-L substitution is localized in an amino acid sequence that is conserved in most of the
integrin a subunits and is involved in the folding of the N-terminal region of the a6 integrin into a
b-propeller domain. Transfer of the mutant a6 cDNA into a6-null keratinocytes con®rmed the
deleterious effect of mutation 286 S-to-L on the expression of the abnormal a6 subunit.
Biochemical analysis of the patient's keratinocytes demonstrated that substitution 286 S-to-L is
suf®cient to trigger the massive proteolytic degradation of the a6 integrin and showed that the
lysosomal pathway is implicated in the proteolytic process. Our results show for the ®rst time that
the conformation alteration of extracellular domain of a6 integrin induced by a single amino acid
substitution triggers the massive degradation of integrin a6b4 and give rise to a lethal PA-JEB
phenotype.
070
Deletion of a Cytoplasmic Domain of Integrin b4 Causes Epidermolysis Bullosa Simplex
M. F. Jonkman, H. H. Pas, and G. van der Steege
Groningen, the Netherlands
Integrin a6b4 is a hemidesmosomal transmembrane molecule involved in maintaining basal cell±
matrix adhesion through interaction of the large intracytoplasmic tail of the b4 subunit with the
keratin intermediate ®lament network, at least in part through its binding with plectin and BP180/
type XVII collagen. Here we report a patient with predominant features of epidermolysis bullosa
simplex due to a mutation in the integrin b4 gene. The patient, a 49-year-old-female, had mild
acral blistering from birth on, dystrophy of the nails with onychogryposis, and enamel hypoplasia.
She had no alopecia and no history of pyloric atresia. Electron microscopy and antigen mapping of
a skin blister revealed that the level of separation was intraepidermal, low in the basal keratinocytes
between the inner and outer attachment plaque of the hemidesmome. Immuno¯uorescence
microscopy revealed absent binding of monoclonal antibody 450±11 A against the third ®bronectin
III repeat on the intracellular domain of integrin b4, whereas binding was reduced with
monoclonal antibodies recognizing epitopes on the extracellular domain. At the molecular level
the phenotype was caused by a novel two base-pair deletion 4733delCT in ITGB4, resulting in-
frame skipping of exon 36 and a deduced 50 amino acid deletion (1573±1622) within the third
®bronectin type III repeat in the cytoplasmic domain of the integrin b4 polypeptide. Immunoblot
analysis demonstrated a 5-kDa shorter b4 polypeptide. The 4733delCT mutation was
heterozygously present in the DNA. The patient is also expected to be heterozygous for a null
allele, since no full size protein was detected In vitro and the epitope 450±11 A was absent in vivo.
This case learns us that deletion of the third ®bronectin type III repeat in the cytoplasmic domain
of integrin b4, which is thought to interact with BP180/type XVII collagen, is clinically
pathogenic and results in a mild phenotype with predominant features of epidermolysis bullosa
simplex.
071
Experimental Mouse Model of Bullous Pemphigoid Using Antibodies Generated
Against an Antigenic Epitope of Hemidesmosomal Plaque Protein BP230
S. Husz, M. Kiss, T. JaÂnossy,* J. MolnaÂr,² I. Marczinovits,² I. Korom, and A. Dobozy
Departments of Dermatology, *Surgical Research and ²Physiology, University of Szeged, Hungary
Bullous pemphigoid (BP) is an IgG-mediated autoimmune blistering disease targeting the
hemidesmosomal plaque protein BP230 and the transmembrane protein BP180. Immuno-
dominant and pathogenic epitopes associated with BP have been mapped to the extracellular
domain of BP180, but the pathogenetic role of anti-BP230 antibodies remains unclear. To
investigate this phenomenon, rabbit polyclonal antibodies were generated against the antigenic
segment of the human BP230 antigen (BPAG 1, 1914±34), a sequence which shows 74%
homology in human and mouse BP230 protein. The rabbit polyclonal immune serum was tested
on human and mouse skin by indirect immuno¯uorescence and immunoblotting, and also by the
ELISA technique, using antigenic epitope-coated wells. The speci®city and titres of the rabbit
immune serum (1:2840) were suitable for passive transfer experiments. The puri®ed rabbit IgG
from immunized rabbit serum was transferred subcutaneously into the dorsal skin of neonatal CBA
mice (n = 7) in a dose of 5 mg IgG per 50 mL. After 6 h, the dorsal skin areas of the injected animals
were markedly erythematous, whereas in the control animals injected with PBS or control rabbit
IgG, the sites of injection cleared up. After 24 h, one animal exhibited a small blister clinically, but
the dorsal skin areas of all the injected animals were constantly erythematous and upon gentle
friction produced ®ne persistent wrinkling of the epidermis. Mice were then sacri®ced and
immunohistological examinations revealed linear rabbit IgG deposition along the basement
membrane zone of the perilesional mouse skin, and in 5 animals subepidermal blister formation was
also demonstrated. The rabbit IgG deposition labelled the epidermal roofs of the vesicles.
Haematoxylin-eosin stained sections showed the separation of the epidermis from the dermis,
producing a subepidermal vesicle. A slight intradermal in¯ammatory reaction was also detected.
These ®ndings demonstrate that antibodies against an antigenic epitope of BP230 protein can cause
subepidermal blister formation in neonatal mice.
072
Paraneoplastic Pemphigus Sera Display Plakophilin-3 Autoreactivity
J. Lambert, S. BonneÂ,* H. H. Pas,² S. De Schepper, F. van Roy,* and J. M. Naeyaert
Department of Dermatology and *Department of Molecular Cell Biology, Ghent University, Belgium;
²Department of Dermatology, Groningen University Hospital, the Netherlands
Paraneoplastic pemphigus (PNP) is a not well-understood auto-immune mucocutaneous bullous
disorder appearing in association with neoplasia. Classically, patients with PNP develop
autoreactivity against desmosomal plaque proteins of the plakin family like desmoplakin1/2,
envo- and periplakin and plectin, against desmosomal cadherins like desmoglein 1/3 and also
against a yet unidenti®ed 170 kDa protein. In this study we tested whether PNP is associated with
autoreactivity against another intracellular desmosomal protein namely the armadillo-repeat
containing plakophilin-3 (PKP3) protein. HEK293 cells were transiently transfected with a pEF6/
myc-his and a pEGFPN2 construct encoding human PKP3 (85 and 115 kDa Mr, respectively) and
protein lysates were made in Laemmli buffer. Lysates underwent 7,5% SDS-PAGE and Western
blots were subsequently labelled with 5 PNP sera, 4 PV sera, 2 PF sera, 5 BP sera, 1 CP serum and 1
LAD serum. A mouse monoclonal anti-PKP3 antibody raised against a 20 AA peptide of human
PKP3 was used as a positive control. Autoreactivity against, respectively, 85 and 115 kDa
recombinant PKP3 protein products was detected in all 5 PNP sera and in 1 PV serum. None of
the basement membrane zone bullous diseases reacted with these proteins. The presence of
autoantibodies against PKP3 in PNP-sera was subsequently con®rmed on human epidermal lysate
blots. This is the ®rst report of PKP3 reactivity in bullous disorders, seemingly consistently present
in the patients with PNP tested. The presence of PKP3 reactivity in one PV patient is not
surprising, since also in this disease the desmosome is targeted. We are currently investigating
whether PKP-3 autoreactivity is merely a secondary phenomenon induced by keratinocyte injury
or whether it can act primarily to induce blisters.
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Animal Models for Skin Blistering Conditions: Absence of Laminin 5 Causes Hereditary
Junctional Mechanobullous Disease in the Belgian Horse
F. Spirito, A. Charlesworth, K. Linder,* J-P. Ortonne, J. Baird,* and G. Meneguzzi
INSERM, U385, Nice, France; *University of Guelph, Guelph, Canada
Recent achievements in the genetic correction of keratinocytes isolated from patients with
junctional epidermolysis bullosa (JEB) have brought somatic gene therapies within reach. Because
gene therapy protocols require preclinical validation in animals, we have elucidated the genetic
basis of the hereditary junctional mechanobullous disease in the Belgian horse, a condition
characterized by blistering of the skin and mouth epithelia, and loss of the hoof.
Immuno¯uorescence analysis associated the condition to the absent expression of the g2 chain
of laminin 5 and designated lamc2 as the candidate gene. Comparative analysis of the nucleotide
sequence of the full-length g2 cDNA isolated by RT-PCR ampli®cation of total RNA puri®ed
from the epithelium of a JEB foal and a healthy control disclosed the homozygous basepair
insertion 1368insC in the affected animal. Mutation 1368insC results in a downstream premature
termination codon and is predicted to cause absent expression of the laminin g2 polypeptide. Our
results also show that: (1) the horse JEB genetically corresponds to the severe Herlitz form of JEB in
man; (2) the amino acid sequence and structure of the horse laminin g2 chain are virtually identical
to the human counterpart; (3) the moderate eruption of skin blisters in the affected animals with
respect to the human H-JEB patients correlates with the protection provided by hair. Our
observations demonstrate that the affected foals are a convenient source of epithelial cells from
tissues that cannot be obtained from human JEB patients, and suggest that hairless strains of animals
with recessive skin disorders would be the best models for in vivo gene therapy approaches of skin
blistering diseases.
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Dose-Effect Relation in SJS or TEN Related to Allopurinol
J.-C. Roujeau, P. D. Ghislain, M. Mockenhaupt,* J. N. Bouwes Bavinck,² L. Naldi,³ A.
Sidoroff,§ S. Halevy,¶ and A. C. Paty**
Henri Mondor, CreÂteil, France; *Freiburg University, Freiburg, Germany; ²Leiden University, Leiden,
Netherlands; ³Milan University, Milan, Italy; §Innsbruck University, Innsbruck, Austria; ¶Ben Gurion
University, Be'er Sheva, Israel; **INSERM U 444, Paris, France
By opposition to idiosyncratic reactions, allergic reactions are generally considered dose-
independent. In this debate, we have been interested by studying the relation between the drug
dose and the risk of SJS (Stevens±Johnson syndrome) and TEN (toxic epidermal necrolysis). We
used the database of EuroSCAR, an international ongoing case-control surveillance of severe
cutaneous adverse reactions. The data of this presentation concern patients included between 07/
1997 and 07/2001 (370 cases of SJS/TEN and 1308 controls). Many causative drugs were
identi®ed. For our study of the dose-effect relation, we selected a drug frequently used at different
doses and to which a suf®cient number of cases included in EuroSCAR had been exposed.
Allopurinol met both criteria. We identi®ed 75 cases and 31 controls exposed to allopurinol (odds
ratio 10.7, 5.9±19.6) Doses missed or were unprecise for 33 cases and 16 controls. Weight missed
for another case patient. Median doses were 300 mg per day for cases and 100 mg for controls.
Mean doses were signi®cantly higher in cases (235 mg per day) than in controls (143) (p < 0001)
Range was nearly the same. Odds ratios were 1.8 (0.6±5.2) for < 100 mg per day, and for
doses > 100 mg per day and 28.1 (10.9±72.1) for higher doses. Patient weight was not a bias, the
mean doses by kg were higher in cases than in controls (3.53 mg per kg per day vs. 1.91, p
< 0.001). Prior data already suggested that high doses of medication could be related to higher risk
of ADR's. For example, in AIDS patients, the rate of reactions to cotrimoxazole were higher for
high doses used for treating pneumocystosis than for low doses used in prevention. In conclusion,
we consider that the dose is a major risk factor for allopurinol-induced SJS or TEN. Further studies
are needed to verify this ®nding with other drugs.
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Detection of Circulating IgG and IgA Antibodies against Pulmonary Tissue in
Paraneoplastic Pemphigus
K. Preisz, T. Hashimoto,* M. Amagai,² A. HorvaÂth, and S. KaÂrpaÂti
Budapest, Hungary; *Kurume, ²Tokyo, Japan
Progressive respiratory failure with bronciolitis obliterans might lead to death in patients with
paraneoplastic pemphigus (PNP) especially in cases with lichenoid skin symptoms. Possible causes
of the respiratory failure include infection, toxic effects induced by chemotherapy, neoplasia and
autoantibody-mediated pulmonary injury. Previously G. Anhalts group detected IgG in the
pulmonary tissue of severe PNP cases, however, the binding site of circulating IgG has not been
determined and its antigenicity remained obscure. Blood samples of two immunologically veri®ed
PNP patients with severe pulmonary involvement have been studied. Both patients had lichenoid
skin symptoms, extended erosive stomatitis, laryngitis and corneal erosions as well as severe
dyspnoe. Although both skin and mucosal symptoms got into remission under high doses of
immunosuppressive treatment and/or surgical excision of the underlying tumor, the dyspnoe
showed in both cases rapid progression leading to death. Both circulating IgA and IgG bound to rat
pulmonary tissue along the bronchial respiratory epithelial cell surfaces. Control sera didn't show
similar reactivity. The detection of circulating autoantibodies against respiratory epithelium
suggests, that these antibodies might have a pathogenic role in the pathomechanism of pulmonary
injury in PNP.
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Osteopontin Polarizes Dendritic Cell Maturation Towards a Dendritic Cell 1 Phenotype
A. C. Renkl, J. Wussler, T. Ahrens,* K. Thoma, C. Bernardi, J. C. Simon, and J. M. Weiss
Department of Dermatology, Universtity of Freiburg, *Institute of Biology, Basel University
Immature dendritic cells (DC) are located at epithelial borders. After activation and antigen uptake
they mature and migrate into secondary lymphatic organs to initiate T-cell mediated immunity. As
DC1 (high secretion of IL-12) or DC2 they are able to polarize naive T-cells towards either a Th1
or Th2 phenotype, decisively affecting the outcome of an immune response. Recently we
demonstrated that Osteopontin (OPN) is important in cutaneous contact hypersensitivity by
guiding DC into lymph nodes. Since OPN has been identi®ed to have Th1 cytokine like
properties, we now explored the effect of OPN on the phenotypic and functional maturation of
DC. Human monocyte derived DC were cultured +/± OPN and supernatants and cells were
analyzed after 24 and 48 h by ELISA or FACS. OPN strongly induced DC activation, up-
regulating their expression of HLA-DR, CD40, CD80, CD86, CD44 and CD56 and their TNF-a
secretion. In allogeneic mixed lymphocyte reactions (MLR) OPN was either added directly into
MLR with immature DC or OPN prestimulated DC were used. When OPN was added to MLR
with immature DC, T-cell proliferation was enhanced, while addition of OPN to T-cells alone
had no effect on their proliferation or cytokine secretion. However, when MLR was performed
with OPN activated DC a strongly increased T-cell proliferation was detected compared to control
DC. In MLR supernatants we found that both addition of OPN to MLR or OPN prestimulation
of DC induced an up-regulated secretion of the Th1 cytokine IFN-g. Furthermore, high amounts
of IL-12p70 were detected when OPN was added to the MLR, while IL-10 was not modulated.
Our ®ndings indicate that OPN induces DC maturation and their polarization towards a DC1
phenotype, indicating that the Th1 cytokine like properties of OPN are at least in part mediated
through its effect on DC.
077 [Oral 021]
Dendritic Cell-Derived Interleukin 13, Induced by Exposure to Protein-Allergens and
Subsequent Activation of STAT6, is a Key Factor for the Acquisition of their Capability
to Induce Th2 Cytokine Production
I. Bellinghausen, P. Brand, B. Klostermann, J. Knop, and J. Saloga
Mainz, Germany
Dendritic cells (DC) are able to induce not only Th1 but also Th2 immune responses after
stimulation with allergens. While DC-derived IL-12 and IL-18 are the key factors for the
induction of Th1 cells, early signals being involved in Th2 differentiation are less well characterized
so far. To analyze such early signals we used an antigen-speci®c setting with CD4+ T cells from
atopic donors stimulated in the presence of autologous mature DC, which were pulsed with
different allergen doses. The addition of increasing amounts of allergen during DC maturation with
TNF-a, IL-1b and prostaglandin E2 resulted in enhanced secretion of IL-6 and IL-12 by DC
followed by increased production of Th1 (IFN-g) as well as Th2 (IL-4, IL-5) cytokines by CD4+ T
cells. The coculture of allergen-treated DC and CD4+ T cells also led to a dose-dependent
expression of active STAT6 which was visible already after 1 h. Additionally, rapid phosphoryla-
tion of STAT6 was seen in immature DC after stimulation with allergens but not with LPS or
HSA. STAT6 phosphorylation was associated with the production of IL-13 by DC. The addition
of neutralizing anti-IL-13 antibodies during maturation of DC inhibited their capability to induce
IL-4 and to a lesser extend IL-5 production, but not IFN-g production. Addition of exogenous IL-
13 enhanced mainly the secretion of IL-4. Taken together, DC-derived IL-13 which is released
after exposure to allergens appears to be one of the critical factors for DC, which express IL-13
receptors, to acquire the capability to induce Th2 cytokine production.
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Inhibition of STAT1 Pathway by Suppressor of Cytokine Signaling (SOCS) 1 Prevents
the IFN-g-Induced Expression of Pro-In¯ammatory Genes in Human Keratinocytes
C. Albanesi, C. Scarponi, M. L. Giustizieri, M. Federici, and G. Girolomoni
IDI-IRCCS, Rome, Italy
Contribution of keratinocytes to the pathogenesis of immune-mediated skin diseases is linked to
their intrinsic capacity to respond to pro-in¯ammatory stimuli. IFN-g is the cytokine to whom
keratinocytes are more susceptible and respond producing a broad array of in¯ammatory mediators,
and its inactivation would be advantageous in pathologic conditions. SOCS1 and SOCS3 are
negative feedback regulators of IFN-g signaling and are induced in many cell types by IFN-g itself
and other cytokines. We show here that SOCS1, SOCS2, SOCS3 and cytokine-inducible SH2-
containing (CIS) mRNA were up-regulated by IFN-g in normal human keratinocytes whereas
only SOCS1 or SOCS1 and CIS were induced by TNF-a or IL-4, respectively. SOCS1, SOCS2,
SOCS3 proteins were undetectable in healthy skin, and highly expressed in the epidermis of
psoriasis and allergic contact dermatitis but only weakly in atopic dermatitis skin. In keratinocytes
transiently transfected with SOCS1 or SOCS3 the IFN-g-induced transactivation of an IFN-g-
responsive reporter gene was markedly inhibited. SOCS1 and SOCS3 overexpression in
keratinocyte stable clones inhibited IFN-g-induced phosphorylation of IFN-gRa, and activation
of STAT1 and STAT3. Furthermore, SOCS1 and, to a lesser extent SOCS3 reduced membrane
expression of ICAM-1 and HLA-DR, and IP-10, Mig and MCP-1 release by keratinocyte clones
promoted by IFN-g. SOCS1-expressing keratinocytes showed constitutive higher, but not IFN-g-
inducible, IL-8 levels compared to SOCS2 and SOCS3 clones, and were resistant to IFN-g-
mediated growth inhibition. Targeting keratinocyte SOCS1 may represent a novel therapeutic
approach to IFN-g-dependent skin diseases.
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Autoimmunity Against Retroviral Proteins Patients with Psoriasis
J. P. MoleÁs, J. C. Hadi, and J. J. Guilhou
Montpellier, France
Increasing evidences suggest that Human Endogenous Retroviruses (HERVs) could participate in
the pathogenesis of autoimmune diseases, including multiple sclerosis or rheumatoid arthritis. We
have previously found that different families of human endogenous retroviral sequences were up
regulated in the psoriatic lesion including the HERV-W, -K and ±E families. In addition, we have
characterised a new variant within the HERV-W family that was almost speci®cally expressed in
psoriatic lesions. Since this family belongs to the Murine Leukemia Virus (MLV)-like group of
HERVs, we have searched for antibodies against MLV proteins in the sera of psoriatic patients to
assess a possible role in autoimmune processes of the disease. The screening for anti-MLV
antibodies was performed in 49 psoriatic and 32 control sera by western-blot on MLV proteins
obtained after collecting and centrifuging the supernatant of FlyE packaging cell line. Anti-MLV
IgAGM antibodies were detected in both psoriatic and control sera. However, their detection was
signi®cantly increased in psoriatic samples compared to control (87% vs. 50%, respectively,
p = 0.001). In addition the seroconversion to an IgG response was dramatically increased in
psoriatic sera (85% vs. 10%, respectively, p < 0.0001). This immunoreactivity was observed against
the products of both the gag (p30) and env (p15E and gp65±70) genes and the most antigenic
proteins was the gp65±70. The IgM response to MLV has already been described in normal
individuals and is supposed to participate to the innate immune response, however, the
seroconversion to an IgG response has only been previously described in HIV positive patients. To
further characterize this seroconversion, we blot-puri®ed the antibodies reacting with the p30
MLV protein and detected a protein with a molecular weight of 50 kDa in human skin protein
extracts from both normal and psoriatic reconstructed skin. These results suggest that a speci®c
seroconversion to an IgG response against MLV proteins occurs in psoriasis and that these
antibodies could cross-react against a protein present in normal human skin. The characterization
of this protein would help to further understand the role of immune response against HERVs in
the pathogenesis of psoriasis.
080
Human Keratinocytes Synthesize Factor H: Synthesis is Regulated by IFN-g
K. K. Timar, M. C. Pasch, H. Jarva, S. Meri, N. H. A. van den Bosch, J. D. Bos, and S. S. Asghar
Amsterdam, the Netherlands and Helsinki, Finland
Locally synthesized complement plays an important role in host defense and in¯ammation at tissue
and organ level. Keratinocytes have been shown to synthesize two soluble complement
components, C3 and factor B. We investigated whether factor H, which controls the activities
of C3 and factor B, is also synthesized and released by keratinocytes. Regulation of factor H
synthesis by some in¯ammatory mediators was also studied. Keratinocytes were cultured for 72 h in
the presence and absence of supernatant of activated peripherial mononuclear cells, IL-1a, IL-2,
IL-6, TGF-b1, TNF-a or IFN-g. Factor H was measured in culture supernatants by ELISA.
Molecular species of released factor H were identi®ed by Western blotting. Factor H transcripts
were detected by RT-PCR. Regulation of factor H message was studied by a semiquantitative
RT-PCR. For measurement of factor H bioactivity, cell supernatants were incubated with 125I-
C3b and factor I and were run on an SDS-page gel; C3b cleavage was visualized by
autoradiography. Human keratinocytes constitutively released biologically active factor H. None of
the above mentioned cytokines, except IFN-g regulated its release. IFN-g induced release of factor
H was inhibited by cycloheximide. Factor H mRNA was constitutionally expressed in
keratinocytes and was strongly up-regulated by IFN-g. Keratinocytes are capable of synthesizing
factor H and this synthesis is regulated by IFN-g at pretranslational level.
081
EGF Receptor Ligands Regulate Chemokine Expression in Human Keratinocytes
S. Pastore, F. Mascia, V. Mariani, and G. Girolomoni
IDI-IRCCS, Rome, Italy
During chronic in¯ammatory disorders of the skin, cytokines released by in®ltrating leukocytes
induce keratinocytes to overexpress EGF receptor (EGFR) ligands, including transforming growth
factor (TGF)-a, amphiregulin (AR), and heparin-binding EGF-like growth factor (HB-EGF),
which are directly responsible of the hyperproliferative state of the involved epidermis. Little is
known about the impact of EGFR ligands on TNF-a- or IFN-g- driven keratinocyte activation.
In this study we have investigated the capacity of EGFR ligands to modulate spontaneous and
TNF-a- or IFN-g-induced expression of a cluster of chemokines relevant in skin in¯ammation,
such as GM-CSF, IL-8, MCP-1, RANTES and IP-10. Subcon¯uent cultures were treated with
EGFR ligands alone, or associated to TNF-a or IFN-g. A modest increase in basal GM-CSF and
IL-8, and down-regulation of RANTES and IP-10 mRNA levels were evident as early as 2 h
following stimulation with EGFR ligands. Moreover, EGFR ligands dose-dependently synergized
with TNF-a or IFN-g in the induction of GM-CSF and IL-8, whereas they counteracted
lymphokine induction of RANTES, MCP-1, and IP-10. Parallel variations were detected at the
protein level in the supernatants collected after 24 h. Pharmacological abrogation of EGFR ligand-
dependent autocrine loop, performed either with EGFR blocking antibody or speci®c EGFR
kinase antagonists, or using a broad spectrum hydroxamate inhibitor of matrix metalloproteases,
signi®cantly affected TNF-a- or IFN-g-stimulated chemokine expression. GM-CSF and IL-8
were suppressed, whereas RANTES, IP-10 and MCP-1 were signi®cantly up-regulated. Analysis
of chemokine mRNA decay kinetics in the presence of the transcriptional blocker actinomycin D
indicated that abrogation of EGFR signaling perturbed both mRNA neosynthesis and stability.
Finally, EGFR kinase antagonists increased expression of IP-10 and inhibit IL-8 expression in the
epidermis of skin organ cultures treated with IFN-g. Our data suggest that cross-talk between
lymphokine-induced signals and EGFR-mediated signals regulates keratinocyte activation during
in¯ammatory processes of the skin.
082
Regulation of Expression of the Chemokine CCL27 (CTACK) During Allergic Contact
Dermatitis
S. Gibbs, S. Spiekstra, M. Toebak, J. Flier, D. Boorsma, T. Rustemeyer, B. M. E. von Blomberg,
R. J. Scheper, and D. P. Bruynzeel
Free University Medical Centre, Amsterdam, Netherlands
Chemokines are important mediators of immune-regulated skin disorders such as allergic contact
dermatitis (ACD). The differential and sequential expression of chemokines regulates the type as
well as the timing of the in®ltrate into the affected area. CCL27 is such a chemokine ± recently it
has been shown that CCL27 is inducible during the early stages of ACD and is responsible for
attracting activated T cells into the skin. Whether or not this chemokine is triggered in general by
early danger signals (chemical exposure) or whether it is restricted to allergens is unknown. Also
how this chemokine relates to the induction, elicitation and recovery phases of ACD is largely
unknown. In order to determine whether CCL27 expression is induced upon exposure to both
allergen and irritant danger signals, we have patch tested human skin equivalents derived from
nonsensitized individuals with allergens (nickel sulphate, potassium dichromate) and the irritant:
sodium lauryl sulphate. 24 h later the culture medium was harvested and the amount of chemokine
secretion was measured by ELISA. Non toxic concentrations of both allergens and irritant resulted
in an increase in CCL27 secretion above its basal expression. In order to determine how this
chemokine relates to the induction, elicitation and recovery phases of ACD, volunteers recruited
from the contact dermatitis clinic with known contact allergy were patch tested and biopsies taken
before and 4 h, 48 h, 72 h and 21 days after patch testing. In situ RNA hybridization showed that
CCL27 mRNA was already induced 4 h after patch testing and remained increased for at least
21 days after patch testing. This indicates that increased CCL27 expression occurrs very early and
remains longer than the visible effects of the patch test reaction. The late in¯ammatory
chemokines, CXCL9, CXCL10 and CXCL11, in contrast were not induced until 48 h after patch
testing and were no longer detectable 21 days after patch testing. In conclusion, CCL27 secretion is
increased upon chemical exposure and is not retricted to allergenic contacts. Furthermore, CCL27
mRNA levels remain increased after the visible effects of ACD have disappeared. This may in part
explain the phenomena known as ``local skin memory'' and ¯are up reactions at previous ACD
sites.
083
Interferon-g Release from Peripheral Blood Lymphocytes Following In Vitro Challenge
with Drugs in Patients with Cutaneous Adverse Drug Reactions ± Comparison with In
Vivo Tests
S. Halevy, A. D. Cohen, and N. Grossman
Beer-Sheva, Israel
In vitro drug-induced cytokine release suggests a drug-speci®c immune response. The aim of the
present study was to compare between In vitro drug-induced interferon-g (IFN-g) release tests and
in vivo tests with the same drugs in a series of patients with cutanous adverse drug reactions
(CADRs). Drugs taken by 36 patients with CADRs were classi®ed into 3 categories of clinical
drug suspicion: high, possible and low. Twenty-two patients taking a similar pro®le of drugs
without adverse reactions served as controls. Following incubation of peripheral blood
lymphocytes with drugs, the supernatants were collected for the detection of IFN-g release. For
each drug tested the increase in IFN-g release was calculated. A value higher than the mean
percentage increase of IFN-g + 2SD (threshold level) measured in the controls, was determined as a
positive IFN-g-test. In vivo tests, including withdrawal and/or challenge tests with drugs, were
evaluated in 32 patients. Positive IFN-g release tests were recorded for 28/36 (78%) of the patients
towards 56/118 (47%) of the drugs. IFN-g release recorded for drugs taken by the patients
(72.0 6 90.7%) was higher (p < 0.001) than that recorded for drugs taken by the controls
(18.7 6 20.1%). The proportion of positive IFN-g responses was associated with the degree of drug
suspicion: 64%, 36%, and 28%, respectively. Positive IFN-g responses recorded for the highly
suspected drugs were increased as compared to the low suspected drugs (p = 0.001). Analysis of the
results revealed 71.8% percent agreement between the results of In vitro drug-induced IFN-g
release tests and in vivo tests, k = 0.44, which implies intermediate-good agreement. The results of
in vivo tests support the diagnostic role of in vitro drug-induced IFN-g release in CADRs.
084
Alterations in Interferon-Gamma (IFN-g) and Interleukin-4 (IL-4) Expression in
Psoriatic Skin after Narrow Band Ultraviolet B (NB-UVB) Therapy
G. Piskin, J. D. Bos, and M. B. M. Teunissen
Amsterdam, the Netherlands
There is a predominance of type 1 (i.e. IFN-g) cytokines in diseased skin and peripheral blood of
psoriasis patients. We showed that a single exposure to high dose of broad band UVB-radiation
changes the type 1/type 2 (i.e. IL-4) cytokine balance of normal skin in favor of type 2 cytokines.
In this study, we aimed to show whether a change in the expression of IFN-g and IL-4 also takes
place in psoriatic skin after NB-UVB therapy thrice weekly for several weeks. Skin biopsies were
obtained from psoriasis patients (n = 10) before, at the 3rd week and at the end of NB-UVB
therapy. Expression of IFN-g and IL-4 was determined in situ by immunohistochemistry in frozen
sections. Intracellular expression of these cytokines was measured by ¯ow cytometry in isolated
dermal CD4+ and CD8+ T cells. IFN-g was abundantly expressed in all pretreatment biopsies, but
this expression was decreased after the treatment with NB-UVB. Interestingly, IL-4 was also
expressed, though weakly, in most of the pretreatment biopsies and this expression diminished after
the NB-UVB therapy. Although there was a high interpatient variability in intracellular IFN-g
expression, dermal CD4+ and CD8+ T cells expressed less IFN-g after the treatment. No clear
change of intracellular IL-4 expression was observed upon NB-UVB therapy. In sum, NB-UVB
therapy reduces the expression of IFN-g and IL-4 in psoriatic skin. IFN-g production of remaining
T cells in skin after therapy diminishes upon restimulation. These could contribute to the
therapeutic action of NB-UVB.
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Pimecrolimus Demonstrates Signi®cant Immunosuppressive Properties in a Rat Heart
Transplant Model
Y. Sudo, H. Senoh, J. Hiroi, Y. Ohkubo, and S. Mutoh
Osaka, Japan
Pimecrolimus is an ascomycin macrolactam derivative which inhibits the proliferation of human
T-cells. The aim of the study in hand was to assess the immunosuppressive properties of this
compound. We employed a rat heart transplant model which has been used as a standard method
to assess the in vivo immunosuppressive potency of substances since the introduction of cyclosporin.
Thirty rats in the ACI-to-Lewis rat-strain combination underwent heterotopic heart transplanta-
tion. The rats were allocated to 3 groups with ASM 981 dosages of 0.3 mg per kg i.m. (n = 8),
1.0 mg per kg i.m. (n = 8) and 3.0 mg per kg i.m. (n = 7) plus a control group receiving placebo
i.m. (n = 7). Intramuscular injections were administered once daily from the day of transplantation
(Day 0) until Day 13. Allograft rejection was de®ned as cessation of heart beat, grafts were palpated
on a daily basis. Concerning survival times, the median graft survival time (MST) in the control
group was 5 days. The ASM 981 group receiving the lowest dosage (0.3 mg per kg i.m.) did not
show a signi®cantly prolonged survival time. In contrast, the 1.0 mg per kg i.m. and 3.0 mg per kg
i.m. treatment groups showed a signi®cantly increased graft survival duration (MST 14.5 days and
26 days respectively, p < 0.01 versus placebo for both groups). Our ®ndings show that
pimecrolimus signi®cantly prolongs allograft survival in rat heart transplantation. We therefore
conclude that pimecrolimus has substantial immunosuppressive potency and displays comparable
ef®cacy in vivo to cyclosporin.
086
Topical Tacrolimus is More Ef®cacious Than Pimecrolimus in Inhibiting Acute Contact
Dermatitis in a Rat Model
Y. Fujii, S. Sakuma, H. Senoh, J. Hiroi, Y. Ohkubo, and S. Mutoh
Osaka, Japan
The immunomodulatory ef®cacy of tacrolimus and pimecrolimus was compared in a standardised
model of oxazolone-induced skin in¯ammation in the rat. Three concentrations of acetone
solution containing either tacrolimus (0.001%, 0.01%, 0.1%) or pimecrolimus (0.01%, 0.1%, 1.0%)
were applied to the ears of rats one hour prior to challenging with oxazolone. Topical application
of the solutions was repeated three hours later. The amount of swelling observed 72 h following
challenge was inhibited in a dose-dependent manner by the application of either tacrolimus or
pimecrolimus solution. Signi®cant inhibition of the immunological response was observed
following the application of a concentration of 0.01% tacrolimus or more and 0.1% pimecrolimus
or more. Complete inhibition was achieved following application of 0.01% and 0.1% tacrolimus
and 1.0% pimecrolimus. In conclusion, this model demonstrated that tacrolimus has at least a 10
times higher potential for inhibiting acute contact dermatitis compared with pimecrolimus. These
preclinical data suggest that, in the clinical setting, tacrolimus ointment may show considerable
superiority to pimecrolimus in the treatment of moderate to severe cases of atopic dermatitis.
087
Sera From Patients with Palmoplantar Pustulosis Induce Immuno¯uorescence on
Endothelial Cells in Several Organs
E. Hagforsen and G. MichaeÈlsson
Uppsala, Sweden
We previously found antibodies to nicotinic receptors in PPP sera. Forty-seven per cent of the PPP
sera gave an immuno¯uorescence (IF) on endothelial cells in normal palmar skin from a
nonsmoker, especially in the papillary dermis. On palmar skin from smokers there was also IF in
the sweat duct. The staining intensity was stronger in PPP patients with nAChR ab than in those
without nAChR ab both on skin from nonsmokers and smokers. The reactivity to PPP sera has
now also been studied in other skin areas and in sections from normal thyroid and parathyroid
gland, intestinal mucosa and pancreas as PPP patients have an increased prevalence of several
autoimmune diseases. Sera was obtained from 5 PPP patients, 5 healthy nonsmoking persons and 5
patients with hand eczema. Skin biopsy specimens from healthy nonsmoking persons from scalp,
®ngertip, elbow, forearm and back were used together with biopsy specimens of normal thyroid
and parathyroid gland, intestine and pancreas. The results showed that there was IF in the
endothelium also in other skin areas but the strongest and most widespread IF pattern in the skin
was found in the palmar endothelium. This difference in IF pattern might mean that palmar
endothelium may have a different antigenic pro®le than other skin areas. PPP sera also induced an
IF in endothelium in other organs, e.g. thyroid and parathyroid glands, intestinal mucosa and
pancreas. Sera from healthy controls and patients with hand eczema produced no IF. The results
further indicate that PPP is a systemic disease.
088
Bio®lms of Pseudomonas aeruginosa: A New Approach for Understanding P. aeruginosa
Skin Infections
L. Schwichtenberg, J. Harder, B. GoÈthel, and J. M. SchroÈder
University of Kiel, Kiel, Germany
The success of P. aeruginosa (PA), an ubiquitous opportunistic human pathogen, to colonize
epithelia is due to its broad spectrum of virulence factors which are induced under stress
conditions. The ability of these virulent pathogens to form so-called bio®lms as the consequence of
density quorum-sensing is of high relevance for its pathogenity. Therefore the aim of this study was
to analyse whether human keratinocytes are capable of distinguishing between highly pathogenic
bio®lm-forming P. aeruginosa and nonbio®lm forming P. aeruginosa. We investigated different
cultures of PA incubated under stress conditions and evaluated their ability to induce the
production of proin¯ammatory cytokines (like IL-8, IL-1b, and TNF-a) in primary human
keratinocytes. The mRNA-expression in keratinocytes was measured by using RT-PCR and
Realtime-PCR. We found that bio®lms were formed under static growth conditions with low
oxygen and starving conditions. Supernatants of these bacteria showed a highly increased induction
of several proin¯ammatory cytokines compared to nonbio®lm bacteria. RP-HPLC of these
inducing activities revealed elution in single fractions indicating a panel of different inducing
bacterial molecules. A molecular characterization of these pathogen-associated molecules (PAMs) is
currently in progress. In conclusion, our ®ndings support the hypothesis that human skin
keratinocytes recognise highly pathogenic bio®lm-forming microorganisms such as PA via
different PAMs to mount an epithelial defense reaction by producing proin¯ammatory cytokines to
recruit professional phagocytes.
089
Investigations of mRNA Expression Patterns of Different Neuropeptide Receptors in
the Lesional and Non-Lesional Skin of Patients with Psoriasis Vulgaris
M. Kiss, L. KemeÂny, S. Husz, G. Michel,* A. Mirmohammadsadegh,* T. Ruzicka,* and A.
Dobozy
Department of Dermatology, University of Szeged, Szeged, Hungary; *Department of Dermatology,
Heinrich Heine University, DuÈsseldorf, Germany
There is increasing evidence that the cutaneous neurosensory system can modulate in¯ammatory
responses in the skin via the release of neuropeptides. Neuropeptides have been presumed to play
roles in a variety of in¯ammatory skin diseases. The biological responses to different neuropeptides
in the skin depend on the expressions of special neuropeptide receptors on the cells. In this work,
the substance P receptor (NK-1R), the calcitonin gene-related peptide receptor (CGRP-1R), the
melanocortin receptor (MC1-R) and two types of vasoactive intestinal polypeptide receptors (VIP-
1R and VIP-2R) were investigated as concerns the mRNA level in skin biopsies from 11 patients
with a hyperproliferative in¯ammatory skin disorder, psoriasis vulgaris, and 5 healthy persons
undergoing plastic surgery. The biopsies were taken from psoriatic nonlesional (n = 5) and lesional
areas (n = 11). Total RNA was isolated, and semiquantitative RT-PCR reactions were then
performed by speci®c primer sets for different neuropeptide receptors. In the healthy control skin
biopsies, only the MCR-1R was detected. In contrast, in the nonlesional psoriatic skin, NK-1R
and CGRP-1R mRNAs appeared in 2 cases, each. MC-1R mRNA expression was also
demonstrated in 3 of 5 nonlesional skin samples, but neither the VIP-1R nor the VIP-2R were
detected. In the lesional psoriatic skin samples, NK-1R mRNA expression was demonstrated in 9
cases, CGRP-1R and MC-1R mRNAs in 8 cases and VIP-1R expression in 3 samples. Pairwise
comparison of the mRNA expressions of NK-1R and CGRP-1R in nonlesional and lesional
psoriatic areas of 2 patients, revealed higher mRNA levels in the lesional skin. These results support
that both nonlesional and lesional psoriatic skin could be more susceptible to neuropeptide signals
due to higher expression of neuropeptide receptors.
090
Angiogenesis Induced by HPV16 Harboring Tumor Cells is Related Both to Generation
of Angiogenic Factors and Decreased Activity of Interleukin-18
S. Majewski, M. Malejczyk, M. Marczak, B. Mlynarczyk, B. Benninghoff,* and S. Jablonska
Warsaw School of Medicine, Warsaw, Poland; *3M Medica, Borken, Germany
Tumor-induced angiogenesis, i.e. new blood vessel formation within solid tumors is prerequisite
for progression of solid tumors, including HPV-associated cervical carcinoma and other ano-
genital tumors. In addition to tumor cell-derived angiogenic factors, an important source of
angiogenesis-regulating cytokines are tumor in®ltrating mononuclear cells. They produce both
angiogenic cytokines (e.g. IL-6, IL-8) and several inhibitors of angiogenesis- inducing IFNs, IL-12,
IL-18 and others. In previous study using the murine cutaneous model of angiogenesis we
disclosed a strong angiogenic potential of tumor cells harboring HPV16 (SKv). In this study with
the use of RT-PCR and ELISA we found that this potential is due to production of vascular
endothelial growth factor (VEGF). We also studied whether SKv could affect production of
angiogenesis-regulating factors by human peripheral blood mononuclear cells (PBMC). In order to
detect biological activity of IL-18 we studied by ELISA IFNaÄ production by PBMC of healthy
donors. PBMC were in incubated with OKT-3 antibodies against CD3 molecules (0.01, 0.1,
1.0 mg per ml), with or without conditioned media from SKv cells. We found that addition of SKv
conditioned media reduced signi®cantly production of INFg (from 1700 pg per ml to 800 pg
per ml) and proliferation of PBMC. The possible mechanism of this reduction could be
inactivation of IL-18 by E6 protein of HPV16, as shown in other experimental system. Since we
have recently shown that IL-18 has an antiangiogenic capability, it is conceivable that this E6-
dependent effect could contribute to in vivo stimulation of tumor angiogenesis. In addition,
abrogation of IL-18 activity could result in down-regulation of NK and T cell activity, leading to
escape of HPV-16 harboring tumor cells from immune surveillance. Thus we showed that the
angiogenesis induced by HPV16 harboring tumor cells might be related, at least in a part, to a
decreased antiangiogenic activity of interleukin-18.
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Down-Regulation of m-Opiate Receptor and b-Endorphin in Epidermis of Atopic
Dermatitis and its Correlation to INF-g In Vitro
M. Bigliardi-Qi,*² L. Sumanovski,*² S. BuÈchner,² T. Ru¯i,² and P. L. Bigliardi²³
*Zentrum fuÈr Lehre und Forschung and ²Dermatologische UniversitaÈtsklinik, University Basel;
³Kantonsspital Schaffhausen, Switzerland
The presence of the mu-opiate receptor system in human epidermis presents a new dimension to
the research in neuro-immuno-dermatology. We have previously shown that human epidermal
keratinocytes express a functional active mu-opiate receptor. Using modern confocal imaging
microscopy and colocalization analysis we demonstrated that mu-opiate receptor is not only
expressed in keratinocytes but also on unmyelinated peripheral nerve ®bers in dermis and
epidermis. Using immunohistochemistry technique with classical microscopy as well as ¯uorescent
confocal microscopy we are able to show that in epidermis of atopic dermatitis the expressions of
both mu-opiate receptor and b-endorphin are down regulated compared to normal skin. The
staining was semiquanti®ed using a digital imaging system and statistical software in confocal
microscope. Furthermore we incubated human skin organ cultures for 48 h with INF-g, a Th1
pathway cytokine, and measured the expression of mu-opiate receptor and b-endorphin by
confocal microscopy. These functional experiments show a signi®cant increase of the mu-opiate
receptor and its ligand in the epidermis after exposure to INF-g. It is well known that in atopic
dermatitis the expression of INF-g is decreased. Therefore as we expected the expression of mu-
opiate receptor and its ligand is down regulated in epidermis of atopic dermatitis. Additionally we
observed that in the epidermis of atopic dermatitis the terminal nerve endings are different in
quantity and quality compared to normal skin. All these results suggest that the opiate receptor
system in epidermis might be involved in some of the crucial symptoms associated with atopic
dermatitis such as itch. Our results add new proof that the opiate receptor system play an important
role in the crosstalk among the skin, the nerve system and the immune system.
092
Increased Activities of D-Dopachrome Tautomerase (DDT) and Macrophage Migration
Inhibitory Factor (MIF) at UVB-Induced In¯ammation in the Skin
B. Sonesson, E. Rosengren, A.-S. Hansson, and C. Hansson
Lund, Sweden and Gothenburg, Sweden
Macrophage migration inhibitory factor (MIF) is a proin¯ammatory cytokine with enzymatic
properties. MIF is produced by several types of cells including human keratinocytes and it is also
known to be involved in several autoimmune diseases. An increased production of MIF is induced
at physiological levels of glucocorticoids but MIF is also known to antagonize the
immunosuppressive effects of glucocorticoids. Taken together this indicates a complex regulatory
interplay between MIF and steroids. D-dopachrome tautomerase (DDT) is an enzyme that is
structually related to MIF but with unknown immunologic properties. DDT and MIF both
catalyze a conversion of D-dopachrome, but with different endproducts, the DHI (5,6-
dihydroxyindole) for DDT activity and the DHICA (5,6-dihydroxyindole-2 carboxylic acid) for
MIF activity. In this study we have focused on DDT in skin in¯ammation. We measured DDT
and MIF in blister ¯uid by using the suction blister method. Prior to suction we induced
experimental skin in¯ammation by UVB irradiation of the forearm in 10 healthy subjects. Non-
irradiated sites were used as controls. The blister ¯uid was subsequently analysed for DHI and
DHICA by HPLC and a ¯uorescence detector. DDT and MIF activities were demonstrated in
blister ¯uids in all 10 subjects. All but one of these showed an increase in activity of DDT and MIF
after irradiation with 3 MED UVB. The mean activities of both DDT and MIF increased
approximately twofold after UVB irradiation. These differences were highly signi®cant. The
presence of DDT in epidermis was con®rmed by immunohistochemical stainings in both control
and irradiated human skin sections. In this study we demonstrate the presence of DDT in the skin.
We also show for the ®rst time that DDT can be related to in¯ammation, and the covariation
between DDT and MIF strengthens this observation.
093
Keratinocyte Unresponsiveness Towards Interleukin-10: Lack of Speci®c Binding Due
to De®cient IL-10 Receptor 1 Expression
B. Gruenberg, M. Seifert, R. Sabat, P. Donner, G. Gruetz, H.-D. Volk, K. Wolk, and K.
Asadullah
Berlin, Germany
Whereas the effects of interleukin (IL)-10 on several epithelial cell-types are well established the
capability of IL-10 to target keratinocytes (KC) is still a matter of debate. The purpose of the
present study was to further investigate direct effects of IL-10 on keratinocytes and to address the
reason for potential IL-10 unresponsiveness using keratinocyte like cell line HaCaT as well as
primary foreskin keratinocytes. Using real time RT-PCR we demonstrated that IL-10 is neither
able to induce its typical early gene product suppressor of cytokine signalling (SOCS) 3 nor to
modulate the interferone (IFN)-g induced expression of SOCS 1 and 3. Although ¯owcytometric
analyses showed binding of biotin labelled IL-10 to HaCaT cells, blocking experiments indicated
that this resulted from unspeci®c binding. Moreover, scatchard plot analyses excluded speci®c
binding to primary KC and HaCaT cells. Finally, real time mRNA analyses demonstrated that the
absence of any speci®c binding results from the lack of IL-10R1 (a chain) expression, whereas the
IL-10R2 (b chain) is constitutively expressed. Our data indicates that IL-10 unresponsiveness of
keratinocytes could be explained by a lack of IL-10R1 expression and suggest that any IL-10 effects
on these cells observed are indirectly mediated. This, however, is of considerable importance, since
IL-10 is a major anti-in¯ammatory, immunosuppressive cytokine with impact on the cutaneous
homeostasis. In particular with regard to recently proven clinical effective IL-10 therapy in
psoriasis. Response to therapy is associated with normalisation of typical parameters of keratinocyte
pathology.
094
Pyoderma Gangrenosum Induced by Montelukast Sodium ± Con®rmation by
Interferon-g (IFN-g) Release Test
A. D. Cohen, N. Grossman, and S. Halevy
Beer-Sheva, Israel
Previous reports demonstrated that pyoderma gangrenosum (PG) may be caused by drugs. In vitro
drug-induced interferon-g (IFN-g) release test was previously used to con®rm the role of suspected
culprit drugs in patients with cutanous adverse drug reactions. A 53-years-old male with asthma has
been treated by Montelukast sodium (Singulairq) 10 mg per d. Two months later, painful ulcers
appeared on the dorsal side of the arms. Additional medications were inhalation Salbutamol,
inhalation Salmeterol and T. Prednisone 5 mg per d. Skin examination revealed ulcers with
purpule-red, raised, undermined borders. A biopsy specimen revelaed a dense neurtrohilic
in®ltrate. A diagnosis of PG was made according to the clinical and histological ®ndings. Extensive
laboratory and imaging investigations did not reveal an associated sytemic disease. PG was
attributed to drug intake, with Montelukast sodium being the suspected culprit drug. All systemic
medications were withdrawn and the patient was treated by prednisone 60 mg per d with gradual
resolution. Patch tests with Montelukast sodium were borderline positive in concentrations 0.01%
and 0.1%. In order to con®rm the role of Montelukast sodium as the culprit drug, IFN-g release
test was performed. Brie¯y, following incubation of peripheral blood lymphocytes with drugs, the
supernatants were collected for the detection of IFN-g release. The increase in IFN-g release was
calculated for each drug tested. A positive IFN-g-test was de®ned as a value higher than the mean
percentage increase of IFN-g + 2SD (threshold level) measured in controls taking the same drug
por®le. IFN-g release for Montelukast sodium (the suspected culprit drug) was 53.3% as compared
to a control threshold of 44.8%. IFN-g release for prednisone (which was not suspected as a culprit
drug) was not increased as compared to controls. In conclusion, in the patient described, the results
of IFN-g release test support the role of Montelukast sodium as the culprit drug in the induction of
PG.
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Agonists of Proteinase-Activated Receptor-2 Stimulate Activation of NFkB and Up-
Regulation of ICAM-1 in Human Keratinocytes
J. Buddenkotte, C. Stroh, C. Moormann, I. H. Engels, V. M. Shpacovitch, D. Vestweber, K.
Schulze-Osthoff, T. A. Luger, and M. Steinhoff
Boltzmann Institute for Immunbiology of the Skin, MuÈnster, Germany
It is well known that serine proteases are generated in the skin and are involved in several biological
processes such as growth, differentiation and in¯ammation. Proteinase-activated receptor-2 (PAR-
2) belongs to a new G protein-coupled receptor subfamily activated by various serine proteases.
PAR-2 has been demonstrated to play a role during cutaneous in¯ammation in vivo. PAR-2 is
expressed by human keratinocytes (KTC) and regulates in¯ammatory responses, proliferation and
differentiation in these cells. However, the underlying mechanisms of PAR-2 activation in KTC
are still incomplete. Northern blot analysis revealed PAR2-RNA in primary KTC and endothelial
cells. Moreover, increased RNA levels were detected in lesional skin of patients with atopic
dermatitis. Ca-mobilization studies demonstrated that PAR-2 is functional in human KTC
induced by PAR2 agonist tryptase. PAR-2 agonists induce up-regulation of ICAM-1 RNA by
RT PCR. Electrophoretic mobility shift assays and morphological transduction studies revealed
PAR2-induced activation and translocation of NFkB in KTC and also in microvascular endothelial
cells (HDMEC) with a maximum after 1 h. Use of NFkB inhibitor BAY7082 prevented up-
regulation of the cell adhesion molecule ICAM-1 in KTC. In conclusion, PAR-2 induces NFkB
activation and up-regulation of cell adhesion molecules such as ICAM-1. Thus, PAR-2 may play
an important regulatory role on human KTC function under physiological and pathophysiological
conditions.
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Evidence for a Proin¯ammatory Role of PAR-2 During Cutaneous In¯ammation In
Vivo
M. Steinhoff, S. Seeliger, C. Derian,* R. Nawroth, C. SunderkoÈtter, J. Buddenkotte, D. Metze,
D. Vestweber, and P. Andrade-Gordon*
Boltzmann Institute for Immunbiology of the Skin, Department of Dermatology, MuÈnster, Germany; *RW
Johnson Pharmaceutical Research Institute, Spring House, USA
Contact dermatitis (CD) is a frequent dermatological disease with a high socio-economical impact
characterized by acute to chronic in¯ammation of the skin often leading to therapy-resistent
excema. Proteinase-activated receptor-2 (PAR-2), a G protein-coupled receptor for certain serine
proteases, is localized on keratinocytes, endothelial cells and nerve ®bers, and has been
demonstrated to play a role during in¯ammation of several tissues. However, the precise role of
PAR-2 and the underlying mechanism of PAR2-induced regulation of in¯ammation is still
fragmentary. Therefore, we were interested in whether or not PAR-2 is involved in cutaneous
in¯ammation using a model of experimentally induced allergic (ACD) and irritant (ICD) contact
dermatitis. In wild-type (PAR2+/+) mice, PAR2 agonists induced an increased intradermal edema
and enhanced plasma extravasation with a maximum between 3 and 24 h. These in¯ammatory
responses were signi®cantly diminished in PAR2-de®cient (PAR2±/±) mice and controls (vehicle).
Morphological analysis revealed a dramatic increase of spongiosis and intradermal edema along
with enhanced in®ltration of neutrophils and monocytes in PAR2+/+ mice as compared to
PAR2±/± mice. Interestingly, nitric oxide (NOS)-inhibitors signi®cantly diminished these effects
indicating a role of NO in PAR2 -induced in¯ammatory responses of the skin. Functional studies
at the RNA- and protein level further revealed PAR2-induced up-regulation of the cell adhesion
molecules ICAM-1 and E-selectin by dermal microvascular endothelial cells during in¯ammation
suggesting that PAR-2 directly regulates cell adhesion molecule function during skin
in¯ammation. PAR2 agonists also stimulated up-regulation of mediators involved in cutaneous
in¯ammatory responses such as IL-6 and NO in murine and human (dermal) endothelial cells.
Together, these results strongly suggest a proin¯ammatory role of PAR-2 during CD and probably
other in¯ammatory dermatoses, especially during the early phase characterized by edema, plasma
extravasation and recruitment of in¯ammatory cells to the site of in¯ammation. Thus, PAR-2
antagonists may be helpful tools for the treatment of in¯ammatory skin disorders such as contact
dermatitis and atopic eczema.
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Tumour Necrosis Factor-a Induced Up-Regulation of Ela®n and Antileukoprotease
Enhances the Skin Barrier
J. K. Henderson, H. R. Taylor, C. O. BaÊvik, S. J. Ward, M. J. Cork, and R. Tazi-Ahnini
University of Shef®eld, Shef®eld, UK
In normal human epidermis, there is a balance of corneodesmosome proteolysis and inhibition of
the proteases involved in order to maintain stratum corneum thickness and skin barrier function.
This balance is known to be disrupted in diseases such as psoriasis whose symptoms include a
thickening of the stratum corneum. Proteolysis of corneodesmosomal proteins is thought to be
involved in the maturation of corneodesmosomes, and the cleavage of proteins such as
corneodesmosin, desmocollin, desmoglein, plakoglobin and desmoplakin is thought to be a
prerequisite for desquamation. Recently, corneodesmosin and plakoglobin have been shown to be
processed by stratum corneum chymotryptic and tryptic enzymes (SCCE and SCTE) In vitro.
Antileukoprotease (SLPI) and ela®n are two serine protease inhibitors which serve to inhibit SCCE
and SCTE, suggesting that SLPI and ela®n are involved in the regulation of the proteolysis of
corneodesmosomal proteins. Tumour Necrosis Factor-a (TNF-a) is known to up-regulate the
expression of ela®n. In addition, TNF-a, SLPI and ela®n expression are up-regulated in epidermis
from psoriasis patients. Here we used semiquantitative RT-PCR to measure the expression of
ela®n and SLPI in human reconstituted epidermis and psoriatic skin. Epidermal equivalents were
treated with 2.5 ng per ml TNF-a with or without 10 mg per ml monoclonal anti-TNF-a antibody
or medium only for 20 h at 37°C. Total RNA was extracted from treated and untreated
reconstituted skin and from psoriatic epidermis. RT-PCR was performed on serial RNA dilutions.
Both ela®n and SLPI were shown to be up-regulated in skin treated with TNF-a. This effect was
completely inhibited when anti-TNF-a was added to the culture medium. We con®rm the up-
regulation of ela®n expression by TNF-a and show that this effect is speci®cally due to TNF-a by
the loss of the effect following neutralisation with a monoclonal antibody. We also report that
TNF-a up-regulates SLPI expression in a similar manner to ela®n. In conclusion, in psoriasis
TNF-a promotes in¯ammation by recruiting T-cells but also impairs desquamation by up-
regulating SLPI and ela®n thus decreasing the proteolysis of corneodesmosomal proteins.
Therefore, anti-TNF-a antibody treatments for psoriasis are effective due to their anti-
in¯ammatory effect but also via the inhibition of the enhancement of the skin barrier caused by
TNF-a.
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Implication of Epstein-Barr Virus in SeÂzary Syndrome
A. C. Knol, Y. Guilloux, M. C. Pandol®no, P. Foulc, S. Leroy, N. Chebassier, F. Jotereau, and B.
Dreno
Inserm U463, Nantes, France
Cutaneous T cell lymphomas (CTCL) are characterized by the in®ltration of the skin by activated
T lymphocytes of the CD2+ CD3+ CD4+ CD45RO+ DR+ phenotype. The aetiology of this
pathology remains still unknown. Some viruses such as EBV and HTLV-1 have been investigated
for years to play a role in this disease, but the results remain still debated. The aim of our study was
to precise the potential role of EBV in CTCL knowing that EBV DNA has previously been
identi®ed in cutaneous lesions of CTCL. This work was performed with blood samples of patients
whose SeÂzary Syndrome has been con®rmed by histology, immunochemistry and clonal
rearrangement and with more than 50% of circulating SeÂzary cells. We tried to determine if an
EBV speci®c T lymphocyte response towards the autologous B-EBV line could be detected in
these patients which could play a trole in the chronic stimulation of T lymphocytes. This response
was measured by proliferation test, cytotoxicity and production of cytokines TNF-a, IL-4 and
IFN-g. Effectors cells were clones of PBL, PBL stimulated and grown with IL-2 and IL-7, or T
lymphocytes extracted from lesional skin of the patients and grown with either IL-2 and IL-7, or
IL-2 and IL-15 or IL-7 and IL-15. Concurrently, we have investigated the PBL non sorted or
positively Vb cell-sorted, for the presence of mRNA of EBV, EBER-1 and BZLF-1. We showed
neither a cytotoxic activity nor a production of cytokines, speci®c of the T lymphocytes towards
the autologous B-EBV line.EBV DNA not detected in the patients' PBL. However, we observed
that T lymphocytes populations proliferated strongly in the presence of the autologous B-EBV cell
line. These results suggest that EBV could play a role in the development of CTCL, perhaps as an
antigenic stimulus by maintaining the proliferation of the T lymphocyte population in the lesional
skin. Moreover, since B-EBV cell lines do not express the whole proteins of the virus, it would be
of interest to study T lymphocytes populations towards Cos cells transfected with one of the 18
cDNA coding for the EBV proteins.
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The Serum Concentration of IP-10 in In¯ammatory Skin Diseases
M. Sticherling, M. Bechara, E. Christophers, E. Wandel, and J. SchroÈder
Leipzig, Germany and Kiel, Germany
In the past, chemokines have been shown to be involved in homeostatic regulation as well as in
in¯ammatory tissue reactions. They are able to focus and amplify the cellular response by activation
and attraction of both resident and migratory cells. The chemokine IP10 (10 kDa peptide, induced
by IFN g) has been well characterized before de®nition of the chemokine family. It seems to play
an important role in chronic in¯ammation, as indicated by its T-cell stimulating properties and
local involvement in psoriatic tissue reactions. The aim of this study was to determine whether
serum levels of IP-10 re¯ect such processes. A speci®c and sensitive IP-10 ELISA could be
established by using two monoclonal antibodies raised in the laboratory. IP-10 serum levels were
evaluated of patients with psoriasis vulgaris (n = 40), generalized eczema (n = 10), erysipelas
(n = 12), herpes zoster (n = 10) and healthy volunteers (n = 40) In the healthy control group IP-10
was below the detection limit whereas in all disease groups elevated serum IP-10 levels were found.
Highest IP-10 concentrations were found in erysipelas (mean 2,1 ng per ml) and psoriasis (mean
0,58 ng per ml). In psoriasis, data did neither correlate with disease activity nor with therapeutic
response. Therefore, IP-10 seems to be a marker for in¯ammatory skin diseases but is rather
unspeci®c concerning their activity and pathogenesis. Accordingly, release of chemokines into
circulation is different in in¯ammatory skin disorders and perhaps re¯ects differential roles in
systemic in¯ammatory processes.
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Activation/Inactivation of Classical Pathway of Complement in Nonlesional SLE Skin
A. Mohamed, P. Wordsworth, and F. Wojnarowska
Oxford, UK
Lupus erythematosus (LE) is characterized by the deposition of immunoreactants at the basement
membrane zone of the skin (the lupus band). The infrequent ®nding of MAC in nonlesional skins
with positive lupus band raised two questions: Does complement activation occurs in the
nonlesional SLE skin? If it is activated, why there is no skin damage? A probable answer is that
complement activation in nonlesional SLE skin might be incomplete. We postulated that in the
nonlesional SLE skin, IgG binds C1q and activates the classical pathway of complement and, if the
MAC is formed, it is inactivated by the induction of protectin (CD59). Non-lesional skin from 5
DLE and 20 SLE patients were investigated. Sections of skin lesions from 10 patients with DLE, 5
lichen planus, and normal skin were used as controls. C4d, the degradation product of C4 was used
as a marker of complement activation. Cryostat sections (7 mm were incubated with the mouse
Moab C4d (Quidel, France), washed with PBS and then incubated with FITC-conjugated rabbit
antimouse antibody. Other skin sections were used to identify CD59 expression by the rat Moab
MCA715 (Serotec, UK). Skin sections were incubated with the MCA715 antibody, washed with
PBS and then, incubated with FITC-conjugated goat antirat antibodies (Dako, Denmark). The
results showed C4d deposition in 18/20 (90%) of nonlesional SLE skin. C4d was not detected in
the nonlesional skin from the 5 DLE patients. The nonlesional SLE skin showed strong expression
of CD59 in 16/20 SLE patients. The 5 nonlesional DLE skin demonstrated CD59 staining
comparable to normal skin. CD59 expression was low in 7/10 DLE lesions. The lichen planus
samples showed normal expression of CD59 suggesting that the low CD59 expression in DLE is
not related to the in¯ammatory component. In conclusion, the classical complement pathway is
activated and the expression of the complement regulatory protein CD59 is up-regulated in the
nonlesional SLE skin. This ®nding suggests that the protection of skin during the presence of
immunoreactants in SLE skin might be facilitated by the induction of complement regulatory
protein CD59. This could explain the link between the lupus band and the pathogenesis of
cutaneous lupus.
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Hepatocyte Growth Factor/Scatter Factor (HGF/SF) Up-Regulates b1 Integrin
Expression on Melanoma Cell Surface
T. Takahashi and A. Igarashi
Tokyo, Japan
HGF/SF is known to have a motogenic effect on tumor cells leading to tumor cell invasion into
connective tissue and distant metastasis. Despite the putative involvement of HGF/SF in the
progression of malignant melanoma, the mechanism responsible for the invasion and metastasis
process has largely been unexplored. In this study, the possible role of HGF/SF in melanoma
progression was assessed by analyzing the regulatory effect of HGF/SF on integrin expression and
motile activity in melanoma cells. HGF/SF dose- and time-dependently augmented b1 integrin
expression in melanoma cell lines expressing c-Met but failed to regulate that in a c-Met negative
melanoma cell line. On the other hand, the expression of a1-a6 and b3 integrin subunits was not
modulated by HGF/SF at any concentration and in any stimulation period. In accordance to the
increment of b1 integrin expression, HGF/SF stimulation enhanced attatchment of c-Met positive
melanoma cell lines to type I, type III, type IV collagen, ®bronectin and laminin. Furthermore,
HGF/SF effect on b1 integrin expression enhanced both the invasiveness of melanoma cells
through Matrigel composed of basement membrane components and the migration activity of
melanoma cells on extracellular matrix-coated substrate. The ®ndings suggest the important role of
HGF/SF in invasive and metastatic potential of melanoma cells.
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Control of Caspase-1 Activity by Caspase Recruitment Domain (CARD) Proteins in
Human Keratinocytes
J. B. Mee and R. W. Groves
Imperial College, London, UK
The cysteine protease caspase-1 (formerly interleukin (IL)-1b converting enzyme/ICE) cleaves the
precursors of the cytokines IL-1b and IL-18 into their bio-active, mature forms. We have
previously demonstrated constitutive expression of proIL-1b and proIL-18 by human keratinocytes
and were interested to determine whether the absence of processing was the result of a de®ciency
in caspase-1 production or more complex inhibition. Total RNA and protein extracts were
prepared from primary human keratinocytes and assessed for caspase-1 production. Constitutive
caspase-1 transcription was demonstrated by RT-PCR and Western blotting revealed that caspase-
1 was consistently present in the inactive 45 kDa form. Functional caspase-1 activity was con®rmed
in lysates from the monocytic cell line THP-1, by the presence of processed IL-18 whereas only
precursor was seen in keratinocytes. Caspase-1 is synthesised as a zymogen which oligomerises and
autoprocesses upon receipt of an appropriate signal. A series of novel proteins which speci®cally
bind caspase-1 and facilitate oligomerisation have been described over the last 2 years. Like caspase-
1, they all possess a CARD through which association occurs. Two molecules, RICK and IPAF/
CARD-12 induce cleavage of caspase-1 on binding, whereas the CARD proteins ICEBERG,
COP/pseudoICE and CARD-8/CARDINAL all inhibit caspase-1 processing. RT-PCR analysis
of human keratinocytes demonstrated strong constitutive expression of all three antagonistic
CARD proteins and RICK, whereas IPAF was weakly transcribed. Further, ICEBERG mRNA
production was signi®cantly higher in keratinocytes than any other cell type tested, suggestive of a
net anticleavage phenotype in these cells. These results indicate that activation of caspase-1 in
keratinocytes requires a complex regulatory mechanism involving at least 5 speci®c CARD
proteins which may in¯uence the activity of pro-in¯ammatory cytokines such as IL-1b in
cutaneous in¯ammation.
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Interleukin-10 Therapy Reduces the Incidence of Relapse and Prolongs the Relapse-
Free Interval in Psoriasis
M. Friedrich,* W. D. DoÈcke,² A. Klein,* S. Philipp,* H. D. Volk,² W. Sterry,* and K.
Asadullah*³
Departments of *Dermatology and ²Immunology, University Hospital ChariteÂ, RBA Dermatol, ³Schering-
AG, Berlin, Germany
The ability of interleukin-10 therapy to reduce the severity of exacerbated psoriasis has been
demonstrated recently. Considering the immunobiological properties of this cytokine we
investigated the effects of long-term interleukin-10 application on the immune system and
duration of psoriasis remission. We performed a placebo-controlled, double blind, phase II trial
using interleukin-10 in patients with chronic plaque psoriasis in remission. Patients received
subcutaneous injections with either interleukin-10 (10 mg per kg body weight; n = 7) or placebo
(n = 10) 3 times per week until relapse or study termination after 4 month. The treatment was well
tolerated. In the placebo group almost all patients (90%) showed a relapse during the observation
period. In contrast to this, only 2 out of 7 patients (28.6%) relapsed in the interleukin-10-treated
group. Kaplan Meier analysis revealed a signi®cantly lower relapse incidence in the interleukin-10
than in the placebo group (p = 0.02). The mean relapse-free interval time was 101.6 6 12.6 days in
the interleukin-10 group in comparison to 66.4 6 10.4 days in the placebo group. Immunological
activity of interleukin-10 application was indicated by an increase in soluble interleukin-2 receptor
plasma levels and higher ex vivo interleukin-4 secretion capacities. Remarkably, a signi®cant
negative correlation was demonstrated between the IL-4 secretion capacity and Psoriasis Area and
Severity Index score (r = 0.36, p < 0.01). Our data suggest that interleukin-10 therapy is
immunological effective, decreases the incidence of relapse and prolongs the disease-free interval in
psoriasis. Its value should be further determined in larger trials and for the prevention of re-
exacerbation of other in¯ammatory disorders with a similar immunological pro®le.
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The Expression and Function of Pattern Recognition Receptors in Vaginal Epithelial
Cells
A. Pivarcsi, M. SzeÂll, Cs. Szeg, Zs. GyoÄrffy, Zs. Bata-CsoÈrgoÄ, A. Dobozy, and L. KemeÂny
Szeged, Hungary
Epithelial cells of the vagina are important in providing protection against various pathogenic
microorganisms, e.g. Candida albicans. It is known that vaginal epithelial cells produce antimicrobial
peptides, which mediate the killing of pathogenic fungi. Toll-like receptors (TLRs) are known to
be important in mediating mechanisms of innate host defence. We aimed to explore whether Toll-
like receptors and activation of NF-kB could be responsible for the protection against pathogenic
microorganisms by vaginal epithelial cells. RT-PCR and Western-blot analysis were used to
examine the expressions of the two main pattern recognition receptors (TLR2 and TLR4) in
immortalized vaginal epithelial cells (PK cells). PK cells were transfected with NF-kB luciferase
construction and the activation of NF-kB was examined by measuring luciferase activity in the
cells induced with Candida albicans or lipopolisaccharide (LPS). Real-Time RT-PCR was used to
examine the expressions of TLRs and interleukin-8 (IL-8) after incubation with Candida albicans
and LPS. ELISA was used for detection of cytokines produced by PK cells. We found that
unstimulated cultured vaginal epithelial cells expressed TLR2 and TLR4 receptors. The
expressions of TLR2 and TLR4 were up-regulated by induction with Candida albicans or LPS.
Candida albicans and LPS induced the expression of IL-8 gene and the production and secretion of
IL-8. In our work, we give the ®rst evidence that vaginal epithelial cells express toll-TLR2 and
TLR4 and microbial compounds activate NF-kB, which may be involved in pathogen-mediated
intracellular signalling. Our ®ndings stress the importance of the role of vaginal epithelial cells as
participants of innate immunity.
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Cellular In®ltrate and Related Cytokines of Autologous Serum Induced Wheals in
Patients with Chronic Idiopathic Urticaria
W. Volpi, M. Caproni, B. Giomi, D. Macchia, M. Manfredi, L. Melani, A. D'Agata, and P. Fabbri
Florence, Italy
Chronic autoimmune urticaria identi®es a group of patients with chronic idiopatic urticaria (CIU)
and circulating autoantibodies (IgG) against the high-af®nity IgE receptor and/or against IgE.
These autoantibodies have the capability to provoke in vivo a wheal and ¯are response in a
considerable group of patients by intradermal injection of autologous serum (autologous serum skin
test, ASST). Serial biopsies of autologous serum induced wheals were performed at different times
(10¢, 30¢, 60¢, 24 h, 48 h) from the onset of the wheals, in order to assess the evolution of the
cellular in®ltrate and to clarify the possible pathogenesis of this skin-disorder. The study was
performed on induced wheals of 27 patients (13M, 14F; median age: 43,9 years; range: 22±69)
compared with the skin of 4 healthy donors. We performed an immunohistochemical analysis of
the in®ltrating cells (mast cells, T lymphocytes, neutrophils, eosinophils), related cytokines (IL4,
IL5, IL8, IFN-g), and chemokine-receptors (CCR3, CXCR3) as well as integrins (ICAM-1, V-
CAM, ELAM-1). In the early wheals (10¢) we documented an increased number of T lymphocytes
and eosinophils when compared to healthy skin. Perivascular neutrophils and eosinophils showed a
tendency to increase from 10 min to 1 h, as well as T lymphocytes did. At 60 min neutrophils
(80 6 57,6) rappresented the main cellular population. Activated eosinophils were increased at 24 h
(EG2 19,3 6 5) and 48 h (EG2 28 6 2,8) whereas neutrophils decreased and mast cells did not
show a signi®cant variation. Referring to cytokines IFN-g showed a focal dermal staining that
remained almost constant at different times; IL-4 was increasing within the ®rst hour and then
decreased while IL-5 was mainly appreciated at 30¢ and 60¢. Our analysis in induced wheals
demonstrated the presence of a T cell population with a prevalent Th2-like pattern, as we already
observed in spontaneous wheals.
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Transduction of Murine Dendritic Cells by Antigen-Encoding Lentivirus Vectors
Permits Antigen Processing and MHC Class I-Dependent Presentation
S. Zarei, F. Leuba, J. F. Arrighi, C. Hauser, and V. Piguet
Geneva University Hospital, Geneva, Switzerland
Because antigen-presenting dendritic cells (DC) play a major role in the polarization of T cells,
including Th2 cells involved in allergy, strategies to modify DC genetically are required. The
purpose of this investigation was to transduce murine bone marrow-derived DC with lentiviral
vectors encoding antigen and to demonstrate antigen processing by the endogenous pathway and
MHC class I dependant presentation. Bone marrow leukocytes were incubated with antigen-
encoding lentiviral constructs and cultured with GM-CSF, IL-4 and Flt-3 ligand. The capacity of
the resulting DC to express, process and present antigen was examined In vitro. An average of 40%
of DC expressed antigen after one week of culture when antigen was green ¯uorescent protein
encoded by the lentiviral vector construct. To demonstrate that transduced antigen can be
presented by DC on MHC class I, we chose the lymphocytic choriomeningitis virus glycoprotein
(gp) as a model antigen that can be recognized by CD8 T cells from transgenic mice expressing an
MHC class I-restricted T cell receptor speci®c for the epitope of positions 33±41 from gp. DC
transduced with lentiviral construct encoding gp and matured with LPS activated transgenic T cells
in an antigen-speci®c fashion. Using transporter-associated with antigen presentation (TAP)-
de®cient mice, we showed that presentation of the gp33±41 epitope is TAP-dependent,
con®rming processing of gp by the endogenous pathway. These results demonstrate that CD8 T
cells can recognize MHC class I epitopes processed from antigen by DC transduced with lentiviral
vectors. Targeting of DC and antigen presentation to CD8 T cells could be exploited for
immunotherapy because allergen-speci®c CD8 T cells have been shown to be suppressive in IgE-
dependent allergy models.
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Polymorphism A(±596)G of Interleukin-6 Gene is Associated with Cutaneous T-Cell
Lymphoma
J.-A. Vasku, V. Vasku, and A. Vasku
Brno, Czech Republic
Skin lesions from patients with mycosis fungoides contain high levels of interleukin-6. Thus, the
aim of the study was to investigate the possible effects of genetic polymorphism A(± 596)G of
interleukin-6 in patients with cutaneous T-cell lymphoma (CTCL). We performed a case-control
study to compare genotype distributions and/or allelic frequencies between 61 Czech patients with
CTCL and 61 control subjects matched for aged and sex. In all of these subjects, polymorphism
A®G of promoter of interleukin-6 gene at position ±596 was determined by PCR and restriction
analysis. There was a highly signi®cant difference of distribution of genotypes between the patients
and the controls (p = 0.001). When the male and female patients group were compared to controls
separately, this difference kept the statistical signi®cance (p = 0.04 for males, p = 0.03 for females).
Further analysis showed a signi®cantly higher relative risk of the heterozygote (AG) genotype in
patients (OR = 3.94, 95% con®dential interval 1.84±8.45, p = 0.0003). This genotype is associated
with higher relative risk for T-lymphoma both in males (OR = 3.23, 95% con®dential interval
1.24±8.44, p = 0.01) and in females (OR = 5.20, 95% con®dential interval 1.41±19.18, p = 0.01),
where the strongest association has been investigated. We conclude that A(±596)G polymorphism
of interleukin-6 gene is associated with cutaneous T-cell lymphoma. Heterozygote genotype
carries signi®cantly higher relative risk for cutaneous T-cell lymphoma, especially in women.
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Resistance to Fas-Mediated Lymphocyte Cell Death in Sezary Syndrome: Partial
Reversal by Interferons
K. E. Kerl-Bullani, R. Shane, M. Zaki, A. H. Rook, and L. E. French
Department of Dermatology, University of Geneva, Switzerland; University of Pennsylvania School of
Medicine, Philadelphia, Pennsylvania, USA
Membrane bound Fas ligand (FasL, Apo-1 L, CD95L) induces rapid apoptosis of Fas (CD95)±
sensitive cells upon interaction with Fas, and is an important effector molecule of cytolytic T
lymphocytes. Cutaneous lymphomas including Sezary syndrome (SSy) are responsive to therapies
that stimulate cellular immune responses but tend eventually to escape immune destruction. We
investigated Fas expression and function in 2 SSy cell lines (Myla, SeAx), as well as in peripheral
blood mononuclear cells (PBMC) from 11 SSy patients and 4 healthy controls. Fas expression was
found to be virtually absent in SeAx cells, but conserved in Myla cells. Analysis of sensitivity to
recombinant human FasL In vitro revealed that loss of Fas surface expression correlated with
resistance to FasL-mediated cell death, SeAx cells being resistant as opposed to Myla cells. In SSy
patients, when compared to healthy controls, Fas surface expression was reduced on CD4+
lymphocytes in 5/11 cases (45%). When susceptibility to FasL-mediated apoptosis was tested in
PBMC from these patients 6/11 (55%) were signi®cantly more resistant to FasL as compared to
healthy controls. To determine if susceptibility to FasL-mediated apoptosis can be enhanced, we
tested the effect of interferon a (IFNa) and g (IFNg) on Fas expression and signaling function in
PBMC from 2 healthy controls and 2 SSy patients with low lymphocyte Fas expression. IFNa and
IFNg induced a signi®cant increase in Fas expression in both healthy control and SSy CD4+ cells.
Under these conditions, an increase in sensitivity to FasL-mediated apoptosis was also observed.
This data shows that resistance to Fas-mediated apoptosis is common in CD4+ lymphocytes of SSy
patients. It also suggests IFNa and IFNg can sensitize SSy patients CD4+ cells to FasL, and has
important implications for the use of interferon-related therapy of Sezary syndrome.
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Detection of Clonal T Cell Receptor Rearrangements Correlates with the Occurrence of
Clonal Chromosomal Aberrations in Cutaneous T Cell Lymphomas
J. M. Muche, L. Karenko, S. Gellrich, W. Sterry, and A. Ranki
ChariteÂ, Berlin, Germany and HUCH, Helsinki, Finland
Detection of clonal T cell receptor (TCR) gene rearrangement by PCR and subsequent high-
resolution electrophoresis has become an important tool in the diagnosis of cutaneous T cell
lymphomas (CTCL). However, TCR clonality indicates a quantitative alteration of T cells and
cannot demonstrate malignancy since it is also found in a substantial portion of certainly benign
dermatoses as lichen sclerosus et atrophicus, lichen ruber, and pityriasis lichenoides. We therefore
asked, whether TCR clonality in CTCL can be correlated with the occurrence of clonal
chromosomal aberrations (chromosomal clonality) indicating qualitative and functional alteration
of the affected cells. Forty samples derived from skin, blood or lymph nodes from 20 patients
suffering from large plaque psoriasis (LPP, n = 3), mycosis fungoides (MF, n = 12), or SeÂzary's
syndrome (SS, n = 5) were simultaneously and blindly investigated for TCR and chromosomal
clonality. To determine TCR clonality, ¯uorescence fragment analysis and TCR sequencing was
applied, whereas chromosomal clonality was analysed by G-banding, comparative genomic
hybridisation and interphase or 24-color in situ hybridisation methods. Twenty-eight samples gave
results with both approaches, which corresponded in 22 (18 clonal, 4 nonclonal) but diverged in 6
(4 clonal by TCR analysis only, 2 clonal by chromosome analysis only). Identity of the cells bearing
clonal TCR rearrangement and clonal chromosomal aberration was demonstrated by investigation
of single cells, which were picked according to their in situ hybridisation pattern and subsequently
analysed by sequencing the TCR rearrangement. We here, for the ®rst time, show that TCR
clonality correlates with the occurrence of clonal chromosomal aberrations in CTCL. Divergence
of the results in 6 of our cases may be due to sensitivity problems of G-banding, comparative
genomic hybridisation and interphase hybridisation techniques as well as nonampli®cation of the
clonal TCR rearrangement. In conclusion, detection of a TCR clone indicates a qualitative T cell
alteration, at least in CTCL.
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Inhibiting Tumor-Angiogenesis by Speci®c T Cell Immune Responses
H. BraumuÈller, B. J. Pichler, A. Sakrauski, M. Kneilling, N. MuÈller-Hermelink, R. Haubner, K.
Ghoreschi, W. A. Weber, and M. RoÈcken
Munich, Germany
The transgenic mouse RIP1-Tag2 is a model of multistage carcinogenesis. In these mice SV40 T
antigen (Tag) is expressed only in insulin-producing b cells of the pancreas, causing about 2% of the
islets to develope into adenomas and carcinomas. At 14 weeks mice die of hypoglycemia. Based on
recent data obtained with transplanted tumors, we analyzed the capacities of Tag-speci®c
CD4+ Th1 cells in the therapy of this endogenous, MHC class II-negative tumor. Tag-speci®c
Th1 cells were generated by stimulating CD4+ cells from T cell receptor (TCR) transgenic C3H
mice bearing a TCR speci®c for a Tag peptide. Starting at 7 weeks, the time of early adenoma
development, RIP1-Tag2 mice recieved 107 Th1 cells weekly. We followed, blood glucose,
histology and angiogenesis. Therapy with Tag-speci®c Th1 cells prolonged life two-fold.
Surprisingly, Th1 therapy did not induce diabetes even though all islet cellls express Tag. At
13 weeks histology showed large, vascularized insulinomas in sham-treated mice. In sharp contrast,
Th1-treated animals had only small poorly vascularized adenomas. Depletion of CD8+ cells
in¯uenced tumor development neither in sham-treated nor in Th1-treated RIP1-Tag2 mice.
Tumor-angiogenesis is closely associated with the expression of the avb3 integrin on endothelia.
To quantify angiogenesis, we determiend uptake of radiolabeled cyclic Gluco-RGD that selectivly
binds to avb3. In untreated mice Gluco-RGD uptake started to increase at 7 weeks of age and
reached 8-fold higher levels at 8 weeks. In sharp contrast, over the same period Gluco-RGD
uptake remained at back ground levels in Th1-treated mice. Again, inhibition of angiogenesis was
not inhibited by CD8 depletion. Thus, adoptive transfer of Tag-speci®c Th1 cells was highly
ef®cient in tumor therapy and did not cause detectable side-effects. Surprisingly, these Tag-speci®c
Th1-cells did not destroy the cells bearing the tumor-associated antigen but delayed growth and
development of Rip-Tag2 tumors by arresting tumor anngiogenesis. The data provided here
unravel a novel mode of interaction between tumor and speci®c immune responses.
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Cutaneous Lymphocyte Associated Antigen (CLA)+CD25+CD4+ T Lymphocytes
Regulate Nickel-Speci®c T Cell Responses
A. Cavani, F. Nasorri, S. Sebastiani, and G. Girolomoni
IDI-IRCCS, Rome, Italy
Regulatory CD4+ T cells involved in the maintenance of peripheral tolerance have been recently
identi®ed. These cells constitutively express the CD25 antigen, are anergic In vitro upon triggering
of the TCR, and suppress T lymphocyte activation through a mechanism requiring cell-to-cell
contact. We found that approximately 20% of the peripheral blood CD4+CD25+ T cells express
the cutaneous lymphocyte-associated antigen, a marker for skin-homing T lymphocytes. Here, we
evaluate whether CD4+CD25+ T cells obtained from the peripheral blood of individuals with
nickel allergy and from healthy controls could affect nickel-speci®c T cell responses In vitro.
CD4+CD25± T cells from both allergic (n°6) and non allergic (n°6) donors strongly proliferate to
nickel. Puri®ed CLA+CD4+CD25+ T cells from allergic individuals proliferate and secrete IFN-g
and IL-10 when exposed to the metal, but fail to suppress nickel-speci®c T cell responses when
cocultured with CD4+CD25± and CD8+ autologous T lymphocytes in the presence of antigen
presenting cells. In contrast, CLA+CD4+CD25+ T cells from healthy, non allergic individuals show
a limited or absent proliferation to nickel, but up-regulate the CTLA-4 antigen, and dose-
dependently suppress (50±85%) the proliferation and the cytokine release of CD4+CD25± T cell
population in the presence of the metal. The lack of suppressive capability of CD4+CD25+ T cells
from allergic donors appear limited to nickel-speci®c T cell responses, since both allergic and non
allergic CD4+CD25+ cells strongly suppress allogeneic CD4+ T cell activation. These results
indicate that CD4+CD25+ cells can regulate peripheral immune responses to haptens, and they
may have a role in preventing the development of undesired skin allergies.
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Proteasome Inhibitor PS519 Reduces Delayed-Type Hypersensitivity Response via
Inhibition of Carbohydrate Determinant Synthesis of Cutaneous Lymphocyte-
Associated Antigen (CLA) and T-Cell Rolling
M. Podda, C. Pien,* R. Ludwig, J. Schultz, K. Hardt-Weinelt, W. H. Boehncke, P. J. Elliott,* R.
Kaufmann, and T. M. Zollner
Department of Dermatology, University of Frankfurt, Germany; *Millennium Pharmacaeutical Inc., Boston,
USA
The ®rst step in the process of T-cell recruitment to skin is mediated through the interaction of
cutaneous lymphocyte-associated antigen (CLA) and its ligand E-selectin, a central prerequisite for
delayed-type hypersensitivity (DTH) responses. In the set of glycosyltransferases involved in the
synthesis of CLA a1,3-fucosyltransferase VII (FucT-VII) and b1,4-galactosyltransferase I (b4GalT-
I) are believed to be mainly responsible for the regulation of its expression on T-cells. Since at least
FucT-VII has a putative NF-kB binding site we addressed the question if the proteasome inhibitor
PS519 suppresses CLA expression, T-cell rolling and DTH. PBMCs from healthy volunteers were
stimulated with the superantigen TSST-1, a known inducer of CLA expression on T-cells, in the
absence or presence of nontoxic concentrations of PS519 (1±10 mg per ml). PS519 blocked the
activation of NF-kB as visualized by EMSA and markedly reduced the expression of FucT-VII as
determined by RT-PCR. A parallel quantitative determination of the backbone (PSGL-1) and the
set of glycosyltransferases involved in the synthesis of CLA (C2GnT, b4GalT-I, FucT-IV, FucT-
VII) by real-time PCR (ABIPrism7700) revealed a decrease of FucTVII, C2GnT and b4GalT-I
upon PS519 treatment (5 mg per ml). Concomitantly, CLA showed a constant inhibition by PS519
up to 7 days (38,8 6 13,6 vs. 5,8 6 3,1, n = 5, mean 6 SD) as did CD15s expression and E-selectin
binding. Using intravital microscopy with ¯uorescently labeled human T-cells injected
retrogradely into the right carotid artery of mice we observed a signi®cantly decreased in vivo
rolling of PS-519 treated T-cells in the left ear postcapillary venules (16,9 6 5,7 vs. 1,8 6 2,6%,
n = 3/13, p < 0.001). The functional relevance of these ®ndings could be further corroborated in a
DTH model were a signi®cant decrease of ear swelling could be observed in 1 mg/KGbw i.v.
treated BALB/c mice (161 6 37 vs. 92 6 46 mm, n = 130, mean 6 SD). We conclude that the
inhibition of NF-kB through PS519 reduces the expression of FucT-VII in T-cells leading to
decreased CLA expression with less rolling in skin vessels and reduced DTH response in vivo.
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Abrogating the Pathogenicity of Autoreactive T Cells with Anti-Psoriatic Agents
K. Ghoreschi, C. Deng, R. Z. Hussain, O. Viale, C. Reitmeier, A. E. Lovett-Racke, M. K.
Racke, and M. RoÈcken
Munich, Germany and Dallas, USA
Psoriasis is an in¯ammatory T cell mediated autoimmune disease dominated by interferon g (IFN-
g) producing type 1 T cells in®ltrating skin lesions. Therapy with fumaric acid esters (FAE) is
effective for psoriasis in a large number of patients. In order to understand the underlying
mechanisms we compared the In vitro and in vivo effects of FAE on human and mouse T cells.
Eighteen patients with chronic psoriasis were treated with FAE according to a standard regimen.
The dose of FAE was increased individually, serum and PBMC were analyzed at regular intervals.
Leukocyte counts and relative distribution of subsets remained largely unaffected, except for an
increase of eosinophils. Serum IgE levels were not in¯uenced. In humans, intracellular cytokine
analysis of freshly isolated T cells showed a signi®cant suppression of the IFN-g/Interleukin 4 (IL-
4) ratio of CD4+ T cells, starting at about 3 weeks of treatment. Importantly, suppression of the
IFN-g/IL-4 ratio in peripheral CD4+ T cells was accompanied by a marked decrease of PASI
(> 70%). To determine whether this deviation of Th1 into Th2 responses was causally related to
the improvement, we investigated the effect of FAE on autoreactive Th1 cells to transfer
autoimmune diseases in mice with experimental autoimmune encephalitis (EAE). Feeding FAE
signi®cantly delayed onset and decreased severity of EAE, even in mice dearing T cells bearing a
transgenic T cell receptor (TCR) speci®c for myelin basic protein (MBP). As observed in CD4+ T
cells of humans, FAE did not only improve the disease: it prevented Th1-development and skewed
the autoreactive myelin MBP-speci®c Th cells toward a Th2 phenotype in vivo. To determine
whether this in vivo-induction of MBP-speci®c Th2 cells was related to the clinical improvement,
we transferred TCR-transgenic, MBP-speci®c Th2 cells from FAE-treated mice. These MBP-
speci®c T cells were unable to cause EAE following adoptive transfer into naõÈve mice, showing that
FAE-treatment abolished pathogenecity of autoreactive T cells in vivo. Thus, abrogating the
pathogenic potential of autoreactive T cells in vivo is promising as therapy of Th1-mediated
autoimmune diseases such as psoriais, rheumatoid arthritis, multiple sclerosis or autoimmune
diabetes.
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Direct Detection and Quanti®cation of Speci®c MHC-Peptide Complexes on Malignant
and Nonmalignant Cells Using Recombinant TCR-Like Antibodies
D. Zehn, C. J. Cohen,* Y. Reiter,* and P. Walden
ChariteÂ, Berlin, Germany; *Technion, Haifa, Israel
T cells recognise and respond to speci®c MHC-Peptide complexes expressed at the surfaces of
other cells. Although a large number of T cell epitopes have been identi®ed in recent years it was
not possible to directly demonstrate and quantify speci®c MHC-peptide complexes at the surfaces
of cells. All studies which relate to the quantity of such complexes are based on functional T cell
assays and titrations of soluble peptides without knowledge of the resulting numbers of the speci®c
MHC-peptide complexes. To overcome this limitation and to gain a deeper insight into the dose±
response relationships of T cell responses we have developed from phage-display libraries
recombinant antibodies with T cell receptor-like speci®cities, i.e. they recognise a speci®c peptide
only in the context of the corresponding MHC allomorph. These antibodies display the same ®ne-
speci®city as the corresponding T cells, yet, in contrast to the notoriously low af®nities of T cell
receptors, they bind their ligands with the high af®nity. Using these antibodies we analysed antigen
presentation by dendritic cells (DC), melanoma cells, B lymphoblastoid cells, TAP-de®cient T2
cells, monocytes, normal periphery blood CD19+ B cells and CD4+ lymphocytes. We could detect
speci®c MHC-peptide complexes on all these cell types and establish the dose±response
relationship of the peptide concentrations used for pulsing and the resulting densities of the cognate
MHC-peptide complexes at the cell surfaces. These densities could be correlated with the
responses of T cells with the same speci®city. A comparison of these cell types for the loading rates
and the turnover of speci®c complexes revealed that DC handle the peptides very differently than
other cells. They require higher peptide concentrations for loading but, once pulsed, retain the
peptides much longer, viz. the half-life of speci®c MHC-peptide complexes is much longer than
for the other cell types. Some of the tumour cells, at the other extreme, incorporate peptides into
their surface MHC-molecules at a relatively low peptide concentration already but also loose the
speci®c complexes very quickly. These data demonstrate that peptide binding and the turnover of
speci®c MHC-peptide complexes is different and more ef®cient on DC than on other cell types.
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Application of Dendritic Cells Transfected with cDNA Encoding a T Cell Receptor
Mimic Peptide, Prevents T Cell Activation in a Murine Contact Hypersensitivity Model
K. Mahnke, Y. Qian, J. Knop, and A. Enk
UniversitaÈts-Hautklinik Mainz, Mainz, Germany
A 8-amino acid peptide (TCRpep) encoding the sequence of the transmembrane region of the T
cell receptor (TCR) a chain is able to block T cell activation by preventing the assembly of an
functional TCR. Addition of this peptide to MLR reactions blocked T cell proliferation in vitro
and after topical application onto psoriatic or eczematic skin, improvement of the skin diseases
could be recorded. However, if the peptide was applied systemically a generalized immunsuppres-
sion occured. Our aim was therefore to develop a system that releases the mimic peptide locally at
the site of T-cell activation. Therefore we cloned the DNS sequence encoding for the peptide into
recombinant Adenoviruses and transduced DC. Initial results showed, that transduced DC-cellines
released the peptide into the culture supernatant, resulting in reduced T cell proliferation in MLR
assays. When transduced DC were injected into OVA-TCR transgenic DO11.1 mice,
proliferation of OVA speci®c T cells was reduced as compared to controls, demonstrating
suppressive activity of the TCRpep transduced DC in vivo. Next we tested the effect of TCRpep
in CHS experiments. Mice were injected with TCRpep transduced DC that had been pulsed with
the hapten TNBS, and respective controls. After 6 days mice were challenged with TNCB at the
ears and ear swelling was determined 24h later. In these experiments ear swelling was markedly
reduced in mice injected with TCRpep transduced DCs. The effect was largely antigen speci®c
since sensitization against other contact allergens was not affected. Thus these data show, that DC
expressing the TCRpep are able to prevent T cell activation in vivo and might be a useful tool to
induce antigen speci®c immune suppression.
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Engagement of ILT2/CD85j in SeÂzary Syndrome Cells Inhibits Their CD3/TCR
Signaling
P. Musette, M. Nikolova,* L. Boumsell,* A. Bensussan,* and M. Bagot*
INSERM 532, Institut de Recherche sur la Peau. Paris, France; *INSERM 448 and Dermatology
Department, FaculteÂ de MeÂdecine de CreÂteil, CreÂteil, France
Extensive phenotype analysis of cutaneous T cell lymphoma (CTCL) malignant cell lines revealed
surface expression of receptors usually not detected on normal circulating CD4+ CD45RO+
lymphocytes. We previously found that CTCL malignant cells express KIR3DL2/CD158k,
whereas they fail to express the other KIRs. We tested the surface expression of ILT2 with the
GHI/75 mAb on freshly isolated PBL from SeÂzary syndrome patients and on Pno and Cou-L
CTCL cells lines. In order to demonstrate that ILT-2 expressed by CTCL malignant cells can
deliver a negative signal suf®cient to inhibit cell proliferation, we studied the functional
consequence of ILT2 molecule engagement on Pno CTCL cells triggered to proliferate through
their CD3/TCR receptors. The cross-linking of ILT-2 receptors resulted in a signi®cant decrease
of the proliferation rate of CTCL cells triggered by immobilized anti-CD3 mAb. Interestingly, the
cross-linking of ILT2 receptors alone did not in¯uence the IL7-dependant proliferation of Pno
malignant cells. We found that the malignant CD4+ ILT2+ population was less sensitive to anti-
CD3 mAb induced cell death than the CD4+ normal population. In the present study, we report
for the ®rst time that ILT2/CD85j receptor is found on SeÂzary cell lines and on circulating SeÂzary
malignant CD4+ cells while it is hardly detectable on circulating CD4+ lymphocytes from normal
individual. We demonstrate that ILT2 is functional on CTCL cells as its triggering leads to the
speci®c inhibition of CTCL malignant cell proliferation induced by CD3/TCR stimulation.
Interestingly, we found that separated CD4+ ILT2+ circulating malignant SeÂzary cells are less
susceptible to anti-CD3 mAb-induced cell death than autologous CD4+ ILT2- lymphocytes.
Therefore, the resistance to apoptosis of SeÂzary cells may result from distinct mechanisms including
speci®c expression of inhibitory receptors involved in lymphocyte survival.
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The Antimicrobial Peptide LL-37 is Required for Re-Epithelialization of Human Skin
Wounds and is Lacking in Chronic Ulcers
J. D. Heilborn, M. Frohm Nilsson, G. Kratz, G. Weber, O. Sorensen, N. Borregaard, and M.
StaÊhle-BaÈckdahl
Stockholm, Sweden and Copenhagen, Denmark
The human antimicrobial protein, hCAP18 is a component of the innate immune system and has
broad antimicrobial activity conferred by its C-termus LL-37. hCAP18 is constitutively produced
in leucocytes and is induced in barrier organs upon in¯ammation and infection. We demonstrate
here a novel role for this peptide in keratinocyte migration and re-epithelialization of skin wounds.
We have investigated the expression pattern of hCAP18 in acute and chronic wounds. We show
that high levels of hCAP18 are produced in skin in vivo upon wounding and hCAP 18 is being in
the in¯ammatory in®ltrate and in the migrating epithelium. The highest hCAP18 levels are
attained at 24 h postinjury, declining to preinjury levels upon wound closure. In chronic ulcers
however, hCAP18 levels are low and bioactive LL-37 barely detecable. Using a nonin¯ammatory
ex vivo wound healing model, composed of organ-cultured human skin, we show that hCAP18 is
strongly expressed in migrating skin epithelium, and that treatment with antibodies raised and
af®nity puri®ed against LL-37, inhibits re-epithelialization in a dose-dependent manner. We
suggest that, in addition to being an antimicrobial peptide, LL-37 also plays a role in wound closure
and that its reduction in chronic wounds impairs re-epithelialization and may contribute to their
failure to heal.
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Localized Th2-type Dermatitis and Strong Hev b 6.01, But Not Hev B 1, Speci®c IgE
Response After Repeated Topical Natural Rubber Latex Sensitization
H. Alenius, M. Lehto, M. Koivuluhta, G. Wang, I. Amghaiab, M.-L. Majuri, K. Turjanmaa, T.
Reunala, H. Wolff, A. I. Lauerma, and T. Palosuo
Helsinki and Tampere, Finland
Natural rubber latex (NRL) allergy may manifest as protein contact dermatitis on the hands of
health-care workers and other NRL glove users, in addition to immediate type I allergy symptoms.
The role of repeated epicutaneous (EC) sensitization with NRL proteins in the development of
dermatitis and antibody response was studied in a murine model. EC sensitization with NRL
produced signi®cant in¯ux of mononuclear cells, T cells and eosinophils to the sensitized skin sites.
The number of degranulated mast cells in NRL-sensitized skin sites was signi®cantly higher
compared to PBS-treated sites (p < 0.01). IL-1b and IL-4 mRNA expression were markedly
increased in NRL-sensitized skin sites. Moreover, signi®cant increases in MCP1, Eotaxin-1,
MIP1-a and MIP1-b mRNA were found in sensitized skin sites. EC sensitization with NRL
induced a striking increase in total and speci®c IgE levels but not in IgG2a levels. In contrast,
intraperitoneal (IP) immunization with NRL induced a strong NRL speci®c IgG2a response.
Interestingly, EC-sensitization with NRL elicited strong IgE response against Hev b 6.01 but not
against Hev b1. On the contrary, IP immunization with NRL elicited strong IgG2a production to
Hev b1 but not to Hev b 6.01. These results demonstrate that EC-sensitization with NRL induces
Th2-dominated dermal in¯ammation and strong IgE response in a murine model. EC-sensitization
to NRL proteins eluting from the latex gloves may play an important role in the development of
speci®c IgE and in clinical manifestations of acute and chronic hand dermatitis in patients.
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Expression Pro®ling of the Basal Cell Carcinomas After Imiquimod Treatment
M. Urosevic, T. Maier, J. Willers, G. Burg, and R. Dummer
Zurich, Switzerland
Imiquimod, a potent immune response modi®er, exhibits its immunomodulatory activity primarily
through interferon (IFN)-a induction and through release of other cytokines thus promoting the
shift towards cell-mediated immune response. Basal cell carcinoma (BCC) of the skin has been
shown to respond to imiquimod treatment. To investigate altered gene expression pro®les of the
basal cell carcinomas treated with imiquimod cream (Aldaraq), we used Affymetrix GeneChipq
arrays containing 12 000 known human genes. To investigate whether imiquimod exerts its action
directly on the tumor cells or indirectly through the immune modulation, imiquimod gene pro®les
BCC cell lines treated with imiquimod or IFN-a In vitro were compared to the pro®les of the skin
BCC after imiquimod therapy in vivo. In the skin, imiquimod up-regulated the whole cascade of
interferon-inducible genes (i.e. MxA and B protein, various OAS, STAT1 and 2) which matched
the pattern and the intensity observed in BCC cell lines treated with IFN-a. In addition,
imiquimod treatment in vivo induced a whole spectrum of genes involved in antigen processing and
presentation (i.e. PA28, TAP-1, PSMB6 and 10), adhesion (i.e. SLAM, ICAM-2, PECAM-1),
apoptosis (i.e. Fas, caspase 10, TRAF1, TRADD) and immune activation (CD40, CD86, LAG-3,
RANTES, MIP-1R, CCR7R, etc.). On the contrary, no changes similar to the gene patterns
could be detected in BCC cell lines after sole imiquimod treatment. These results indicate that IFN
induction is mainly responsible for imiquimod immunomodulation and underlines the importance
of immune cells in the skin are necessary for the responsiveness to imiquimod.
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FceRia is Expressed on Langerhans' Cells (LCs) in the Skin of Subjects with Both Active
Atopic Dermatitis (AD) and Other Allergic Diseases
A. E. Semper, I. G. Reischl, K. Heron, A. C. S. Woollard, J. P. Kochan, M. K. Church, and P. S.
Friedmann
Southampton, UK
Surface FceRI is on LCs in the skin of subjects with atopic dermatitis (AD) and has been suggested
to be a prerequisite for the condition. However, it is our hypothesis that surface expression of
FceRI on LCs is not restricted to AD but is present in all active systemic allergic diseases. To test
this, epidermal sheets were obtained using suction blisters from 6 nonatopic controls (NAC), 11
with AD and 11 with a history of atopic disease other that AD (NAD). Sheets were either ®xed
immediately in acetone or left un®xed prior to incubation with antibodies against CD1a, FceRIa
(antibody 22E7), IgE or vimentin (control) and examined by confocal microscopy to assess the
frequency of CD1a+ LCs immunoreactive for FceRIa or IgE. Comparison of ®xed and un®xed
preparations allowed us to distinguish between cell surface and cytoplasmic immunoreactivity. LCs
from all individuals contained cytoplasmic FceRIa., Cell surface FceRIa expression accompanied
by IgE staining, was seen in 8/11 AD and 5/11 NAD. No surface FceRIa was seen in NAC.
Thus, epidermal LCs express surface FceRIa and bind IgE, not only in AD but also in allergic
asthma and rhinitis. That it is seen only in subjects with active or recently active allergic disease,
suggests it occurs as a consequence of active systemic atopic allergic disease and is not restricted to
AD.
732 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
121
Withdrawn
122
Drug Hypersensitivity Reactions ± Role of T-Cells
W. J. Pichler
Division of Allergology, Inselspital, Bern, Switzerland
Hypersensitivity reactions to drugs can cause a great variety of diseases affecting mainly the skin but
often also other organs. Drug speci®c T-cells play a decisive role both by orchestrating the immune
response and in¯ammation, and by acting themselves as killer cells: They are found in the
circulation as well as in the affected tissue of clinically distinct forms of drug allergy and their
functional analysis In vitro is in agreement with the ®ndings in immunohistology. Both, CD4+ and
CD8+ T-cells recognize the drug by their ab-TCR in an MHC dependent way. Drugs are
stimulatory for T-cells, when they covalently bind to peptides or proteins, but also if the drug has
structural features allowing it to bind in a rather labile manner (noncovalently) to the MHC-
peptide complex. In maculopapular exanthema immunohistology of the affected skin and
functional tests of drug speci®c T-cell clones demonstrate the presence of cytotoxic CD4+ and to a
lesser degree of CD8+ T-cells in the dermis and epidermis, both containing perforin and
granzymeB. These cytotoxic T-cells are in close contact to keratinocytes that show signs of cell
destruction. In patients with bullous skin disease there is a higher percentage of cytotoxic,
CD8+ T-cells emigrating into the epidermis. Drug speci®c T-cells also release various cytokines, in
particular IL-5 and in pustular forms of drug allergy even IL-8. In conclusion, the ®ndings
demonstrate the decisive role of T-cells in various drug allergic diseases and allow to attribute
distinct clinical forms of drug hypersensitivity to different T-cell reactions.
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Characterisation of Nickel Speci®c T-Cells in Patients with Allergic Contact Dermatitis
H. Moed, D. M. Boorsma, B. M. E. von Blomberg, R. J. Scheper, D. P. Bruynzeel, S. Gibbs, and
T. Rustemeyer
Department of Dermatology, VUMC, Amsterdam, the Netherlands
Allergic contact dermatitis (ACD) is a delayed type hypersensitivity reaction mediated by T
lymphocytes. The role of different allergen speci®c T-cell subsets and the way these subsets can
migrate to the site of in¯ammation is still unclear. One of the major molecules on T-cells involved
in homing to the skin is the cutaneous lymphocyte associated antigen (CLA), but also other
molecules, like chemokine receptors, can play an important role in this migration. In this study we
characterise nickel speci®c T-cell subsets and their chemokine receptor expression in nickel allergic
patients. To test nickel speci®c reactivity in different T-cell subsets (CD4/CD8, CD45RO/
CD45RA, CLA, CXCR3/CCR4/CCR10/CCR6), PBMC from nickel allergic patients were
depleted from respective subsets and cultured in the presence or absence of nickel sulphate. After
6 days of culture proliferation was measured by 3H-thymidine incorporation. To study chemokine
receptor- and CLA-expression on different T-cell populations after stimulation with nickel
sulphate triple FACS-stainings were performed. Depletion of CD4+ or CD45RO+ cells gave a
decrease of nickel-speci®c proliferation compaired to nickel-speci®c reactivity measured in total
PBMC. Depletion of CD8+ or CD45RA+ cells did not impair the nickel speci®c reactivity.
Depletion of CLA+ cells completely abrogated nickel speci®c proliferation while puri®cation
resulted in an increased speci®c response. After 6 days culture of PBMC with nickel sulphate an
increase of CD4+/CLA+ cells was visible by FACS-staining. These cells express the chemokine
receptors CXCR3, CCR4 and CCR10, but not CCR6. Indeed, preliminary data show that nickel
speci®c proliferation is increased in T-cells which express the chemokine receptors CXCR3,
CCR4 or CCR10. In conclusion, nickel reactive T-cells in peripheral blood of allergic patients are
characterized by CD4-, CD45RO-, and CLA positivity. Besides CLA also CCR4, CCR10 and
CXCR3, but not CCR6 seem to be relevant homing receptors expressed on allergen speci®c
effector T-cells. Current studies demonstrate the contribution of this T-cell population in allergic
in¯ammatory skin reactions and their interactions with regulatory T-cells.
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The Immunosuppressive Potency of Pimecrolimus is Greater Than That of Cyclosporin
In Vitro
S. Sakuma, Y. Fujii, H. Senoh, J. Hiroi, Y. Ohkubo, and S. Mutoh
Osaka, Japan
Orally administered cyclosporin has often been used to treat very severe and recalcitrant cases of
psoriasis and atopic dermatitis. However, as there are several known side-effects associated with
cyclosporin, pimecrolimus (ASM-981) has been proposed as a better treatment option. In this
study, the immunosuppressive potency of pimecrolimus was compared with that of cyclosporin in
several different In vitro models. In the human mixed lymphocyte reaction, IC50 values of 0.26 ng
per ml and 14.4 ng per ml were reported for pimecrolimus and cyclosporin, respectively. The
second model measured the release of histamine from human basophils and the IC50 value
obtained for pimecrolimus was 46.0 ng per ml and 333.5 ng per ml for cyclosporin. In addition, the
Th1 cytokine (IFN-g) production from human peripheral blood mononuclear cells (PBMC)
stimulated with CD3/CD28 was evaluated, and pimecrolimus and cyclosporin had IC50 values of
9.94 ng per ml and 100.0 ng per ml, respectively. Finally, measurement of Th2 cytokine (IL-4)
production from human PBMC stimulated with anti-CD3/CD28 revealed IC50 values of 3.61 ng
per ml and 13.6 ng per ml for pimecrolimus and cyclosporin, respectively. In conclusion, these four
different In vitro models have demonstrated unequivocally that pimecrolimus has substantially
higher immunosuppressive potency than cyclosporin.
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T Cells: Link Between Streptococcal Angina and Psoriasis
J. Prinz and S. Vollmer
Munich, Germany
Psoriasis vulgaris is a disorder of abnormal keratinocyte proliferation induced by antigen-speci®c
activation of T lymphocytes in the skin. Still unresolved is the question of how tonsillar infection
with Streptococcus pyogenes (Strep) which is a major trigger of ®rst psoriasis onset may contribute to
lesional psoriatic T cell activation. To analyze this relationship at the T cell level we compared the
T cell receptor (TCR) usage in skin lesions and tonsils of patients with Strep-induced psoriasis. The
TCR b-chain V gene repertoire was ampli®ed by PCR using 26 different BV gene speci®c primers
together with a BC primer in skin lesions and tonsil of the patients. PCR products were analyzed
by fragment length analysis, cloning and sequencing of TCR cDNA. By this approach clonally
expanded TCR rearrangements were detected in skin lesions of both patients that indicated
antigen-induced T cell activation. Strikingly, these particular TCR rearrangements were also
identi®ed within the tonsils. When tonsillar T cells were sorted according to the expression of the
cutaneous lymphocyte-associated antigen (CLA), which acts as a skin homing receptor for T cells,
the clonal TCR rearrangements from the skin lesions could be selectively assigned to the CLA-
positive T cell fraction. Together these results demonstrate that T cells of the same T cell clone are
present in psoriatic skin lesions and tonsillar tissue of psoriasis patients with recurrent streptococcal
angina. They suggest that T cells activated during streptococcal tonsillitis are primed to enter the
skin where they become reactivated to induce psoriatic in¯ammation. Our data therefore suggest
that T cells may constitute the functional link between streptococcal throat infection and skin
in¯ammation in the pathogenesis of psoriasis.
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Afferent and Efferent Phases of Allergic Contact Dermatitis (ACD) Can be Induced after
a Single Skin Contact with Haptens. Evidence Using a Mouse Model of Primary ACD
P. Saint-MeÂzard, M. Krasteva, C. Chavagnac, S. Bosset, H. Akiba, J. Kanitakis, D. Kaiserlian, and
J.-F. Nicolas
Lyon, France
Allergic contact dermatitis (ACD) to haptens is a T cell-mediated DTH reaction, which occurs
upon hapten challenge in already sensitized individuals. The in¯ammatory response in ACD
requires a sensitization phase leading to induction of antigen-speci®c T cells in the lymph nodes
(afferent phase) and an elicitation phase responsible for T cell activation in the tissue (efferent
phase). Conversely, previously unsensitized individuals may develop a ``primary allergic reaction''
after the ®rst skin contact with haptens leading to a skin in¯ammation with all the features of ACD.
Here, we used an experimental model in Balb/c mice, refered to as contact hypersensitivity (CHS),
to study the pathophysiology of primary allergic reactions and their relationship to classical ACD.
We show that ACD can develop after a single exposure to DNFB and FITC applied onto the skin
without subsequent challenge. Indeed, one epicutaneous application of a non irritant dose of
hapten was suf®cient to induce an optimal ACD reaction at the site of primary contact with the
hapten, which started on day 6 after skin painting, peaked at day 7 and resolved by day 9±10. As in
classical ACD, the skin in¯ammation was mediated by IFN-g producing, CD8+ effector T cells
which were induced in the draining lymph nodes at day ®ve post sensitisation and down-regulated
by CD4+ T cells. RT-PCR analysis revealed that PACD reaction was mediated by an early
recruitment of CD8+ T cells at the sensitization skin site at day 6 post sensitization. Analysis of the
fate of the hapten in the skin revealed its persistance for up to 14 days after skin painting. Thus,
primary ACD develops in the absence of secondary challenge, due to the persistance of the hapten
in the skin which allows activation of speci®c CD8+ T cells at the site of the single hapten
application.
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Blockade of Skin Dendritic Cell Migration by Topical Application of MMP- and PKC-
Inhibitors
F. BeÂrard, P. Saint-MeÂzard, C. Chavagnac, S. Bosset, N. Piccardi,* P. Msika,* and J. F. Nicolas
INSERM 503, Lyon, France and Laboratoires Pharmascience, R & D Center, Epernon, France
Epidermal langerhans cells (LC) and skin dendritic cells (DCs) are potent antigen presenting cell
(APC) in the induction of primary T cell-mediated immune responses in the skin. They capture
foreign antigens (Ags) and migrate to regional lymph nodes (LNs) to carry and present this antigen
to naive T cell. This mechanism is critical in the initiation of different cutaneous pathology such as
Psoriasis, Contact Dermatitis or Contact Hypersensitivity (CHS). Several molecules regulate the
migration of skin DC, among which metalloproteinase (MMPs) and proteine kinase C (PKC). The
aim of this study was to evaluate the participation of MMPs and PKC in the in vivo migration of
murine skin DCs, using topical inhibitors for MMP and PKC. Mice were ear painted with FITC
and DC migration to auricular LNs was assessed 24 h later by ¯ow cytometry quanti®cation of
FITC+, CD86+, MHC class II high positive cells. Topical application of MMP or PKC inhibitors
on the skin once a day for 4 consecutive days induced a dose-dependant reduction in the number
of FITC+ migrating DC (around 30% of inhibition for the optimal dose), compared to placebo
application. When PKC and MMP inhibitors were mixed in the same ointment, the inhibitory
effect was more pronounced (86% of inhibition), suggesting a synergistic action. These data
indicate that, topical use of inhibitors of PKC plus MMPs, could inhibit skin DC migration, which
could have strong therapeutic implications in the treatment of skin in¯ammatory dermatoses.
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Delayed-Type Reactions to Amoxicillin are Detected by Skin Patch Tests But Not by
Lymphocyte Transformation/Activation Tests
A. Rozieres, K. Rodet, F. Cousin, F. Berard, S. Nancey, K. Philips, G. Cozon, L. Guilloux, J.
Bienvenu, and J. F. Nicolas
Lyon, France
Adverse cutaneous drug reactions may involve activation of innate (pseudo-allergy) or speci®c
immunity, the latter corresponding to hypersensitivity reactions. Drug-induced cutaneous DTH
reactions often present as maculo-papular rashes and are due to the activation in the skin of drug-
speci®c T cells. Diagnosis of DTH reactions to drugs rely on the demonstration of the presence of
drug-speci®c T cells, using two main types of tests: (i) in vivo epicutaneous and intradermal tests
which induces a localized contact dermatitis or DTH reaction in sensitized patients; (ii) In vitro
lymphocyte transformation (LTT) and activation (LAT) tests which measure the proliferation of
peripheral blood T cells, or the expression of cell surface activation markers, respectively. The aim
of this work was to test for the sensitivity and the speci®city of LTT and LAT as an In vitro
diagnostic tool in 8 patients with typical DTH reaction to amoxicillin (i.e. amox-induced maculo-
papular exanthema and positive skin patch tests/and ID tests to amox.). PBMC were recovered
from patients 1±3 months after the resolution of the exanthema. Total PBMC, puri®ed CD4+ and
CD8+ T cells were cultured with/without amox. or an irrelevant drug in the presence of irradiated
autologous antigen presenting cells and tested for amox-speci®c proliferation (LTT) and amox-
induced expression of CD69/CD25 antigens (LTA). Results show that LTT and LTA are not
usefull for the diagnosis of DTH to amox. Since: (i) LTT / total PBMC was positive in only 4/8
patients; (ii) LTT / CD4 and LTT / CD8 was postive in 2/5 patients; (iii) LTA / CD25 was
positive in 2/5 patients. In conclusion, the high proportion of false negative LTT and LTA tests in
selected patients with T-cell mediated amox-induced exanthema is incompatible with their use as
in vitro diagnostic tests for DTH to amox.
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Inhibitors of Dipeptidyl Peptidase IV (DP IV, CD26) Suppress the Proliferation of
Peripheral Blood Mononuclear Cells in Psoriasis
R. BoÈckelmann, D. Reinhold, A. Recke, K. Neubert, H. Gollnick, and B. Bonnekoh
Magdeburg and Halle (S.), Germany
The ectoenzyme dipeptidyl peptidase IV (DP IV, CD26) is known to play a crucial role in T cell
activation. Recently it has been shown that synthetic inhibitors of DP IV enzymatic activity
suppress DNA synthesis as well as cytokine production of stimulated T cells suggesting a potential
therapeutic application of these agents in autoimmune diseases. As an example of a T cell mediated
putative autoimmune disease we studied psoriasis, characterized by epidermal hyperproliferation
and vascular in¯ammation of the skin. The expression of DP IV/CD26 on peripheral blood
mononuclear cells (PBMC) was examined by immuno-¯owcytometry in patients with psoriasis as
well as the effects of the two DP IV inhibitors Lys[Z(NO2)]-thiazolidide and Lys[Z(NO2)]-
pyrrolidide on the proliferation of these cells ex vivo. The portion of CD3+/CD26+ PBMC did not
differ signi®cantly in psoriasis compared with healthy controls. In vitro, both DP IV inhibitors
(20 mM) led to a substantial signi®cant suppression of DNA synthesis of phyto-hemagglutinin (1 mg
per ml)-stimulated PBMC from patients with psoriasis (70.2 6 13.1%, 66.9 6 11.9%, respectively)
and from healthy donors (81.6 6 13.2%, 74.4 6 9.2%, respectively, compared to 100% of untreated
controls). The viability of PBMC was not impaired by the two DP IV inhibitors under the chosen
conditions. Thus, we could demonstrate that the inhibition of the enzymatic activity of DP IV in
PBMC may be a possible therapeutic target in psoriasis.
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Effector Cells and Effector Mechanisms in CD8+ and CD4+ T Cell Mediated Murine
Contact Hypersensitivity
S. Martin, J. Dudda, and J. C. Simon
Freiburg, Germany
It has recently been demonstrated that the dominant effector T cells in contact hypersensitivity
(CHS) induced by haptens are cytotoxic, IFN-g producing CD8+ Tc1 cells. For CD4+ T cells a
regulatory role has been shown. One of the crucial pathogenetic factors of this allergic disease
seems to be T cell mediated cytotoxicity which may be responsible for the dominance of CD8+ T
cells as well as for the pathogenetic processes in the skin, e.g. cytolysis of keratinocytes. In the
current study we analysed the potential effector role of CD4+ T cells and the evaluation of their
effector mechanisms in CHS as compared to CD8+ T cell mediated CHS. We made use of
C57BL/6 mice which in response to TNP and DNP develop a Tc1 mediated CHS and of CD8+ T
cell de®cient b2m Knockout (KO) mice which have been reported to be unable to mount a CHS
response to DNP. When we compared CHS responses to DNP in the two mouse strains we found
a good CHS response in C57BL/6 mice but no CHS in b2m KO mice as reported. However, we
could show that also in the b2m KO mice DNP-speci®c T cells were induced. Interestingly, when
we used TNP we found that b2m KO mice mounted a good CHS response which was similar to
the TNP response in C57BL/6 mice in its kinetic. These data show that depending on the hapten
used a CHS response can be mediated by CD4+ T cells in the absence of CD8+ T cells. We are
currently analysing the effector mechanisms responsible for CD4+ T cell mediated CHS and the
reasons for the absence of DNP-induced CHS in these mice despite the priming of DNP-speci®c
T cells.
131
Intradermal Application of Bone-Marrow Derived Dendritic Cells Primes for a Skin
Homing CD8+ T Cell Subset
J. Dudda, J. C. Simon, and S. Martin
Freiburg, Germany
Skin associated immune responses are driven by a T Cell (TC) subset specialized for skin homing
by expression of chemokine receptors like CCR4, CCR10 and adhesion molecules like E-selectin
ligand. Little is known about the factors which determine the targeting of TC to speci®c tissues.
For example, the site of priming or the speci®c antigen presenting cell (APC) could be crucial.
Based on our observation that, in contrast to intradermal (i.d.) injection, intravenous (i.v.) injection
of In vitro generated bone marrow-derived hapten-modi®ed Dendritic Cells (DC) is inef®cient in
sensitizing mice for hapten-induced contact hypersensitivity we compared the homing properties
of CD8+ effector TC depending on the immunization route. We used the adoptive transfer of
TCR transgenic CD8+ P14 TC speci®c for peptide p33 from LCMV glycoprotein to generate a
high number of antigen-speci®c and traceable CD8+ effector TC in C57BL/6 recipient mice.
After in vivo priming of the transferred TC with peptide-pulsed DC given i.v. or i.d., skin
in¯ammation was induced by painting the contact sensitizer trinitrophenyl (TNP) on both ears and
the TC emigrated In vitro from ear sheets were analysed by FACS. In general we found 2±10 times
more CD8+ P14 TC emigrating from in¯amed ear skin if the DC had been given i.d. compared to
i.v. injection. E-Selectin Ligand was signi®cantly increased on blood P14 TC only after i.d.
immunization suggesting an important role for this molecule in the observed homing differences.
Obviously, during TC priming the APC and/or the lymphoid tissue microenvironment crucially
in¯uences the homing properties of CD8+ TC.
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Analysis of the Repertoire and Function of Lesional Skin In®ltrating CD8 T
Lymphocytes in HIV-Infected Patients With Psoriasis
M. Kemula, B. Flageul, C. Parizot, L. Dubertret, G. Gorochov, and H. Bachelez
Institut de Recherche sur la Peau, INSERM U532, HoÃpital Saint Louis and Laboratoire d'immunologie,
INSERM U543 HoÃpital PitieÂ-SalpeÃtrieÁre, Paris, France
Incidence and severity of psoriasis seem to be exacerbated in HIV-infected patients as compared to
the general population. The worsening of psoriasis along the evolution of the immune de®ciency is
contradictory with the usual pathogenic role of CD4+ T cells. We have previously shown that skin
in®ltrating lymphocytes in HIV-infected patients with psoriasis are mostly memory CD8+ T cells
expressing the HLA-DR activation marker and cytotoxicity markers such as Ti-A1, perforin and
granzyme B, suggesting that a chronic antigenic stimulation, possibly of retroviral origin, could
participate in the lymphocytic activation. The ef®cacy of highly active antiretroviral therapy
(HAART) on psoriatic lesions is another argument in favour of this hypothesis. We have studied
the repertoire of psoriatic plaques' in®ltrating lymphocytes by the immunoscope method in 9
HIV-infected patients and 10 noninfected patients. The results show an oligoclonal pattern of
CDR3 region size pro®les, in both populations. Moreover the skin repertoire bias is not site-
speci®c as no difference is observed between pro®les obtained from two dictinct plaques at the
same time. No anti-HIV speci®city could be evidenced from peripheral blood mononuclear cells
nor psoriatic skin-derived cell lines using HIV peptide/HLA-class I tetramer and ELISPOT
interferon secretion detection. These results argue against the hypothesis of a cutaneous CD8+ T
cell selection by HIV antigens, and are more in favour of an indirect pathogenic role of the
retroviral infection via chemokine/chemokine±receptor interactions.
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CD123+/CD4+ Cells ± A Predominant Dendritic Cell (DC) Population in Allergic
Contact Dermatitis
C. Bangert, G. Stingl, and T. Kopp
Department of Dermatology, DIAID, University of Vienna Medical School, Vienna, Austria
While the importance of Langerhans cells (LCs) and dermal dendritic cells (DDCs) in the induction
phase of allergic contact dermatitis (ACD) is well established, their role, if any, in the effector phase
has yet to be demonstrated. In this study, we searched in ACD lesions for the presence of not only
DCs normally residing in the skin, but also of other members of the DC family. Biopsies from
positive 72 h epicutaneous patch tests (ECTs; n = 9) as well as from normal human skin (NHS)
(n = 3) were subjected to immunohistologic analysis. CD1a was used as a marker for LCs, CD1c
for DDCs and CD123/CD4 for plasmacytoid DCs (pDCs). NHS contained CD1a+ and CD1c+
cells in both the epidermal (16.3/mm- and 1.3/mm basement membrane, respectively) and dermal
(10/mm2 and 13.7/mm2, respectively) compartment. In ECT lesions the number of dermal CD1a+
cells (47.5/mm2) was signi®cantly increased at the expense of their epidermal counterpart (12.5/
mm basement membrane). Similar phenotypic changes were observed in the CD1c+ population of
ECT specimens. As opposed to the situation in NHS, a substantial proportion (10.4±38%) of
epidermal and dermal CD1a+ and CD1c+ cells expressed the activation marker CD83. These
®ndings are indicative of events occurring in hapten-challenged skin, i.e. LC/DDC migration and
maturation. We also detected a small number of the newly de®ned CD123+/CD4+ pDC
population in the dermal compartment of NHS (2.9/mm2). Interestingly, these cells represented
the vast majority of the entire DC in®ltrate in ECT lesions. They were numerically increased in
the upper dermis (71.3/mm2) and, to a lesser extent, in the epidermis (7/mm basement membrane)
of ECTs. It is tempting to speculate that their attraction to ACD lesions is a regulatory mechanism
aimed at dampening, and eventually, terminating undesired T-cell responses.
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Absent or Low Expression of T-Cell Receptor z-Chain in T-Cells In®ltrating Human
Pathological Skin Conditions
M. Alaibac, B. Pigozzi, A. Saponeri, A. Belloni-Fortina, and A. Peserico
Institute of Dermatology, University of Padua, Italy
Antigen recognition by the T-cell receptor (TCR) is mediated by the clonotypic TCR ab or
TCR gd chains that are derived from the products of site-speci®c DNA recombination events
during development. The remaining chains of the TCR, which include the CD3g, d and e chains
and a z-family dimer, are responsible for signal transduction. The cytoplasmic domain of the z
chain is involved in signal transduction necessary for T-cell activation and subsequent proliferation.
Up to now, the in situ situation concerning the expression of TCR z-chain has not yet been
investigated on in®ltrating T-lymphocytes in neoplastic and in¯ammatory cutaneous diseases. In
this study, we analysed the expression of TCR z-chain in situ in a large series of human
pathological skin conditions using immunohistochemical methods. Air-dried acetone-®xed frozen
sections were incubated with two anti-TCR-z-chain denominated TIA-2 and G3 and processed
with a standard alkaline phosphatase antialkaline phosphatase (APAAP) technique. No or at most
scarce expression of TCR z-chain was detectable in the in¯ammatory skin conditions investigated
as compared to CD3 positive cells. In cutaneous T-cell lymphomas (CTCL), stricking reduction of
TCR z-chain reactive cells were found in either reactive or malignant T-cell components.
Cutaneous B-cell lymphomas (CBCL) were also negative. The mechanism(s) responsible for the
absent or low expression of the z chain in skin in®ltrating T lymphocytes are unclear and various
explanations may be advanced. It is possible that this TCR defect is induced by the skin
microenvironment as an effect of local immunoregulatory in¯uences. Alternatively, lymphocytes
located in the skin may generally not express this molecule and the low expression in T-cells
in®ltrating in¯ammatory and neoplastic skin conditions may be unrelated to the underlying
pathological process. In conclusion, the salient ®nding of this report is the demonstration of low or
absent TCR-z-chain expression in T-lymphocytes in®ltrating neoplastic and in¯ammatory skin
conditions. The mechanisms responsible for reduced TCR z chain expression in skin-in®ltrating
T-cells and the biological signi®cance of these ®ndings remain to be elucidated.
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T-Cell Receptor Excision Circle (TREC) Content is Reduced in CD8+T-Cells From
Patients with Atopic Dermatitis (AD)
H. Just, B. Deleuran, M. Deleuran, and K. Thestrup-Pedersen
Aarhus, Denmark
Earlier studies have shown increased telomerase activity and shortened telomere length in T-cells
from blood of patients with AD indicating an increased cellular turnover of CD4+ and CD8+ T-
cells. In order to investigate the cellular turnover and/or thymic output of T-cells in patients with
AD, TREC content was measured in peripheral blood from 15 patients and 15 age matched
healthy donors. Measurement of TREC has within the last years become an established method to
estimate recent thymic immigrants. Peripheral blood mononuclear cells (PBMC) were isolated
from the blood samples and subsequently CD4+ and CD8+ T-cells were isolated by positive
immunoselection using Dyna-Beads. TREC levels were analysed by real-time quantitative PCR.
To normalize for the input of DNA, the CaÂ constant region and b2microglobulin were ampli®ed
in every sample tested. The results show signi®cantly lower TREC content in CD8+ T-cells from
patients with AD compaired to TREC content in CD8+ T-cells from age matched healthy donors
(p = 0.02), whereas no difference was seen between the two groups regarding the CD4+ T-cell
subpopulation. Signi®cantly lower ratio of TREC content in CD8+ T-cells over TREC content
in CD4+ T-cells were also seen for patients with AD compaired to donors (p < 0.01). These
®ndings surgest that patients with AD have decreased thymic output and/or an increased peripheral
proliferation of their CD8+ T-cells. These new observations together with the previous ®ndings
demonstrate universal changes in the peripheral T lymphocyte system of AD patients. Further
studies are needed to evaluate and con®rm the ®ndings.
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Expression and T Cell Costimulatory Function of the TNF Ligand BAFF
B. Huard, L. Arlettaz,* V. Kindler,³ D. Mauri,§ E. Roosnek,* J. Tschopp,² P. Schneider,² and L.
E. French
Department of Dermatology, University Medical Center, Geneva, Switzerland; *Division of Immunology
and Allergology, University Hospital, Geneva, Switzerland; ²Institute of Biochemistry, Lausanne
University, 1066 Epalinges, Switzerland; ³Division of Hematology, University Hospital, Geneva, and
§Apotech Corp., 1066 Epalinges, Switzerland
BAFF (B cell activating factor from the TNF family) is a member of the tumor necrosis factor
(TNF) ligand superfamily. BAFF provides an important survival signal to immature B cells, and
recently a T cell costimulatory activity was reported. While BAFF function appears well
understood, the cellular source of this TNF ligand has not been fully characterized. Here, we
studied expression of BAFF in peripheral blood leukocytes. We found that BAFF is preferentially
expressed in dendritic cells (DC). Indeed, ex vivo DC and DC derived from monocytes or CD34
stem cells express high level of BAFF mRNA. A low level of BAFF mRNA, up-regulated upon
cellular activation, was also found in resting T cells. In DC, LPS stimulation up-regulated BAFF
mRNA. Functionally, we show that blockade of this endogenous production of BAFF with a
soluble form of one of its receptors (TACI-Ig or BAFF-R-Ig) signi®cantly inhibited T cell
activation. This inhibition was observed when total peripheral blood mononuclear cells and, to a
lesser extent, when puri®ed T cells were used. This demonstrates that endogenous production of
BAFF by circulating antigen presenting cells (APC) and activated T cells provide some level of T
cell costimulation. In conclusion, the expression pattern observed in this study reveals a
predominant expression of BAFF in APC and therefore con®rms its immunostimulatory function.
The potential similarity with the other closely related TNF ligand APRIL (a proliferation inducing
TNF ligand) will be discussed.
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Autologous Stimulation of T Cells from Psoriatic Plaques In Vitro
J. Foerster, W. Urban, W. Sterry, and P. Walden
Department of Dermatology, ChariteÂ Hospital, Berlin, Germany
The speci®city of T cells in psoriasis is unknown. As a ®rst step toward a characterization of T cell
receptor speci®cities, we characterized stimulation of T cells isolated from active psoriatic plaques
by autologous plaque cells using a g-interferon ELISPOT assay. Spot formation in the presence of
an activating CD3-antibody served as positive control. The number of IFN-g producing T cells,
quanti®ed as spots per 5 3 104 cells, increased by at least 50% in the presence of autologous plaque
cells in six out of nine patients. There was high interindividual variation with respect to absolute
spot number, stimulation magnitutde relative to anti-CD3 stimulation, distribution of T cell
subsets, and T cell activation status (as quanti®ed by expression of CD69). Patients were classi®ed as
``responders'' when the increase in spot formation elicited by autologous plaque cells reached at
least 10% of that elicited by anti-CD3. When using this classi®cation, there was a signi®cant
difference in relative abundance of double-negative (CD4- CD8-) T-cells (44 6 33% in responders
vs. 10.1 6 8.4% in nonresponders; p < 0.1; n = 4 per group). Other differences in T-cell subset
distributions were nonsigni®cant. There was no obvious correlation between any T ± cell subset
frequency, activation status and number of g-interferon secreting cells. When T cell clones were
generated by limiting dilutaion, three of three proliferating clones could be re-stimulated by
autologous plaque cells. Together, these data show that autologous stimulation of T-cells by cells
derived from the same psoriatic plaque can be reconstituted In vitro. This approach should be
valuable for the assessment of biological relevance of individual T cell clones.
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avb3-Integrin Differentiate Between Acute and Chronic Delayed Type Hypersensitivity
Reactions
M. Kneilling, B. J. Pichler, L. Hueltner, R. Mailhammer, R. Haubner, C. Bodenstein, H.
BraumuÈller, T. Biedermann, C. Sander, W. A. Weber, and M. Roecken
Munich, Germany
Chronic and recurrent episodes of in¯ammation can lead to tissue destruction and regenerative
processes while acute episodes may resolve without. Angiogenesis plays a major role in organ-
speci®c autoimmune diseases caused by delayed type hypersensitivity reactions (DTHR) and
contact hypersensitivity reactions (CHSR). Vascular cell integrin avb3 is selectively induced during
angiogenesis and mediates cellular adhesion to extacellular matrix proteins. To better understand
mechanisms of chronic in¯ammation, we investigated the role of avb3-integrin in acute- (A-
CHSR ± one episode of in¯ammation) and chronic contact hypersensitivity reactions (C-CHSR ±
recurrent episodes) using RGD-peptide which selectively binds to avb3-integrin. Mice were
sensitized and challenged with TNCB to induce and elicit CHSR. 12 h after TNCB challenge
animals were injected with [18F]Galacto-RGD or [125I]Gluco-RGD peptide and scanned in vivo
with the small animal positron emission tomograph MADPET or uptake was determined by
autoradiography. In vivo MADPET images showed intense RGD peptide uptake in C-CHSR but
not in A-CHSR. No uptake was determined in C-CHSR mice pretreated with unlabeld RGD
peptide. The uptake ratio -right ear (treated) vs. left ear (untreated)- was 2.9 for C-CHSR, no
increase was seen in A-CHSR. RGD peptide uptake in C-CHSR increased with episodes of
in¯ammation. Maximum activity appeared 12±24 h after challenge. Immunohistochemical staining
con®rmed b3 expression exclusively on blood vessels in ears with C-CHSR but not with A-
CHSR. H&E stained sections con®rmed enhanced angiogenesis in C-CHSR. Since TNF±/± and
IL-4±/± mice showed normal avb3-integrin expression, angiogenesis seems to be independent from
these two cytokines. Thus, angiogenesis and avb3-integrin plays an essential role in C-CHSR but
not in A-CHSR. Thus, we demonstrate a new model for examination of angiogenesis also
potentially applicable in clinical dermatology. Furthermore, our data may help to bring new
insights in the pathogenesis of T cell mediated autoimmune diseases. Since avb3-integrin
antagonists are available and capable to block angiogenesis, these compounds may led to new
strategies for the treatment of atopic dermatitis, psoriasis or rheumatoid arthritis.
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Toll-like Receptor 2 and 4-Dependent Regulation of In¯ammatory Signaling in Human
Sebocytes
M. K. Oeff, H. Seltmann, N. Hakiy, B. Bogdanoff, A. Nastos, R. Walters, S. R. Bornstein, and
Ch. C. Zouboulis
Berlin and Duesseldorf, Germany
Human sebocytes are able to regulate in¯ammatory and immune processes, involved in the
development of acne lesions, by intrinsic mechanisms. On the other hand, a bacterial role in the
potentation of in¯ammatory acne has been widely accepted. Toll-like receptors (TLRs) are
involved in innate immunity and are able to recognize microbial components. We address here a
possible mechanism of gram-negative and gram-positive bacterial compo-nent action on human
sebocytes through a modulation of TLR2 and TLR4 expression. We investigated the actions of the
bacterial cell wall components lipopolysaccharides (LPS) and lipoteichoic acid (LTA) upon TLR2
and TLR4 mRNA expression in SZ95 sebocytes after prolonged (+24 h) exposure. Changes in
TLR expression by these agents were compared to the action of retinoids and hydrocortisone. The
mRNA and protein levels were detected by RT-PCR and immunocytochemistry. The regulation
of TLR mRNA levels was investigated by using the TaqMan quantitative PCR method. To detect
the possible pro- or anti-in¯ammatory effects of microbial components and immunosuppressive
drugs we measured the IL-8 expression in SZ95 sebocytes and its secretion by TaqMan
quantitative PCR and ELISA, respectively. SZ95 sebocytes expressed TLR2 and TLR4 on
mRNA and protein levels. LPS enhanced TLR2 and IL-8 expression (n = 4, p < 0.05), while LTA
suppressed TLR2 expression, but barely regulated IL-8 expression. Hydrocortisone did not
regulate TLR2 expression. On the other hand, preliminary data suggest that LTA suppresses TLR4
expression, whereas LPS exhibited no effect. Hydrocortisone showed a suppressive effect on TLR4
and IL-8 expression (n = 4, p < 0.05). Neither IL-8 nor TLR expression was regulated by retinoids
after prolonged (+24 h) exposure. The present work provides ®rst evidence that bacterial cell wall
components may directly affect human sebocytes via a speci®c receptor-dependent mechanism in
the absence of in¯ammatory cells.
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a-Melanocyte Stimulating Hormone Suppresses Antigen-Driven Lymphocyte
Proliferation In Vitro and is Unrelated to Melanocortin-1 Receptor Genotype
A. J. Cooper, C. L. Jackson, T. Al-Bader, P. S. Friedmann, and E. Healy
Dermatopharmacology, University of Southampton, UK
The neuropeptide a-melanocyte stimulating hormone (a-MSH) has potent immunomodulatory
and anti-in¯ammatory activity. The effects of a-MSH are mediated via a family of ®ve
melanocortin receptors (MC1±5R), and it has previously been reported that human monocytes
express the melanocortin-1 receptor (MC1R). Activation of MC1R on monocytes by a-MSH
alters costimulatory molecule expression and stimulates release of interleukin-10 (IL-10).
Monocytes act as antigen-presenting cells and cause lymphocytes to proliferate to a variety of
antigens in vitro. Genetic variants of MC1R have been shown to have compromised function, and
are associated with red hair, fair skin and an increased susceptibility to skin cancer. However, it is
not known whether MC1R variants alter monocyte function or their ability to stimulate
lymphocytes. Here we show that a-MSH suppresses monocyte-mediated lymphocyte proliferation
in response to the antigen Varidase In vitro (mean reduction at 10±13 M a-MSH = 30.49%, SEM
4.24; p < 0.001) with widespread variability between individual subjects. MC1R expression on
human monocytes and monocyte-derived dentritic cells was con®rmed by RT-PCR. Sequencing
of MC1R suggested that the suppression by a-MSH is independent of MC1R genotype.
Furthermore, preliminary experiments suggest that a-MSH induced suppression of lymphocyte
proliferation occurs via an IL-10 independent mechanism.
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TLR2-Mediated Skin In¯ammation by Mycoplasma Lipopeptide MALP-2 is Mast Cell-
Independent
M. Metz, K. Grote,* J. Knop, and M. Maurer
Department of Dermatology, Johannes Gutenberg University, Mainz, Germany; *Department of Cardiology
and Angiology, Medical School, Hannover, Germany
Mast cells (MCs) have recently been found to express toll like receptor 2 (TLR2), the receptor of
macrophage-stimulating lipopeptide-2 (MALP-2), which is released by mycoplasmas. Since we
and others have shown that activated MCs protect from the pathology and mortality associated
with infections by enterococci, we hypothesized that MCs can initiate innate immune responses to
mycoplasmas after stimulation via MALP-2/TLR2. Here, we tested whether MCs contribute to
the induction of MALP-2 mediated in¯ammation. The injection of MALP-2 into the ear skin of
mice (240 U per ml, 20 mL) resulted in pronounced in¯ammatory reactions, measured by
earswelling (after 1 h: 97.4 6 10.6 mm, vs. 54.0 6 8.1 mm, p < 0.005) similar to MC-dependent
anaphylactic skin responses in course and strength. However, MALP-2 induced skin reactions in
genetically MC-de®cient KitW/KitW±v mice were virtually identical to those in normal Kit+/+ mice.
In addition, MALP-2 failed to degranulate MCs ex vivo, indicating that the induction of MALP-2-
mediated skin in¯ammation is MC-independent. To clarify why TLR2+ MCs are unresponsive to
MALP-2 we performed RT-PCR analyses for TLRs and MyD88. We found that MCs, unlike
macrophages, do not show full length transcripts for TLR2 and that MCs express mRNA only for
the extracellular domain of TLR2 while they lack expression of the TLR2 signalling domain. Our
data explain why MCs cannot be activated via MALP-2/TLR2 and show that the induction of
MALP-2/TLR2-mediated skin in¯ammation is not initiated by MCs. These ®ndings should
inspire further investigation of the unique structure of MC-TLR2 and its functions.
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The RANTES Containing Granule System in T Lymphocytes: First Description and
Hyperreleasability of T Cells from Patients with Exacerbated Atopic Dermatitis (AD)
A. Ambach, B. Bonnekoh, and H. Gollnick
Magdeburg, Germany
Perforin (Perf)-granules represent an essential component of the lytic machinery in cytotoxic T
lymphocytes (CTLs) and NK cells. Recently, a Perf-reduction and -hyperreleasability from atopic
CTLs was demonstrated. Since RANTES was shown to be stored in Perf-granules, we asked, if
these RANTES storage organelles in AD-T cells are altered as well. Ficoll-isolated peripheral
blood mononuclear cells of 6 patients with exacerbated AD and of 6 healthy controls (HC), and
the constitutive RANTES-expressing T lymphoma line Jurkat (Kab 14) as a control were ®xed in
2% formaldehyde, permeabilized with 0.2% saponin, and stained with directly labeled monoclonal
antibodies (mAB) against CD8, CD4, Perf (HoÈlzel, Cologne, Germany) and two different mABs
against RANTES (Pharmingen, Heidelberg, Germany; R & D Systems, Abingdon, UK). Staining
was controlled by isotype matched mAbs. In addition, degranulation was induced by PMA and
ionomycin, and the reduction of intracellular staining (mean ¯uorescence intensity, MFI) over
time was quanti®ed in a FACScan. Intracellular RANTES was detected in all Perf+ CD8hi+ CTLs.
The percentage of Perf+ CD8hi+ CTLs was signi®cantly lower in AD-patients (15 6 6%) as
compared to HC (45 6 16%, p < 0.01) and, thus, so was the percentage of RANTES+ Perf+
CD8hi+ CTLs. RANTES staining was detected in other lymphocytes as well. In the total of
lymphocytes, there was no signi®cant difference between AD-cells and HC with regard to
RANTES staining. However, by setting the MFI for RANTES at time point zero for 100%, a
RANTES-hyperreleasability was found: in PMA/ionomycin-stimulated AD-lymphocytes, the
MFI for RANTES was 56 6 19%, 45 6 12%, and 42 6 14% (of the initial MFI) after 10, 20 and
30 min, respectively, as compared to HC (83 6 18, 69 6 20, and 60 6 16%, respectively; p < 0.05).
Taken together we demonstrate (i) strong evidence for the existence of a so far undescribed
intracellular pool of RANTES containing granules in CD4+ and CD8+ T cells (ii) that these
organelles can be mobilized fast to the cell surface (iii) a hyperreleasability for RANTES-granules
in AD-lymphocytes. This supports the etiopathogenetic concept of a cell type independent
granule-hyperreleasability as a major pathogenetic factor in AD.
143
Modulation of Protease-Activated Receptor-2 Expression in Skin Tissue and Cell Lines
N. Castex-Rizzi, N. DeÂcanis, M. CharveÂron, and Y. Gall
Institut de Recherche Pierre FABRE/CERPER, Cell Biology Laboratory, Toulouse, France
Protease-activated receptor-2 (PAR-2) is activated by cleavage of the N terminus of the receptor
by a serine protease such as trypsin or tryptase. PAR-2 is up-regulated in in¯ammatory skin of
patients with atopic dermatitis or psoriasis suggesting a role of PAR-2 in cutaneous in¯ammation.
Moreover, vascular component participates to the in¯ammatory process through leucocyte
in®ltration Therefore, we were interested in assessing PAR-2 expression and its modulation in
endothelial (EA.hy926) and keratinocyte (HaCaT) cell lines, human skin, hair follicles and
keratinocytes freshly isolated from normal skin. PAR-2 activation was performed with speci®c
stimuli (agonist SLIGKV and trypsin) and in¯ammatory stimuli (TNFa and LPS). Inhibition of
PAR-2 activation was evaluated with soybean trypsin inhibitor (STI) and compared with a natural
soybean extract. Expression of PAR-2 was detected by RT-PCR (mRNA) and immunohis-
tochemistry (protein). Our results showed that PAR-2 mRNA was identi®ed in EA.hy926 and
HaCaT cell lines, and in keratinocytes and hair follicles originating from plastic surgery.
Immunolabelling corroborated these results. PAR-2 like immunoreactivity was present
throughout the skin with stronger labelling in the epidermis and skin appendages (sebaceous
and sweat glands, and hair follicle). PAR-2 mRNA was up-regulated at 4 h and protein was
increased at 24 h after treatments with the different speci®c and in¯ammatory stimuli. Finally,
speci®c PAR-2 inhibitors (STI and soybean extract) tested on cell lines and skin isolated elements
were able to reduce PAR-2 activation at transcriptional and traductional levels. In conclusion, we
have shown that PAR-2 is over-expressed in the human skin and cell lines during in¯ammatory
conditions. Moreover, serine protease inhibitors blocked PAR-2 expression suggesting that the
inhibition of the PAR-2 pathway by soybean extract may be an effective way for reducing skin
in¯ammatory responses.
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Inhibitory Effect of Thermal Spring Water* on Adhesion Molecules-Induced by TNF-
Alpha on Human Endothelial Cell Line
N. Castex-Rizzi, S. Pompon, C. Baudouin, M. Charveron, and Y. Gall
Institut de Recherche Pierre Fabre, CERPER/HoÃtel Dieu, Toulouse, France
Tissue in¯ammation is characterized by local leukocyte in®ltration. Vascular endothelium activated
by cytokines like TNF-a expresses adhesion molecules which interact speci®cally with their
leukocyte ligands. TNF-a induces cytokines expression via the activation of the transcription factor
NF-kB. Thermal Spring Water (TSW) exhibits therapeutic properties for treating atopic dermatitis
and psoriasis. In order to understand its bene®cial effects in these in¯ammatory diseases, we studied
the modulation of adhesion molecules expression by TSW on TNFa-stimulated endothelial cell
line. Experiments were performed on the human endothelial cell line EA.hy926. Cells were
preincubated for 24 h by TSW and stimulated for 4 or 24 h by TNFa (0.5±30 ng per ml). Adhesion
molecules expression was assessed by RT-PCR (mRNA) and immunolabelling (protein). The role
of NF-kB was studied by immunohistochemistry. By cell ELISA and immunohistochemistry, we
showed an inhibitory effect by TSW on two adhesion molecules expression: E-selectin (clinical
marker of atopic dermatitis) and ICAM-1. This inhibitory effect was shown with both waters from
the spring and from the commercialized spray. E-selectin mRNA analysis allowed us to conclude
in a transcriptional inhibition by TSW through the inhibition of the NF-kB transcription factor.
On a model of endothelial cell stimulated by an in¯ammatory cytokine (TNFa) Thermal Spring
Water exhibits a regulation of in¯ammatory parameters through the inhibition of adhesion
molecule involving NF-kB expression. *AveÁne-les-bains France.
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Autoreactive T- and B-Cell Epitopes in Bullous Pemphigoid Preferentially Locate to the
NH2-Terminus of the Extracellular Domain of BP180 (BPAG2)
S. Thoma-Uszynski, S. Schwietzke, L. Borradori,* and M. Hertl
University of Erlangen-NuÈrnberg, Erlangen, Germany; *Geneva University Hospital, Geneva, Switzerland
Bullous pempghigoid (BP) represents a model of antibody (Ab)-mediated autoimmunity.
Autoreactive Ab that target the hemidesmosomal adhesion molecule BP180 are critical for the
loss of dermoepidermal adhesion. Current concepts ascribe autoreactive T cells an active role in
immune pathogenesis by triggering auto-Ab formation. Our strategy was to characterize
autoreactive T- and B-cell responses against BP180 utilizing recombinants of the extracellular
domain (ECD) of BP180. In particular, we investigated the relationship between T-and B-cell
reactivity based on our hypothesis that in individual BP patients, BP180-reactive T cells may target
the same epitopes as subsequently produced auto-Ab. A total of 20 BP patients were studied, all of
whom had IgG reactive with the ECD of BP180. In 19/20 patients, autoreactive T cells
recognized epitopes within the NH2-terminal region, while T cells from 11/20 patients reacted
speci®cally with the COOH-terminus of BP180. In several patients (9/20), additional T cell
epitopes were located throughout the ECD of BP180. Analyzing auto-Ab pro®les with T cell
reactivity, we found that 85% of patients with NH2-terminal reactivity had also IgG directed
against the NC16A-domain. Furthermore, we identi®ed an immunodominant peptide within the
NC16A-domain of the ECD of BP180 which was recogniced by a CD4+ T helper cell clone in a
HLA-DRB1*1301-restricted manner. Our data suggest that T cell epitopes of BP180 may be
similar or identical to the regions that are recognized by auto-Ab. The identi®cation of
immunodominant T cell peptides will hopefully facilitate immunomodulatory strategies in BP.
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Conditional Inactivation of VCAM-1 Attenuates the Cutaneous Hypersensitivity
Response: Evidence for a Role of VCAM-1 as a Costimulatory Ligand in T-Cell
Activation
C. Leuker, C. Wickenhauser, W. Mueller,* N. Wagner, and N. Hunzelmann
University of Cologne and *GBF Braunschweig, Germany
The vascular adhesion molecule (VCAM)-1 is a membrane bound adhesion molecule binding
predominantly to a4b1 integrin and with lower af®nity to a4b7 integrin. Thereby this molecule
takes part in adhesive interactions between leukocytes and endothelial cells. In the cutaneous
hypersensitivity (CHS) response a contribution of this pathway to the migration of leukocytes into
the in¯amed tissue has been suggested. Therefore interferon-a induced Cre-lox P mediated
deletion of the VCAM-1 gene after birth was used to investigate the role of VCAM-1 in the
irritant and the CHS response. Mutant and wild-type mice exhibited equivalent responses to the
irritant croton oil. When mice were sensitized to 2,4-dinitrochlorobenzene a signi®cant reduction
of magnitude and duration of the contact hypersensitivity response in comparison to wild type
mice in the late phase of the reaction (48±96 h) was observed. This reduction was characterized by
a reduced cellularity, speci®cally by a reduction of monocyte and granulocyte counts. Langerhans
cell localization and emigration form the skin was unaffected. As VCAM-1 is also expressed on
APC, antigen-speci®c proliferation was investigated using lymph node cells and CD11c+ dendritic
cells for restimulation. Here, a signi®cantly reduced proliferation of T cells in comparison to wild
type controls was found, indicating that VCAM-1 acts as a costimulatory ligand. Further analysis
revealed that in a mixed lymphocyte reaction allotype CD4+ T cells were only poorly activated by
VCAM-1 de®cient CD11c+ cells. These results indicate that VCAM-1 in addition to its role as an
adhesive molecule for migration to in¯ammatory sites, also acts as an accessory molecule supplying
a crucial costimulatory signal for T cell activation.
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Induction of Psoriasis Involves TNFa Production by Heat Shock Protein Receptor
CD91 Expressing Antigen Presenting Cells and is Independent on Recruitment of
Lymphocytes
O. Boyman, H. P. Hefti, M. Suter, B. J. Nickoloff, and F. O. Nestle
Zurich, Switzerland
Psoriasis is a chronic skin disorder characterized by epidermal hyperproliferation and in®ltration of
numerous activated T cells. Key questions related to the disease pathogenesis of psoriasis include (i)
the necessity of recruitment of activated lymphocytes for disease induction (ii) factors for activation
of resident sentinels of the innate immune system, i.e. antigen presenting cells (APCs). Uninvolved
skin from psoriatic patients (PN skin) was transplanted on RAG knock out (KO) mice de®cient in
T and B cells, double KO mice de®cient in RAG and type I interferon receptor (AR), double KO
mice de®cient in RAG and type II interferon receptor (GR), as well as triple KO mice (AGR).
Only AGR mice demonstrated a conversion to psoriasis (PP skin) (29 out of 30 (= 97%) skin
grafts). Converted PP skin demonstrated a typical psoriatic phenotype on the macroscopic and
microscopic level including an increase of involucrin positive cell layers, keratin 16 expression
throughout the epidermis, strong suprabasal expression of Ki67, expression of high levels of
ICAM-1 and HLA-DR on lesional keratinocytes, increase of CD31 positive blood vessels as well
as expansion of CD4 and CD8 positive T cells. Development of the psoriatic lesions was correlated
with a strong increase in HLA-DR positive APCs. These cells expressed the heat shock protein
receptor CD91 and were in close proximity with CD91 ligand (HSP70) expressing keratinocytes.
Presence of nuclear NFkB as well as TNF a protein production indicated an activated state of
CD91 positive APCs. Abrogation of TNFa signals in CD91 positive APCs using TNFa speci®c
antibodies and TNF receptor fusion proteins led to a blockade of psoriasis disease development in 8
out of 9 (88%) mice. We conclude that development of psoriasis is independent on the recruitment
of circulating lymphocytes and involves the production of TNFa by CD91 expressing APCs.
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Dysregulation of the Perforin (Perf) System in Patients with Alopecia Areata (AA)
I. Schmidt, A. Ambach, B. Bonnekoh, and H. Gollnick
Magdeburg, Germany
Hair follicle-speci®c CD8+ cytotoxic T lymphocytes (CTLs) can re-induce lesions in AA scalp
biopsies grafted onto SCID mice. In the Dundee experimental bald rat, depletion of CD8+ CTLs
restores hair growth. To elucidate in humans the role of the CTL's perforin effector mechanism,
®coll-isolated peripheral mononuclear cells in 22 AA-patients (36 6 13 years; no systemic
therapy; > 20% scalp involvement in n = 9, = 20% scalp involvement in n = 13) were investigated
by immuno ¯ow cytometry and compared to 12 healthy control individuals (HC, 30 6 8 years). In
AA-patients, the percentage of CD8+ lymphocytes was reduced signi®cantly as compared to HC
(AA: 29 6 7%; HC: 35 6 7%; p < 0.05). The number of CD4+ cells was increased (AA: 49 6 9%;
HC: 38 6 13%; p < 0.05). Whereas the percentage of CD3+ T cells was not altered in AA, we
found a signi®cant reduction of CD56+ cells as compared to HC (AA: 12 6 5%; HC: 26 6 13%; p
< 0.05). Perf was expressed signi®cantly less in AA-lymphocytes (AA: 25 6 9%; HC: 36 6 10%; p
< 0.01). Among lymphocytic subpopulations Perf-reduction was signi®cant in CD8+ cells (AA:
52 6 18%; HC: 65 6 9%; p < 0.05), in CD26± cells (AA: 43 6 13%, HC: 60 6 9%, p < 0.001) and
in CD28± cells (AA: 48 6 13%; HC: 67 6 9%; p < 0.001), respectively. However, neither
``classical'' CTLs expressing high amounts of CD8 nor CD56+ NK cells showed any reduction of
Perf-positivity. Since AA is frequently associated to atopy and the Perf-system in atopic CTLs has
formerly been shown to be impaired, we subgrouped AA-patients according to the total serum IgE
level (AA: 223 6 257 kU per l; HC: 14 6 14 kU per l; p < 0.005). There was no signi®cant
difference in Perf-expression of lymphocytic subgroups between AA-patients with normal
(IgE < 100 kU per l; n = 11; Perf: 24 6 8%) or elevated IgE levels (IgE = 100 kU per l; n = 11; Perf:
25 6 10%). Thus, one may conclude that (i) Perf-reduction in AA-lymphocytes may be not related
to IgE levels, and (ii) is probably caused by a loss of Perf-expressing NK cells.
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Presence of the Arachidonic Acid Pro-In¯ammatory Pathway in Human Sebocytes In
Vitro
Th Alestas, S. Fimmel, C. Beutler, N. Hakij, W. Chen, K. MuÈller-Decker, and Ch. C. Zouboulis
Berlin and Heidelberg, Germany and Tainan, Taiwan
Arachidonic acid (AA) is a polyunsaturated fatty acid which is incorporated in the phospholipids of
the cell membrane. Under circumstances, phospholipases support AA release from the cell
membrane. 5-Lipoxygenase (5-LOX) catalyzes the conversion of intracellular or extracellular AA
to hydroperoxy-eicosatetraenoic acid (HPETE) and further to leukotriene A4 (LTA4). LTA4 is
metabolised by LTA4 hydrolase to LTB4, which has been recognised as pro-in¯ammatory
mediator. Leukotrienes cause degranulation, increased vascular permeability and endothelial
adhesiveness, as well as neutrophil chemotaxis and activation. In a previous study, we have
demonstrated that a systemic 5-LOX inhibitor was able to reduce the number of in¯ammatory
lesions and sebum synthesis in patients with acne. Therefore, this work was conducted to
investigate the presence and induction of AA metabolising enzymes and relevant AA in¯ammatory
pathway receptors in human sebocytes. SZ-95 sebocytes were maintained with or without AA and
calcium ionophore A23187. After 1, 6, 12, 24 h, the cells were washed twice with PBS and total
protein and RNA were extracted for Western blotting or RT-PCR, respectively. 5-LOX was
present under AA and calcium ionophore treatment at the mRNA and protein levels. In addition,
preliminary immunocytochemical studies have localised 5-LOX in SZ95 sebocytes. Furthermore,
LTA4 hydrolase and PPARa, being receptor for the natural ligand LTB4, were expressed in SZ95
sebocytes at the mRNA and protein levels. The presence of the enzymes 5-LOX, LTA4 hydrolase
and the detection of PPARa in human sebocytes provide strong evidence that eicosanoids may play
an important role in in¯ammatory sebaceous gland disorders, including acne.
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Long-lasting Ca2+ In¯ux in CD8+ T-Cells Induced by Mature Dendritic Cells Correlates
with Their Proliferative Potential
C. Termeer, M. Averbeck, J. Dudda, S. Martin, and J. C. Simon
Department of Dermatology, University of Freiburg, Freiburg, Germany
Dendritic cells (DC) as potent antigen presenting cells are able to induce MHC class I dependent
CD8+ cytotoxic T-cell responses. Here, we wished to determine, whether the maturational state
of the DC plays a role during the early cell-cell contacts leading to CD8+ T-cell proliferation.
TCR-transgenic CD8+ T-cells were used from P14 mice and coincubated with autologous bone
marrow derived DC in a time-lapse video microscopy system. We found that DC can interact with
T-cells by both short±lived interactions or long±lasting interactions. Low-peptide concentrations
or addition of immature DC mainly induced short-lived Ca2+-in¯ux of 3±5 min in CD8+ T-cells,
even detectable in a low number of T-cells in the absence of peptide or during T-cell/T±cell self
interactions. In contrast, the number of CD8+ T-cells with a persistent Ca2+-in¯ux for 30 min or
more could be substantially raised by the use of higher peptide concentrations or matured DC. 3H-
Thymidine incorporation assays directly correlated with the number of T-cells showing persistent
Ca2+-signals, suggesting that those are critical events needed to induce T-cell proliferation.
Interestingly, DC incubated only for 7 h with the maturational stimulus showed similar
effectiveness to induce long-lasting Ca2+-in¯ux. Therefore, the induction of long-lasting Ca2+-
in¯ux seems to be independent of the maturation-induced up-regulation of MHC and
costimulatory molecules on the surface of DC, since these changes occur much later at the
earliest after 18 h as determined by FACS-analysis. Instead, confocal-microscopy experiments using
small RHO-GTPase inhibitors revealed that a cytoskeletal reorganization of MHC and
costimulatory molecules on DC were responsible for sustained Ca2+-in¯ux resulting in
CD8+ T-cell proliferation.
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Nickel Effects Exerted In Vitro on Lipid Peroxidation, ROS Production and Cytokine
Secretion
B. Buttari, A. Napolitano,* M. d'Ischia,* E. Camera, and M. Picardo
Cutaneous Physiopathology, San Gallicano Dermatological Institute, Rome, Italy; *Department of Organic
Chemistry, University of Naples `Federico II', Naples, Italy
Nickel, a leading cause of allergic contact dermatitis, is thought to exert some of its adverse effects
through promotion/exacerbation of oxidative processes. Arachidonic acid (AA) plays a central role
in cell homeostasis, apoptosis and in¯ammation, and is a susceptible of oxidative modi®cations,
even promoted by transition metals, leading to cytotoxic products. The effects exerted by Ni2+ on
oxidation/decomposition of AA were investigated by TBARS assay, NMR analysis of
hydroperoxides, and GC-MS measurement of 4-hydroxy-2-nonenal (4-HNE). Ni2+ resulted to
poorly initiate AA autoxidation, whereas proved effective in 15-HPETE decomposition and 4-
HNE formation. In Fe2+-induced AA oxidation, Ni2+ inhibited AA decomposition. However, a
decreased inhibition was observed raising Ni2+ concentration. When peroxides were present prior
to Fe2+ addition, as in autoxidated or 15-HPETE-treated arachidonate solutions, Ni2+ accelerated
Fe2+-induced AA consumption and enhanced TBARS formation. The ability of Ni2+ of inducing
ROS production was evaluated following stimulation of HaCat with Ni2+ (2±24 h) at different
concentrations (7±35 mM). Moreover, IL-1b secretion was monitored after 48 h treatment with
35 mM NiSO4. As result, ROS production and IL-1b secretion were signi®cantly induced by Ni2+
incubation. The performed experiments showed that Ni2+ (i) is effective in enhancing AA
decomposition and aldehyde formation in presence of peroxides (ii) triggers ROS generation, and
(iii) induces IL-1b production. In conclusion, ROS over-production associated with the
increment of in¯ammatory mediators may initiate peroxidative process that elevate the peroxide/
Ni2+ ratio rendering Ni2+ more reactive. Activation of Ni2+ facilitates the formation of elevated
levels of 4-HNE and other aldehydes from hydroperoxides breakage, concurring to sensitization
process.
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The Langerhans Cell-Speci®c Costimulatory Molecule, Dectin-2, is a Key Molecule in
the Induction of Regulatory T Cells in Ultraviolet Light-Induced Tolerance
F. Yamazaki, A. Maeda, T. Tezuka, K. Ariizumi,* T. Schwarz,² and Y. Aragane
Department of Dermatology, Kinki University School of Medicine, Osakasayama-shi, Japan; *University of
Texas, Dallas, Texas, USA; ²University of MuÈnster, MuÈnster, Germany
Ultraviolet B light (UV) induces tolerance in a contact hypersensitivity (CHS) response in a
hapten-speci®c manner. Although this phenomenon has long been appreciated, the mechanisms
underlying this process are not completely clear yet. Currently, we could show that Dectin (Dec)-
2, a novel costimulatory molecule selectively expressed on Langerhans cells (LC) plays a pivotal
role in this process. To further delineate the immune pathway involved, we ®rst isolated whole T
cells from UV-tolerized mice that were previously exposed to low doses of UV for 4 successive
days and sensitized thereafter with dinitro¯uorobenzene through an irradiated skin area. Those T
cells, called UV-tolerized T cells, upon transfer induced immune unresponsiveness in recipients
when those were sensitized and challenged. By fractionating UV-tolerized T cells of either soluble
(sol) Dec-2 bound or unbound population, it was found that only transfer of the sol-Dec2-bound
T cell population resulted in suppression of CHS in recipients. Interestingly, however, the sol-
Dec2-unbound T cells, when transferred to recipients, successfully led to vigorous CHS even
when those mice were only challenged without sensitization, indicating that UV-tolerized T cells
are consisted of two population, suppressor- and effector-T cells. Sol-Dec2-bound T cells were
further fractionated with antibodies directed against CD4, CD8, CTLA-4 and CD25, resulting that
only CD4+CD25+ T cells reproduced immune suppression in recipients upon transfer. Together,
the present study indicates that sol-Dec2-bound CD4+CD25+ T cells, a population similar to the
currently highlighted regulatory T cells, are responsible for UV-induced tolerance, which are the
immune outcome determined by the balance between UV-induced T regulatory cells and effector
T cells in a same UV-tolerized animal.
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Restoration of Energy Metabolism Protects From Induction of Photoaging-Associated
Mitochondrial (mt) DNA Deletion
M. Berneburg, S. Wild, V. Wild, L. Declercq,* M. Matsui,* T. Ruzicka, and J. Krutmann
Department of Dermatology, University of DuÈsseldorf, DuÈsseldorf, Germany; *Estee Lauder Laboratories,
Melville, USA
Deletions of mitochondrial (mt) DNA are involved in ultraviolet (UV)-induced photoaging.
MtDNA only encodes for genes of the respiratory chain responsible for generation of energy
intermediates (ATP). It has been hypothesized that the most frequent mutation of mtDNA, the so
called common deletion, induced by reactive oxygen species (ROS) leads to a decreased pool of
energy equivalents. The cell is then believed to increase respiratory chain activity leading to the
generation of more ROS. Evidence for the vicious cycle: ROS ± mtDNA deletions ± energy
reduction ± respiratory chain up-regulation ± ROS ± mtDNA deletions, has been elusive,
however. In the present study it has therefore been assessed whether restoration of energy levels in
cells undergoing chronic UVA exposure could prevent induction of the common deletion. While
cellular ATP levels are volatile, phosphocreatine is a more stable energy equivalent in the cell.
Therefore, employing a semiquantitative nested-PCR assay we investigated whether the
generation of the induction of the common deletion by UVA and subsequent functional changes
(oxygen consumption, MMP-1 induction) could be inhibited by coincubation of human dermal
®broblasts with the energy precursor creatine. Lipid peroxidation assays and absorbance
spectrometry revealed that creatine has no antioxidative or UV absorbing capacities. However,
coincubation of cells with creatine led to a dose dependent decrease of UVA-induced levels of the
common deletion. Most interestingly, creatine coincubation not only reduced mtDNA
mutagenesis but also normalized mitochondrial oxygen consumption and MMP-1 induction
indicating a protective effect of creatine from mtDNA mutagenesis and subsequent functional
changes. These results provide direct evidence for the existence of a vicious cycle in which
mtDNA mutations lead to reduced energy levels, an increase of ROS and thereby to new mtDNA
mutations. Furthermore, application of energy equivalents may represent a new and innovative
way to protect the skin from UV-induced photoaging.
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Topical Retinoids Prevent UVB-Induced DNA Damage in Mouse Epidermis
O. Sorg, C. Tran, P. Carraux, L. Didierjean, and J. H. Saurat
Department of Dermatology, University Hospital, Geneva, Switzerland
We previously showed that mouse epidermis can be highly loaded with retinyl esters by topical
retinoids. Using a model we recently described to assess the ®lter properties of lipophilic molecules,
we observed that retinyl palmitate (RP), the predominant endogenous retinyl ester, can act as a UV
®lter by preventing the photodestruction or the photooxidation of sensitive probes encapsulated
into liposomes. Since the main cellular target of UV radiations is DNA, we wondered if topical
retinoids could prevent the DNA damages induced by UVB. To test this hypothesis, hairless mice
were treated once a day for three days with topical retinoic acid (RA), retinal (RAL), retinol
(ROL), RP or vehicle, then exposed to a single UVB dose of 1 J per cm2. Two kinds of DNA
damages were assessed in the whole skin: apoptotic (sunburn) cells were visualised 24 hours later by
the TUNEL technique, and cyclobutane thymine dimers were identi®ed by immunohistochem-
istry dot blots and quanti®ed by densitometry two or 24 hours after UVB exposure. All four topical
retinoids were shown to decrease the spatial density of apoptotic cells by about 50%. Two hours
following UVB exposure, the mean concentration of thymine dimers was signi®cantly decreased
only by topical RP. However, when assessed 24 hours after UVB exposure, the mean
concentration of thymine dimers was decreased by 55% with topical RA or RP, by 75% with
topical ROL, and by 90% with topical RAL, which is compatible with an increased rate of DNA
repair. In summary, since RP afforded some protection against the formation of apoptotic cells and
thymidine dimers, our data con®rms in vivo the ®lter capacity of RP that we previously
demonstrated In vitro. However, the biological reparation of thymine dimers, which requires
several hours to start, was dramatically accelerated by topical RAL, and only moderately by topical
RP. The mechanism by which this effect is achieved is under study.
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Retinyl Esters Exert UVB-Blocking Effects Similar to Those of Commercial Sunscreens
C. Tran, O. Sorg, L. Didierjean, and J. H. Saurat
Department of Dermatology, University Hospital, Geneva, Switzerland
Our recent studies aiming at assessing the protection afforded by topical retinoids against the
deleterious effects of UVB on mouse epidermis suggested that retinyl esters could have UV-®lter
properties. In order to explore this hypothesis, we developed a model to evaluate UV-®lter
capacity of lipophilic molecules. Thus liposomes are used as a model of cellular membranes. The
molecules to be tested for UV-®lter properties are included into these membranes, whereas a
¯uorescent probe, Indo-1 or 2¢,7¢-dichloro¯uorescin (DCFH) is encapsulated inside the liposomes.
In the present study, we applied this model to compare the UV-®lter capacity of retinyl palmitate
(RP) with that of three well-known sunscreens, i.e. Ocytlmethoxycinnamate (OMC),
Avobenzone (AVO), and Benzophenone-3 (BP3). A UVB dose of 180 mJ per cm2 destroyed
67% of Indo-1 in unprotected liposomes, whereas it destroyed only 37%, 18%, 18% or 7% of Indo-
1 in liposomes containing RP, OMC, BP3 or AVO, respectively. The photooxidation of DCFH
induced by 180 mJ per cm2 UVB in unprotected liposomes was completely abolished in liposomes
containing RP or OMC, whereas BP3 and AVO did not provide any protection against the
photooxidation of DCFH. This indicates that, although AVO and BP3 have good UVB-absorbing
properties, they were not able to prevent the photooxidation of DCFH induced by UVB. RP and
OMC are both good UVB-®lters and inhibitors of photooxidation. In summary, there are two
kinds of sunscreens: those with only ®lter capacity, and those which can also prevent the
photooxidation of hydrophilic molecules, such as those found inside living cells. Interestingly, it
appears that RP, the predominant endogenous retinyl ester, belongs to the latter category.
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EUK-134, a Catalase-Mimic, Inhibits the Activation of Stress-Induced MAPK Pathways
and Reduces UVB-Induced p53 Accumulation in Primary Human Keratinocytes
D. Decraene, D. Gan,² K. Smaers, T. Mammone,² M. Matsui,² L. Declercq,* and M. Garmyn
Department of Dermatology, University of Leuven, Belgium; ²Estee Lauder Companies, Melville, USA;
*Estee Lauder Coordination Center, Oevel, Belgium
UVB damages keratinocytes through both oxidative stress and direct DNA damage. EUK-134, a
synthetic superoxide dismutase (SOD) and catalase mimetic, exhibits powerful antioxidant activity
against lipid peroxidation and might therefore confer protection against UVB-irradiation in
keratinocytes. We investigated the effect of EUK-134 on the UVB induced accumulation of the
p53 protein and on UVB induced activation of the MAPK JNK and p38 by Western blot analysis.
The protein p53, a universal sensor of cellular damage, accumulates in the skin after exposure to
UVB, mediating growth arrest after a low UVB dose and apoptosis after a high UVB dose. Cells
treated with 5±50 mM EUK-134 before UVB-irradiation showed a signi®cantly lower induction of
the p53 protein in a dose-dependent fashion. The stress activated kinases JNK and p38, members of
the Mitogen activated protein kinase (MAPK) family, have been shown to be directly involved in
the accumulation of p53 and the induction of apoptosis. Both are also strongly activated upon
UVB damage. Pre-treatment of keratinocytes with 50 mM EUK-134 prior to UVB-irradiation was
found to strongly reduce the activation of p38 MAPK and JNK as well as the activation of their
upstream kinases, respectively, MKK3-MKK6 and SEK1/MKK4. It has been shown that ligand-
independent clustering of membrane receptors can trigger stress induced MAPK pathways after
UVB-irradiation. UVB-induced membrane damage through oxidative stress is thought to play an
important role in this process. We hypothesize that EUK-134, by direct protection of the
membrane from UVB-induced oxidative damage, reduces stress induced MAPK signaling and as a
result lowers the level of p53 induction. This could, in turn, lead to an enhanced survival of human
keratinocytes after UVB-irradiation.
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High Dose Long Wave Visible Light Induces Perinuclear Vacuolization In Vivo
T. Smits, M. Tjioe, W. A. M. Blokx,* P. C. M. van de Kerkhof, and M. J. P. Gerritsen
Department of Dermatology and *Pathology, University Medical Centre Nijmegen, the Netherlands
With the advancing widespread use of photodynamic therapy (PDT), questions arise about the
necessity to protect the adjacent healthy skin from high dose long-wave visible light used in PDT.
The aim of the present study was to investigate the effects of high dose visible light on the skin of
healthy volunteers with the focus on apoptosis, DNA damage, in¯ammation, melanogenesis and
induction of matrix metalloproteinases (MMP). Fourteen healthy volunteers were included and
irradiated daily on their buttocks with 130 J per cm2 long-wave visible light (560±780 nm) on 5
consecutive days with a cumulative dose of 650 J per cm2. In each volunteer in total 6 biopsies
were taken before and 24 h after irradiation on days 1, 2, 4, 7 and 11. Frozen and paraf®n sections
were investigated by measuring parameters for photodamage (apoptosis, p53, phosphorylated c-
Jun), skin ageing (phosphorylated c-Jun, MMP-1, elastin content) and melanogenesis (melan-A).
Although no sunburn cells were seen, a signi®cant increase in perinuclear vacuolization was noted
(p < 0.0003) from day 5 till 7 days after last irradiation. There was no expression of phosphorylated
c-Jun, whereas the expression of p53, Melan-A, MMP-1 and elastin content did not change. In our
experiment high dose visible light induced a signi®cant increase in perinuclear vacuolization, but
did not result in apoptosis, photodamage or early induction of skin aging.
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Further Characterization of the Activity of UV-Induced T Suppressor Cells
T. Schwarz, A. Schwarz, K. Grosse-Heitmeyer, and S. Beissert
Department of Dermatology, MuÈnster, Germany
Ultraviolet radiation (UV) induced immune tolerance is due to the generation of hapten-speci®c T
suppressor cells which recently have been renamed regulatory T cells. We recently reported that
these T cells express the surface marker CTLA-4 which in contrast to its cognate member CD28
acts as a negative regulatory molecule. CTLA-4 seems to be functionally relevant since blocking of
CTLA-4 with a neutralizing antibody is associated with a loss of suppressive activity. Triggering of
CTLA-4 induces the release of a cytokine pattern which is similar to that of type 1 regulatory T
cells. To further characterize the mechanism by which CTLA-4+ T cells cause suppression, lymph
node cells were obtained from mice which were tolerized against dinitro¯uorobenzene (DNFB) by
UV. Cells were enriched for CTLA-4+ cells and cocultured with bone marrow-derived dendritic
cells (DC) in the presence or absence of the water soluble analogue of DNFB, dinitrobenzene-
sulfonic sodium salt (DNBS). After 48 h apoptosis of DC was analyzed by Annexin V staining.
While CTLA-4 negative cells did not affect DC in their survival rate, pronounced apoptosis of DC
was observed upon coincubation with CTLA-4+ cells. However, CTLA-4+ cells exerted their
apoptotic activity only in the presence of DNBS. To analyze the pathway by which CTLA-4+
cells induce apoptosis, expression of the death receptor CD95/Fas on DC was checked by FACS
analysis. CD95, however, was only slightly induced by CTLA-4+ T cells. Therefore, the
expression of the antiapoptotic proteins Flip and Bcl-xL was determined in DC by intracellular
FACS analysis. Both proteins were constitutively expressed, but signi®cantly down-regulated in
the presence of CTLA-4+ T cells and DNBS. Taken together, these data indicate that UV-
induced T suppressor cells seem to exert their inhibitory capacity on antigen presentation via
induction of apoptotsis of DC and that down-regulation of the antiapoptotic proteins Flip and Bcl-
xL is involved in this process.
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The In¯uence of Heat Shock on DNA-Repair after UVB
C. Jantschitsch, G. Klosner, C. Jonak, C. Kokesch, I. Kindas-MuÈgge, and F. Trautinger
Division of Special and Environmental Dermatology, University of Vienna, Austria
It has been reported that heat pretreatment protects cultured human keratinocytes and normal
murine human skin from ultraviolet (UV) induced cell death. Whether this is a bene®cial (less cell
death) or a harmful (survival of mutated cells) effect is not yet clear. In the present study we
investigated whether heat shock interferes with the formation and repair of UV-B-induced
photoproducts (thymine (TT)-dimers). This DNA damage appears shortly after UV-exposure and
is consequently repaired by ef®cient repair mechanisms. In our experiments we compared the
formation of TT-dimers after UV-B exposure in heat treated and control normal human
keratinocytes, melanocytes, and ®broblasts employing a standard ELISA protocol using a
monoclonal antibody against TT-dimers. To investigate the repair kinetics the amount of
photolesions was determined at several time points after UV-B treatment (30 min, 1, 3, 6, and
24 h). For all three cell types investigated we found a slightly increased repair rate in heat shocked
cells within the ®rst three hours after UV-B exposure compared to controls. With continued
culture the curves ¯attened out and 24 h after UV-B exposure the amount of dimers was identical
in heat pretreated cells and controls. We conclude that heat shock does not negatively interfere
with the removal of UV-B-induced TT-dimers. In contrast, our results might indicate that heat
shock enhances DNA repair immediately after UV-B exposure. Whether heat shock protects from
UV-induced mutagenesis remains to be investigated.
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The Cytotoxicity of UVA Depends on the Mode of Exposure
H. Merwald, G. Klosner, R. Knobler, H. HoÈnigsmann, and F. Trautinger
Vienna, Austria
The reciprocity rule (Bunsen-Roscoe law) states that a photochemical reaction is directly
proportional to the total energy dose, irrespective of the dose distribution. The dose is the product
of intensity and duration of exposure. In photomedicine the validity of this rule is generally taken
for granted, although the in¯uence of radiation intensity and dose fractionation are largely
unknown. We have examined the effects of fractionation at a constant total dose on viability,
apoptosis, and proliferation in the human squamous carcinoma cell line A431. For these
experiments UV-A and UV-B from a metal halide source were delivered either as a single dose or
as three equal fractions separated by intervals of 10, 30, 60, 120, and 240 min 12 h after initiation of
exposure cells were investigated for Annexin V binding, viability (MTT assay), and BrdU
incorporation. With UV-A fractionation with intervals of 10, 30, and 60 min led to a decrease in
viability of up to 40%, compared to an identical single dose. In contrast, intervals of 120 and
240 min increased the viability up to 30%. Corresponding results were obtained for Annexin V
binding and BrdU incorporation. With UV-B we observed no in¯uence of dose fractionation on
the rate of cell death. These results indicate that in a simple experimental model the Bunsen-
Roscoe law is not valid with regard to biologically relevant endpoints. Our observations might be
explained by cumulative oxidative stress caused by fractionated UV-A radiation with short
intervals. On the other hand, the protective effects of repetitive low irradiation with long intervals
may be attributed to an up-regulation of antioxidative defense mechanisms.
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Human Sun-Exposed Skin and Sun-Protected Skin Differ in Their Number and
Composition of Cutaneous T Cells
S. Di Nuzzo, P. Pavanello, and G. De Pan®lis
Parma, Italy
The purpose of this study was to compare the number and phenotype of cutaneous T cell
populations in habitually sun-exposed sites vs. sun-protected sites. Several punch biopsies were
obtained from 24 healthy volunteers. In order to study the epidermal and dermal CD3+, CD3+/
CD4+ and CD3+/CD8+ T cell populations we performed immunohistochemistry on cryostat
sections. Compared with skin from sun-protected site, both intraepidermal and dermal CD3+ T
cell numbers of habitually sun-exposed site were signi®cantly lower (p < 0,05). Double staining
showed that the number of intraepidermal CD3+/CD8+ T cells was signi®cantly lower (p < 0,05)
in sun-exposed than sun-protected skin, whereas the numbers of CD3+/CD4+ T cell were similar
in both sites. Therefore the CD4/CD8 ratio in the epidermal compartment was markedly higher in
the sun-exposed area compared to the sun-protected area. The numbers of both CD3+/CD4+ and
CD3+/CD8+ dermal T cells were lower in sun-exposed than sun-protected skin; however, the
CD3+/CD8+ T cell population was more markedly reduced. The dermal CD4/CD8 ratio in the
sun-exposed and sun±protected skin was 2.37 and 1.42, respectively. Our study showed that
compared with the sun-protected skin, the sun-exposed skin had reduced number of T cells and
altered CD4/CD8 ratio. We suggest that alterations in number and composition of intraepidermal
and dermal T-cells in habitually sun-exposed skin may be responsible for local immunosuppression
and therefore increased risk in skin cancer.
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Apoptosis of Keratinocytes After UVA Irradiation in the Presence of the Photosentitizer
Tiaprofenic Acid Involves Reactive Oxygen Species and p53 Protein Stabilization
V. Lartillot, F. Jean-Louis, L. Dubertret, and L. Michel
INSERM U532 ± Institut de Recherche sur la Peau ± HoÃpital Saint-Louis, Paris, France
Tiaprofenic acid (TPA) is a nonsteroidal anti-in¯ammatory drug exhibiting photosensitizing
properties if simultaneously administered with UVA exposition. Previously, we demonstrated the
formation of photoadducts in human epidermal cells and the induction of cell death via an
apoptotic process after UVA irradiation in the presence of TPA. In the present work, we have
studied the mechanisms involved in the induction of the programmed cell death of human
keratinocytes following incubation with TPA and UVA irradiation. Our results demonstrated that
TPA led to an early (< 2 h) and a delayed apoptosis (24 h to 48 h after irradiation). The immediate
apoptosis was observed for TPA concentrations = 50 mM associated with UVA doses = 5 J per cm2,
whereas a delayed apoptosis was depicted for lower UVA and TPA doses. Apoptosis was
characterized by phosphatidyl serine exposure (annexin V-Fitc 3 propidium iodide staining), DNA
fragmentation and PARP cleavage. Reactive oxygen species, especially hydrogen peroxide and
superoxide anion, as well as a strong lipid peroxidation were produced during cell irradiation in the
presence of the drug. They might play a major role during the early apoptotic process since
antioxidants like N-acetylcysteine and vitamin E partially prevented these immediate phototoxic
effects. The delayed apoptosis involved the stabilization of the protein p53, cytochrome c release
from mitochondria and caspase 9 activation. The cell cycle regulator protein p21 was not induced
during these events. The use of p53±/± keratinocytes con®rmed p53 implication in the delayed
apoptosis. P53 induction and PARP cleavage were transiently induced for the lower doses (TPA
25 mM + UVA 5 J per cm2) and cells showed a cell cycle arrest in the G2/M phase. Forty-eight h
after irradiation, cell proliferation restarted. During both the early and delayed events,
mitochondrial membrane potential (DY) decreased and was partially reversed by antioxidants.
Taken together, these data indicate that TPA phototoxicity induces cellular alterations through
rapid p53 induction, that leads to an apoptotic process with mitochondria and caspase 9 activation
when no cell reparation was possible.
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The Phenotypical and Functional Analysis of Soluble Dectin-2-Bound Regulatory T
Cells in UV Induced Tolerance
Y. Aragane, A. Maeda, F. Yamazaki, T. Tezuka, K. Ariizumi,* and T. Schwarz²
Kinki University School of Medicine, Dermatology, Osakasayama-shi, Japan; *University of Texas, Dallas,
USA; ²University of MuÈnster, MuÈnster, Germany
We currently showed that the induction of tolerance is mediated by Dectin-2 (Dec-2), a novel
costimulatory molecule selectively expressed on dendritic cells. Because T suppressor cells (Ts) are
believed to play a pivotal role in ultraviolet radiation (UV)-induced tolerance, we were interested
whether Dec-2-mediated signals are required for the immune regulatory properties of Ts. C3H/
HeN mice, which were exposed to low doses of UV and sensitized with dinitro¯uorobenzene
(DNFB) through the UV-irradiated skin areas, exhibited profound suppression of contact
hypersensitivity (CHS). When soluble Dec-2 (sol-Dec2), a competitive inhibitor of Dec-2, was
injected into the UV-tolerized mice before resensitization, mice responded with a pronounced
speci®c ear swelling response upon rechallenge, indicating that sol-Dec2 breaks UV-induced
tolerance. Transfer of T cells obtained from UV-tolerized mice into naive animals inhibited the
induction of CHS in the recipients. Suppression, however, was not observed when T cells were
depleted of the fraction binding to sol-Dec2. Three channel FACS analysis revealed that sol-Dec2-
bound T cells are CD4+CD8±CD25+, thus being phenotypically similar to the recently identi®ed
regulatory T cells (Tr). Co-incubation of hapten-pulsed epidermal cells with T cells that were
isolated from UV-tolerized mice resulted in enhanced expression of the death receptor Fas on Ia+
Langerhans cells (LC) and in augmented apoptosis rate. Apoptosis of LC was signi®cantly reduced
by sol-Dec2. Together, these data indicate that UV-tolerized Ts belong to the family of Tr cells
and are able to induce apoptosis of LC mediated via Dec-2. This indicates that Dec-2 may be a
critical molecule, which induces death signals in LC and thereby causes UV-induced tolerance.
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Neutral Sphingomyelinase is Modulated by Glutathione in Keratinocytes UVB-Induced
Apoptosis
C. Magnoni, L. Benassi, M. R. Rinaldi, G. Bertazzoni, and A. Giannetti
Department of Dermatology, University of Modena and Reggio Emilia, Italy
The sphingomyelin pathway is an ubiquitous, evolutionary conserved signaling system which plays
a role in intracellular signal transduction. The action of a ligand binding to a surface receptor results
in early activation of the enzyme sphingomyelinase (SMases) with consequent hydrolisis of
membrane sphingomyelin (SM) and generation of ceramide. Increase in intracellular ceramide
level is followed by three major cellular responses: cell growth arrest, induction of cell
differentation and/or induction of apoptosis. Recent evidences have shown that reduced
glutathione (GSH), but not other antioxidative agents, is able to inhibit apoptotic cell death and
necrosis induced by hypoxia in PC12 cells. This protective effect is mediated by GSH direct
inhibition of Neutral SMase activity and ceramide formation. In the present study we report that
GSH inhibits activation of Neutral SMases and generation of ceramide and partially prevents
apoptotic cell death induced by UVB radiation in keratinocytes. Normal human keratinocytes
were cultivated with mitomycin-treated 3T3 cells in Dulbecco's modi®ed Eagle's medium/Ham's
F12 medium. At precon¯uency cells were incubated with GSH for 2 h and then irradiated with a
UVB dose of 75 mJ per cm2. At different times after UVB irradiation, cells were harvested for In
vitro measurement of neutral SMase activity, lipid extraction and Western blot analysis. In vitro
measurement of Neutral SMases activity showed an early induction 15 min after UVB exposure
with a subsequent decrease to control level after 2 h. Exposure to UVB radiation resulted in a rapid
sphingomyelin hydrolysis and generation of ceramide as measured by TLC analysis. The ceramide
accumulation started at 15 min after UV exposure and progressively increased up to 24 h. Addition
of GSH signi®cantly inhibited activation of Neutral SMase and generation of ceramide in UVB-
treated keratinocytes. Moreover UVB-induced cleavage of PARP, a marker of the apoptotic
response, was partially inhibited by GSH treatment. These data indicate that GSH plays a critical
role in UVB signaling pathway regulating Neutral SMase activity.
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The Effect of Constitutive Pigmentation on Erythema Response in UVB Dose
Dependent. T. Ha
L. Naysmith, H. Javedan, K. Waterston, and J. L. Rees
Systems Group Dermatology, University of Edinburgh
In a series of experiments, we have studied the relationship between objective skin colour
(measured using a re¯ectance instrument and chromameter) and UVB-induced erythema.
Experiment 1: A range of broadband UVB doses (119±300 mJ per cm2) using a Diffey prototype
lamp (TL12) was delivered to the lower back of 25 subjects. Constitutive skin colour and UVB-
induced skin erythema was assessed 24 h after irradiation using the melanin index and erythema
index derived from re¯ectance spectroscopy (Diastron, UK). Results: Using a linear ANOVA
model (S and S-plus version 2, Insightful 2001), the relationship between melanin index and skin
erythema was statistically signi®cant for all doses delivered. The gradient coef®cients were ±0.30
(119 mJ per cm2), ±0.47 (150 mJ per cm2), ±0.60 (189 mJ per cm2), ±0.71 (238 mJ per cm2) and ±
0.76 (300 mJ per cm2), all p<0.01. The degree that melanin index explained erythema were
R2=0.27 (119 mJ per cm2), R2 = 0.29 (150 mJ per cm2), R2=0.49 (189 mJ per cm2), R2 = 0.50
(238 mJ per cm2) and R2=0.61 (300 mJ per cm2); all p<0.01. Experiment 2: In 50 subjects with a
wide variation of skin colour and skin phototypes, we delivered a range of broadband UVB doses
(119±300 mJ per cm2) to the lower back. Skin erythema was assessed at 48 hours after irradiation
using the erythema index derived from re¯ectance spectroscopy (Diffey). In addition, a-
characteristic angle as an index of baseline skin colour was derived from chromameter readings
taken from lower back skin. Results: Using a linear ANOVA model, the relationship between a-
characteristic angle and skin erythema was statistically signi®cant for all doses delivered. The
gradient coef®cients were 0.85 (119 mJ per cm2), 1.50 (150 mJ per cm2), 2.34 (189 mJ per cm2),
2.90 (238 mJ per cm2) and 2.95 (300 mJ per cm2); all p<0.01. The degree that a-characteristic
angle explained erythema were R2 = 0.10 (119 mJ per cm2), R2 = 0.13 (150 mJ per cm2), R2 = 0.21
(189 mJ per cm2), R2 = 0.31 (238 mJ per cm2) and R2 = 0.35 (300 mJ per cm2); all p<0.01.
Conclusion. We have demonstrated that the degree to which melanin index and a-characteristic
angle accounts for the cutaneous erythema response to UVB increases as the dose of UVB
increases. These results af®rm the importance of constitutive skin colour on UVB-induced
erythema, and demonstrate that the effect of constitutive skin colour becomes ``stronger'' as UVB
dosage increases.
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Expression and Regulation of Cytoprotective Genes by Ultraviolet Radiation in Skin of
Patients with Psoriasis
G. Smith, R. S. Dawe, A. T. Evans, M. M. Comrie, J. Ferguson, C. R. Wolf, and S. H. Ibbotson
Dundee, UK
We have investigated whether interindividual differences in the cutaneous expression of
cytoprotective genes may contribute to variability in sensitivity and response to controlled UV
exposure (UVR) in the treatment of psoriasis. We have used real-time quantitative RT-PCR
analysis to characterise the expression of genes including cytochrome P450s (P450s), glutathione S-
transferases (GSTs), drug transporters and stress response genes in 29 patients with psoriasis
commencing phototherapy. Skin biopsies were taken from buttock sites: (a) 24 h after irradiation
with a solar simulator (1±4 3 MED site) (b) untreated psoriatic plaque and (c) control site. UVR
treatment signi®cantly induced the expression of the stress response gene cyclooxygenase 2
(median 4.6-fold induction, range 0.14±22.6) and lead to more modest (~2-fold) inductions of
P450 CYP2S1, glutathione peroxidase, GSTP1 and the drug transporter MRP1. In contrast, P450
CYP2S1 (3.24-fold, 0.6±15.5), GSTP1 (3.36-fold, 1.3±33.1) and MRP1 (3.53-fold, 1.3±24.8)
were signi®cantly increased in psoriatic plaque, as were P450 CYP2E1 (3.45-fold, 1±28.9) and
heme oxygenase (8.43-fold, 2.9±49.7), implying a global up-regulation of drug and oxidant
metabolism in lesional psoriatic skin. We found considerable interindividual variation in
constitutive cytoprotective gene expression and inducibility, indicating that individual patient
phenotype may be a signi®cant factor in determining response to UVR exposure and topical drug
treatment in psoriasis patients.
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Bene®cial Effect of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Acute
Photodamage
B. Farkas, B. Csete, M. Magyarlaki, J. NeÂmeth, V. Tubak, P. LiteraÂti Nagy, and B. SuÈmegi
PeÂcs, Budapest, Hungary
The ultraviolet (UV) components of sunlight induce damage to the DNA in skin cells, which is
considered to be the initiating step in the harmful biological effects of UV radiation. Repair of
DNA damage results in the formation of single-strand DNA breaks, which activate the nuclear
enzyme PAR. Overactivation of PARP worsens the oxidative cell damage and impairs the energy
metabolism, raising the possibility that moderation of PARP activation following DNA damage
may protect skin cells from UV radiation. The topical effects of the novel PARP inhibitor O-(3-
pyperidino-2-hydroxy-1-propyl) pyridine-3-carboxylic acid amidoxime monohydrochloride
(BGP-15 M) were investigated on UV-induced skin damage in a hairless mouse model. For
evaluation of the UV-induced acute photodamage to the skin and the potential protective effect of
BGP-15 M, DNA injury was detected by measuring the formation of single-strand DNA breaks
and counting the resulting sunburn (apoptotic) cells. The ADP-ribosylation of PARP was assessed
by Western blot analysis and then quanti®ed. In addition, the UV-induced immuno-suppression
was investigated by the immunostaining of tumor necrosis factor a (TNFa) and interleukin-10
(IL-10) expressions in epidermal cells. The signs of in¯ammation were examined clinically and
histochemically. Besides its primary effect in decreasing the activity of nuclear PARP, topically
applied BGP-15 M proved to be protective against solar and arti®cial UV radiation-induced acute
skin damage. The DNA injury was decreased (p < 0.01). An inhibition of immunosuppression was
observed by down-regulation of the epidermal production of cytokines IL-10 and TNFa. In the
mouse skin, clinical or histological signs of UV-induced in¯ammation could not be observed.
These data suggest that BGP-15 M directly interferes with UV-induced cellular processes and
modi®es the activity of PARP. The effects provided by topical application of the new PARP-
regulator BGP-15 M indicate that it may be a novel type of agent in photoprotection of the skin.
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Chronic UV Exposure Leads to Alterations in DNA Repair Capacity of Skin Cells
M. Chazal, E. Roux, C. Lalou, C. Baudouin, M. Charveron, Y. Gall, C. Alapetite,* C. Roulin,*
E. Moustacchi,* R. Porcher, and N. Basset-SeÂguin
INSERM U532, sur Institut de Recherche, Paris, France; *la Peau, U. M. R. CNRS 218, DeÂpartement
de RadiotheÂrapie Oncologique, Paris, Institut Curie, France, CERPER/HoÃtel-Dieu, Toulouse, Institut de
Recherche Pierre Fabre, France and Informatique MeÂdicale, DeÂpartement de Biostatistique, Paris, France,
HoÃpital Saint Louis
UVB induce DNA lesions which are implicated in skin photocarcinogenesis. DNA repair capacity
in¯uences individual susceptibility to skin cancer development as illustrated in DNA repair
de®cient XP (Xeroderma Pigmentosum) patients who develop multiple skin cancer on sun
exposed skin. In this work, our objective was to study if chronic sun exposure could lead to
acquired alterations in DNA repair capacity in human skin as observed in the hairless animal model.
Seven volunteers of phototype II to III undergoing surgical excision of a skin carcinoma located on
sun exposed skin and having no germinal DNA repair de®ciency, were studied. Keratinocytes and/
or ®broblasts were isolated from 6 mm punch biopsy of chronically sun exposed and sun protected
normal skin from each individual after informed consent. DNA repair capacity was studied using
the comet assay up to 120 min post UVB irradiation (300 J per m2). In all subject studied and
whatever the cell type analyzed, chronically sun exposed skin derived-cells showed a signi®cant
reduction in the DNA incision process, maximum 1 h post-UVB irradiation. This de®ciency was
not explained by mutation in p53 gene as veri®ed by direct sequencing of genomic DNA.
Differential gene expression was analyzed using commercially available DNA macroarrays
(Clontech) and allowed us to identify 2 genes down regulated in chronically sun-exposed skin
potentially implicated in DNA repair capacity. These results were further con®rmed by Northern
blot. This work show that genetic alterations due to chronic sun exposure and independent of p53
can play a role in the susceptibility of chronically sun exposed skin to cancer development. These
results could be of importance to further optimize skin photoprotectors.
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Differential Gene Expression Pro®ling in Individuals with De®cient and Pro®cient DNA
Repair as a Predictive Tool for Individual Skin Cancer Risk
T. Gremmel, S. Wild, V. Kuerten, T. Ruzicka, J. Krutmann, and M. Berneburg
Duesseldorf, Germany
Xeroderma pigmentosum (XP) is a disorder characterized by defective repair of ultraviolet (UV)-
induced DNA damage comprising 7 complementation groups (A to G). Patients with XP have a
highly increased skin cancer risk with the clinical phenotype varying according to the speci®c
compl. group. The highest skin cancer risk is found in group A, an intermediate risk in group D
and the lowest risk in group F. The high skin cancer risk is partly due to defective DNA repair, but
other pathways also play a role (immune surveillance). Available test systems assessing the risk to
develop skin cancer thus far only detected gross differences between single parameters. In order to
increase the sensitivity and predictive power of a test system, employing DNA-array technology,
we compared differential mRNA expression in ®broblasts from XP patients of the above
complementation groups with a high, intermediate and low skin cancer risk after UVB irradiation.
A dose dependent tendency from mild to severe was detected in 17 genes with 11 genes involved
in functionally relevant pathways (DNA repair, cell-cycle, apoptosis, transcription, matrix-
degradation). Thus it is possible to use DNA array technology to identify distinct patterns of UV-
induced gene expression correlating with the skin cancer risk in XP patients. We were therefore
next interested to see if this approach could also be used to determine the skin cancer risk in DNA
repair pro®cient individuals which nevertheless exhibited an increased skin cancer risk. The gene
patterns previously identi®ed in XP patients could also be observed in patients with > 2 skin
tumours and an age < 35 years. Expression levels of genes were lower than in XP cells but higher
than in age matched normal cells. Thus it is possible to correlate the skin cancer risk with the
complementation groups in XP patients, thereby identifying a limited number of genes with
possible functional relevance for photocarcinogenesis. Furthermore this data could be transferred
into the DNA repair pro®cient background and may provide a predictive test system to determine
the skin cancer risk of clinically normal individuals.
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eNOS Knock Out Mice Undergo Increased Dermal and Epidermal Apoptosis Following
UVB Irradiation
R. Weller, T. Billiar, and Y. Vodovotz
Pittsburgh, USA
Nitric oxide (NO) is released from the skin by constitutive and inducible forms of NO synthase
following ultraviolet (UV) irradiation. NO has both pro and antiapoptotic actions, and we wished
to determine which of these effects predominated in the skin. We compared the responses to UVB
of mice null for endothelial NOS or iNOS (eNOS±/± and iNOS±/± mice, respectively). Apoptosis
in frozen skin sections was detected with a ¯uorescently labelled antibody to the active site of
Caspase 3. In the epidermis, wild type (wt) mice underwent 0.36 6 0.12%, 0.71 6 0.23%, and
3.79 6 0.82% apoptosis, 24 h after irradiation with 0, 400 and 1000 mJ per cm2 UVB. eNOS±/±
mice underwent 0.1 6 0.02%, 2.86 6 0.84% and 3.7 6 0.74% apoptosis; and iNOS±/± 0.22 6 0.1%,
1.49 6 0.21% and 3.19 6 1.02% apoptosis. In the dermis, the ®gures were: wt, 0.94 6 0.42%,
4.74 6 0.79%, and 11.94 6 2.71%; eNOS±/±, 2.58 6 1.13%, 13.23 6 1.21%, and 28.8 6 1.14;
iNOS±/±, 0.98 6 0.2%, 8.81% 6 2.21%, and 14.09 6 3.71%. eNOS±/± mice show signi®cantly
more apoptosis than wt and iNOS±/± at 400mJ per cm2 in the epidermis and at all UV doses in the
dermis. Irradiation with UVB or addition of the NO synthase (NOS) inhibitor L-NAME increased
apoptosis in the human keratinocyte cell line CCD 1106 KERTr, and apoptosis was greater when
the two agents were given in combination. Addition of the chemical NO donor S-nitroso-N-
acetyl-D,L-penicillamine (SNAP) immediately after UVB completely abrogated the rise in
apoptosis induced by L-NAME, and largely reduced apoptosis due to UVB. Caspase-3 activity, an
indicator of apoptosis, doubled in keratinocytes incubated with L-NAME as compared with the
inactive enantiomer, D-NAME. This rise in caspase-3 activity was partially reduced by SNAP.
Apoptosis was reduced by the addition of 8-Bromo cyclic GMP, and increased upon addition of
1,H-[1,2,4]oxadiazole[4,3-a]quinoxalon-1-one (ODQ), an inhibitor of soluble guanylate cyclase.
We conclude that NO released by eNOS following UVB irradiation, limits apoptosis in the
epidermis both by direct inactivation of caspases, and indirectly via cyclic GMP dependent
pathways. At higher doses of UVB, the protective effects of NO are overwhelmed in the
epidermis. Autologously released NO limits UVB induced death in the skin, and we believe has a
physiologically vital function in ensuring the relatively high UV resistance of keratinocytes.
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UVA1 Therapy of Cutaneous Chronic GVHD
P. Calzavara-Pinton and M. Venturini
Spedali Civili, Brescia, Italy
Despite improvements in post-transplant immunosuppression, up to 60% of patients who receive
an allogeneic bone-marrow transplantation will develop chronic graft vs. host disease (cGVHD)
that contributes substantially to morbidity and mortality. Skin is a very frequent target of cGVHD.
In recent years, the role of UVA1 (340±400 nm) radiation in the modulation of skin immune
functions and collagen metabolism has with been assessed. We have treated 8 patients: 4 with
generalized lichenoid (2) or sclerodermoid (2) and 4 with localized sclerodermoid cGVHD skin
lesions. Patients had only mild or no other organ involvment. Skin lesions in areas that were
inaccessible by UVA1 radiation were chosen to serve as unirradiated controls. All patients had
failed to respond to conventional therapies and 7 out of 8 patients had developed signi®cant drug
toxicity, opportunistic infections, or both. Fixed daily exposures of 50 J per cm2 of UVA1 radiation
were delivered 3 times weekly. UVA1 therapy gave a complete clinical remission in 5 patients and
a partial improvement in two after 19,25 6 6.90 treatments. The remission was accompanied by
improvement of histopathological ®ndings. Unirradiated control lesions were not modi®ed by
treatment. Immunocytological studies did not show changes of circulating lymphocyte subsets.
Adverse effects to UVA1 therapy were not registered. The gradual improvement of skin lesions
allowed the timely reduction and discontinuation of most oral immunosuppressive agents leading
to the improvement or, at the very least, cessation of progression of drug adverse effects and
opportunistic infections. Extracutaneous cGVHD manifestations remained unchanged. At follow-
up, patients with lichenoid cGVHD showed early relapses and entered in a prolonged maintenance
regimen whereas sclerodermoid lesions showed more persistent remission. In conclusion, UVA1
radiation seems to represent an effective and well tolerated treatment option for cutaneous cGVHD
without relevant short-term adverse effects although the risk of long-term toxicity, namely skin
carcinogenesis, remains to be established.
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UVB-Induced Cell Cycle Arrest and DNA Repair Capacity in Human Epidermis is
Enhanced After Vitamin C and Vitamin E Administration
M. Placzek, U. Kerkmann, and B. Przybilla
University of Munich, Munich, Germany
UVB irradiation causes a time dependent decrease of the proliferative activity of the human
epidermis, which results from p53 tumor suppressor gene induction. The ensuing accumulation of
p21 leads to cell cycle arrest in the G1-phase. This checkpoint mechanism is necessary to eliminate
UV-damaged DNA sequences. Reentry into the cell cycle has been shown to require
transcriptional activation of the c-Jun protooncogene, resulting in down-regulation of p21 levels.
C-Jun expression in regulated by the MAPK pathway, signalling casade which can be activated by
free radicals generated by UV. 17 volunteers (patients plus controls) were given a oral combination
of 2 g ascorbic acid and 1000 IU d-a-tocopherol daily for 3 months. Biopsies were taken from
unirradiated and UVB-irradiated skin (minimal erythema dose 2) before and after 90 days of
vitamin administration. Biopsies were immediately incubated with 60 mM BrdU for 2 h. BrdU-
positive cells were visualized in sections of paraf®n-embedded tissue using a-BrdU antibodies and
APAAP. BrdU is incorporated during the S-phase of cycling cells. The number of cells staining
positive for BrdU is a marker of epidermal activity. After irradiation, a decrease in the number of
proliferating cells (median of proliferating cells/length of sample: 9/mm before irradiation, 6/mm
after irradiation) could be observed. Proliferative activition decreased even further after
administration of vitamins (median of proliferating cells/length of sample: 8/mm before
irradiation, 4/mm after irradiation; p = 0,021, T-test). Our ®nding suggest that administration of
antioxidants results in an extension of the UV-induced cell cycle block and thereby allows for more
time to repair DNA-damage, ultimately reducing the risk of mutations.
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In Vivo UVB Irradiation Induces Clustering of Fas (CD95) on Human Epidermal Cells
B. Bang, R. Gniadecki, J. K. Larsen, O. Baadsgaard, and L. Skov
Copenhagen, Denmark
Both animal and In vitro studies with human cell lines have demonstrated a role for Fas in UV
induced apoptosis. The purpose of the present study was to investigate the regulation and function
of Fas and FasL in human skin after single dose UVB irradiation. Normal healthy control persons
were irradiated with 3 MED UVB on forearm or buttock skin. Suction blisters from unirradiated
and irradiated skin were raised and Fas, FasL and apoptosis were demonstrated on epidermal cells
by ¯ow cytometry. Clustering of Fas was demonstrated by confocal laser scanning microscopy on
cryostat sections. Soluble FasL was quantitated by ELISA. Flow cytometric analysis demonstrated
increased expression of Fas with changes in mean ¯orescence intensity from unirradiated control:
290, 24 h: 304, 48 h: 580 and 72 h: 802 (n = 4). Apoptosis was demonstrated by TUNEL reaction
and maximum of apoptotic epidermal cells was observed 48 h after irradiation. Double staining
with Fas and TUNEL showed no correlation between Fas expression and formation of apoptotic
cells. Expression of FasL transiently decreased with mean ¯orescence intensity in unirradiated skin:
1900, 24 h: 1605, 48 h: 1382 and returned to the preirradiation level 72 h after irradiation: 1925
(n = 4). Soluble FasL concentrations in suction blister ¯uid from UVB irradiated skin did not differ
from unirradiated skin (n = 5). Confokal laser scanning microscopy showed rapid clustering of Fas
within 30 min after irradiation. Our results are in accordance with previous ®ndings and suggest
that Fas is activated in vivo in UVB exposed human skin.
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Induction of Apoptosis and Cell Death in Peripheral Blood Mononuclear Cells (PBMC)
by Different Wavebands of Ultraviolet A (UVA) Radiation
A. Tanew, W. Jerney, M. Hilgarth, E. HofstaÈtter, K. Schulmeister, J. Schwarzmeier, and H.
HoÈnigsmann
Vienna and Seibersdorf, Austria
UVA1 radiation (340±400 nm) is increasingly employed in the phototherapy of T-cell mediated
skin diseases. Several lines of evidence suggest that UVA1-induced T-cell apoptosis is a key factor
for the therapeutic effect. In the present study we addressed the question whether this effect is
speci®c for UVA1 radiation or can also be induced by biologically equivalent doses of UVA (315±
400 nm) or UVA2 (315±340 nm) radiation. For the experiments a high pressure UV metal halide
lamp was used whose spectral power emission was modi®ed by different ®lter combinations to
generate UVA, UVA1 or UVA2 radiation. Irradiance and relative spectral intensity were
determined with a Bentham DM 150 double monochromator. Dose±response curves for
cytotoxicity as determined by MTT assay were constructed for each of the three UVA spectra by
exposing isolated PBMC of healthy volunteers to increasing doses of the respective wave band.
The cells were then treated with equitoxic doses (LD10, LD25 and LD50, based on the MTT assay)
of UVA, UVA1 and UVA2 and quantitative analysis of apoptotic and dead cells was performed by
¯ow cytometry and double staining of cells with annexin V and propidium iodide. Sham irradiated
cells served as a control. Independent of exposure dose and UVA spectrum the percentage of
annexin V-positive/propidium iodide-negative (A+/PI±) cells was not signi®cantly raised above
control levels at 24 h after exposure. In contrast, there was a marked dose and UVA spectrum-
dependent increase in annexin V-positive/propidium iodide-positive (A+/PI+) cells with UVA1
inducing much higher levels of A+/PI+ cells at all applied doses than UVA or UVA2. Our data
indicate that UVA1 differs in its effects on PBMC from UVA and UVA2 and is substantially more
effective in inducing cell death.
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All-Trans-Retinoic-Acid Up-Regulates Caspases-3, ±6, ±7, and ±9 and Sensitizes
Primary Keratinocytes to UV-Induced Apoptosis
P. Mrass,* M. Rendl,* C. Ballaun,* M. Mildner,* and E. Tschachler*²
*University of Vienna Medical School and ²CERIES, Neuilly, France
Previous experiments in our laboratory have shown that all-trans-retinoic-acid (ATRA) up-
regulates caspase-3 at the protein-level in keratinocytes (KC). Western blot analysis revealed that
ATRA-treatment also up-regulated the effector-caspases-6, ±7, as well as the mitochondrial
initiator caspase-9. Despite this up-regulation ATRA treatment alone was not suf®cient for
inducing apoptosis in KC. However, when in addition cells were irradiated with UVB ± at doses
not lethal for nontreated KC- the majority (> 70%) of ATRA-treated cells detached and showed
signs of apoptotic cell-death, which was con®rmed by the demonstration of caspase-3 activation
and DNA-laddering. This increased susceptibility to apoptosis could only be seen when con¯uent
KC were treated for at least 2 days with ATRA. In contrast, in noncon¯uent KC, or KC entering
terminal differentiation the response of DMSO and ATRA-treated KC to UVB was comparable.
UVB-induced apoptosis of ATRA-treated KC could be completely blocked when the p53-
inhibitor a-pi®thrin was added to the KC after UVB-irradiation. Blockade of death-receptor
activation by incubating the cells on ice prior to and during irradiation, did not have any protective
effect. These results show that KC are sensitized to UV-induced, p53-dependent apoptosis by
ATRA treatment, probably due to an up-regulation of pro-apoptotic caspases. The increased
sensitivity of KC to UV-induced apoptosis might be involved in the synergistic effect of combined
UV and retinoid treatment in psoriasis.
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FOXM1 is a Downstream Target of Hedgehog Signalling in Basal Cell Carcinomas
(BCC)
M.-T. Teh, S.-T. Wong, G. Neill, L. Ghali, M. Philpott, and A. Quinn
London, UK and Singapore
Forkhead box (FOX) proteins have been shown to play important roles in regulating the
expression of genes involved in cell growth, proliferation, differentiation, longevity and
transformation. The functional importance of this gene family in normal human skin physiology
and disease processes is not well understood as there is a paucity of information on the expression of
these genes in the human skin. Activation of Sonic Hedgehog (Shh) signalling plays a key role in
the development of BCCs of the skin in humans. Recent studies have established that some FOX
genes are downstream targets of Shh signalling. We have investigated the role of FOX proteins in
transducing Shh effects in human skin by using degenerate PCR to identify FOX genes
differentially expressed in BCCs. All three known FOXM1 isoforms (a, b and c) were detected in
human skin and cultured keratinocytes and the transcriptionally active FOXM1b isoform was
found to be up-regulated in BCCs. Real-time quantitative RT-PCR showed that the increase in
FOXM1 mRNA level was speci®c for BCCs and not a re¯ection of increased cell proliferation in
that no up-regulation was seen in squamous cell carcinomas (SCCs) or proliferating primary
human keratinocyte cultures. The dissociation between the cell cycle and FOXM1 expression was
further supported by immunostaining studies which showed intense nuclear and cytoplasmic
staining throughout BCC tumor islands and not con®ned to the periphery regions of the tumor
where proliferating Ki-67-immunopositive cells are predominantly localized. In contrast to the
mixed cytoplasmic and nuclear localization seen in BCCs, constitutive expression of an EGFP-
FOXM1b fusion construct in cultured primary and immortalized epithelial and mescenchymal cells
showed nuclear localization. Expression of the Shh target glioma transcription factor-1 (Gli1) in
primary keratinocytes and other cell lines caused a signi®cant elevation of FOXM1 mRNA level
and transcriptional activity indicating that FOXM1 is a downstream target of Shh signaling.
Although Gli1 expression in C3H10T1/2 cells stimulated the endogenous differentiation marker
alkaline phosphatase (AP) activity, this was not seen with ectopic FOXM1b expression which
suggests that FOXM1 is not mediating the differentiation signal in this model of Shh signaling. Our
®ndings provide the ®rst evidence that activation of Shh signaling is an important determinant of
FOXM1 expression in mammalian cells. Given the role of FOXM1 in cell proliferation, the up-
regulation of FOXM1 in BCCs may be one of the mechanisms whereby Shh signalling exerts its
mitogenic effect on basal keratinocytes leading to the development of this common human cancer.
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High Killing Ef®cacy of a New Silicon Phthalocyanine in Human Melanoma Cells
Treated with Photodynamic Therapy by Early Activation of Mitochondrion-Mediated
Apoptosis
J. Barge,*² R. DecreÂau,* M. Julliard,* A. S. Sabatier,² J. J. Grob,² and P. Verrando²
*Laboratoire AM3, Fac Sci. St JeÂroÃme and ²LIMP (EA3291), UniversiteÂ de la MeÂditerraneÂe, Marseille,
France
Photodynamic therapy (PDT) is a promising therapeutic modality that utilizes a combination of a
photosensitizer and visible light for the destruction of diseased tissues. Using human pigmented
melanoma cells, we examined the photokilling ef®cacy of new silicon-phthalocyanines (SiPc) that
bore bulky axial substituents. The bis(cholesteryloxy) derivate (Chol-O-SiPc) displayed the best In
vitro photokilling ef®cacy (LD50 = 6 3 10±9 M) and was 9-times more potent than chloro-
aluminium Pc (ClAlPc), a known photosensitizer used as a reference. The rate of Chol-O-SiPc
uptake by cultured melanoma cells was higher than that of ClAlPc, leading remarkably to 30-fold
more maximum accumulation. Although Chol-O-SiPc was half as potent as ClAlPc for promoting
photo-oxidative membrane damage in a cell-free assay, early events of mitochondrion-mediated
apoptosis upon PDT were triggered much faster. This was demonstrated by kinetics studies
examining cells with permeabilized mitochondrial membranes detected by a spec®c probe,
cytochrome c release followed by confocal microscopy and caspase-9 activation monitored by an
enzymatic assay. Inhibition of caspase-9 activity by a substrate analogue showed its central role in
the pro-apoptotic events leading to photokill by Chol-O-SiPc PDT, while cytochrome c release
was not affected. Thus, although the other Pc used as reference acted on the same apoptotic
pathway, Chol-O-SiPc ef®cacy relies mainly on a high cell uptake and an early triggering of pro-
apoptotic events mediated by the mitochondrion, enlightening thus a major role of this organelle
in Pc PDT. Conclusively, Chol-O-SiPc represents a potential high ef®ciency photosensitizer,
especially suitable for the photokill treatment of melanized cells and tumors, which usually prove
refractory to PDT.
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Effect of Disruption of Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Function
on the Distribution of Desmosomal Proteins
J. Dhitavat, C. Cobbold, N. Leslie, S. Burge, and A. Hovnanian
University of Oxford, Oxford, UK
SERCA is a membrane bound Ca2+ activated ATPase. It actively transports Ca2+ from the cytosol
into the endoplasmic reticulum (ER) lumen to maintain cytosolic Ca2+ concentration. Increase in
intracellular Ca2+ is shown to initiate the assembly of desmosomes in the epidermal cells In vitro. In
addition, mutations in the SERCA2 gene cause Darier's disease, which is characterised by
disruption of desmosomal complexes and abnormal epidermal differentiation. Using indirect
immuno¯uorescence and Western blotting, we investigated the effects of SERCA disruption on
cell-to-cell adhesion and expression of the desmosomal proteins desmoplakin, desmoglein, and
desmocollin in normal human keratinocytes. SERCA function was inhibited by preincubation of
cells with thapsigargin, a highly speci®c SERCA inhibitor. When SERCA function was blocked
with thapsigargin, traf®cking of the desmosomal proteins to the cell surface was inhibited. These
proteins showed substantial colocalisation with the ER marker protein calnexin, suggesting that
they were retained in the ER. We then extracted protein from these cells with mild detergent and
separated into detergent soluble and insoluble fractions. In the presence of thapsigargin, the
majority of desmosomal proteins were observed as detergent insoluble aggregates. Our ®ndings
suggest that inhibition of SERCA function prevents ef®cient differentiation and transport of
desmosomal proteins to the cell surface, which may remain in the ER as aggregates. These results
represent a ®rst step towards a better understanding of the molecular mechanisms underlying
impairment in cell-to-cell adhesion in Darier's disease.
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BMP-4 Can Induce Keratinocyte Commitment by Inhibition of the Neural
Antiapoptosis Pathway
D. Aberdam, C. Coraux, T. Virolle, C. Hilmi, C. Gambaro, D. Momier, and M. Rouleau
INSERM U385, Nice, France
It has been stated that the differentiation of epidermis requires inductive signals while the
neuralization of the dorsal ectoderm requires only an inhibition of this signaling, interpreted as a
``default'' state. BMP4 is a key regulator of this commitment since it can directly induce epidermal
fate and inhibit the formation of neural tissue. Embryonic stem (ES) cell technology is an attractive
model system for studying the initial molecular mechanisms underlying lineage differentiation.
Under appropriate culture conditions, we show that these pluripotent cells can undergo ef®cient
keratinocyte commitment. Furthermore, the ES-derived keratinocytes are able to reconstituted a
pluristrati®ed epidermis with a6b4 integrin expression to the basal layer and deposition of laminin-
5. cDNA microarray technology was used for a search of genes whose steady-state levels are
modulated during the early induction (2 h) by BMP-4. As con®rmed by Real Time PCR, BMP-4
prominently repress neural embryonic-speci®c markers including genes encoding neural
antiapoptotic ligands. BMP-4 activity has been identi®ed as part of apoptotic mechanisms in
many cell types In vitro. Therefore, we suggest that, as an active inducer of keratinocyte
commitment, BMP-4 may interfere with the survival of neural precursor cells by inhibition of the
neural antiapoptosis pathway.
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Proteasome Inhibition Results in Trail Sensitization of Primary Keratinocytes by
Removing the Resistance-Mediating Block of Effector Caspase Maturation
M. Leverkus, M. R. Sprick,* T. Mengling, B. Baumann,² E. Ser¯ing, E. B. BroÈcker, M.
Goebeler, M. Neumann, and H. Walczak*
University of WuÈrzburg, Department of Dermatology, WuÈrzburg, Germany; *DKFZ, Heidelberg,
Germany; ²University of Ulm, Ulm, Germany
TNF-related apoptosis-inducing ligand (TRAIL) exerts potent cytotoxic activity against
transformed keratinocytes, whereas primary keratinocytes are relatively resistant. In several cell
types, inhibition of the proteasome sensitizes for TRAIL-induced apoptosis by interference with
NF-kB activation. Here we describe a novel intracellular mechanism for TRAIL-resistance of
primary cells and how this resistance is removed by proteasome inhibitors. In contrast to ®ndings in
other cell types, retroviral infection of primary keratinocytes with IkBa (IkBa-TD) mutant or
kinase dead IKK2 (IKK2-KD) dominant-negative mutants, potent inhibitors of NF-kB, did not
result in modulation of TRAIL sensitivity, suggesting that sensitization by proteasome inhibition
utilizes different signalling pathways. This sensitization was not mediated at the receptor-proximal
level of TRAIL DISC formation or caspase 8 activation but further downstream. Activation of
caspase 3 was critical as it only occured when mitochondrial apoptotic pathways, as re¯ected by
Smac/DIABLO and cytochrome release, were activated. Smac/DIABLO is needed to release the
XIAP-mediated block of full caspase 3 maturation. XIAP can effectively block caspase 3
maturation and, intriguingly, is highly expressed in primary but not in transformed keratinocytes.
Our data suggest that breaking of this resistance via proteasome inhibitors, which are potential
anticancer drugs, may sensitize primary keratinocytes to TRAIL-induced apoptosis and could
complicate their clinical application.
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Identi®cation of a 4.2 kb 5¢-Flanking Region of the Human Cdsn Gene That Directs
Variable Expression in Hair Follicle and Epidermis of Transgenic Mice
H. Gallinaro, N. Jonca, L. Langbein,* C. Vincent, G. Serre, and M. Guerrin
Department ``Epidermis Differentiation and Rheumatoid Autoimmunity'', Toulouse-Purpan
Pathophysiology Center INSERM- Toulouse III University, IFR 30, Toulouse, France; *German
Cancer Research Center, Cell Biology, Heidelberg, Germany
Corneodesmosin (Cdsn) is a protein secreted by the epidermis granular keratinocytes then
incorporated into their desmosomes. Cdsn is also expressed in the inner root sheath (IRS) of
human hair follicles. The homophilic adhesive properties of Cdsn reported In vitro argue for a role
of the protein in intercellular cohesion. Transgenic mice bearing a 4.2-kb-long human genomic
DNA fragment corresponding to the region located upstream the Cdsn translation initiation codon
were generated. This fragment was obtained by screening a chromosome 6 genomic library (Max
Planck-Institute of Molecular Genetic; Berlin) and sequenced. It was linked to the coding region
of a nls-lacZ reporter gene. The mouse screening, performed by Southern blot and PCR, allowed
identi®cation of 4 independent founders. The reporter gene expression was searched by
histoenzymology using X-gal as a b-galactosidase substrate in different skin sites (back, ventral, tail)
as well as in ®ve mouse organs (kidney, thymus, heart, spleen and liver). All mouse lines exhibited
the same b-galactosidase expression pattern although some variations were observed in the
expression level. The promoter activity was clearly detected in the nuclei of medulla cells of skin
hair follicles. Furthermore, it was detectable in IRS Henley layer (lower follicle) and Huxley layer
(upper follicle) cells, in new-born as well as in adult mice, but not in hair cortex cells. Surprisingly,
we could not detect any enzymatic activities in the granular layer of the interfollicular epidermis,
which is the main site of Cdsn expression in mice and humans. However, topical application of
retinoic acid or phorbol 12-myristate 13-acetate (PMA) resulted in activation of the transgene
expression in the epidermis parakeratotic corni®ed cells. Our results indicate that Cdsn expression
in the interfollicular epidermis and the hair follicle may be controlled by different genomic
sequences. The speci®city of the transgene expression gives an interesting tool for driving protein
to speci®c hair follicle compartments.
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DCoH/HNF-1 Transcription of Human Tyrosinase
J. M. Wood, S. Kothari, S. Kauser, N. A. Hibberts, N. J. Lindsey, N. C. J. Gibbons, and K. U.
Schallreuter
University of Bradford, UK
Human melanocytes express the entire system for the de novo synthesis, recycling and regulation
of 6 (R) L-erythro 5,6,7,8 tetrahydrobiopterin (6BH4) the essential cofactor/electron donor for the
biosynthesis of L-tyrosine from L-phenylalanine via phenylalanine hydroxylase (PAH). Pterin 4a
carbinolamine dehydratase (PCD) is the rate limiting enzyme for the recycling of 6BH4 and
therefore this enzyme is an important control point for the supply of L-tyrosine for melanogenesis
in melanocytes. In the melanocyte cytosol PCD exists as a tetramer, but its dissociation to a dimer
produces the dimerisation catalyst (DCoH) for the transcription factor Hepatocyte Nuclear Factor
1a (HNF-1). Immunohistochemical examination of melanocytes in situ in the epidermis, and in cell
cultures, establish colocalisation of PCD/DCoH and HNF-1in both the cytosol and the nucleus.
These results show for the ®rst time the presence of DCoH/HNF-1 transcription factor in the
nucleus of melanocytes. The human tyrosinase gene promotor contains a 16-base inverted
palindrome with sequence homology to the HNF-1 homodimer binding site (i.e.
GTTAATATTCTAACCA) indicating a possible role for DCoH/HNF-1 in the transcription of
the tyrosinase gene. A 439-bp fragment of the human tyrosinase promoter containing the DCoH/
HNF-1 homodimer binding site was isolated from 3 individuals. All 3 DNA sequences were
identical to the tyrosinase promoter sequence. Speci®c binding of pure DCoH/HNF-1
(recombinant proteins) to the tyrosinase promoter was conferred by band shift analyses. Since
this binding domain is located 184 bases away from the TATA- box we can conclude a dual
function for PCD/DCoH in the control of melanogenesis by melanocytes (a) by regulation the L-
tyrosine supply via PAH and (b) by transcription of the tyrosinase gene.
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Interactions of Human Myosin Va Isoforms are Tightly Regulated by the Tail Domain
W. Westbroek, J. Lambert, R. Busca,* P. Bahadoran,* M. C. Herteleer, F. Van Nieuwpoort,² M.
Mommaas,² R. Ballotti,* and J. M. Naeyaert
Ghent, Belgium; *Nice, France; ²Leiden, the Netherlands
Myosin Va encoded by the dilute gene (d) in mice and the Griscelli locus in humans, is a dimer that
through its mechanochemical N-terminal head domain facilitates movement of cargo along
subcortical actin ®laments. Primary human epidermal melanocytes express six endogenously
myosin Va isoforms. It was already shown that isoforms containing exon F are most abundant in
melanocytes, therefore we hypothesized that these isoforms probably have a melanocyte-speci®c
function. To uncover the biological role of the six isoforms we introduced eGFP-myosin Va tail
constructs in human melanocytes and melanoma cells. Using immuno-¯uorescence confocal
microscopy and immuno-electron microscopy, we found that exon F is absolutely required for
myosin Va to interact with melanosomes in human melanocytes. Our yeast two hybrid screening
and coimmunoprecipitation assays revealed a direct interaction of melanophilin and an indirect
interaction of rab27a, with exon F transcripts. These data indicate that in human melanocytes
rab27a serves as a myosin Va receptor on the melanosome membrane with melanophilin acting as a
bridging molecule. Our data also shows that isoforms lacking exon F but containing exon D are
suspected to associate with Golgi-derived vesicles. These results indicate that the myosin Va medial
tail domain provides the globular tail domain with organelle-interacting speci®city.
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Characterization of a Human Melanocyte Transcript Coding for a New Protein, Mel-
46.2, and the Hypothetical Brain Protein my038. Involvement in Melanocytic Cell
Response and Resistance to UV-B Radiation
C. ValeÂry, B. Bon, A.-S. Sabatier, J.-J. Grob, and P. Verrando
LIMP (EA3291), UniversiteÂ de la MeÂditerraneÂe, Marseille, France
cDNA microarray analysis of normal human melanocyte (NHM) transcripts modulated by a
pseudo-physiological ¯uence of arti®cial ultraviolet UV-B radiation allowed for the selection of a
strongly up-regulated Expressed Sequence Tag, EST46, that was characterized. EST46, was found
expressed by RT-PCR at rather high levels in several melanoma cell lines but variably in
melanoma tumors, suggesting a possible interaction with melanocarcinogenesis. EST46 sequence
aligned with the 830 bp DNA sequence of the hypothetical brain protein my038 of unknown
function. In NHM, Northern-blot experiments using an EST46-derived probe identi®ed two
transcripts of ~0.8 kb and ~1 kb. Sequencing of the EST46 clone spotted on the microarray showed
that it included the previously reported my038 sequence with additional DNA stretches. Using the
5¢-RACE methodology, we assessed the full-length sequence of the EST 46 related transcript,
which corresponded to 1014 bp. We con®rmed its presence in SK-MEL-2 melanoma cell line and
in NHM. Entire EST46 mapped to chromosome 16 (16p12.2), within a region yet devoided of
known Single Nucleotide Polymorphisms (SNP) and cytogenetic alterations. Two open reading
frames (ORF) were borne by the full-length transcript. One coded for my038 (71 amino acids) and
the other for a new melanocyte protein that we termed Mel-46.2 (51 amino acids). Similarly to
my038, Mel-46.2 harbors three putative consensus protein sequence sites. Two are phosphoryla-
tion targets for protein kinases C and casein kinase II, whereas the other is a N-myristoylation site.
Instrumental over-expression of my038 and Mel46.2 fusion proteins in SK-Mel-2 line using the
new GATEWAYTM technology showed a cytoplasmic distribution. Importantly, functional studies
ascribed a role for Mel-46.2 and my038 in melanocytic resistance to UVB radiation. In conclusion,
we have characterized an unknown melanocyte transcript that responds to UV-B stress and that
codes for both my038 protein and a new protein temed Mel-46.2Mel- which are involved in cell
resistance to UVB, a risk factor for melanoma.
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Functional Expression of CCR3 But Not of CCR7 in Lymphogenic Melanoma
Metastasis
A. T. Kyi, C. Dudli, G. Burg, and F. O. Nestle
University of Zurich, Zurich, Switzerland
Involvement of chemokines and their cognate receptors in tumor metastasis has been shown
recently. In this study, we analyzed melanoma cells for the expression of CCR3. We examined
lymph node metastases derived (n = 4) and CNS metastases derived melanoma cell lines (n = 4) as
well as normal melanocytes (n = 3). CCR3 expression was detected in all the samples examined at
the mRNA and protein level. Functional CCR3 was shown in all lymph node derived cell lines
examined by means of migration and actin polymerization assays. CCR3 was not functional in
CNS derived melanoma cell lines and normal melanocytes. We next looked at CCR7 expression
which has recently been suggested to be involved in lymphatic metastasis. CCR7 expression was
detected at the mRNA level but not on the protein level. No cell migration in direction of the
CCR7 ligand 6Ckine could be observed when performing migration assays. Inhibition of G
proteins and PI3 kinase abolished CCR3 mediated cell migration towards ist ligand eotaxin in
lymph node derived tumor cells whereas MEK inhibition did not result in a reduced number of
migrated cells. This suggests an involvement of the PI3 kinase pathway in CCR3 signaling in
lymph node derived melanoma cell lines. To assess levels of CCR3 ligands eotaxin and RANTES,
quantitative PCR was performed. mRNA amounts of these chemokines were highest in lymph
nodes. Taken together, our data suggests that a functional PI3 kinase signaling pathway may lead to
metastasis of melanoma cells expressing CCR3 to organs secreting high levels of the respective
ligands.
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1a,25(OH)2D3 Inhibits IL-1a Induced NF-kB Activation and IL-8 Synthesis in Cultured
Normal Human Keratinocytes by Increasing the IkB Expression
J. Riis, C. Johansen, B. Gesser, K. Kragballe, and L. Iversen
Aarhus, Denmark
IL-1a is an important in¯ammatory cytokine in the skin. It is expressed by the keratinocytes and
has been suggested to play a key role in hyperproliferative and in¯ammatory skin diseases like
psoriasis. IL-1a contributes to the activation of the nuclear transcription factor, NF-kB, which is
an inducible enhancer of many in¯ammatory genes. NF-kB comprises a family of homo- and
heterodimers of Rel proteins. The purpose of this present study was to determine the effect of
1a,25(OH)2D3 on the IL-1a induced NF-kB activation. NF-kB DNA binding activity was
determined by EMSA using a consensus oligonucleotide containing the kB sequence from either
the IL-8 or the p53 promotor. Cultured normal human keratinocytes were preincubated with
1a,25(OH)2D3 (10-7±10-8 M) for 12 and 24 h before stimulated with IL-1a (10 ng per ml) for
15 min. When using the IL-8 consensus oligonucleotide a signi®cant time dependent decrease in
NF-kB DNA binding activity was seen with a 72% 6 12 and 65% 6 15 inhibition at 10±7 M and
10±8 M 1a,25(OH)2D3, respectively, after 24 h. Only insigni®cant changes were seen in NF-kB
binding to the p53 consensus oligonucleotide under similar condidtions. As determined by ELISA
the inhibition of NF-kB binding to the IL-8 oligonucleotide was parallelled by an inhibition of
48% 6 9 in the IL-1a induced IL-8 expression after incubation with 1a,25(OH)2D3 (10±7 M) for
24 h. Incubation of cultured normal human keratinocytes with 1a,25(OH)2D3 (10±7 M) for 1±48 h
also lead to a time dependent increase in the expression of the NF-eÃB inhibitor, IkB, as determined
by Western blotting. This increase became signi®cant after 6 h and was maximal (105% 6 52) after
24 h of incubation. We conclude that 1a,25(OH)2D3 inhibits IL-1a induced NF-kB activcation
and the resulting IL-8 expression in cultured human keratinocytes by increasing the IkB
expresssion. Since no inhibition of NF-kB binding to the p53 oligonucleotide were seen, our
®ndings indicate that 1a,25(OH)2D3 inhibits speci®c NF-kB homo- and heterodimers leading to
decreased transcription of in¯ammatory genes.
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Eumelanin and Phaeomelanin Contents of Depigmented and Repigmented Skin of
Vitiligo Patients
D. Parsad, S. Ito,* Wakamatsu,* and B. Kumar
Postgraduate Institute of Medical Education and Research, Dermatology, Chandigarh, India; *Nagoya, Japan
Background: There are two chemically distinct types of melanin: the red±yellow phaeomelanin
and the brown black eumelanin. Both types of melanin have been detected in human hair,
epidermis and cultured melanocytes. Objectives: The cascade of events leading to disappearance/
inactivation of melanocytes in pathogenesis of vitiligo is still not clear. The ratio of eumelanin and
phaeomelanin have not been studied in vitiligo subjects. We conducted this preliminary study to
quantify levels of both eumelanin and phaeomelanin in depigmented as well as repigmented
patches of vitiligo on various treatments. Patients and Methods: We enrolled seven patients of
vitiligo for this study. We took 3mm punch biopsies from either depigmented or repigmented skin
of these patients except for two patients (RA and PI) in whom punch biopsies were taken both
from repigmented as well as depigmented lesions. Two patients were on PUVA, one on PUVAsol,
one on antioxidant, two on topical steroids and one untreated. The eumelanin and phaeomelanin
contents of the skin biopsies were quanti®ed by high performance liquid chromatography (HPLC)
as described previously (Ito and Fujita 1985). Results: We analyzed melanin contents in ®ve
repigmented and four depigmented lesions. In ®ve repigmented lesions average AHP/PTCA ratio
was 0.85 (range 0.63±1.14) whereas in four depigmented lesions average ratio was 5.8 (range 3.36±
9.95). Conclusions: Depigmented lesions showed predominantly phaeomelanin whereas
repigmented lesions showed predominantly eumelanin. In complex sequence of events leading
to death/inactivation of melanocyte, decreased tyrosinase activity or other factors leading to switch
to phaeomelanin must be playing a vital role in pathogenesis of vitiligo. We could detect melanin
in depigmented lesion of vitiligo of 5 years duration. It seems some residual melanocytes are still
active in depigmented lesions.
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Hyperexpression of Extracellular Signal-Regulated Protein Kinase (ERK) 1/2 Mitogen-
Activated Protein Kinase (MAPK) in Cultured Caucasian Melanocytes
K. H. Zhang, J. Nip, D. Pocalyko, and M. Barratt
Unilever Research, Edgewater, New Jersey, USA
Variations in human pigmentation among different ethnic groups are due to differences in the
amount and type of melanin produced in the epidermis. Considerable evidence supports a key role
of melanocytes in determining the phenotypic difference between ethnic groups. The activity of
the melanocyte-speci®c enzyme tyrosinase, which catalyzes the ®rst step in the biosynthesis of
melanin, is higher in melanocytes of black skin than those found in Caucasian skin. Recently, the
MAPK signaling pathway has been implicated in the regulation of melanogenesis in B16 murine
melanoma cell lines. Activation of MAPK in these cells inhibits melanogenesis. In addition,
inhibition of MAPK signaling in human melanoma cells with either anthrax lethal toxin or MAPK
inhibitors results in a dramatic increase in melanin production. We were interested in determining
whether a correlation exists between activated MAPK and melanin production in melanocytes
derived from Caucasian and Black donors. In immunoblot analyses using antibodies directed
against activated MAPK we observed signi®cantly more phosphorylated ERK 1/2 in the less
pigmented Caucasian melanocytes than in Black melanocytes. Furthermore, westernblot analyses
indicated signi®cantly more hyperphosphorylated Rb in the Caucasian melanocytes than in the
Black melanocytes. Rb is a negative cell cycle regulator, however, in its phosphorylated form it
plays a key role in the transition from the G1 to S phase of the cell cycle. This increased pRb is
consistent with the observed higher proliferation rate of Caucasian melanocytes. Our data indicate
that ERK activation in cultured human epidermal melanocytes is inversely proportional to
melanogenesis.
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Expression of Ca2+ Binding Protein S100A4 (mts-1) in Normal Human Skin, Malignant
Melanoma and Other Cutaneous Malignancies
K. Schirra, A. Kerber, E. Lukanidin,* and J. Reichrath
Department of Dermatology, The Saarland University Hospital, Homburg, Germany; *Department of
Molecular Cancer Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
S100A4 (mts-1), a member of the S100 gene family, has been shown to be associated with cancer
development and metastasis. We have evaluated the expression of S100A4 protein in melanocytic
nevi (n = 38), primary cutaneous malignant melanomas (n = 39), cutaneous (n = 25) and lymph
node (n = 15) metastases of malignant melanoma, squamous cell carcinomas (n = 4), basal cell
carcinomas (n = 4), cutaneous T-cell lymphomas (n = 3), Kaposi sarcomas (n = 6), and Merkel cell
carcinomas (n = 2) using a highly speci®c primary monoclonal antibody and immunohistochemical
techniques (paraf®n sections, conventional labeled streptavidin-biotin technique as well as laser
scanning microscopy). In melanocytic tumors, staining was correlated with immunoreactivity for
S100 and HMB-45 as well as with prognostic markers including tumor thickness and clark level. In
contrast to previous observations, we found strong cytoplasmic and nuclear staining for S100A4 in
melanocytic nevi, primary cutaneous malignant melanomas, cutaneous and lymph node metastases
of malignant melanomas, T-cell lymphomas as well as Kaposi sarcomas, while S100A4
immunoreactivity was undetectable or very weak in basal cell carcinomas and squamous cell
arcinomas. In S100A4-positive tumors, staining was in general focally pronounced in peripheral
cells while central areas revealed reduced or no staining. In conclusion, we here report in contrast
to previous observations strong immunoreactivity for S100A4 in melanocytic nevi, primary
cutaneous malignant melanoma, cutaneous and lymph node metastases of malignant melanomas,
T-cell lymphomas as well as Kaposi sarcomas. Our ®ndings indicate that S100A4 expression may
be of importance for the growth characteristics and metastatic potential of these malignant skin
tumors, and the results encourage studies to evaluate the potential value of using S100A4
expression levels as markers in the clinical management of melanoma.
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Human Melanocytes Express b2-Adrenoceptors In Situ and Produce Catecholamines
J. M. Gillbro, L. K. Marles, and K. U. Schallreuter
University of Bradford, UK
Previously it was reported that human epidermal melanocytes neither express b2-adrenoceptors nor
produce catecholamines. However, we have demonstrated that cultured human epidermal
melanocytes express tyrosine hydroxylase isozyme I mRNA (TH), the rate limiting enzyme in
catecholamine biosynthesis. Subsequent RT-PCR and immunohistochemical analyses con®rmed
the expression of TH, dopa decarboxylase and dopamine-b-hydroxylase enzymes without the
presence of phenylethanolamine-N-methyl-transferase (PNMT), the last enzyme in the
catecholamine biosynthesis cascade. This result suggests that human melanocytes are noradrenergic
cells. This data is supported by our previous ®nding of a time- dependant induction of a1-
adrenoceptors on melanocytes in response to noradrenaline, suggesting an autocrine regulation. By
contrast human epidermal keratinocytes produce adrenaline. Here we report that human epidermal
melanocytes also express b2-adrenoceptors under in vitro conditions. Using the double-immuno-
¯uorescense technique for the b2-adrenoceptor and HMB-45 for the detection of melanocytes in
cryostat sections of human epidermis, high levels of b2-adrenoceptors were found in melanocytes.
Since adrenalin is a speci®c agonist for the b2-adrenoceptor, yielding increased cAMP production
in melanocytes, this adrenergic signal could regulate de novo pigmentation via the b2-adrenoceptor/
cAMP cascade. This paracrine control supports the symbiotic relationship existing between
melanocytes and keratinocytes in the human epidermis.
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Bcl-2 Independent Induction of Apoptosis by Bisphosphonates in Human Melanoma
Cells
A. M. Forsea, C. Riebeling, C. MuÈller, C. E. Orfanos, and C. C. Geilen
The Free University of Berlin, Berlin, Germany
Bisphosphonates are synthetic pyrophosphate-analogues, well established in the treatment of
osteoclast-mediated resorbtive bone diseases, including osteoporosis, Paget's disease of bone and
tumour induced osteolysis. Recent studies suggest that, beside inhibiting bone resorbtion,
bisphosphonates may also exert a direct antitumour effect, and this class of drugs has been shown to
inhibit proliferation and to induce apoptosis In vitro in different human tumour cell lines. In the
case of the nitrogen-containing subclass of bisphosphonates, this antineoplastic activity could be
related to the inhibition of the mevalonate pathway, and consequently, of the prenylation of
signalling proteins such as small GTPases. We examined the In vitro effect of nitrogen containing
bisphosphonates pamidronate and zoledronate, as well as of the nonamino bisphosphonate
clodronate on melanoma cell lines A 375, M186 and on the bcl2 overexpressing melanoma cell line
A375/Bcl2. Apoptosis, proliferation and cell cycle changes were assesed. We could show that
bisphosphonates are able to induce apoptosis, to inhibit cell growth and to induce S-phase changes
of the cell cycle in melanoma cell lines, in dose dependent manner. The intensity of these
antitumoral effects did not correlate well with the relative antiresorbtive potency of the
bisphosphonates. Interestingly, the susceptibility of melanoma cells to bisphosphonates-induced
apoptosis was not in¯uenced by bcl2 overexpression. Our results indicate for the ®rst time that
bisphosphonates have a direct antitumour effect on melanoma In vitro and suggest that these
substances could play a role in the adjuvant therapy of melanoma in the future.
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Normal Human Epidermal Keratinocytes (NHEK): Active In¯ux Transport is Mediated
by Members of the Organic Anion Transport Polypeptide Family
R. Schiffer, M. Neis, F. Rodriguez, D. HoÈller, F. Lammert, A. Dreuw, G. Zwadlo-Klarwasser, H.
F. Merk, F. Jugert, and J. M. Baron
Aachen, Germany
Normal human epidermal keratinocytes (NHEK) have been shown to express a cell type speci®c
pattern of extrahepatic cytochrome P450 enzymes and ef¯ux transport proteins indicating the
ability of keratinocytes to metabolize and excrete a variety of xenobiotics. Recently transport
proteins involved in the uptake of xenobiotics have been detected and here we analysed the
mRNA- and protein- expression pro®les and functional activities of these proteins in keratinocytes
in comparison to primary liver cells. The transporters studied included the subtypes A, B, C, D and
E of the organic anion transporting polypeptide (OATP) family which are responsible for the
uptake of various anionic and neutral molecules and especially organic cations including drugs. In
our study we were able to show a constitutive expression of OATP -B, -D and -E in normal
epidermal keratinocytes using RT-PCR and Northern blot analysis, as well as in human skin tissue
shown by tissue blot hybridization and immunostaining. Expression of OATP-A and -C was not
detected in any of the keratinocyte samples. In contrast, liver tissue showed a signi®cant expression
of OATP-A and -B as well as OATP-C, a weak expression of OATP-D and no expression of
OATP-E. These data revealed that human epidermal keratinocytes express a speci®c pro®le of
transporters involved in drug in¯ux. In addition using a newly developed uptake-transport assay,
we were able to show, that uptake of known OATP substrates like 3H-estradiol-17b-glucuronide
in NHEKs can be inhibited by speci®c inhibitors like taurocholate, proving the functional activity
of the expressed OATPs. Even though the substrate speci®city of the OATP isoforms is only
partially known till now, our ®ndings give strong evidence that the uptake of large organic cations
like drugs in keratinocytes is an active transport process mediated by members of the OATP family.
In vitro this process can be modulated by speci®c competitive inhibitors.
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Altered Gene Expression in Normal Human Epidermal Keratinocytes (NHEK) by
Retinoic Acid (RA) Isomers and Their 4-oxo-Metabolites
R. Schiffer, G. Zwadlo-Klarwasser, H. F. Merk, F. Jugert, D. R. Bickers, and J. M. Baron
Aachen, Germany and New York, USA
Vitamin A and its natural and synthetic derivatives (retinoids) exert profound effects on
fundamental processes such as vision, embryonic development and cell proliferation and
differentiation. Retinoids are effective in the treatment of numerous dermatologic disorders.
There is increasing evidence that target tissue metabolic transformation is crucial for regulation of
their biological and pharmacological activity. In this experiment RA isomers and their 4-oxo
metabolites were incubated with cultured NHEK for 24 h and analysis of differentially expressed
genes was performed using DNA-Chip-technology. We examined 4400 sequence-validated
cDNAs and ESTs arrayed on DermArray GeneFilters microarray and analyzed suitably exposed
autoradiograms with Pathway analysis software. Incubation of cells with all-trans-RA for 24 h
revealed up-regulation of the human metallothionein (MT)I-F gene, corticotropin releasing
hormone-binding protein, glutathione S-transferase M5, epidermal growth factor, keratins 8 and
13 and interleukin 18 receptor. Genes encoding for keratin 10, human interleukin enhancer
binding factor 3, steroid-5-a-reductase and CYP2C8 were down-regulated simultaneously.
Incubation with 4-oxo-all-trans-RA showed a different gene expression pro®le with up-regulation
of keratin 15, thiosulfate sulfurtransferase, ®broblast growth factor receptor 2, d-aminolevulinate-
synthase 1, CYP3A3 and TIMP3. In contrast 9-cis- and 4-oxo-9-cis RA as well as 13-cis-RA and
4-oxo-13-cis RA revealed different expression pro®les. Genearray analysis is a powerful tool for
exploring retinoid effects in the skin.
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Defective Traf®cking and Cell Death are Characteristic of Skin Disease-Associated
Connexin 31 Mutations in Keratinocytes
W. L. Di, J. Monypenny, J. E. A. Common, C. T. C. Kennedy, K. A. Holland, E. L. Rugg, I. M.
Leigh, D. Zicha, and D. P. Kelsell
Centre for Cutaneous Research, Queen Mary's, London, UK
Distinct germline mutations in the gene encoding connexin 31 (Cx31) underlie the skin disease,
Erythrokeratoderma variabilis (EKV) or sensorineural hearing loss with/without peripheral
neuropathy. Here we describe a number of functional analyses to investigate the effect of these
different disease-associated Cx31 mutants on connexon traf®cking and intercellular communica-
tion. Immunostaining of a skin biopsy taken from an EKV patient harbouring the R42P mutation
revealed sparse epidermal staining of Cx31, and, when present, it had a perinuclear localisation.
Transfection and microinjection studies in both keratinocytes and ®broblast cell lines also
demonstrated that R42P and three other EKV-associated mutant Cx31 proteins displayed defective
traf®cking to the plasma membrane, being either retained in the Golgi apparatus or in the
cytoplasm. However, the defective traf®cking was not shown in nonepidermal cells such as HeLa,
with some gap junction plaque formation. In contrast, the deafness/neuropathy mutant 66delD and
R32W, a variant with no identi®ed disease association, could traf®ck to the plasma membrane but
did not form gap junction plaques and were unable to dye-transfer. Another interesting
characteristic feature observed with the dominant skin-disease Cx31 mutations was a high
incidence of blebbing and cell death. This was not observed with wildtype, 66delD or R32W
Cx31 proteins. In conclusion, we have identi®ed some key phenotypic differences with respect to
different disease-associated Cx31 mutations. The mechanism of cell death associated with the EKV
Cx31 mutation is currently under investigation.
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Characterization of a First Domain of Human High Tyrosine/Glycine and High Sulfur
Keratin Associated Protein (Kap) Genes on Chromosome 21q22.1
M. A. Rogers,* L. Langbein, H. Winter,* C. Ehmann,* S. Praetzel, and J. Schweizer*
Divisions of *Biochemistry of Tissue-speci®c Regulation and Cell Biology, German Cancer Ressearch Center,
69120 Heidelberg, Germany
Analysis of the EMBL/Genebank database using nonhuman keratin associated protein (KAP)
cDNA sequences as a query resulted in the identi®cation of a ®rst domain of high tyrosine-glycine
and high sulfur KAP genes located on human chromosome 21q22.1. This domain, present on
BAC clones AP001078 and AP001709, was c. 535 kb in size and contained 17 high tyrosine-
glycine- and 7 high sulfur KAP genes, as well as 9 KAP pseudogenes. These genes could be divided
into 11 families (the KAP6-8, 11, 13, 15, and 19±23 families) based on amino acid homology
comparisons of the putative KAP gene open reading frames. Systematic cDNA isolation and in situ
hybridization expression studies of all of the KAP genes identi®ed in this region showed varying
degrees of expression of 12 members of the high tyrosine/glycine- and 6 members of the high
sulfur KAP genes in the differentiating portions of the hair ®ber cortex and cuticle.
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Diverse Effects of Interleukin-1 on Apoptosis Induced by Ultraviolet B Radiation
D. Kulms and T. Schwarz
University of MuÈnster, Germany
Irradiation of cells with ultraviolet B (UVB) induces apoptotic cell death by triggering at least two
different and independent pathways. On the one hand, UVB induces genomic DNA damage, on
the other hand, it causes activation of membrane bound cell death receptors like CD95/Fas or the
TRAIL-receptors. Interleukin (IL)-1 was shown to prevent the epithelial cell line KB from
undergoing apoptosis induced by the death ligands CD95L or TRAIL. In contrast, UVB-induced
apoptosis was not only not prevented, but was even enhanced upon pretreatment with IL-1. It was
the aim of the study to elucidate the mechanism responsible for IL-1 to act once anti- and once
proapoptotic. Western blot analysis revealed that prestimulation of KB cells with IL-1 leads to a
NFkB-dependent up-regulation of the inhibitor of apoptosis proteins (IAP), c-IAP and x-IAP,
which ultimately rescues cells from CD95L- or TRAIL-induced apoptosis. In contrast, stimulation
of cells with IL-1 15 min prior to UVB exposure induces the proapoptotic cytokine tumor necrosis
factor-a (TNFa). This up-regulation is also dependent on NFkB. Time course studies revealed
that the temporal sequence of the addition of IL-1 and the apoptotic stimulus critically determines
whether NFkB targets the IAPs or TNFa. Addition of IL-1 8±6 h prior to UVB results in up-
regulation of IAPs and reduction of UVB-induced apoptosis. The closer IL-1 prestimulation gets
to UVB irradiation (120±15 min), the stronger apoptosis is induced and this coincides with an
increase of TNFa release. The same applies when IL-1 is added after UVB irradiation. IL-1 given
15±60 min after UVB results in enhancement of apoptosis and increased release of TNFa, whereas
later applications of IL-1 do not affect UVB-induced apoptosis. Taken together, the study
demonstrates that the anti/proapoptotic activity of a stimulus does not only depend on its nature
and on the stimulus causing apoptosis but also on the temporal sequence when the stimulus is
applied.
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Biological Effects of Sphingosine 1-Phosphate on Keratinocytes
T. Nishijima, T. Kitahara, and Y. Takema
Biological Science Laboratories, Kao Corporation, Japan
Sphingosine 1-phosphate (S1P), which is a lipid mediator, is stored in platelets, and is released upon
their activation. S1P has potent biological activities such as effects on cell proliferation,
differentiation and cell motility for endothelial cells and melanoma cells. Although it has been
reported recently that S1P also has an effect on cutaneous wound healing of diabetic model mice,
the biological effects of S1P on keratinocytes have not yet been investigated. In this study, we
examined not only the biological effects of S1P on keratinocytes but also its physiological effects on
the skin. RT-PCR analysis of S1P receptors revealed that human keratinocytes express edg±3 and
edg±5 mRNAs, which are transcripts for S1P receptors. Addition of S1P to cultured keratinocytes
raised the concentration of intracellular calcium within 1 min, while the growth of keratinocytes
was not affected. An In vitro scratch assay, which evaluates cell mobility, showed that S1P has an
inhibitory effect on keratinocyte motility in the presence of bovine pituitary extract. When
keratinocytes were seeded on collagen gels and the diameter of the gel was measured 1 h after
removal from the plate, keratinocyte contractile ability was augmented in the presence of S1P. S1P
was also applied once daily to 6 mm-diameter full thickness wounds of normal rat dorsal skin.
Comparing the relative wound areas 6 days later, treatment with S1P accelerated wound healing.
These ®ndings suggest that S1P has various biological effects on keratinocytes via its speci®c
receptors and on the physiological function of the skin, such as the promotion of cutaneous wound
healing.
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Corticotropin Releasing Hormone (CRH): An Autocrine Hormone That Promotes
Lipogenesis in Human Sebocytes
Ch. C. Zouboulis, H. Seltmann, N. Hiroi, W. Chen, M. Young, M. Oeff, W. A. Scherbaum, C.
E. Orfanos, S. M. McCann, and S. R. Bornstein
Berlin and DuÈsseldorf, Germany, Bethesda, Maryland and Baton Rouge, LO, USA; Tainan, Taiwan
Sebaceous glands may be involved in a pathway conceptually similar to that of the hypothalamic-
pituitary-adrenal (HPA) axis. Such a pathway has been described and may occur in human skin and
in the sebaceous glands since they express neuro-peptide receptors. CRH is the most proximal
element of the HPA axis and it acts as central coordinator for neuroendocrine and behavioral
responses to stress. To further examine the probability of a HPA equivalent pathway we
investigated the expression of CRH, CRH-binding protein (CRH-BP) and CRH receptors
(CRH-R) in SZ95 sebocytes In vitro and their regulation by CRH and several other hormones.
CRH, CRH-BP, CRH-R1 and CRH-R2 were detectable in SZ95 sebocytes at the mRNA and
protein levels: CRH-R1 was the predominant type (CRH-R1/CRH-R2 = 2). CRH was
biologically active on human sebocytes: it induced biphasic increase in synthesis of sebaceous lipids
with a maximum stimulation at 10±7 M and up-regulated mRNA levels of 3b-hydroxysteroid
dehydrogenase/D5±4 isomerase, although it did not affect cell viability, cell proliferation or IL1b-
induced IL-8 release. CRH, dehydroepiandrosterone and 17b-estradiol did not modulate CRH-R
expression, whereas testosterone at 10±7 M down-regulated CRH-R1 and CRH-R2 mRNA
expression at 6±24 h and GH switched CRH-R1 mRNA expression to CRH-R2 at 24 h. Based
on these ®ndings, CRH may be an autocrine hormone for human sebocytes that exerts
homeostatic lipogenic activity, whereas testosterone and GH induce CRH negative feedback. The
®ndings implicate CRH in the clinical development of acne, seborrhea, androgenetic alopecia, skin
aging, xerosis and other skin disorders associated with alterations in formation of sebaceous lipids.
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Characterization of the Protein Responsible for Mal de Meleda
F. Chimienti, M. Huber, J. Fischer,* and D. Hohl
Laboratory for Cutaneous Biology, Department of Dermatology, CHUV, Lausanne Switzerland; *Centre
National de GeÂnotypage, 91057 Evry, France
Mal de Meleda (MDM) (OMIM 284300) was originally described in patients from the island of
Meleda, Croatia. This disease is inherited in an autosomal recessive manner with an estimated
frequency of 1:105 in the general population. Mal de Meleda is characterized clinically by an
in¯ammatory palmoplantar keratoderma and transgressive pachyderma mainly involving palms and
soles. Histological features include acanthosis, hyperkeratosis and pseudospongiosis. The MDM
gene was within a cluster of Ly-6 homologous genes, which are members of the Ly-6/uPAR
family of receptor and secreted proteins. Sequence analysis of patients suffering from MDM
revealed three different homozygous mutations in the ARS (component B) gene, encoding SLURP-
1 (Secreted Ly-6/uPAR Related Protein 1). Expression analysis of SLURP-1 transcripts by
Northern blot and RT-PCR reavealed that SLURP-1 is mainly expressed in plantar, and most
likely, in palmar skin, which corresponds to the sites of MDM lesions. SLURP-1 has homologies
with the uPAR (urokinase Plasminogen Activator Receptor) family, which acts as a scaffolding
protein of integrins, but does not contain a GPI membrane anchor. Furthermore, SLURP-1 has
homologies with snake toxins. These properties will serve as candidate avenues to explore the
function of SLURP-1, which is likely to function as a ligand for a receptor yet to be identi®ed. To
this end, a myc-tagged SLURP-1 cDNA has been cloned in p-Bud. Both palmoplantar and
nonpalmoplantar keratinocytes are transfected by SLURP-1; protein expression and localization is
monitored by immuno¯uorescence and immunoblot analysis. Recombinant myc-tagged SLURP-
1 protein was obtained after Ni-NTA puri®cation from transfected 293T cells culture medium,
indicating that SLURP-1 is a secreted protein. The recombinant protein is used for the
identi®cation and molecular characterization of the binding partner of SLURP-1.
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Transcriptional Effect of a Mallow Extract in Human Reconstituted Epidermis Using
cDNA Macro-Array
M. Bonnet-Duquennoy, F. X. Bernard,* J. Franchi, F. BonteÂ, S. Schnebert, and R. KurfuÈrst
LVMH Branche Parfums et CosmeÂtiques, Laboratoires R & D, St Jean de Braye, France; *BIOalternatives,
GencËay, France
Many clinical studies reported the positive effect of all-trans retinoic acid topical application on
photo-damaged skin and on wrinkles. Thus, in order to investigate the antiageing activities of a
mallow ¯ower extract, we studied the modi®cations of the gene expression patterns induced by
this extract, vs. all-trans retinoic acid (RA), in a human epidermis model (RHE). The mRNA
expression pro®les were studied using a customized cDNA macro-array system containing 598
skin-related genes. Differentiated RHE were treated with the Malva sylvestris extract (3%) or with
RA (1 mM) dissolved in culture media for 8 h or 24 h. After RHE lysis, mRNAs were isolated,
reverse-transcribed, 33P-labelled and the probes obtained were hybridized to the cDNAs on the
membranes and revealed by phosphorimaging. Qualitative analysis from all RHE showed that
more than 25% of the selected genes were signi®cantly detected on the array. No signi®cant
difference in the gene expression pro®les was observed when untreated RHE were analysed after 8
or 24 h of incubation. According to the nature and the length of the treatments, more than 40
genes were found to be modi®ed. Comparison of the expression pro®les after 24 h treatments with
RA or Malva sylvestris extract showed differences in only 15% of genes. We observed that genes
previously reported to be modulated by RA were also regulated by the Malva sylvestris extract
treatment (cytokeratin 10, 2E, calgranulin A and B, IL-1RA,¼). These results show that the Malva
sylvestris extract, studied in the human reconstructed epidermis model, induces a gene expression
pro®le very similar to that observed with a known antiwrinkle molecule.
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Effects of Recombinant Overexpression of PKCa and d on Receptor-Coupled Calcium
Handling in HaCaT Keratinocytes
M. GoÈnczi, H. Papp, E. BodoÂ, L. KovaÂcs, T. BõÂroÂ, and L. Csernoch
Department Physiol, MHSC, University Debrecen, Debrecen, Hungary
We have previously shown that the modi®cation of protein kinase C (PKC) activity by forbol
esters affects the kinetic properties of the purinergic receptor-mediated calcium response in HaCaT
keratinocytes. In the present study we investigated the features of certain (purinergic,
bradykininergic) receptor-coupled processes that result in an increase of intracellular calcium
concentration ([Ca2+]i) on keratinocytes which stably overexpress either the classic a or the novel d
isoform of PKC. The clones were found to have essentially the same resting [Ca2+]i (65.4 6 2.4 nM
in a and 71.3 6 2.3 nM in d clones) but responded with larger calcium transients to the application
of 180 mM ATP (223 6 18 for a and 238 6 21 nM for d clones vs. 156 6 18 nM in control cells).
Examining the declining phase of the calcium signals revealed a 37.4 6 7.3 s time constant for
calcium removal in control and 39.8 6 7.1 s in PKCa overexpressing cells. However, PKCd
clones displayed a prolonged falling phase characterised by a 63 6 4.8 s time constant. While ATP
was effective on all cells examined, including both clones, bradykinin (20 mM) failed to induce a
calcium transient in 50% of control cells. The responsiveness to bradykinin was greatly suppressed
in PKCa and PKCd overexpressing keratinocytes (less than 20%). However, if the given cell did
respond to the drug, the evoked calcium signal displayed all characteristics described for those
induced by ATP, namely, the removal of calcium from the cytoplasm was slower in PKCd clones.
Unlike the ATP induced elevation of [Ca2+]i, bradykinin evoked signals tended to decline even in
the continous presence of the drug indicating a faster desensitisation of the bradykininerg pathway.
In this respect the clones did not differ signi®cantly from control cells. Together with changes in
calcium handling, the stable overexpression of these PKC isoforms altered the proliferation and
differentiation properties of the cells. Both the PKCa and d clones displayed decreased
proliferation tendencies and increased expressions of the late diferentiation marker involucrin.
These observations argue that certain PKC isoenzymes play crucial roles in the regulation of
calcium handling and differentiation of keratinocytes.
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Stretch-Activated Channels and Their Regulation by Protein Kinase C in HaCaT
Keratinocytes
N. SzentandraÂssy, M. GoÈnczi, H. Papp, J. LaÂzaÂr, J. KovaÂcs, T. BõÂroÂ, and L. Csernoch
Department Physiol, MHSC, University Debrecen, Debrecen, Hungary
The skin is almost continuosly under mechanical stress. Certain areas observe increased pressures
while others are stretched, as the marginal cells of the wound bed. These mechanical forces are
believed to induce proliferation and/or differentiation of keratinocytes. Here we demonstrate the
presence and their regulation by protein kinase C (PKC) of stretch-activated channels in the
human keratinocyte cell line HaCaT in culture. Cells were voltage clamped using the whole-cell
patch-clamp technique, changes in intracellular calcium concentration were assessed using the
¯uorescent calcium probe fura-2. Alterations in the membrane potential were followed using a
conventional microelectrode. The activation of these cells by hypotonic stress, a drop in osmolarity
to 75% and 50%, caused hyperpolarisation, by 15.2 and 39.7 mV, respectively, from a resting value
of ±28.4 6 4.8 mV. The changes were readily reversible. Similar alterations in the membrane
potential were observed by changing the hydrostatic pressure. An overnight incubation with
100 nM phorbol 12-miristate 13-acetate (PMA), which induced a down-regulation of PKC
isoforms, caused a pronounced hyperpolarisation of these cells by 16 6 3.2 mV, but did not affect
their ability to respond to the hypotonic challenge. Consistent with these ®ndings, the
recombinant overexpression of PKCa resulted in a depolarization of the membrane potential (to ±
20.1 6 2.5 mV). Hypotonic solutions caused a small increase in intracellular calcium concentration,
from a resting value of 77 6 4±124 6 16 nM and from 72 6 7 to 118 6 24 nM in 50% and 75%
hypotonic solution, respectively. However, the development of these changes and the return to the
initial level was much slower than those evoked by ATP. The pretreatment with PMA did not
in¯uence the calcium transients evoked by hypotonic solutions. The intracellular calcium
concentration increase was 57 6 13 nM in 50% and 43 6 11 nM in 75% hypotonic solution in
pretreated cells. These ®ndings connect the observed changes in voltage following mechanical
stress to the activation of Cl ± and probably to Ca2+-activated potassium channels. Furthermore, the
regulation of the above process by certain PKC isoforms is probable.
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Mutations of Connexin 31 and 30.3 in Erythrokeratodermia Variabilis
L. Plantard, P. Meda,* M. Huber, and D. Hohl
Dermatology, CHUV, Lausanne, Switzerland; *Morphology, CMU, Geneva, Switzerland
Gap junctions are clusters of intercellular channels connecting the cytoplasm of neighbouring cells.
The subunits of the channels are formed by the connexins (Cx), proteins containing four
transmembrane domains. Functionally, gap junctions allow rapid transfer of ions and small second
messenger molecules, of less than 1 kDa in size, between adjacent cells. Therefore they permit
coordinated response of groups of cells to external stimuli. This cell-cell communication is crucial
for growth control and differentiation, as well as for maintaining tissue homeostasis. Each tissue
expresses a speci®c subset of connexins. In skin, at least 9 connexins are expressed, including Cx31
and Cx30.3. Mutations in either Cx31 or Cx30.3 have been described to be causally involved in
erythrokeratodermia variabilis (EKV). Erythrokeratodermia variabilis is a genetically heterogeneous
disorder of corni®cation, transmitted in an autosomal dominant manner and caracterised by ®xed
patches of hyperkeratosis and migrating erythematous areas. The speci®c role of each of these
connexins in the physiology and pathophysiology of epidermal tissues and the clinical phenotype of
connexin mutants have not been elucidated yet. Cx31 and Cx30.3 coding regions have been
subcloned in different combination in a vector designed to drive simultaneously constitutive, high-
level expression of two transgenes in order to test the capacity of mutant and wild type Cx30.3 to
form active channel. Expression, traf®cking, localisation and interaction of the proteins are studied
in communication-de®cient HeLa cells. In transfected cell, wild type Cx31 and Cx30.3 colocalised
at plasma membrane especially at cell-cell contact and it appears that they interact with cytoskeletal
proteins. The intercellular coupling of Cxs is studied by examining the transfer of Lucifer yellow
between stable HeLa cell lines expressing Cx31 and wild type or mutant Cx30.3.
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Characterisation and Function of Novel EDC Genes
R. Contzler, L. Falquet, H. Burcelin, M. Huber, and D. Hohl
Laboratory of Cutaneous Biology, Dermatology, CHUV and Swiss Institute of Bioinformatics, Lausanne
The epidermal differentiation complex (EDC) on human chromosome 1q21 contains three
clustered families of genes encoding: (1) precursor proteins of the corni®ed cell envelope (2) S100
proteins and (3) the fused gene family combining characteristics of both. In this study we searched
for novel genes on 1q21 expressed in the epidermis. We identi®ed in silico a new member of the
``fused'' subgroup of S100 proteins (TRP). TRP transcripts were detected by RT-PCR in fetal
bladder, scalp, foreskin, and in cultured primary keratinocytes. Analysis of a contig spanning ~680
kbp from human chromosome 1q21 allowed to identify several XP5 homologues as well as the
complete XP32 and XP33 genes which differ from previously published incomplete sequences.
Using XP5a and XP32 probes for analyzing a wide range of human tissues by RT-PCR and
Northern blotting, we found high levels of transcripts in scalp and foreskin. XP33 RNA was
detected in cultured keratinocytes, adult kidney, scalp skin, foreskin, and fetal bladder. In order to
gain further insights into the functions of TRP and XP genes, coding sequences of the TRP and
XP genes were cloned in frame to GST in the bacterial expression vector, pGEX-4T-1.
Recombinant proteins have been puri®ed from bacterial lysates using Glutathione Sepharose 4B
af®nity chromatography. Polyclonal rabbit antibodies against peptides of human XP5a, XP32,
XP33 and TRP have been developed and are af®nity puri®ed. Antibody speci®cities are tested by
Western blot analyses of bacterially expressed GST-fusion proteins. To investigate the protein
distribution and subcellular localization of these proteins, fusions between GFP and the TRP, XP5,
XP32 and XP33 coding sequences are constructed. HEK293T and HaCat cells transfected with
these constructions are analysed by immuno¯uorescence. In future experiments we will investigate
the differential expression of the XP family members, as well as TRP by tissue microarrays using
antibodies and speci®c in situ probes.
207
BP180 Autoantibody Detection in Bullous Pemphigoid Sera: Improved Sensitivity of a
NC16A ELISA with Additional BP180 Selected Epitopes
F. Mariotti, F. Grosso, M. Terracina, M. Ruffelli, P. Cordiali-Fei, G. Zambruno, A.
Mastrogiacomo, and G. Di Zenzo
IDI-IRCCS and San Gallicano IRCCS, Rome, Italy
The bullous pemphigoid (BP) antigen BP180 contains an immunodominant region, NC16A,
mapped within the membrane-proximal non collagenous stretch of the extracellular domain.
ELISAs with NC16A domain have been recently developed as a diagnostic tool for BP
autoantibody detection. Since BP180 autoantibody reactivity is not restricted to NC16A, we have
investigated the possibility to develop an ELISA based on selected epitopes in addition to NC16A.
At ®rst, a glutathione-S-transferase (GST) -NC16A ELISA was set up and used to test the reactivity
of 77 BP sera. Autoantibodies against the NC16A domain were detected in 62 of 77 BP sera (81%),
with a sensitivity similar to that of previously described BP180 ELISAs. In order to assess if the
15 BP sera negative in our NC16A ELISA recognised other antigenic sites on the BP180 molecule,
we have then analysed their reactivity against 16 BP180 epitopes exposed on l bacteriophage.
These epitopes had been previously af®nity selected from a BP180 random epitope l library using
BP sera. The epitopes were transferred on nitrocellulose ®lters and used as targets in the
immunological screening procedure with the 15 BP sera negative in NC16A ELISA. 5 and 3 of 15
sera recognised the C-terminus (AA 1331±1404) and the mid-portion of BP180 ectodomain (AA
1080±1107), respectively. Therefore, two additional GST fusion proteins (GST-1080 and ±1331)
were produced and used to set up an ELISA system with three recombinant proteins (GST-
NC16A, ±1080- and ±1331). Using this approach 69 of our 77 BP sera resulted positive, with an
increase in sensitivity from 81% to 90%. Our ELISA based on selected BP180 epitopes is not only
more sensitive but also more informative of BP sera epitope pattern than ELISA using GST-
NC16A fusion protein alone. Furthermore, these results show that the epitope mapping strategy
represents a powerful tool to select epitopes to be exploited for diagnostic purposes.
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Induction of Connexins Cx30 and Cx26 in Epidermis Adjacent to Malignant Melanoma
but Not to Melanocytic Nevi
N. K. Haass, J. M. Brandner, E. Wladykowski, P. von den Driesch, S. Kief, P. Houdek, and I.
Moll
Hamburg, Germany
Communication between cells is performed by exchange of small molecules through gap junctions.
Gap junctions connect adjacent cells and form communicating channels. They consist of two
connexons (one of each cell), each formed by six transmembrane proteins called connexins (Cx).
Ten of the known 21 different connexins are expressed in human skin. Gap junctions formed by
different connexins are selective for different small molecules (e.g. second messengers). Thereby
they control the speci®city of cell-cell-communication. There is evidence suggesting that
connexins play a role in tumour biology. This work concerns the expression of Cx30 and Cx26 in
malignant melanoma and melanocytic nevi and in epidermis adjacent to these lesions.
Investigations were performed by immuno¯uorescence microscopy using previously described
speci®c antibodies. As previously shown Cx30 and Cx26 are only weakly, if at all, expressed in
normal interfollicular epidermis. Now we show that both proteins neither occur in malignant
melanoma nor in melanocytic nevi. In contrast both Cx30 and Cx26 are expressed in the epidermis
adjacent to malignant melanoma but not to melanocytic nevi. These results clearly show an
induction of Cx30 and Cx26 in normal interfollicular epidermis adjacent to malignant melanoma.
There is no such induction in benign melanocytic nevi. Previously we demonstrated similar results
investigating gap junction proteins in malignant epithelial skin tumours. So there is evidence that
the change of the composition of gap junctions in the epidermis adjacent to malignant skin
tumours may play a role in the metastasation of these tumours. Ongoing investigations will
elucidate the function of Cx30 and Cx26 in normal interfollicular epidermis adjacent to malignant
skin tumours.
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Characterisation of Keratinocytes Upon Low-Dose Acetaldehyde Exposure
B. Held, D. Schaefer, K. Schreml, K. HoÈrmann, and C. Bayerl
University Medical Center Mannheim, Mannheim, Germany
Acetaldehyde (AAL) is an indoor pollutant, used for the production of desinfectants and plastic
materials, and therefore might effect the skin by direct or aerogen contact. Furthermore, AAL is
synthesised during alcohol metabolism. So far no speci®c data are available concerning the effects
on human keratinocytes. Therefore we studied effects of low-dose concentrations of AAL on
cytoskeleton and proliferation. Normal human epidermal keratinocytes were cultured under
serum-free conditions. Cells were exposed for eight hours to variable concentrations of
acetaldehyde (0.01, 10, 1000 mM). Differentiation and proliferation associated Cytokeratines
(CK) 1, CK 10, CK 6, CK 16 and the marker of mitosis MIB-1 were labeled
immunocytochemically using monoclonal antibodies. Additionally, proliferation was quanti®ed
¯uorometrically using the alamarBlue assay. The synthesis of CK 1, CK 10, and CK 6 were not
affected by AAL, whereas the number of CK 16 positive cells were 25% higher than controls.
MIB-1 was not altered by AAL. Using the alamarBlue-assay, a high dose of acetaldehyde
(1000 mM) caused an inhibition of 66 6 8,7%, an intermediate dose (10 mM) caused no change,
whereas a low dose (0.01 mM) increased the proliferation of keratinocytes by 24 6 3,1%, compared
to controls. In contrast to high doses of AAL, which most likely cause cytotoxicity, low doses of
AAL induced keratinocyte proliferation. AAL might be considered as cofactor for proliferative,
possibly precancerous, processes in skin.
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Caspase-14 Expression is Regulated by Cooperation of Transactivating and Repressing
Factors During Keratinocyte Terminal Differentiation
C. Ballaun, P. E. Mrass, S. Karner, J. Bach, and E. Tschachler
Vienna Austria and Neuilly, France
Caspase-14, a recently identi®ed member of the caspase family of proapoptotic proteases is thought
to be involved in epidermal differentiation. Caspase-14 expression is highly restricted to suprabasal
layers of the epidermis. In order to understand the regulation of this protease, we investigated
factors controlling keratinocyte speci®c caspase-14 gene-expression. Deletion mapping of the 5¢-
region of caspase-14 revealed a minimal promoter sequence of ~270 bp relative to the start sites of
transcription. This minimal promoter element contains two potential AP-1 sites (AP-1.2, AP-1.3)
three potential AP-2 binding sites and one potential NFkB site. Transfection experiments and
electrophoretic mobility shift assays encompassing these transcription factor binding sites and their
mutated counterparts showed that caspase-14 AP1.3 and NFkB sites were functional in
keratinocytes. Caspase-14 promoter constructs showed higher activity in postcon¯uent
keratinocytes as compared to precon¯uent cells. This ®nding demonstrates that keratinocyte
differentiation is indeed a determining factor for caspase 14 promoter activity. In addition we
identi®ed three functional repressor sites (f1/2, f5/6, f6/8) in the caspase 14 promoter region. One
of them (f5/6) contains a PAUSE-1 recognition sequence, a silencer element recently identi®ed in
the plasminogen activator inhibitor (PAI-2) gene, which has an identical expression pattern as
caspase-14 in the epidermis. Our data demonstrate that the speci®c expression of caspase-14 in the
suprabasal layers of the epidermis is regulated by enhancing (AP-1, NFkB) as well as silencing
(PAUSE-1) regulatory elements. Modulation of these transcription factors therefore is likely to
have an effect on caspase 14 expression and represents a potential strategy for in¯uencing epidermal
barrier formation.
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Ceramide C-2 and Hydrogen Peroxide Induce Apoptosis by Two Different Pathways in
Human Keratinocytes
T. Zuliani,*² C. Jayat,³ R. Duval,§ M. Salamagne,² M. Dumas,* and M. H. Ratinaud²
*LVMH R & D, Branche Parfums et CosmeÂtiques, Saint-Jean de Braye, France; ²UMR CNRS 6101,
Fac de MeÂdecine; ³SUC, Fac des sciences; §UPRES EA 1085, Fac de pharmacie Limoges, France
Apoptosis is a physiologic programmed cell death (PCD) that occurs throughout the epidermis. It
contributes to epidermal protection and maintenance by removing damaged or unwanted cells
averting in¯ammation and tissu alterations. Ceramides, synthesized after activation of the
sphingomyelin cycle, have been shown to be the major second messengers of this process and to be
produced by oxidative stress. To better understand intracellular events linked to oxidative stress-
induced PCD, the induction of apoptosis was carried out by comparing ceramide C-2 and
hydrogen peroxide both on HaCaT cells, a human keratinocyte cell line mutated on both alleles of
the p53 gene, and normal human keratinocytes (NHK). Apoptosis signalling was investigated by
measuring caspases-1, ±3, ±8, ±9 activities, mitochondrial transmembrane potential (¯uorescent
probe, JC-1), and plasmic membrane integrity (¯uorescent probe, Toto-3). For NHK and HaCaT
cells, the mitochondrial transmembrane potential (Dym) was not affected by ceramide C-2
treatment, while a collapse in Dym was induced by H2O2 in both cell types. This phenomenon was
associated with a dramatic increase of caspase-8 and, to a smaller extent, of caspases-9 and ±3
activities. In conclusion, signalling pathways induced by ceramide C-2 or hydrogen peroxide are
based on two distinct mechanisms. Moreover, the mutated p53 of the HaCaT cells, do not affect
their response to the biologically active lipid C-2 and to H2O2 compared to normal cells.
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The Low-Af®nity Neurotrophin Receptor p75 Mediates the Proapoptotic Activity of
Brain-Derived Neurotrophic Factor in Keratinocytes
A. Marconi, C. Fila, M. Pignatti, A. Giannetti, and C. Pincelli
Institute of Dermatology, University of Modena and Reggio Emilia, Italy
The low-af®nity neurotrophin (NT) receptor p75 is a member of the Fas/tumor necrosis factor
(TNF) receptor family which mediates cell death. The NT brain-derived neurotrophic factor
(BDNF) is synthesized by human keratinocytes, while these cells express p75 but not the BDNF
high-af®nity receptor trkB. The aim of the present study was to elucidate the role of p75 in
cultured keratinocytes. BDNF dose-dependently decreased the number of keratinocytes, as shown
by crystal violet staining (p < 0.05). Moreover, BDNF dose-dependently induced keratinocyte
apoptosis, as shown by MTT assay (p < 0.05). BDNF also increased the rate of apoptosis induced
by the trk inhibitor K252. As keratinocytes do not express trkB, it is likely that BDNF activities are
mediated through p75. Indeed, antip75 neutralizing antibody alone induced keratinocyte
apoptosis, as compared to controls. Secondly, simultaneous addition of BDNF and antip75
resulted in a rate of apoptosis similar to that of antip75 alone. In order to support the proapoptotic
role of p75, parental (SK-N-BE) or p75 transfected (SK-N-BE p75) neuroblastoma cell lines were
used. While BDNF did not induce apoptosis in SK-N-BE cells, it caused cell death in SK-N-BE
p75, as shown by TUNEL. Finally, UVB-induced apoptosis was markedly increased in SK-N-BE
p75, as compared to parental cell line. These results indicate that BDNF acts as a proapoptotic NT
in human keratinocytes through p75, even in the presence of other trk receptors. Moreover, p75
seems to play a role in UVB-induced apoptosis. Taken together, these data con®rm the
proapoptotic role of p75 and represent the ®rst functional evidence of p75 acting as a death
receptor in keratinocytes.
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Distinct Isoforms of CD1d are Expressed in Keratinocytes in a Proliferation-
Differentiation Dependent Manner
A. Koreck, M. SzeÂll, A. Pivarcsi, Zs. Bata-CsoÈrgoÄ, A. Dobozy, and L. KemeÂny
Szeged, Hungary
CD1d is a nonclassical antigen-presenting molecule capable to present glycolipid antigens to NKT
cells, which have been suggested to play a role in the pathogenesis of psoriasis. There are
con¯icting results concerning CD1d expression in keratinocytes. The aim of the present study was
to investigate the expression of CD1d in healthy skin, psoriatic lesional and nonlesional skin and in
synchronized HaCaT cells. Immunohistochemistry was performed on tissue samples and on
cultured HaCaT cells using CD1d NOR 3.2 and CD1d51 monoclonal antibodies (mAb). In
healthy and uninvolved psoriatic skin two distinct staining patterns were obtained depending on
the antibodies used: CD1d was expressed by differentiated keratinocytes beneath the stratum
corneum (CD1d NOR 3.2 mAb) or by the whole epidermis (CD1d51 mAb). In psoriatic lesions,
both antibodies showed a strong and diffuse expression. To clarify the cause of these different
staining patterns RT-PCR, real-time PCR and Western blot analysis were carried out on
synchronized HaCaT cells. RT-PCR results showed that CD1d was not detectable in
proliferating, nondifferentiated HaCaT cells, but CD1d expression appeared and increased as the
cells started to differentiate. To a more precise quanti®cation of CD1d gene expression, real-time
PCR was performed with a different primer set. Interestingly, these results showed that CD1d was
expressed most intensely by proliferating cells. Western blot analysis, using CD1d51 mAb, revealed
two products, one at 30 kDa and one at 47 kDa. The expression of the 30 kDa form gradually
increased with differentiation, while the 47 kDa form was present in proliferating cells and was not
detectable in fully differentiated, nonproliferating cells. Here we provide the ®rst evidence that
CD1d exists in two isoforms that are distinctively expressed in HaCaT keratinocytes in a
proliferation-differentiation dependent manner. This could be the result of an alternative splicing
of the CD1d gene.
214
b-Carotene Interferes with Gene Regulation by UVA in Keratinocytes
K. Wertz, P. Buchwald, N. Seifert, G. Riss, and R. Goralczyk
Human Nutrition and Health, Roche Vitamins Ltd, Basel, Switzerland
Objective: assess at the level of gene expression whether b-carotene (bC) can interfere with UVA
effects in keratinocytes. Methods: HaCat cells, treated with 1.5 mM bC, were UVA irradiated, and
subjected to Affymetrix GeneChipq hybridization. Results: 193 genes were found regulated by
UVA. Of those, the UVA effect was reduced by bC for 44, enhanced for 69, and not changed for
80 genes. bC reduced UVA-induced MMP10 expression, indicating reduced extracellular matrix
degradation. Chromatin assembly factor I (CAF I), an indicator of DNA damage and heavily
induced by UVA, was also decreased by bC. bC repressed CENP-E and several cyclins, suggesting
mitotic arrest. Dual-speci®city phosphatases, which preferably inactivate ERKs over SAPK/JNK,
were induced by bC, indicating a net increase of SAPK/JNK signalling. Also, bC enhanced the
UVA-induced upregulation of phosphatidyl-inositol 3 kinase (PI3K). PI3K plays a major role in
regulating Ca in¯ux into cells. As bC increased the transcription of Ca channels, the Ca in¯ux into
bC/UVA-treated cells should have been greatly facilitated. Signalling by Ca and SAPK/JNK can
induce apoptosis. This is consistent with the increased abundance of apoptosis-inducing genes, e. g.
TR3 and GADD153. Apoptosis induction was con®rmed in an assay for caspase 3 activity.
Conclusions: bC interacted with UVA via several mechanisms, the dominating effect being
induction of apoptosis. Apoptosis occurred at physiological bC concentrations and was p53-
independent, as HaCat cells carry an inactivated p53 gene. This suggests that bC should aid killing
UV-damaged, precancerous skin cells.
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Clonal Analysis of Epidermal Cells Derived from Small Human Skin Punch Biopsies
P. E. J. van Erp, M. M. van Rossum, J. B. M. Boezeman, J. Schalkwijk, and P. C. M. van de
Kerkhof
Department of Dermatology, University Medical Centre Nijmegen, the Netherlands
Normal human epidermis consists of two types of proliferating keratinocytes: stem cells, which
have high proliferative potential, and transit-amplifying cells, which are destined to undergo
terminal differentiation after a few rounds of cell division. It is known that, in vivo, stem cells
express higher levels of the b1-integrins than transit-amplifying cells. In this study, we sought to
de®ne these epidermal subpopulations on the basis of phenotype and clonogenic potential. For this
purpose we used single cell suspensions from small human skin punch biopsies. These cell
suspensions were sorted ¯ow cytometrically into a b1-integrin weakly positive (dim) and strongly
positive (bright) subpopulation. Subsequently, the clonogenic potential of these subpopulations
was compared in multiwell cell culture experiments. An image system was used to detect colonies
and determine their growth characteristics. In ®ve consecutive experiments, it turned out that cell
size in the b1-integrin bright subpopulation increased when colonies aged, whereas this was
constant in the dim subpopulation. The total number of colonies formed was higher in the b1-
integrin dim than in the bright subpopulation. The growth rate of colonies in the b1-integrin dim
subpopulation exceeded that of the b1-integrin bright subpopulation. A combination of ¯ow
cytometric analysis and sorting, cell culture and image analysis offers the opportunity to characterise
epidermal subpopulations phenotypically and functionally. With this combination it was shown
that cultured keratinocytes from b1-integrin dim and bright subpopulations differed with respect to
morphology and growth characteristics.
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Elevated Expression of EMMPRIN (CD147) and Membrane-Type Matrix
Metalloproteinases in Chronic Wounds
Y. Herouy, T. Hildenbrand, M. Idzko, E. Panter, E. Bandemir, M. Hartmann,* J. Norgauer
Department of Dermatology, University-Hospital, Freiburg, *Dermatologisch-Phlebologische
Gemeinschaftspraxis, Freiburg
Matrix metalloproteinases (MMPs) contribute to matrix remodeling in venous leg ulcers.
Extracellular matrix metalloproteinase inducer (EMMPRIN) has been reported to increase MMP
expression, and membrane-type-1-MMP or MT1-MMP has been implicated to activate MMPs.
The present study examined whether and to what degree EMMPRIN, MMP-2, MT1-MMP and
MT2-MMP were expressed in venous leg ulcers as well as the association with MMP activity. By
preparing biopsies from healthy skin and lesional tissue from venous leg ulcers EMMPRIN, MMP-
2, MT1-MMP and MT2-MMP were analysed by using zymography and immunohistochemistry.
Our investigations provide direct evidence of increased proteolytic activity of MMP-2 which
could be proven in lesional skin in comparison to healthy controls by zymography.
Immunoreactive staining displays intense staining for EMMPRIN, MMP-2, MT1-MMP and
MT2-MMP in dermal structures of venous leg ulcers, whereas solely EMMPRIN and MMP-2 are
expressed in perivascular regions. Our ®ndings indicate that venous leg ulcers are characterized by
elevated expression of EMMPRIN, MMP-2, MT1-MMP and MT2-MMP. The immunohisto-
logical ®ndings of skin alterations re¯ects the dynamic process of activation of soluble and
membrane-bound MMPs, which may be highly induced by EMMPRIN. These data suggest for
the ®rst time that membrane-bound MMPs may favor enhanced turnover of the extracelluar
matrix und support unrestrained matrix metalloproteinase activity in venous leg ulcers.
748 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
217
PPARb Functions During Adult Murine Skin Regeneration
L. Michalik, N. S. Tan, N. Dipoi, B. Desvergne, and W. Wahli
University of Lausanne, Lausanne, Switzerland
Many nuclear hormone receptors have been implicated in skin maturation and development.
Among them, the retinoic acid pathway is required for normal epidermis development, and ligands
for the thyroid and the glucocorticoid receptors are known to accelerate the epidermal barrier
maturation of rat skin. PPARa ligands were shown to accelerate epidermal development of fetal
rat skin explants, suggesting that PPARs belong to the group of nuclear hormone receptors
participating in the epidermal differentiation. PPARb is absent from the adult interfollicular
epidermis. Interestingly, its expression is strongly up-regulated in this tissue after a skin injury.
Consistent with an implication of PPARb, wound repair is delayed in PPARb mutant mice, due
to impaired adhesion/migration, cell death and proliferation of the mutant keratinocytes. We
present here ®ndings showing that PPARb is an crucial effector regulating keratinocyte behaviour
during the healing of a skin wound and is therefore an interesting therapeutic target.
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Novel Targets for Cancer Chemoprevention: Blockade of Hedgehog Signaling Inhibits
Basal Cell Carcinomas (BCCs) in ptch+/± Knockout Heterozygous Mice
M. Athar, X. Tang, A. L. Kim, M. Aszterbaum,* L. Kopelovich, E. H. Epstein Jr,* and D. R.
Bickers
College of Physicians and Surgeons, Columbia University, Department of Dermatology, New York, USA;
*University of California San Francisco, San Francisco, USA
BCCs induced by solar UVB are the most common form of human malignancy, affecting millions
of patients worldwide each year. Mutations in sonic hedgehog (shh) signaling genes including
patched (ptch), shh and smoothened (smo) activate transcription factors of the Gli family that
regulate target genes ultimately leading to BCCs development. Ptch+/± knockout mice develop
BCCs and trichoblastomas following chronic exposure to UVB radiation resulting in activation of
the shh signaling pathway. In animals, shh signaling is critical for normal morphogenesis and
cyclopamine, a speci®c inhibitor of shh, causes abnormal segmental development. In this study we
evaluated the effect of orally administered cyclopamine on UVB-induced BCCs development in
ptch+/± mice. Mice were irradiated with UVB (240 mJ per cm2 three times a week) for 35 weeks
at which time 50% of the animals had one or more BCCs. At this time point, UVB irradiation was
stopped and the mice were divided into two groups of 30 animals each group having
approximately equal numbers of tumors. Group-1 mice received vehicle whereas group-2 mice
received 0.1 mg percentage cyclopamine (as cyclodextran complex) in drinking water and the
number of tumors recorded weekly. Mice treated with cyclopamine developed 35% fewer tumors
compared to vehicle-treated controls by week 45. In these mice we also assessed the effect of
cyclopamine treatment on the induction of cell cycle regulatory proteins. UVB-irradiated
nontumor bearing skin of these mice manifested high expression of cyclins D1, A2 and B1;
however, in the cyclopamine-treated group there was substantial reduction in the expression of
these proteins. These results indicate that inhibitors of shh signaling block UVB-induced BCCs
development in ptch+/± heterozygous knockout mice and suggest that this could provide a novel
target for cancer chemoprevention.
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Topical Tacrolimus Accelerates Tumor Formation and Carcinogenesis in Mouse Skin
Y. Niwa, T. Terashima,* and H. Sumi²
Niwa Institute for Immunology, Tosashimizu, Japan; *Department of Dermatology, Osaka City University
Medical School, Osaka, Japan; ²Department of Internal Medicine, National Cancer Center Hospital East,
Kashiwa, Japan
Tacrolimus is a potent, fungus macrolide immunosuppressant, widely used for liver and kidney
transplantation. Recently, topical tacrolimus has been found to be effective treatment for atopic
dermatitis (AD) because of the well known effect of T cell immunosuppression. Since 7% of
patients undergoing systemic administration of tacrolimus for liver transplantation subsequently
developed malignancy (Transplantation, 66, 1193, 1998), we investigated the effect of topical
tacrolimus on skin carcinogenesis in one hundred and four mice. The dorsal skin of 7 w old female
CD±1 mice was treated with the tumor initiator of 7, 12-dimethylbenz [a] anthracene (DMBA) at a
dose of 0.2 mmol or acetone alone on day 1 of the experiment, followed by promoting treatment
with 5 mg of 12-O-tetradecanoylphorbol-13-acetate (TPA), with or without 5 nmoles of
tacrolimus, or neutral vehicle (control), twice a week for 20 weeks. Result revealed that after
14 week, there was marked synergy between tacrolimus and the DMBA/TPA regimen, with
0.47 6 0.13 new tumors per mouse per week in the tacrolimus/DMBA/TPA group vs.
0.10 6 0.025 in the DMBA/TPA group (p < 0.01). 8.0% of the tumors were squamous cell
carcinomas and others were papillomas. In mice treated with DMBA plus tacrolimus alone without
TPA, two carcinomas and two papillomas out of 26 mice were found. This dramatic synergy
between topical tacrolimus and conventional carcinogens raises the spectre of a signi®cant risk of
skin carcinogenesis in patients with AD undergoing prolonged treatment with tacrolimus.
Although it has been reported that cyclosporin A (CyA) or tacrolimus does not interfere with NK
cells, patients with a low CD4/CD8 ratio were still reported during systemic administration of
CyA, an immunosuppressant similar to tacrolimus (Cancer, 80, 1141, 1997). In this connection, it
is not unlikely that tacrolimus potently suppresses NK cells. Great caution and restraint in
prescribing this regimen seem advised, as does careful surveillance of skin lesions in patients treated
with tacrolimus for prolonged periods.
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Evidence for Effects of Melanocortin 1 Receptor Variants on Melanoma Cell Behaviour
S. Robinson and E. Healy
University of Southampton, UK
The melanocortin 1 receptor (MC1R) is a seven transmembrane G-protein coupled receptor
which is expressed by melanocytes and melanoma cells. MC1R variants are causally associated with
red hair and fair skin, and increase susceptibility to melanoma and nonmelanoma skin cancer. The
increased risk of skin cancer could be secondary to MC1R variant-induced alterations in skin
pigmentation. However, the results of case control studies, where skin type and hair colour have
been included in the analysis, have suggested that some of this higher risk may arise via effects on
pathways unrelated to pigmentation. In this study, we investigated the nonpigmentary effects of
MC1R variants on melanoma cell behaviour using Mc1r-null B16G4F cells stably transfected with
wild type and variant (Arg151Cys, Arg160Trp and Asp294His) human MC1R. The transfected
lines are amelanotic, and allow for alterations in cell behaviour to be examined independently of
the effects of MC1R variants on pigmentation. In growth inhibition studies, 10-9±10-6 M aMSH
caused a signi®cant reduction in proliferation of wild type transfected B16G4F cells (n = 4 lines, p
< 0.001), but did not suppress growth of any of the variant MC1R transfectants (n = 5 lines).
Adhesion to ®bronectin by the wild type MC1R transfectants was signi®cantly decreased by 10-9±
10-6 M aMSH in each of the four separate lines (p < 0.001), but no alterations in binding to
®bronectin were detected in the variant MC1R transfectants. These results show that human
MC1R variants affect melanoma cell behaviour In vitro, raising the possibility that MC1R variants
alter melanoma susceptibility and/or progression through effects on these pathways.
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Ptch+/± Heterozygous Knockout Mice Over-Expressing Ornithine Decarboxylase:
Possible Model for Multiple Basal Cell Carcinomas (BCCs) in Gorlin's Syndrome
D. R. Bickers, X. Tang, J. Russo, H. Zhang, M. Aszterbaum,* A. Kim, L. Kopelovich, E. H.
Epstein Jr,* and M. Athar
Columbia University, New York, USA; *University of California, San Francisco, San Francisco, USA
Multiple BCCs are a major feature in patients with Gorlin's Syndrome or the Nevoid Basal Cell
Carcinoma Syndrome (NBCCS). Based upon discoveries in NBCCS, mutations in sonic
hedgehog (shh) signaling genes including patched (ptch) are known to underlie BCCs
development. ptch+/± knockout mice develop BCCs and trichoblastomas after chronic exposure
to solar ultraviolet B (UVB) radiation. Because UVB is a potent inducer of cutaneous ornithine
decarboxylase (ODC) activity, which drives the continued proliferation and clonal expansion of
initiated cells leading to tumor development, we reasoned that over-expressing ODC in ptch+/±
heterozygous mice might provide a model of enhanced BCCs development. We have generated
ptch+/± mice over-expressing the ODC transgene, hereafter referred to as ptch+/±/ODC TgN.
Untreated skin at the age of seven months appeared grossly normal; however, histologic
examination showed small basaloid lesions. Immunohistochemical studies of these tumor-like
growths showed positive staining for b-galactosidase (b-gal), gli-1 and shh. Neither the wild-type
nor their ptch+/± littermates manifest such lesions or positive staining for b-gal. Our parent ptch+/±
are heterozygous for deletion of exon 1 and 2 and insertion of lacZ and neo genes. BCCs in
ptch+/±/ODC TgN mice lead to de-repressed transcription of the lacZ gene inserted in the
inactivated ptch locus. b-gal staining demonstrates activation of shh signaling in skin/BCCs-like
lesions in ptch+/±/ODC TgN mice. Chronic UVB irradiation (180mJ per cm2 twice a week) for
10 weeks resulted in multiple small visible tumors, which increased both in number and size after
another 20 weeks of irradiation. Tumor incidence was 100% by week 20. Histologically, these
lesions resemble human BCCs and trichoblastomas and show strong positive staining for b-gal, gli-
1 and shh. Our data show that b-gal positive staining lesions also stain for gli-1/shh. These results
indicate that ptch+/±/ODC TgN mice may be a model for multiple BCCs in patients with
NBCCS.
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Successive Roles of UVB in Skin Carcinogenesis: p53 Mutations, Colonization, and
Breaking the Stem Cell Barrier
N. Wikonkal, W. Zhang,* E. Remenyik,² D. Zelterman,* and D. Brash*
Semmelweis University School of Medicine, Department of Dermatology, Budapest, Hungary; *Yale
University, New Haven, USA; ²University Medical School of Debrecen, Debrecen, Hungary
Upon acquiring a mutation, a single cell must expand into a clone before becoming signi®cant for
carcinogenesis. Forces driving clonal expansion, and the obstacles that must be overcome, are
poorly understood. In a genetic mechanism, acquiring a second mutation conferring a proliferative
advantage would enable the cell to expand autonomously. If carcinogen exposure instead induced a
physiological change, clonal expansion would require the carcinogen's continued presence. To
address this question, we studied microscopic p53 immunopositive clones of keratinocytes in
epidermal sheets of mouse skin. To control the carcinogen exposure, we irradiated mice with UVB
for various times and observed the expansion of p53-mutated cells into clones in mouse epidermis.
p53-mutant clones only grew during chronic UVB exposure and regressed after the cessation of
UVB. Therefore, clonal expansion was not triggered by a proliferative mutation, but was instead
continually driven by UVB. Unexpectedly, the clone size distribution showed periodicity with
maxima at estimated intervals of 16 6 6 cells, the size of the epidermal proliferating unit in murine
dorsal skin. In the absence of UVB, rare ``imprisoned clones'' increased in cell number without
increasing in area. We conclude that UV acts on three levels of carcinogenesis: (1) by causing p53
mutations (2) driving clonal expansion of such p53-mutated cells and (3) allowing mutated cells to
break into an adjacent stem cell compartment, a physical barrier to clonal expansion. Colonizing
adjacent stem cell compartments is the rate-limiting step in clonal expansion; sustained UVB
enables the p53-mutant keratinocyte to colonize without incurring an additional mutation.
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A Novel Connexin26 Mutation in a Patient Diagnosed with Keratitis±Ichthyosis±
Deafness Syndrome
M. A. M. Van Steensel, M. Van Geel, M. Nahuys, J. H. Sillevis Smitt, and P. M. Steijlen
University Medical Center Nijmegen, Nijmegen, the Netherlands
Keratitis-ichthyosis-deafness (KID) syndrome is a rare disorder characterized by erythrokerato-
derma, deafness and keratitis. Scarring alopecia and squamous cell carcinoma can also occur. Most
cases described so far were sporadic. We present evidence that KID syndrome can be caused by a
novel mutation in the connexin26 (CX26) gene. This ®nding expands the spectrum of disorders
caused by defects in connexin26 and implies the gene in normal corneal function, hair growth and
carcinogenesis. We ascertained a patient suffering from KID syndrome. She is the only affected
person in the family. She suffers from severe, extensive spiky erythrokeratoderma, bilateral sensory
deafness and a vascularizing keratitis. She also had a squamous cell carcinoma removed at age 38.
Small, misshapen teeth and hypotrichosis were also part of the phenotype. In CX26 the patient had
a heterozygous GAC to AAC change in codon 50. This changes a conserved aspartic acid into an
asparagine in the ®rst extracellular domain (D50N). Because the G to A change abolishes an AspI
restriction site, we examined controls and the family by restriction analysis. The mutation was not
present in 164 control alleles and could not be demonstrated in the mother and four sibs either.
The D50N change is expected to in¯uence local protein structure and probably affects voltage
gating and channel assembly. There is some evidence that suggests there exists an interaction
between connexin26 and the cytoskeleton. If present, this interaction may explain why only KID
syndrome is associated with squamous cell carcinoma whereas other disorders caused by mutations
in the connexin26 gene are not. Our ®ndings are the ®rst to establish connexin26 as a possible
tumor suppressor gene in humans. Connexins were known to have this function in animals but not
in humans. Further studies are needed to examine how connexin26 is tied into growth regulation
and cell differentiation.
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Genome-Wide CpG Island Methylation and Promotor Methylation Analyses in
Malignant Tumors of the Skin
H. Fujiwara and M. Ito
Department of Dermatology, Niigata University School of Medicine, Niigata, Japan
Epigenetic regulation of gene expression may play an important role in carcinogenesis of the skin.
Genome DNA methylation is one of the most important mechanisms in epigenetic regulation.
With the help of newly developped method, nonisotopic cytosine extension assay (in press) we
analyzed CpG island-speci®c and non-CpG island-speci®c global genome methylation in various
malignant tumors of the skin. In malignant melanoma, non-CpG island hypomethylation was
observed, but CpG island methylation was not affected. Bisul®te treatment of the genome and
following PCR and/or direct sequence revealed lack of p16 gene promotor methylation. The
alteration of genome DNA methylation may be associated with the development of malignant
melanoma. Its detailed mechanism is remained to be elucidated.
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Expression of Tight Junction-Associated Proteins (Occludin, ZO-1, Claudin-1,
Claudin-4) in Squamous Cell Carcinoma and Bowen's Disease
K. Morita, S. Tsukita,* and Y. Miyachi
Department of Dermatology and *Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto,
Japan
The epidermis, which is a typical strati®ed epithelia, has tight junctions (TJs) in the granular layer,
as simple epithelia do. So far, abnormalities of TJs in tumors of simple epithelia have been reported.
Thus, expressions of TJ-associated proteins (occludin, ZO-1, claudin-1 and claudin-4) were
examined in normal human epidermis, ®ve cases of squamous cell carcinoma and Bowen's disease,
by immuno¯uorescence staining. In normal epidermis, occludin, ZO-1 and claudin-4 were
expressed in the granular layer speci®cally or dominantly, whereas claudin-1 was expressed in the
whole layers. In squamous cell carcinoma, occludin, ZO-1, claudin-1 and claudin-4 were
expressed in keratinizing tumor cells such as cancer pearls. In tumor cells with poor differentiation,
expression of occludin, ZO-1 and claudin-4 were decreased or absent in expression. On the other
hands, expression of claudin-1 was increased in some, but decreased in other population of tumor
cells with poor differentiation. In Bowen's disease, occludin, ZO-1, claudin-1 and claudin-4 were
expressed in keratinizing cells. These ®ndings showed that expression of these molecules are
associated with keratinization in malignancy of keratinocytes, as well as normal epidermis, and that
altered expression of claudin-1 in tumor cells with poor differentiation may be related with
carcinogenesis of keratinocytes.
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Expression of Collagen XVII is Altered in Oral Precancers and Squamous Cell
Carcinomas
M. Parikka,* T. Kainulainen,* K. Tasanen,² A. VaÈaÈnaÈnen,* L. Bruckner-Tuderman,§ and T.
Salo*³
*Departments of Diagnostic and Oral Medicine, ²Dermatology and ³Pathology, University of Oulu, and
Oulu University Hospital, Oulu, Finland; §Department of Dermatology, University of MuÈnster, Germany
Collagen XVII (BP180) is a hemidesmosomal transmembrane component that may participate in
signal transduction and keratinocyte motility, in addition to its role in keratinocyte adhesion to the
basement membrane. In squamous cell carcinomas (SCCs), an up-regulated expression of several
hemidesmosome components is observed. In this study, distribution of collagen XVII in oral
precancers and SCCs was examined with immunohistochemical and in situ hybridization methods.
Interestingly, collagen XVII was found to be down-regulated in the basal cells of oral dysplasias,
whereas in the suprabasal cells of moderate and severe dysplasias collagen XVII expression was up-
regulated, as well as in the central tumor cells of grade II and III carcinomas. Collagen XVII could
be extracted In vitro from oral keratinocytes and tongue SCC cells, as well as from tongue SCC
tissue, and an increased collagen XVII expression level was revealed in the malignant cell lines by
immunoblotting. The effect of cytokines TGF-b1, TNF-a, EGF, IL-1 b, IL-6 and PMA in
regulation of collagen XVII gene expression was studied in oral keratinocytes. Ribonuclease
protection assay (RPA) showed a signi®cant induction in collagen XVII mRNA synthesis only by
PMA (phorbol myristate acetate). These results indicate that collagen XVII expression is abnormal
in oral dysplasias and SCCs. The reduced expression in the basal cells of dysplastic mucosa is likely
to re¯ect the disturbed adhesion to the underlying extracellular matrix. Collagen XVII up-
regulation in suprabasal cells of dysplastic mucosa and in central carcinoma cells in the absence of
hemidesmosome formation may re¯ect alternative function of collagen XVII besides its role in cell
adhesion.
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Genetic Aberrations Addressed by Comparative Genomic Hybridization (CGH) in
Keratoacanthomas (KAs); a Benign Lesion with Malignant Phenotype
O. Clausen, M. Beigi, L. Bolund, S. Kùlvraa, P. J. Gjersvik, G. Mùrk, and P. M. DeAngelis
University of Oslo, Oslo, Norway; University of Aarhus, Aarhus, Denmark
KAs are commonly occurring benign skin lesions localized to sun-exposed areas; there is an
increased incidence of KAs among immunosuppressed patients. They typically develop rapidly and
may show cellular atypia and in®ltration like squamous cell carcinomas (SCC), but ®nally regress
spontaneously. We have shown that KAs have a high degree of genetic instability as assessed by
CGH, with 35.7% (25/70) of the lesions harbouring chromosomal abberrations. The same
frequencies were found among immunosuppressed organ transplant recipients (36.4%, 20/55) and
patients without immunosuppression (33.3%, 5/15), indicating a common pathogenetic pathway
in both situations. A higher frequency were found in SCCs, where 70% (7/10) of lesions showed
genetic aberrations. Recurrent aberrations, given as a fraction of lesions with aberrations, were
gains on 8q (20.0%), 1p and 9q (each 16.0%), and deletions on 3p (20.0%), 9p (20.0%), 19p
(20,0%) and 19q (16.0%). The total number of losses and gains were about the same (i.e. 47 vs. 52,
respectively). Many of the most frequently occurring aberrations in KAs were not detected in any
of the SCCs, whereas some aberrations were shared by both types of lesions. Aberrations were
found in early as well as in late stage of tumor development, indicating a role for genetic instability
in the progression as well as in involution of KAs. Aberrations were found among KAs without as
well as with atypia and in®ltrative growth, and there were no signi®cant correlations between the
degree of in®ltration or atypia, respectively, and genetic aberrations, although there was a tendency
for lesions with atypia to have aberrations. Thus, malignant phenotypic development does not
appear to be driven by the detected genetic aberrations, that seems to be associated with the
biological behaviour of KAs in general. More detailed studies of chromosomal areas with recurrent
aberrations are needed for localization of putative genes that determine the biology of KAs, and
that may distinguish them from SCCs.
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The Equilibrium Between Apoptosis Inhibiting and Promoting Genes in Cutaneous T
Cell Lymphoma (CTCL)
U. DoÈbbeling, C. Zhang, J. Kamarashev, R. Dummer, and G. Burg
Department of Dermatology, University Hospital Zurich, Switzerland
Since cutaneous T cell lymphoma lesions show only little mitotises, it is hypothesized that the
increase of tumor mass is mainly due to the enhanced survival of malignant T cells. The survival of
a cell depends on the equilibrium between apoptosis inhibitors and promoters. Here we investigate
the expression of the apoptosis inhibitors bcl-xL and mcl-1 on the one side and the apoptosis
promoters bcl-xs, bad and bax on the other side. The expression of apoptosis regulating proteins in
CTCL cell lines was investigated by Western blotting. The expression and localization of apoptosis
regulating proteins was determined by immunohistochemical stainings with antibodies directed
against the proteins bcl-x, mcl-1, bad and bax. Inactivation of Bad by phosphorylation was studied
by a phosphorylation-speci®c antibody. The function of bax was tested by the addition of the
anticancer drug sulindac, which promotes cell death by bax induction. The Western blot
experiments with CTCL cell lines show, that bcl-xL, mcl-1, bad and bax are present, but that the
expression of the apoptosis promoter bcl-x is missing. Bad was partially inactivated by
phosphorylation. Bax was also ineffective, as sulindac could not induce apoptosis in CTCL cell
lines. The genes bcl-x, mcl-1, bad, and bax were also expressed in all tested CTCL skin lesions. In
two patients we found a signi®cant increase of mcl-1 expression in skin lesions during disease
progression. Increased expression of Mcl-1 and synthesis of nonfunctional Bax and Bad disturb the
equilibrium between apotosis promotors and inhibitors and may be responsible for enhanced
survival and resistance of CTCL cells against sulindac.
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Agonists of Peroxisome Proliferator-Activated Receptor (PPAR) g Inhibit Cell Growth
in Malignant Melanoma
R. MoÈssner, U. Schulz, U. KruÈger, P. Middel,* S. Schinner,² L. FuÈzesi,* C. Neumann, and K.
Reich
Departments of Dermatology, *Pathology, and ²Molecular Pharmacology, Georg-August ± University
GoÈttingen, Germany
Peroxisome proliferator-activated receptor (PPAR) g is a member of the nuclear receptor
superfamily involved in adipocyte differentiation and glucose homeostasis. There is evidence that
PPARg may also act as a tumor suppressor. Here, we demonstrate expression of PPARg in benign
melanocytic naevi, different variants of primary cutaneous melanomas and melanoma metastases.
PPARg protein and PPARg1 mRNA were also detected in human melanoma cell lines. The
PPARg-speci®c agonists 15-deoxy-D12,14-prostaglandin J2, troglitazone, and rosiglitazone dose-
dependently inhibited cell proliferation in four melanoma cell lines, while speci®c agonists of
PPARa had no such effect. At a concentration of 50 mM rosiglitazone, the most potent PPARg
agonist tested, suppressed cell growth by approximately 90%. Apoptosis could be induced in
melanoma cell lines by incubation with tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL). In contrast, the growth inhibitory effect of PPARg activation was independent of
apoptosis and seemed to occur primarily through induction of cell-cycle arrest. Our data indicate
that melanoma cell growth may be modulated through PPARg.
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Spectral Karyotyping Demonstrates Genetically Unstable Skin-Homing T Lymphocytes
in Cutaneous T Cell Lymphoma
H. Padilla-Nash, K. Wu, H. Just, T. Ried, and K. Thestrup-Pedersen
Bethesda, USA, and Aarhus, Denmark
We established cell lines from skin biopsies from four patients (MF8, MF18, MF19, and MF31) in
an early stage of cutaneous T cell lymphoma using growth medium containing IL-2 and IL-4. After
3 weeks of culture an outgrowth of the skin-homing T lymphocytes was obtained. Lymphocytes
were analyzed using the molecular cytogenetic technique, spectral karyotyping (SKY) in order to
detect hidden rearrangements. Two patients (MF18 and MF19) had normal karyotypes. Multiple
nonclonal numerical aberrations were seen in MF8 and MF31. MF8 had two different T
lymphocyte clones, one with trisomy of chromosome 21(12/20 cells), a second revealing loss of
chromosome 22 (3/20 cells). This patient also had a clonal deletion, del(5)(p15.1), as well as several
nonclonal aberrations. MF31 had a clonal deletion, del(17)(p12), and other nonclonal deletions
involving chromosomes 2, 5, 10, 11, and two chromosomal rearrangements. MF18 was the only
patient with two nonclonal balanced translocations (t(1;2)(q32;p21) and t(4; 10)(p15.2; q24). After
two years, three of the patients had new skin biopsies taken from skin lesions from the same
previous sites and new cell lines were established. SKY analysis revealed the presence of a T cell
clone in MF8, with 4/20 cells containing trisomy 21; additionally a new clone (17/20 cells) was
seen, with the del(18)(p11.2). MF31 had only one aberrant cell with del(17)(p12), all other cells
were normal. MF18 revealed clonal deletions (ex. del(1)(p36.1) in 3/20 cells) and nonclonal
deletions (chromosomes 4, 12, 17, and 18), and rearrangements involving chromosomes 3, 5, 6,
12, and 13. Thus, three of four patients had recurrent clonal and nonclonal deletions and structural
aberrations, with one patient two years later, still exhibiting the same T lymphocytes clone
(47,XX, + 21). Our ®ndings demonstrate a very high degree of genetic instability among skin-
homing T lymphocytes in patients with cutaneous T cell lymphoma, in early stages of the disease
and thus con®rms previous observations of cytogenetic analysis of blood lymphocytes of CTCL
patients with advanced disease.
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Functional Characterization of Neurotensin Receptors in Human Cutaneous T Cell
Lymphoma Malignant Lymphocytes
E. Poszepczynska, M. Bagot, C. Pruvost, L. Boumsell, J.-M. Culouscou,* M. Magazin,* D.
Caput,* P. Ferrara,* and A. Bensussan
INSERM U448. FaculteÂ de MeÂdecine de CreÂteil, Service de Dermatologie, HoÃpital Henri Mondor, 94010
CreÂteil Cedex, *Sano®-SyntheÂlabo Recherche, 31676 LabeÁge Cedex, France
Cutaneous T-cell lymphomas (CTCL) are a clonal proliferation of CD4+ T lymphocytes primarily
involving the skin. Mycosis fungoides is an epidermotropic CD4 + CTCL, and a more aggressive
form Sezary syndrome occurs when the malignant cells become nonepidermotropic. The role of
neuropeptides on the growth and chemotaxis capacity of CTCL cells remains unknown. Here we
report that CTCL cells, similarly to normal resting T lymphocytes, expressed neurotensin
transcripts. We used an IL-2-dependent CTCL malignant T cell line derived from CTCL lesions
in order to study the role of neurotensin on the proliferation and the migration of these malignant
cells. First, we determined that these malignant cells expressed neurotensin receptor-1 (NT-1) but
not neurotensin receptor-2 (NT-2) on their cell membrane. Functional results indicated that
neurotensin did not stimulate the growth of the cell line. However, we found that it enhanced the
spontaneous migration of the malignant cells as ef®ciently as other chemokines such fractalkine and
stroma cell-derived factor-1 (SDF1). We demonstrated that in CTCL, the NT1 receptor is
responsible for NT-induced migration and that its engagement induces redistribution of the
cytoplasmic tyrosine kinases focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK-
2). This results suggests that neurotensin in skin can play a role in the disease by stimulating their
chemotaxis capacity.
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Fine Mapping of 10q Deletions in Mycosis Fungoides
E. M. Wain, T. J. Mitchell, J. J. Scarisbrick, R. Russell-Jones, and S. J. Whittaker
London, UK
Primary cutaneous T-cell lymphoma (CTCL) represents a heterogeneous group of extranodal
non-Hodgkins' lymphomas of which mycosis fungoides is the most common. The pathogenesis of
CTCL is poorly understood. Cytogenetic G-banding, ¯uorescence in situ hybridisation (FISH) and
comparative genomic hybridisation (CGH) studies have all identi®ed chromosomal abnormalities
at 10q in mycosis fungoides/Sezary syndrome. Previous loss of heterozygosity (LOH) studies
performed in our department using 8 microsatellite markers have shown two minimal areas of
deletion at 10q23.3 and 10q24. Allelic loss was demonstrated in 10/44 patients (23%). This study
®ne maps the area of deletion on chromosome 10q using 20 microsatellite markers in the region
10q23.2±10q25.2. DNA extracted from patients' skin biopsies (45) and matched unaffected
peripheral blood mononuclear cells (controls) was analysed for LOH at each of the microsatellite
markers. Loss of heterozygosity is representative of an area of chromosomal loss in the tumour
DNA compared with the normal control DNA from the same patient. In this study allelic loss was
found in 15/45 samples (33%). Of these 15 patients: 1 had stage Ia disease, 1 had Ib disease, 12 had
IIb disease and 1 had IVb disease. The frequency of allelic loss has increased from 23% to 33% using
this extended panel of microsatellite markers between 10q23.2 and 10q25.2. The pattern of LOH
con®rms our previous ®ndings of 2 minimal regions of deletion and further characterises these
regions to lie at 10q23.3 (D10S185) and 10q24.2 (D10S221). This extensive allelotyping data
serves to identify two common regions of deletion in mycosis fungoides which are potential sites of
putative tumour suppressor genes involved in the pathogenesis of mycosis fungoides. These results
also provide the basis for future candidate gene analysis within these 2 minimal regions of deletion.
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Chromosome 12q Breakpoint Associates with Cutaneous T-Cell Lymphoma
L. Karenko, R. Karhu, M. KaÈhkoÈnen, S. KytoÈ laÈ, B. Nedoszytko, M. Pesonen, J. Roszkiewicz, T.
Visakorpi, and A. Ranki
Helsinki and Tampere, Finland and Gdansk, Poland
Patients with cutaneous T-cell lymphoma (CTCL) show a large variety of chromosomal
aberrations with no previously known common or speci®c aberration. Our aim was to seek the
most common aberrations using in situ hybridization methods, that allow the identi®cation of
chromosomes taking part in translocations, and to further characterize them with locus-speci®c in
situ hybridizations. Blood lymphocytes of seven consecutive patients with SeÂzary syndrome (SS)
and four patients with mycosis fungoides (MF, stages IA to IIB) were cultured with standard
methods and studied with 24-colour in situ hybridization (multicolour FISH, MFISH or spectral
karyotyping, SKY). Chromosomal breakpoints of clonal cells were further de®ned with G-
banding. The most common cytogenetic breakpoint was studied with 14 YAC-probes (CEPH,
Jean Dausset, France) of a contig located in two main bands, with additional YACs depending on
the translocation, and further de®ned with BACs (Research Genetics). Five SS-patients had clonal
chromosome 12q aberrations, four of them with breakpoint in q21 or q22. The ®fth aberration
involved a short segment of 12q. Four MF patients showed clonal or nonclonal breakpoints in 12q,
three of them in q21 or q22. The breakpoint in two SS-patients was speci®ed with YAC-and
BAC-probes to one band. Thus, de®ned break points are common in all stages of CTCL, and
identi®cation of candidate genes is in progress.
234
Melanocortin 1 Receptor Gene Variants are Associated with an Increased Risk for
Cutaneous Sporadic Melanoma in an Italian Population
M. C. Fargnoli, E. Altobelli, G. Keller, A. Ferrari, S. Chimenti, H. HoÈ¯er, and K. Peris
L'Aquila and Rome, Italy, and Munich, Germany
Melanocortin 1 receptor (MC1R) gene variants have been associated with phenotypical features
such as fair skin and red hair as well as sun sensitivity which are known risk factors for melanoma.
Recently, speci®c MC1R allelic variants have been also associated with an increased risk for the
development of both familial and sporadic melanoma in Northern European and Australian
populations. We investigated the relationship of MC1R allelic variants, phenotypic features and
occurrence of sporadic melanoma in an Italian population, who has a darker skin type than the
populations examined to date. A standardized personal interview, a total skin examination and
molecular analysis of the entire coding sequence of the MC1R gene by DNA sequence analysis
were performed in 100 patients with sporadic melanoma and 100 control subjects. Conditional
logistic regression models were used to evaluate the association between allelic variants of the
MC1R gene and risk of cutaneous sporadic melanoma. The odds ratio with a 95% con®dence
interval was used as association measure. Unreported MC1R allelic variants in addition to
previously described variants have been detected in our study population. Analysis of all different
MC1R gene variants combined showed that the presence of MC1R variants accounted for a
higher melanoma risk which seemed independent of skin type and hair color and that the
Val60Leu variant conferred the highest melanoma risk in our population.
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Genetic Alterations in Patients with Multiple Melanomas
K. Peris, M. C. Fargnoli, A. Paci®co, T. Surrenti, W. Stolz, H. P. Soyer, and S. Chimenti
l'Aquila, Italy; Tor Vergata, Italy; Regensburg, Germany; Graz, Austria
Germline mutations of the CDKN2A gene play a crucial role in the pathogenesis of familial
melanoma: Although the occurrence of multiple primary melanomas may have a genetic
background, the presence of a genetic predisposition in patients with multiple primary melanomas
(MPM) in the absence of a family history has not yet been investigated in detail. Recent studies
have demonstrated that allelic variants of the MC1R gene may increase the penetrance in patients
with CDKN2A mutations. In order to identify a genetic susceptibility to the development of
MPM, we analyzed the CDKN2A gene for germline and somatic mutations as well as MC1R gene
for germline mutations in 14 patients with 2 or more primary melanomas and no evidence of a
family history of the disease. Polymerase Chain Reaction and direct DNA sequencing were used to
screen the CDKN2A and MC1R genes for germline mutations. Loss of heterozygosity (LOH) and
microsatellite instability analysis at different loci on 9p21 (D9S974, D9S126, D9S171) were
performed in a total of 30 tumor specimens of all MPM patients. Mutational analysis of genomic
DNA showed germline mutations in exon 2 of the CDKN2A in 3 of 14 MPM patients and the
presence of allelic variants of MC1R gene in 11 of 14 MPM patients. LOH at different
microsatellite loci has been detected in 1 of 3 patients in 2 of 7 melanoma tissues con®rming a
double somatic mutation of the CDKN2A gene in 1 of 14 MPM patients. Based on our results,
germline mutations of the CDKN2A gene associated with the presence of allelic variants of MC1R
gene in patients with MPM but no family history, is highly suggestive of a genetic predisposition to
the development of multiple melanomas. In addition, our data support the pathogenetic role of bi-
allelic inactivation of the CDKN2A gene in melanoma development.
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Different Patterns of Chromosomal Aberrations in the Subtypes of Primary Cutaneous
B-Cell lymphoma
C. Hallermann, K. Kaune, R. Siebert, B. Gunawan, M. Vermeer, R. Willemze, and C. Neumann
GoÈttingen and Kiel, Germany. Leiden, Netherlands
Introduction: Primary cutaneous B-cell lymphomas (PCBL) are a heterogeneous group of B-cell
lymphomas primary manifesting in skin. They differ from their extracutaneous counterparts by a
different clinical behavior and a different immunophenotype. In primary systemic B-cell
neoplasms, the detection of recurrent chromosomal aberrations has contributed to lymphoma
classi®cation and has provided insights into the molecular mechanisms underlying lymphomagen-
esis. Surprisingly so far, with the exception of controversial PCR-based studies on the translocation
t(14;18), there exist hardly any data on cytogenetic aberrations in PCBL. Methods: A collection of
different subtypes of primary cutaneous B-cell lymphomas was analysed by comparative genomic
hybridization (CGH) (n=23) and by ¯uorescence in-situ hybridization (FISH) (n=27). FISH
probes ¯anking the IGH, MLT, BCL6 and MYC gene loci were used. In case of breakpoints in
these loci the translocation partners have been identi®ed by translocation speci®c probes. Results:
In 16/23 PCBL numerical aberrations have been detected by CGH. The more aggressive subtype
of PCBL, the large B-cell lymphoma of the leg (LBCLL) shows more aberrations per case than the
primary cutaneous follicle center cell lymphoma (PCFCCL). Gains in 18q and losses in 6q seem to
be more frequent in LBCLL(8/13; 4/13) than in FCCL (1/10; 0/10). By FISH no translocations of
the loci under study were detected in primary cutaneous marginal zone lymphomas (PCMZL) and
in PCFCCL, but in 11/14 (79%) of LBCLL. Most frequently, the breakpoints affected the IGH,
MYC or the BCL6 locus. The most frequent translocation was t(8;14)(q24;q32) in 5/14 LBCLL.
In further 5 cases there was a translocation involving the bcl-6 locus on 3q27, with translocation to
the IgH locus (t(3;14)) in two cases and with translocation to the Ig-l locus (t(3;22)) in one case. A
translocation t(14;18) was not detected in any of the PCBL studied. Conclusion: There are strong
cytogenetic differences between the subtypes of PCBL. Translocations with breakpoints in loci
commonly involved in systemic B-cell lymphomas were detectable in 79% of LBCLL, but in none
of the PCBL. LBCLL also shows more numerical aberrations, re¯ecting its more aggressive clinical
behavior. In contrast to nodal B-cell lymphomas the translocation t(14;18) is of no signi®cance in
PCBL.
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Tumor±Stroma Interactions in Malignant Melanoma ± Characterisation of a Novel
cDNA
U. Anderegg, K. Breitschwerdt, U.-F. Haustein, and A. Saalbach
University of Leipzig and Saxon Academy of Science, Leipzig, Germany
In previous investigations we could demonstrate the activation of ®broblasts by tumour cells from
malignant melanoma In vitro. The ®broblasts become activated by culture supernatants of
melanoma cells, express elevated levels of MMPs and support the tumour cells to invade
collagenous matrices In vitro. Beside the up-regulation of known genes, soluble mediators of
melanoma cells are able to induce a so far unknown cDNA in ®broblasts detected by PCR-Select
(Clontech) technology. Using RACE-PCR we have isolated the complete coding sequence giving
a hypothetical protein of about 40 kDa. The cDNA is only weakly expressed in healthy skin and in
biopsies of nonmalignant nevi detected by in situ hybridisation (ISH). The cDNA is strongly
expressed in most of the melanomas (n = 15) investigated. However, there are different results on
the expressing cells in situ: We have found melanomas with preferential expression by cells located
in HMB45-positive regions suggesting that in contrast to In vitro data the melanoma cells
themselves express this gene. In contrast, we have got also data on melanomas where the cDNA is
expressed in regions staining for mAb AS02 (®broblasts and activated endothelial cells) suggesting
an activation of stromal cells known from In vitro experiments. The evaluation of clinical and ISH
characteristics should give some answers whether differentiation of the tumour plays a role in the
expression of this cDNA. Using In vitro expression studies we investigated the nature of the
inducing agent (cytokine or chemokine?) in the supernatants of melanoma cells that induce the
cDNA in ®broblasts In vitro. Fibroblast cultures have been exposed to various cytokines and
chemokines in serum free medium and the gene expression has been analysed by RealTime RT-
PCR. TGFb1 and IL-1b obviously induce the expression of this mRNA in dermal ®broblasts In
vitro. Investigations with blocking antibodies should show the signi®cance of our results.
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Characterisation of the Cylindroma Tumour Suppressor Gene
A. Regamey, J. W. Liu, R. Toftgard,* A. B. Unden,* P. Itin,² D. Hohl, and M. Huber
Dermatology, CHUV, Lausanne, CH; *Karolinska, Huddinge, SE; ²Kantonsspital, Aarau, Switzerland
In this project, we investigate the molecular cause of adnexal skin tumour formation, in particular
cylindroma and trichoepithelioma. In a large Swiss family affected with the Brooke±Spiegler
syndrome (presence of cylindroma and trichoepithelioma), linkage analysis showed association to
chromosome 16q21. Loss of heterozygosity analysis demonstrated that the same region was deleted
in about 70% of the cylindroma tumour tissues arguing for the implication of this region in tumour
formation. Mutational analysis in genes localized to the candidate interval revealed mutations in a
single gene, named the cylindromatosis (CYLD) gene, in both familial and sporadic
cylindromatosis cases. All mutations observed so far are either base substitution leading directly,
or small deletion leading indirectly, to premature stop codons. Surprisingly, all mutations are
clustered in the C-terminal two-thirds of the protein indicating possibly the presence of N-
terminal domains exerting a dominant-negative effect of the truncated protein. The ubiquitously
expressed CYLD gene encodes a protein of unknown function but contains several domains with
homologies to CAP-Gly sites found in microtubule binding proteins, to the catalytic domain of
deubiquitinating enzymes and to Zn ®nger proteins. Transfection of the full-length and mutant
CYLD cDNA into different mammalian cells, as well as GFP-fusion proteins, demonstrated that
wild-type and mutant proteins are localized to the cytoplasmic compartment.
Coimmunoprecipitation experiments revealed the presence of several CYLD-associated proteins.
Colocalization studies by confocal immuno¯uorescence microscopy, microtubule binding assays
and the N-terminal sequence of the 50-KDa CYLD-associated protein suggest a weak association
between the CYLD protein and b-tubulin. Yeast two-hybrid experiments using HaCat cell cDNA
library as prey and full-length CYLD as bait, identi®ed several CYLD interacting candidate
proteins which are currently characterized further. These preliminary results suggest that CYLD is
associated with microtubules during one part of the cell cycle and that its deubiquitinating activity
could reduce the degradation of proteins suppressing cell proliferation or promoting apoptosis.
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Promoter Hypermethylation of the INK4A-ARF Locus in Skin Carcinomas
S. Queille, O. Thibaudeau, N. Sou®r, I. Leigh,* L. Dubertret, and N. Basset-Seguin
U532 INSERM, Institut de Recherche sur la Peau, HoÃpital Saint-Louis, Paris, France; *ICRF Skin
Tumor Laboratory, Departement of Dermatology, St Bartholomew's and The Royal London School of
Medecine, London, UK
The INK4A-ARF locus encodes two cell cycle-regulatory proteins, p16INK4a and p14ARF, that act
through the Rb-CDK4 and p53 pathways. In our previous work, we have described UV-induced
point mutations in this locus in 19% of squamous cell carcinomas (SCCs) and in 3,5% of basal cell
carcinomas (BCCs). Considering that inactivation of INK4a-ARF locus by promoter
hypermythylation is frequently detected in a large variety of tumors including melanoma and
epithelial cancers, we have analyzed the promoter hypermethylation of the INK4A-ARF locus in
17 SCCs and 16 BCCs already analyzed for the presence of point mutation. Genomic DNA of skin
tumors were treated by bisul®te reagent and ampli®ed by Methylation Speci®c PCR (MSP) of the
p16 and p14 gene promoters followed by direct sequencing of PCR product to verify the
methylation status. We observed hypermethylation of the p16 gene promoter in one out of 17
SCCs (6%) and in none of the BCCs. Surprisingly, we found hypermethylation of the p14 gene
promoter in four out of 17 SCCs (23,5%) and in 6 out of 16 BCCs (37,5%). Comparison of
mutations and hypermethylation in the INK4a-ARF locus showed that only one BCC and one
SCC presented simultaneously alteration and promoter hypermethylation of the p14 gene while
one other SCC had mutation and promoter hypermethylation of the p16 gene. Our data
demonstrate for the ®rst time that the promoter hypermethylation of the INK4A-ARF locus is a
frequent event in skin carcinomas, particularly in the p14 gene promoter. Inactivation of the
INK4a-ARF locus is a frequent event that occurs in 41% of SCCs and 37,5% of BCC, a prevalence
closed to that described for the p53 gene alteration (20% and 37%, respectively, in our tumors).
240
Mechanisms of Inactivation of p16INK4a & p14ARF in Cutaneous Squamous Cell
Carcinoma
V. L. Brown, C. A. Harwood, T. Crook, D. P. Kelsell, and C. M. Proby
London, UK
The CDKN2A locus on human chromosome 9p21 is implicated in the pathogenesis of cutaneous
SCCs, but the precise mechanisms and genes involved have not been de®ned. CDKN2A encodes
two candidate tumour suppressor genes (TSGs), p16INK4a and p14ARF which function as crucial cell
cycle regulators in the Rb and p53 pathways, respectively. In addition to direct mutation, TSGs
can be inactivated by promoter methylation, an epigenetic mechanism of gene silencing. The role
of human papillomavirus (HPV) in the aetiology of cutaneous SCC remains controversial. If HPV
plays a role, there may be genetic differences between HPV positive and HPV negative SCCs at
key genetic loci, such as CDKN2A, where virus-derived proteins could abrogate TSG function by
mechanisms other than mutation. We have investigated changes in p16INK4a and p14ARF in 40
cutaneous SCCs and correlated the results with tumour HPV status. Loss of Heterozygosity (LOH)
studies, mutational analysis (using denaturing high performance liquid chromatography) and
assessment of methylation status (with methylation speci®c PCR) were performed. LOH of 9p21
microsatellite markers was seen in 27% of informative cases. Solitary point mutations in exon 2
were discovered in 4/40 (10%) SCCs. These mutations create different single amino acid
substitutions within p16INK4a alone (n = 1), p14ARF alone (n = 1) and both p16INK4a and p14ARF
(n = 2). Promoter methylation of p16INK4a and p14ARF was detected in 11/28 (39%) and 13/31
(42%) cases, respectively. Three tumours had both a mutation and promoter methylation in the
same gene: one SCC for p16INK4a and two SCCs for p14ARF. In all cases with biallelic events, an
adverse effect on the function of the gene is likely with consequent loss of cell cycle control. There
was no correlation between presence/absence of genetic/epigeneitc events and HPV status. This is
the largest and most comprehensive study of the CDKN2A locus in cutaneous SCCs to date.
Promoter methylation in cutaneous SCCs has never previously been demonstrated. For both
p16INK4a and p14ARF promoter methylation seems to be a more important mechanism of gene
inactivation than direct mutation in cutaneous SCC carcinogenesis.
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The Vitamin D System in Cutaneous Squamous Cell Carcinomas (SCC)
J. Reichrath, L. Ra®, V. Meineke,* T. Mitschele, W. Tilgen, and M. F. Holick²
Department of Dermatology, UniversitaÈtskliniken des Saarlandes, Homburg, Germany; *Institute of
Radiobiology, Federal Armed Forces Medical Academy, Munich; Germany; ²Vitamin D, Skin and Bone
Research Laboratory, Boston University Medical Center, MA, USA
We analyzed key components of the vitamin D system in cutaneous squamous cell carcinomas
(SCC). Intensity of vitamin D receptor (VDR)-immunoreactivity was increased in SCCs as
compared to normal human skin (HS). However, staining did not correlate with histological type
or grading of skin tumors. Comparing VDR-staining with staining for Ki-67, cytokeratin 10,
transglutaminase K and apoptotic cells (terminal UTP nucleotide end labeling assay), no correlation
was found. In SCL-1 and SCL-2 squamous cell carcinoma cells, the majority of tumor cells
revealed VDR-immunoreactivity In vitro. Incubation of SCl-1 and SCL-2 cells with 1,25(OH)2D3
(10±8 M) resulted in a reduction of the number of Ki-67-positive tumor cells, indicating
responsiveness of these cell lines to the antiproliferative effects of 1,25(OH)2D3. Using real time
PCR (LightCycler), we have quanti®ed mRNA expression of vitamin D receptor (VDR) and of
the major enzymes involved in the synthesis and metabolism of 1,25(OH)2D3 (vitamin D-25-
hydroxylase [25-OHase], 25-hydroxyvitamin D±1 a-hydroxylase [1a-OHase], 25-hydroxyvitamin
D-24-hydroxylase [24-OHase]) in SCCs and HS. Expression levels were determined as ratios
between target genes (VDR, 1a-OHase, 25-OHase, 24-OHase) and the reference gene GAPDH.
Interestingly, ratios for VDR/GAPDH, 25-OHase/GAPDH, 1a-OHase/GAPDH and 24-
OHase/GAPDH were signi®cantly (Wilcoxon-Mann±Whitney-test) elevated in SCCs as
compared to HS. Our ®ndings indicate that (i) VDR protein as well as mRNA for VDR, 25-
OHase, 1a-OHase and 24-OHase are increased in SCCs as compared to normal human skin. (ii)
VDR expression in cutaneous SCCs is not exclusively regulated by the proliferative activity or by
the differentiation of these tumor cells, but by additional, unknown mechanisms (iii) alterations in
VDR expression and in the synthesis and metabolism of vitamin D metabolites may be involved in
the growth regulation of SCCs (iv) SCCs may be considered as potential targets for therapy with
new vitamin D analogs that exert little calcemic side-effects or by pharmacological modulation of
1,25(OH)2D3 synthesis/metabolism in these tumor cells.etabolism in these tumor cells.
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L1 Adhesion Molecule in Human Primary Cutaneous Malignant Melanoma, Metastases
of Malignant Melanoma and Acquired Melanocytic Nevi
A. Abu-Dahi, M. Fogel,* S. Mechtersheimer,² T. Georg,³ A. Smirnov,* M. Husar, W. Tilgen, J.
Reichrath, P. Altevogt,² and P. Gutwein²
Department of Dermatology and ³Institut fuÈr Medical Biometrie, Epidemiologie und Informatik, The
Saarland University Hospital, Homburg/Saar, Germany; *Department of Pathology, Kaplan Hospital,
Rehovot, Israel; ²Tumor Immunology Programme, G0100, German Cancer Research Center, Heidelberg,
Germany
There is increasing evidence demonstrating an important function of the L1 adhesion molecule for
tumorigenesis and tumor progression in various malignancies, including ovarian carcinoma. We
have analyzed immunohistochemically L1 expression in paraf®n embedded speciments of acquired
melanocytic nevi (n = 26), primary cutaneous melanomas (n = 24), and cutaneous (n = 15) and
lymph node (n = 9) metastases of malignant melanomas using highly speci®c mAb UJ127.11 upon
antigen retrieval. We found an increase in L1 immunoreactivity in malignant melanomas and
metastases of malignant melanomas as compared to acquired melanocytic nevi that was statistically
signi®cant (p < 0.05). Additionally, a correlation of L1 immunoreactivity with histological data of
prognostic value such as Clark level was found. We have shown previously that CD171 is released
in various cell types from the cell surface in a soluble form (L1-200) into the medium and and that a
32-kDa fragment (L1-32) is retained in the membrane. We have now detected soluble L1-200 by
Western blotting in the conditioned medium of cultivated melanoma cells, with MelJuso giving
the highest release. MelJuso cells also revealed the presence of L1-32. Recent data have shown that
ADAM10 is involved in L1 shedding. ADAM10 was present in the lysate of all melanoma lines in
the proform of 97 kDa. The proform has to be processed by pro-proteinconvertase to generate the
active enzyme. Only MelJuso and col38 cells showed signi®cant amounts of active ADAM10. In
conclusion, our ®ndings demonstrate that L1 is strongly expressed in primary cutaneous malignant
melanoma and soluble L1-200 is released in the conditioned medium of cultivated melanoma cells,
indicating that L1 ag may be of importance for progression and metastatic behaviour of malignant
melanoma.
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Bcl-xL Mediates Chemoresistance in Human Melanoma In Vivo
E. Heere-Ress,*² V. Wacheck,² E. Fuchs,*² C. HoÈller,* K. Wolff,* B. Jansen,*²§ and H.
Pehamberger*³
*Department of Dermatology/Division of General Dermatology, ²Department of Clinical Pharmacology,
³Ludwig Bolzmann Institute for Clinical Experimental Oncology, University of Vienna, Austria; §Prostate
Center, University of British Columbia, Vancouver, Canada
Malignant melanoma is one of the most aggressive human neoplasms and responds poorly to
numerous treatment modalities including chemotherapy. Expression of genes that regulate
apoptotic cell death plays an important role in determining the sensitivity of tumor cells to
chemotherapeutic intervention. Bcl-xL is an antiapoptotic member of the Bcl-2 family and is
universally expressed in human melanoma. It is reasonable to assume that high levels of Bcl-xL are
capable of blocking chemotherapy induced apoptosis thereby mediating chemoresistance. In this
study we investigated the in¯uence of Bcl-xL overexpression in melanoma in a xenotransplantation
SCID mouse model. A transfection system was used to examine the in¯uence of Bcl-xL expression
in melanoma on chemotherapy treatment in vivo. Bcl-xL overexpressing human melanoma tumors
grown in SCID mice were signi®cantly more chemoresistant to cisplatin and dacarbazine
compared to the two controls (vector control, parental cell line). Treatment of Bcl-xL
overexpressing tumors with chemotherapy resulted in a signi®cant decrease of apoptotic cells in
comparison to the control groups. Based on these ®ndings we suggest that Bcl-xL is a
chemoresistance factor in human melanoma and thereby may indirectly contribute to its
chemoresistance and its poor prognosis.
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Analysis of Cutaneous T-Cell Lymphoma by Comparative Genomic Hybridisation
(CGH): Correlation with Clinical Course
T. C. Fischer, S. Gellrich, J. M. Muche, H. Audring, W. Sterry, and H. ToÈnnies
Berlin, Germany
Cutaneous T-Cell lymphomas (CTLC) are a rare group of malignancies with indolent to aggressive
clinical course. Comparative genomic hybridization was used to analyse chromosomal imbalances
(CI) in 31 patients with CTLC (19 patients with indolent forms and 12 patients with aggressive
forms). Indolent forms included Mycosis fungoides and large cell anaplastic CD30+-lymphoma and
aggressive subtypes comprised SeÂzary Syndrome, cytotoxic CD30± lymphoma and additionally
transformed disease subtypes. CI were seen in 23 patients (74%). Loss of chromosomal material was
observed more often than gain (55% vs. 45%). Diminished chromatin (= loss) was localised most
frequently (> 20%) to the chromosomal regions 6q, 10p/q, 13q and 17p. Enhancement of
chromatin (= gain) occurred most frequently in the chromosomal regions 3q, 7p/q and 8p/q.
Other chromosomal aberrations were seen with lower frequencies. The number of aberrations per
patient sample varied between 0 and 19 and correlated with clinical tumor stages: from none in
stage Ia to 9.43 6 3,56 (mean 6 S.E.M) in stage IVb. CI occured more frequently in the aggressive
subtypes (7.92 6 2.29) than in indolent (2.08 6 0.6) subtypes. A high number of CI (> 5) was
associated with shorter survival. Gain of chromatin in 7q and loss of chromatin in 13q correlated
with a signi®cantly shorter survival whereas the most frequently observed aberration (loss in 17p)
did not in¯uence the prognosis of the disease. In summary, CGH revealed recurring chromosomal
gains and losses in CTLC. The association of the imbalances with the clinical course of the disease
suggests that genes encoded at these loci in¯uence tumor development and progression.
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Absence of Type I Collagen Gene Transactivation Upon TGF-b Stimulation in Fos±/±
Fibroblasts
F. Verrecchia, C. Tacheau, J. Laboureau, E. F. Wagner,* and A. Mauviel
INSERM U532, Institut de Recherche sur la Peau, HoÃpital Saint-Louis, Paris, France; *Research Institute
for Molecular Pathology, University of Vienna, Vienna, Austria
Fos and Jun proteins belong to the AP-1 family of transcription factors involved in type I collagen
gene regulatory programs induced by various stimuli, including TGF-b. Investigating TGF-b
responsiveness in a cellular context devoid of Fos expression, we identi®ed that COL1A2
transactivation previously identi®ed as a TGF-b/Smad3 target, was not achieved by exogenous
addition of TGF-b to Fos±/± mouse embryonic ®broblast cultures. A speci®c de®ciency in Smad3-
dependent signaling was identi®ed, whereas Smad2-dependent gene transactivation and activation
of ERK signaling in response to TGF-b was similar to that observed in wild-type ®broblasts. The
defect in Smad3 signaling was speci®c for the Fos knockout, as it was not observed in either JunB±/±
or cJun±/± ®broblasts. Ectopic transient expression of Fos or Fra-1/Fosl1 into Fos±/± ®broblasts failed
to restore COL1A2 gene expression in response to TGF-b, whereas Fosfosl1/fosl1 ®broblasts exhibited
functional Smad3 signaling. EMSA experiments demonstrated reduced Smad/DNA complex
formation when comparing nuclear extracts from TGF-b-treated Fos±/± ®broblasts vs. those from
wild-type cells. Transfection of a Smad3 expression vector, but not that of either TGF-b receptors
or Smad4 alone, restored Smad3-dependent transcription in Fos±/± ®broblasts. Western and
northern analyses revealed signi®cantly reduced Smad3 expression in Fos±/± ®broblasts as compared
to the wild-type cells, whereas identical levels of expression for Smad2, TGF-b receptors types I
and II, Smad2,and inhibitory Smad7, were detected. Nuclear transfection of a Smad3 expression
vector in Fos±/± ®broblasts restored Smad/DNA complex formation and up-regulation of
endogenous COL1A2 gene expression by TGF-b. Our results demonstrate that Fos plays a critical
role in allowing Smad3 gene expression at levels suf®cient to sustain COL1A2 gene transcription in
response to TGF-b.
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Tissue Inhibitor of Metalloproteinases-3 Induces Apoptosis in Melanoma Cells by
Stabilization of Death Receptors
M. Ahonen, M. Poukkula, A. Baker, M. Kashiwagi, H. Nagase, J. E. Eriksson, and V.-M. KaÈhaÈri
Turku Finland, Glasgow, UK, London, UK
Tissue inhibitors of metalloproteinases (TIMPs) are important regulators of matrix metallopro-
teinase (MMP) and adamalysin (ADAM) activity. We have previously shown that adenovirally
expressed tissue inhibitor of metalloproteinases-3 (TIMP-3) induces apoptosis in melanoma cells
and inhibits growth of human melanoma xenografts. Here, we studied the role of death receptors
in apoptosis of A2058 melanoma cells induced by TIMP-3. Our results show, that exposure of cells
to recombinant TIMP-3, N-terminal MMP inhibitory domain of TIMP-3, and to adenovirally
expressed TIMP-3 results in stabilization of tumor necrosis factor receptor-1 (TNF-RI), FAS, and
TNF-related apoptosis inducing ligand receptor-1 (TRAIL-RI) on A2058 cells and sensitizes them
to apoptosis induced by their respective ligands. Stabilization of death receptors by TIMP-3 results
in activation of caspase-8 and and caspase-3, and subsequent apoptosis is blocked by speci®c
caspase-8 inhibitor (Z-IETD-FMK) and by pan-caspase inhibitor (Z-DEVD-FMK). Adenovirus-
mediated expression of TIMP-3 in human melanoma xenografts in SCID mice resulted in
increased immunostaining for TNF-RI, Fas, and cleaved caspase-3, and in apoptosis of melanoma
cells. Taken together these results show that TIMP-3 promotes apoptosis in melanoma cells
through stabilization of three distinct death receptors and activation of their apoptotic signaling
cascade through caspase-8.
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Roles of PPARs in Skin Wound Healing
Ns Tan, L. Michalik, N. DipoõÈ, B. Desvergne, and W. Wahli
University of Lausanne, Switzerland
The a, b, and g isotypes of the peroxisome proliferator-activated receptor (PPAR) belong to the
nuclear hormone receptor superfamily. They are activated by fatty acids and eicosanoids, as well as
by hypolipidemic and hypoglycemic drugs. With respect to the mouse epidermis, PPARs are
expressed during foetal development but they disappear progressively from the interfollicular
epithelium after birth. Interestingly, PPAR-a and -b expression is reactivated in the adult
epidermis after various stimuli, resulting in keratinocyte proliferation and differentiation. Using
PPAR-a, -b, and -g mutant mice, we demonstrate that PPAR-a and -b are important for the
rapid epithelialization of a skin wound and that each of them plays a speci®c role in this process.
These ®ndings reveal unpredicted roles for PPAR-a and -b in adult mouse epidermal repair. The
immediate response to a skin injury is the release of in¯ammatory cytokines. Using primary
cultures of murine keratinocytes from wild-type and PPAR-b ±/± animals, we found that such
signals, including TNF-a and IFN-g induce keratinocyte differentiation. This cytokine-dependent
cell differentiation pathway requires an up-regulation of the PPAR-b gene. Transcriptional
stimulation of this gene occurs via the stress-associated kinase cascade, which targets an AP-1 site in
the PPAR-b promoter. Interestingly, the pro-in¯ammatory cytokines also trigger the production
of endogenous PPAR-b ligands, which are shown to be essential for activation of the receptor. We
further show that activated PPAR-b regulates the expression of genes associated with the
inhibition of apoptosis, which results in an increased resistance of keratinocytes to cell death after
an injury and during wound healing.
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1a,25(OH)2D3 Increases AP-1 DNA Binding Activity via the Annexin II Membrane
Receptor by a PI3-Kinase/Ras/MEK/ERK1/2 and JNK1 Dependent Mechanism: In
Vitro and In Vivo Regulation of AP-1 Binding Activity by 1a,25(OH)2D3 and Calcipotriol
C. Johansen, K. Kragballe, J. Henningsen, M. Westergaard, K. Kristiansen, and L. Iversen
Aarhus C and Odense, Denmark
1a,25(OH)2D3 added to human keratinocytes increases differentiation through an activation of the
transcription factor Activator Protein 1 (AP-1). The purpose of this study was to further investigate
the mechanisms by which 1a,25(OH)2D3 and calcipotriol modulates AP-1 DNA binding activity
In vitro and in vivo. Western blotting experiments revealed that 1a,25(OH)2D3 caused a rapid and
transient activation of the MAP-kinases ERK1/2 and JNK1 in normal cultured human
keratinocytes and also lead to an increased expression of the AP-1 subunits, c-Fos, Fra1 and c-
Jun as determined by Northern and Western blotting. The 1a,25(OH)2D3-induced AP-1 DNA
binding activity was completely blocked by the MEK/ERK inhibitor PD98059 indicating that the
MEK/ERK pathway is involved in the activation of AP-1. Transfection experiments showed that
1a,25(OH)2D3 increases the AP-1-dependent transactivation, which was completely blocked by a
dominant negative Ras. Preincubation of the keratinocytes with the speci®c PI3-kinase inhibitors,
Wortmannin and LY294002, demonstrated that the 1a,25(OH)2D3-induced activation of ERK1/
2 and JNK1 was mediated by a PI3-kinase dependent mechanism. Finally, preincubation of the
keratinocytes with an antibody against the membrane receptor annexin II, blocked the
1a,25(OH)2D3-induced activation of ERK1/2 and JNK1. In vivo, AP-1 DNA binding activity
was signi®cantly reduced in keratome biopsies from involved psoriatic skin compared to un-
involved psoriatic skin. The AP-1 subunits c-Fos, Fra1 and c-Jun were also reduced in psoriatic
skin compared to un-involved psoriatic skin. However, topical application of calcipotriol to
involved psoriatic skin for four days resulted in an increased AP-1 DNA binding activity when
compared to vehicle. Our data show that 1a,25(OH)2D3, via binding to the membrane receptor
annexin II, induces activation of the PI3-kinase/Ras/MEK/ERK1,2 and JNK1 signal transduction
pathway resulting in increased expression of c-Fos, Fra1 and c-Jun and subsequently increased AP-
1 DNA binding activity and gene transcription both In vitro and in involved psoriatic skin in vivo.
Stimulation of AP-1 DNA binding activity via this signal transduction pathway may be important
for the antipsoriatic effects of various vitamin D3 analoques.
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Cyclic Adenosine 3¢,5¢-Monophosphate Inhibits Transforming Growth Factor-b/Smad-
Induced Type I Collagen Gene Transcriptional Activation via a PKA Dependent
Mechanism
M. Schiller, F. Verrecchia, and A. Mauviel
INSERM U532, Institut de Recherche sur la Peau, HoÃpital Saint-Louis, Paris, France
Smad proteins transduce signals from TGF-b receptors to regulate transcription of target genes. To
initiate speci®c gene transactivation, phosphorylated Smad3 associates with CBP (CREB-binding-
protein) or closely related p300. Cyclic adenosine 3¢,5¢-monophosphate (cAMP) is the key second
messenger in the cellular response to various hormones, neurotransmitters and neuropeptides.
Among the latter a group of bioactive peptides, the melanocortins have been shown to regulate
immune and in¯ammatory responses, hair growth, and extracellular matrix composition in human
skin cells. Using either an arti®cial Smad3/4-dependent reporter construct or natural TGF-b
responsive promoters, we show that synthetic cAMP prevents TGF-b-induced Smad-speci®c gene
transactivation and type I collagen gene expression in a dose- and time-dependent manner. The
level of intracellular cAMP is regulated by the balance between Gs protein stimulated activity of
adenylate cyclase (AC) and cAMP degrading cyclic nucleotide phosphodiesterase (PDE). In this
context, we demonstrate that cAMP-induced inhibition of Smad signaling and collagen gene
expression is mimicked by either AC stimulation or PDE inhibition. In addition, cAMP-induced
repression of Smad-driven gene transactivation was completely abolished by preventing the activity
of the main effector of increased intracellular cAMP levels, protein kinase A (PKA).
Immuno¯uorescence and EMSA studies revealed that cAMP failed to inhibit nuclear translocation
and DNA binding of Smad3/4 signaling complexes. On the other hand, using a mammalian two-
hybrid system, we observed that Smad3±CBP/p300 interactions are abolished by forskolin. From
these results, we provide a model of suppression of TGF-b/Smad signaling by cAMP-inducing
agents, leading to reduced collagen gene expression: interference with Smad-driven transcription is
achieved by PKA-dependent disruption of Smad complexes from transcriptional coactivators.
Whether these mechanisms contribute to the role of neuropeptides such as a-MSH as regulators of
®brosis and wound healing remains to be elucidated.
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Regulation of Stem Cell Factor Receptor Signaling by Cbl Family Proteins (Cbl-B/C-
cbl)
S. Zeng and J. B. Longley
Department of Dermatology, Zhiheng Xu and Lloyd Greene, Center for Neurobiology and Behavior,
Columbia University, New York, USA
Cbl proteins, Cbl-b & C-cbl, function as ubiquitin ligases (E3) that have been implicated in the
negative regulation of signaling of different nonreceptor and receptor tyrosine kinases. Whether
the Stem Cell Factor (SCF) receptor, KIT, is regulated through the proteosomal pathway or the
involvement of the Cbl-b/C-cbl in this regulation has not been elucidated. Through mammalian
cell coexpression and coimmunoprecipitation studies, we show here that Cbl-b/C-cbl also acts as
E3, binds and leads to the ubiquitination and down-regulation of KIT proteins, especially upon
SCF stimulation. A proteasome inhibitor, lactacystin, blocked Cbl-b-mediated degradation of
activated KIT. Intact tyrosine kinase-binding domain and the Ring ®nger domain of Cbl-b or C-
cbl were essential for KIT degradation in 293T cells. Furthermore, the interaction between Cbl-b
or C-cbl and KIT required the presence of activated Src kinases. Cbl-b or C-cbl mediated
degradation of activated KIT was abolished by coexpression of a double mutant form of c-kit (c-
kitY568F/Y570F), in which the docking sites for binding of Src family kinases in the juxtamembrane
domain of c-kit were mutated. Inhibition of Src kinase activity with PP2, a speci®c Src kinase
inhibitor, also blocked the degradation of activated KIT mediated by Cbl-b or C-cbl. Cbl-b, as
well as C-cbl, was phosphorylated following activation of KIT. The phosphorylation of Cbl-b was
primarily mediated by the Src family kinases. The c-kitY568F/Y570F mutant blocked the
phosphorylation of Cbl-b induced by SCF. In addition, we found that Cbl-b was degraded
shortly after receptor engagement in mast cell lines, while prolonged treatment to mast cell lines
with SCF led to the down-regulation of KIT and stabilization of Cbl-b. Taken together, our data
suggest Cbl-b/C-cbl-mediated ubiquitination of KIT is essential for the degradation of activated
SCF receptor, KIT.
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Mechanical Pressure Induces p38 Phosphorylation in Human Keratinocytes
M. Hofmann, A. Bernd, J. Bereiter-Hahn, R. Kaufmann, and S. Kippenberger
University Hospital, JW Goethe University, Department of Dermatology, Frankfurt, Germany
Human skin is permanently challenged by mechanical forces of different qualities. Mechanical
stretching which is considered as a proliferation stimulus is presented, e.g. in abdominal skin
enlargement during pregnancy. Vice versa other locations like the palms of the hand or the foot
soles are more prone to mechanical pressure. In this context mechanical pressure is thought to
trigger differentiation processes. Additionally, mechanical pressure is also discussed as a trigger
factor of some skin diseases (Koebner phenomena). The underlying molecular signalling pathways
which are involved in transduction of mechanical pressure are still enigmatic yet. In the present In
vitro attempt HaCaT cells were mechanically stimulated by insertion of a Te¯on weight into the
culture dish (0.015 N per cm2). After different time intervals total protein was extracted and
analysed for activation of members of the mitogen-activated protein kinases (MAPK). Mechanical
pressure applied for a total time of 30min showed a peak phosphorylation for p38 at 10min. The
extracellular signal-regulated kinases ERK1/2 showed no alteration in the phosphorylation state. In
order to further dissect the signalling cascade upstream and downstream regulators of p38 were
examined. Mechanical pressure induced the phosphorylation of MKK3/6 indicating this kinase to
be involved in p38 activation. Downstream from p38 the phosphorylation of the small heat shock
protein HSP27 could be demonstrated. Among the well established stimulators of p38 are osmotic
stress, heat shock, and in¯ammatory cytokines, which suggest p38 to be involved in the cellular
stress response. Our data feature mechanical pressure as a new type of cellular stress which yields in
p38 activation. As p38 plays an important role in the IL-8 induction we suggest mechanical
pressure as a pro-in¯ammatory stimulus. These ®ndings may contribute to the molecular
understanding of mechanically triggered skin diseases like psoriasis and vitiligo.
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Granulocyte Macrophage-Colony-Stimulating Factor (GM-CSF) Treatment of Chronic
Venous Ulcers Induces VEGF Up-Regulation
R. Tommasi, F. Cianfarani, C. Failla, M. T. Viviano, M. Papi, G. Zambruno, and T. Odorisio
IDI-IRCCS, Rome, Italy
Granulocyte macrophage-colony-stimulating factor (GM-CSF) has been successfully employed in
the treatment of chronic cutaneous ulcers, but its mechanism of action has not been completely
clari®ed. In this study, we investigated whether GM-CSF treatment of chronic ulcers promotes
neovascularization of the granulation tissue and if this effect correlates with local induction of
vascular endothelial growth factor (VEGF) and of the functionally related placenta growth factor
(PlGF). Seven patients affected by chronic venous ulcers were treated with human recombinant (h)
GM-CSF and skin biopsies were taken at the wound edge before (day 0) and ®ve days after
treatment (day 5). Computer-assisted morphometric analysis on tissue sections stained with an
antibody recognising endothelial cells (anti-PECAM/CD31) or smooth muscle cells (antia-smooth
muscle actin) revealed that small-sized vessel density in the granulation tissue was signi®cantly
increased after GM-CSF treatment. Specimens were then analysed for VEGF and PlGF expression
by in situ hybridisation (ISH). After GM-CSF treatment, a strong up-regulation of the
hybridisation signal for VEGF mRNA was detected in migrating keratinocytes at the wound
edge and in cells within the granulation tissue. On the other hand, PlGF mRNA was faintly
transcribed by migrating keratinocytes at day 0 and not signi®cantly increased at day 5.
Immunohistochemistry, performed with an anti-CD68 antibody on sections serial to those used for
ISH, indicated that several of the cells actively transcribing VEGF within the granulation tissue
were monocyte-macrophages. To analyse the molecular mechanisms underlying our in vivo
observations, we carried out Northern blot and ELISA analysis on cultured human keratinocytes
and on the U937 monocytic cell line treated with hrGM-CSF. No signi®cant increase in VEGF,
both at the RNA and protein level, was detected in GM-CSF-treated keratinocytes, while VEGF
mRNA was up-regulated in the monocytic cell line. Taken together, our results indicate that GM-
CSF treatment of chronic venous ulcers promotes neovascularization. This effect may be mediated
by a direct induction of VEGF in monocyte-macrophage cells and an indirect VEGF induction in
keratinocytes.
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Functional Speci®city and Diversity of the Cyclin-Dependent Kinase Inhibitors p27KIP1
and p21CIP1 in T Cell Anergy ± Towards New Models for Autoimmunity
B. Verdoodt, T. Blazek, P. Rauch, G. Schuler, A. Steinkasserer, M. B. Lutz, and J. O. Funk
Department of Dermatology, University of Erlangen, Germany
The molecular events governing the induction and maintanance of T cell anergy are poorly
understood. Recent evidence points to a central role of basal cell cycle regulators, particularly the
cyclin-dependent kinase (CDK) inhibitors, p27KIP1 and p21CIP1, in the regulation of anergy. Key
evidences include that (i) p27KIP1 protein levels are not down-regulated in anergic in contrast to
productively stimulated T cells; (ii) overexpression of p27KIP1 in T cells mimick an anergy-like G1
arrest; (iii) the association of p27KIP1 with the c-Jun coactivator JAB1 could be involved in the
decreased transactivation of the IL-2 gene; (iv) unexpectedly, p21CIP1±/± mice develop a lupus-like
syndrom with age. However, the precise function of these CDK inhibitors in T cells has remained
elusive. To rigorously evaluate the requirement of p27KIP1 and p21CIP1 for T cell anergy in
comparison to other nonproliferative states, we analyze p27KIP1±/±, p21CIP1±/±, and corresponding
wild-type mice in various scenarios. Phenotypically, puri®ed CD4+ p27KIP1±/± T cells show an
increased fraction of CD25+ cells before stimulation, a shortened cell cycle, and an accelerated
response to stimulation, while p21CIP1±/± T cells closely resemble wild-type cells. In contrast, the
induction and maintainance of proliferative quiescence is unaltered, indicating that neither p27KIP1
nor p21CIP1 are required for this response. Strikingly, p27KIP1±/± T cells exhibit partial resistance to
anergy induction In vitro and in vivo as demonstrated by increased cell duplication, increased BrdU
incorporation, CD25 up-regulation, synthesis of CDK4/cyclin D3 complexes, and retinoblastoma
protein hyperphosphorylation. In comparison, p21CIP1±/± T cells become fully anergic as judged by
these criteria, but show an augmented proliferative response following restimulation postanergy
induction. In conclusion, p27KIP1 and p21CIP1 act as speci®c regulators of T cell anergy in
overlapping but distinct pathways rather than general inhibitors of T cell proliferation. Since each
regulator individually is not absolutely required for T cell anergy, current work aims to identify
additional cell cycle regulators that function speci®cally in T cell anergy vs. quiescence.
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Transactivation of EGF-Receptors and Induction of c-fos Expression by Angiotensin II
in Human Dermal Fibroblasts
U. M. Steckelings, B. M. Henz, and M. Artuc
Berlin, Germany
Angiotensin receptors are expressed by diverse human cutaneous cells including dermal ®broblasts.
This study was designed to identify angiotensin receptor coupled second messengers in this cell
type. Signal transduction mechanisms known to be coupled to angiotensin receptors on ®broblasts
of other origin comprise the transactivation of EGF-receptors and, consecutively, the induction of
c-fos expression. Primary dermal ®broblasts, isolated from human foreskin, were incubated for 1±
5 min (for determination of EGF-receptor transactivation) or 15±60 min (for estimation of c-fos
expression), respectively, with angiotensin II (10-7-10-11 M). Total RNA was isolated from
treated or untreated (control) cells and forwarded to semiquantitative RT-PCR analysis of c-fos
transcripts. The protein fractions of treated and untreated cells were immunoprecipitated using an
antibody directed against the phosphorylated, activated EGF-receptor and subsequently analysed
by Western Blotting. Angiotensin II time-dependently elicited a transactivation of EGF-receptors
with a maximal effect as early as 2 min after stimulation. It, furthermore, time- and dose-
dependently induced c-fos expression, peaking after 30 min at a concentration of 10±7 M
angiotensin II. From our results we conclude, that human dermal ®broblasts express functional
angiotensin receptors. Physiological functions of angiotensin II in ®broblasts derived from
noncutaneous tissues, which are transmitted by a transactivation of EGF-receptors or by an
induction of c-fos expression, include the stimulation of ®bronectin- and TGF-b-synthesis. It is
currently under investigation, whether physiological actions of angiotensin II in human skin may
involve ®brosis.
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Vascular Endothelial Growth Factor-C Expression in Primary Cutaneous Melanomas
Associates with Tumor-Positive Sentinel Lymph Node
F. Cianfarani, F. Sera, C. M. Failla, T. Odorisio, and G. Zambruno
IDI-IRCCS, Rome, Italy
The presence of lymph node metastases is of crucial relevance for the prognosis of most human
tumours, but little is known about the molecular mechanisms which guide metastasis spreading via
the lymphatic system towards regional lymph nodes. Vascular endothelial growth factor-C (VEGF-
C), a member of the vascular endothelial growth factor (VEGF) family, has been demonstrated to
be involved in tumour-induced lymphangiogenesis and lymph node localization of metastases. In a
previous study, we have shown that VEGF-C is expressed by the majority of lymph node
melanoma metastases analysed, suggesting that the production of this growth factor by primary
cutaneous melanomas may be associated with tumour spreading via the lymphatics. To further
investigate this aspect, we have selected 18 cases of primary skin melanomas with metastases at
sentinel lymph node biopsy, observed in our Institute between 1998 and 2000. For each case, a
comparison patient with primary melanoma but negative sentinel lymph node biopsy, matched for
age, sex and Breslow's thickness has been identi®ed. The expression of VEGF-C on the 36 primary
melanoma specimens has been evaluated by immunohistochemistry by two independent, blind
observers. VEGF-C expression was detected in 89% of patients with tumor-positive sentinel lymph
node vs. 22% of control patients. The observed difference in VEGF-C expression was found to be
signi®cant (p = 0.000, McNemar test). Our results show that VEGF-C production by the primary
tumour is associated with the presence of lymph nodal metastases. In order to better understand the
predictive role of VEGF-C expression in melanoma metastatisation we are analysing
lymphangiogenesis in the primary lesions.
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Autocrine Ephrin-B2 ± Eph Receptor Tyrosine Kinase Signaling Enhances Integrin-
Mediated Attachment of Melanoma Cells to ECM Components
S. Meyer, C. Hafner, M. Guba, S. Flegel, E. Orso, M. Landthaler, and T. Vogt
Regensburg, Germany
Eph receptors are a unique family of receptor tyrosine kinases (TK) that play a pivotal role in
embryonic patterning and neuronal development. This is partially attributable to modulation of cell
migration and ECM-adhesion by cell-to-cell signaling. We have previously demonstrated that
advanced melanomas (MM) constitutively overexpress both ephrin-B2, a cell surface bound ligand
of this system, and the corresponding cell surface receptor-TKs of the B-class, suggesting autocrine
stimulatory loops in MM. Currently, the functional consequences for MM progression are
unknown. The aim of this study was to ®nd out, whether cell attachment to ECM-components is
altered by ephrin-B2-ephTK signalling. A panel of 20 MM-cell lines, mouse and human, was
screened by real time PCR for relative expression levels of ephrin-B2. Surprisingly, mouse
B16 MM-cells lacked ephrin-B2 expression completely, whereas most of the others showed
varying expression levels. A full-length mouse ephrin-B2 expression construct was therefore
designed and stably transfected B16-clones were established. Overexpression was con®rmed by
both FACS and Western blotting. Attachment assays were performed by seeding transfectants onto
surfaces coated with laminin, ®bronectin, and collagen. Ephrin-B2 overexpressing clones showed a
signi®cantly increased attachment to laminin (LM) and ®bronectin (FN), but not collagen,
suggesting the involvement of speci®c integrins. The number of attached cells after 30 min
incubation was about doubled when compared with mock-transfected cells (p < 0.05). To further
con®rm the activation of RGD-binding integrins, RGD peptide (Gly-Arg-Gly-Asp-Ser) was used
as a speci®c competitor. Consistently, the increase of attachment could be blocked completely
with mM RGD-doses. To ®nd out if signaling competence of ephrin-B2 cell surface bound ligand
is required we knocked out the cytoplasmic signaling domain of ephrin-B2. B16 stably transfected
with this truncated version did not show a signi®cant increase of ECM-attachment. Taken
together, we collected evidence that autocrine bidirectional ephrin-B2-ephTK signaling among
MM-cells could be an important mechanism of activation of FN- and LM-binding integrins,
which determine MM-cell adhesion, spread, and possibly metastatic growth.
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Smad7 Represses PAI-1 Promoter Activity in Human Dermal Endothelial Cells
K. Korang and A. Mauviel
INSERM U532, Institute de Recherche sur la Peau, HoÃpital Saint Louis, Paris, France
Smad proteins are intracellular proteins which mediate the TGF-b superfamily signaling from the
activated TGF-b receptor complex to the nucleus. Ligand-speci®c receptor-associated Smads bind
to the actived receptor type I and consist of Smad1, 5, 8 for the BMP-signaling cascade and of
Smad2, 3 mediating TGF-b signaling. Once bound to co-Smad Smad4, they translocate into the
nucleus where they bind speci®c DNA targets either alone or in association with other
transcription factors. Inhibitory Smads, Smad6 and Smad7, block TGF-b superfamily signaling by
binding activated type I receptors, thereby preventing receptor-associated Smad phosphorylation
and subsequent nuclear translocation. Smad7 expression is up-regulated by laminar shear stress in
endothelial cells. Until now, although Smad7 can be found in the cell nucleus, little is known
about its nuclear role. Plasminogen activator inhibitor-1 (PAI-1) plays a major role in the control
of physiologically important mechanisms involved in the homeostasis of blood coagulation and
remodeling of extracellular matrix. Using transient cell transfections of endothelial cells we
demonstrate that Smad7 represses the activity of a PAI-1 minimal promoter in a dose-dependent
manner. To get insights into the molecular mechanisms underlying Smad7 effect, we used fusion
proteins of Smad7 fused to the Gal-4 DNA binding domain together with core promoter-speci®c
reporter constructs. These core promoters contain either a cannonical TATA box or a
combination of TATA box with an initiator site (INR) or just an initiator site. The initiator
site is a pyramidine rich region which facilitates initiation of promoter transcription that can be
found either alone or in combination with a TATA box. We demonstrate that Smad7 represses
TATA box- containing as well as TATA-INR-containing core promoters. Repression does not
depend on the phosphorylation state of Smad7 since a phophorylation de®cient Smad7±249 A still
represses in a similar extent. In opposite, TATA-less, INR dependent core promoters do not
become repressed. These results suggest that Smad7 interacts either directly with the basal
transcription machinery or via a transcriptional coactivator like p300/CBP, one of the best
characterized transcriptional coactivators. When using a mammalian two hybrid assay in
endothelial cells however, Smad7 and p300 did not interact with each other. The exact
mechanisms of gene repression by Smad7 in endothelial cells is currently investigated.
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Vaccination of Cutaneous T-Cell Lymphoma Patients with Tumor Lysate Pulsed
Dendritic Cells
T. Maier, A Tun Kyi, R. Dummer, G. Burg, and F. O. Nestle
Department of Dermatology, University Hospital of Zurich, Switzerland
Vaccination with autologous dendritic cells (DC) has been shown to be a promising approach in
the treatment of malignant melanoma. With the use of tumor lysate as a source of tumor antigen
other malignant cutaneous diseases such as cutaneous lymphoma become accessible for vaccination
therapy. We analyzed 10 patients with cutaneous T-cell lymphoma (CTCL) (stage I-IV), who
were treated with tumor lysate pulsed dendritic cells from 1999 to 2001 on an outpatient basis in
our hospital. The preparation of tumor lysate included 4 freeze/thaw cycles. DC were pulsed with
100õÁg per ml tumor lysate protein equivalent and keyhole limpet hemocyanin (50 mg per ml).
Thereafter, injection of 1 3 106 DC into noninvolved lymph nodes was performed once weekly.
Out of 10 treated patients 4 patients (40%) presented with an objective response. Three patients
presented with a partial response meaning a > 50% decrease of lesions lasting at least for one month.
One patient showed a complete response. On average 6.6 6 1.4 vaccinations were necessary for
the induction of a clinical response. Interestingly, in contrast to our experience in melanoma
patients, relapse occured within 2±4 weeks after treatment stop. Continuation of vaccination with
new tumor lysate of progressive lesions in 2 patients induced again a treatment response. In all
patients treated, vaccination therapy was well tolerated. Immunohistology showed massive
in®ltration of CD8 and TIA positive cells at the site of regressing lesions during treatment as well as
molecular remission as assessed by T cell receptor g chain polymerase chain reaction density
gradient electrophoresis. Eight patients presented with a mild to strong DTH skin reaction toward
tumor lysate after DC vaccination with heavy in®ltrates of CD4+, CD8+ and CD45RO+
lymphocytes. We conclude that vaccination of CTCL using tumor lysate pulsed DC is well-
tolerated and achieves clinical regressions in some patients. Compared to the vaccination in
melanoma patients this strategy facilitates the close monitoring of the obvious clinical course during
vaccination treatment.
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Decreased Serum IgG Levels and Circulating B Cell Numbers are Responsible for
Development of Anticonvulsant Hypersensitivity Syndrome Through Reactivation of
HHV-6
Y. Kano, M. Inaoka, K. Hirahara, and T. Shiohara
Tokyo, Japan
Anticonvulsant hypersensitivity syndrome (AHS) is a life-threatening drug-induced reaction.
Although reactivation of human herpesvirus 6 (HHV-6) has recently been shown to contribute to
the development of AHS, it remains unknown why prolonged exposure to certain drugs could
result in HHV-6 reactivation. We therefore investigated whether immune dysfunction that may
allow HHV-6 reactivation could be speci®cally found in patients with AHS. In this study, various
immunological parameters including serum Ig levels and T/B cell counts were studied at various
time points in 10 patients with AHS. Two groups of controls were enrolled: one group was those
who received anticonvulsants for > 3 months without any rashes; and the other was those who
developed maculopapular rashes without systemic involvement. The serum IgG levels (mean 6
SEM, 723 6 157) were dramatically decreased at initial evaluation in patients with AHS as
compared with the two groups of controls (1558 6 294; 1210 6 219): in particular, IgG1 and IgG3
levels were decreased. Circulating B cells were also decreased in number (95 6 55 vs. 247 6 131) in
patients with AHS. These alterations clearly preceded the increase in serum HHV-6 DNA and
anti-HHV-6 titers, which were usually detected 2±4 weeks after onset of the clinical symptoms.
Upon resolution of the clinical symptoms, these alterations were restored. The temporal
relationship between development of AHS and the decrease in serum IgG levels and circulating B
cells provides strong evidence of a causal relation between reactivation of HHV-6 and
development of AHS. Our ®ndings also suggest the clinical utility of monitoring serum IgG
levels and circulating B cell numbers for predicting the onset of AHS.
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Treatment of Toxic Epidermal Necrolysis with High-Dose Intravenous
Immunoglobulin: Multicentre Retrospective Analysis of 48 Consecutive Cases
C. Prins, F. A. Kerdel, R. S. Padilla, T. Hunziker, S. Chimenti, K. Flynn, J. Trent, D. J. Margolis,
J. H. Saurat, and L. E. French
Geneva, Switzerland, Miami, USA, New Mexico, USA, Bern, Switzerland, and Philadelphia, USA
Toxic epidermal necrolysis (TEN, Lyell's syndrome) is a rare adverse cutaneous drug reaction
characterized by an average mortality of 30%. No speci®c treatment exists to date. TEN is caused
by extensive Fas-mediated keratinocyte death, a process that can be inhibited by high dose
intravenous immunoglobulin (IVIG) In vitro. Here we have evaluated the therapeutic potential of
IVIG in TEN and parameters that may affect response to treatment. Forty-eight consecutive
patients with TEN (> 10% body surface area skin detachment, mean 44.8%, range 10±95%) were
treated with standard care and IVIG (mean total dose 2.7 g per kg, range 0.8±5.8 g per kg) in 14
dermatology centers. Objective response to treatment, ®nal outcome at day 45, and parameters that
may affect response to treatment were retrospectively analyzed. Analysis of the Fas-inhibitory
activity of different IVIG batches was also performed. IVIG infusion was associated with a rapid
(mean of 2.3 d, range 1±6 d) interruption of skin and mucosal detachment in 89.6% of patients, and
87.5% overall survival. Patients that responded to IVIG had received on average higher doses of
IVIG and earlier treatment. Furthermore, analysis of 35 IVIG batches revealed important batch to
batch variations in their capacity to inhibit Fas-mediated cell death In vitro. Early infusion of high
dose intravenous immunoglobulin is safe, well tolerated and likely to be effective in improving the
survival of patients with TEN. From our data we would recommend early treatment with IVIG at
a total dose of 3 g per kg over 3 consecutive days (1 g per kg per day). The Fas-inhibitory activity of
IVIG batches available for therapeutic use and tested herein varies from batch to batch.
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Development and Characterization of Optimized Hapten-Carrier Conjugates for
Improved Diagnosis of Immediate Chemical Allergy
A. Lauerma, M. Pakarinen, M. Koivuluhta, N. Kalkkinen, H. Keskinen, T. Estlander, R. Jolanki,
O. Tupasela, P. PfaÈf¯i, and H. Alenius
Helsinki, Finland
At present the diagnosis of IgE-mediated hypersensitivity to chemicals such as phthalic anhydride
(PA) is based on conjugates that are not characterized or standardized. The aim of this study was to
develop optimized and molecularly characterized PA-conjugates that can be used to improve the
diagnosis of PA-allergy. The PA-conjugates were synthesized and the number of haptens bound on
a carrier protein was estimated by matrix-assisted laser desorption/ionization time of light
(MALDI-TOF) mass spectrometry. Conjugates ability to bind IgE antibodies was measured by the
enzyme-linked immunosorbent assay (ELISA). In vivo reactivity of the conjugates was evaluated by
skin prick testing. The most active IgE binding conjugates had a PA:HSA molar ratio of 80. In the
optimal conjugates the average numbers of PA haptens per HSA carrier molecule were 14±16. In
ELISA, all 13 patients and none of the 20 controls had IgE antibodies to optimized PA-conjugate.
The sensitivity and speci®city of the ELISA was comparable or even better to commercial CAP
RAST. PA-conjugates elicited positive test results in skin prick testing showing that conjugates are
immunologically active also in vivo. These results indicate that optimized and molecularly
characterized PA-HSA conjugates can be used both In vitro and in vivo assays to improve the
diagnosis of PA allergy. Similar approach may be useful also with other chemicals capable of
inducing immediate allergy.
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Level of Total Fibronectin and its Functionally High-Grade Fraction in Plasma of
Patients with Psoriasis
A. Arkhipenkova, S. Gennady, V. Victoria, and T. Arkady
Central Research Institute of Dermatology and Venerology MOH, Mitishi, Russian Federation
Methods: the level of total ®bronectin (FN) in plasma of 89 patients with psoriasis was investigated.
Besides total FN, at the surveyed patients simultaneous determination of its fraction capable at
presence heparin on a cold to form precipitate, consisting of FN and ®brinogen was carried out.
The formation of such precipitate is possible only at presence of the free and intact sites for linkage
of appropriate ligands (heparin and ®brinogen) in FN molecule and consequently it in the certain
measure characterizes functional full value of FN. 49 healthy volunteers made up control group.
Results: it was found, that the level of total FN in plasma of patients with psoriasis is signi®cantly
higher in comparison with control group (accordingly 398 6 11.7 mcg per ml and 331.5 6 11.1
mcg per ml; p < 0.01). Thus, signi®cant decrease of the functionally high-grade FN maintenance
(191.4 6 8.1 mcg per ml was marked at norm 255.6 6 17.1 mcg per ml; p < 0.01). Probably, this
decrease could be the consequence of FN linkages in bloodstream with excess of circulating
ligands, and proteolytic damages of FN molecule.
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Peripheral Blood Cellular Responses to Tetanus Toxoid and Tuberculin are Suppressed
After Long-Term Topical Glucocorticosteroid Usage
G. Wang, G. Molander, M. Koivuluhta, H. Alenius, and A. I. Lauerma
Finnish Institute of Occupational Health, Helsinki, Finland
Topical corticosteroids do permeate skin and prolonged systemic corticosteroid use also causes
systemic immune suppression. We wanted to study the effect of long-term topical corticosteroid
use on peripheral blood immune responses to bacterial antigens and to nonspeci®c stimulation by
PHA. Age-matched groups of patients were studied, i.e. 15 healthy volunteers with no history of
topical corticosteroid use, and 16 patients who had been using topical corticosteroids for several
years. The response of peripheral blood mononuclear cells (PBMC) to tetanus toxoid and
tuberculin were measured by H3-thymidine incorporation, as well as IgE, IgG1, IgG2, IgG3 and
IgG4 levels to same antigens by in-house ELISA's. Humoral immune responses, as measured with
ELISA, were not altered by long-term topical corticosteroid use. However, proliferative responses
of PBMC were signi®cantly suppressed to tetanus toxoid (p < 0.05), tuberculin antigen (p < 0.05)
and to nonspeci®c PHA stimulation (p < 0.05) in the patient group that had been using topical
corticosteroids for prolonged periods. It seems that peripheral blood cellular immune responses are
indeed suppressed after long-term topical corticosteroid use, possibly due to percutaneous
absorption.
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47 Patients in 14 Families with the Rare Genodermatosis Keratosis Punctata
Palmoplantaris Buschke-Fischer-Brauer
S. Emmert, W. KuÈster, H. C. Hennies, M. Zutt, H. Haenssle, L. Kretschmer, and C. Neumann
GoÈttingen, Bad Salzschlirf and Berlin, Germany
We summarize the clinical data of 47 patients with the rare genodermatosis keratosis punctata
palmoplantaris Buschke-Fischer-Brauer. The pedigrees of 14 German families were studied. In
three families there was only one member affected, two or more affected members were found in
the other families. These family pedigrees were consistent with autosomal dominant inheritance.
Variable expression of the disease was noted in members within one family. Over pressure points
punctate keratoses coalesced into hyperkeratotic plaques. There was palmoplantar hyperhidrosis in
3 families associated with keratosis. Continuous systemic retinoid treatment can clear symptoms.
Future genetic classi®cation on a molecular basis may reveal the existance of more than one entity
of this clinically heterogeneous genodermatosis.
266
Effect of Indigenous Herbal Drug Ficus Carica In-Patients with Vitiligo
S. Malhotra, A. Singh,* and A. S. Sandhu²
Ind Swift Laboratory, Medicinal Herbs and Natural products, Chandigarh, India; *Postgraduate Institute of
Medical Education, Chandigarh, India; ²National Institute of Pharmaceutical Education, Chandigarh, India
The aim of the study was to evaluate ef®cacy and tolerability of powdered extract of Ficus carica
250 mg (FC250) in the treatment of vitiligo. The incidence of vitilago was investigated by studying
all the patients who were called at Sohana Eye Hospital near Chandigarh during a speci®c day. The
patients were examined thoroughly and it took 3 doctors and 5 h to complete the program. Vitiligo
was present in 28 patients and majority was from rural background. Females in age group of
25 years were predominating. VDRL tests were performed to exclude syphilis. They were directed
to look for any local reaction, itching or blister formation and consult the same doctors after 10 days
for routine checkup. Patients were allocated to receive FC250 for a period of 8 weeks. Paste of the
drug for local application was also recommended. The patients were directed to expose the
hypopigmented patches to sunlight for 2 min, after internal administration of FC250 and local
application of the drug. The response to therapy was evaluated at time interval of 8 weeks by
calculating leucoderma score [L.S] and pigmentation index [P.I]. 23 out of 28 patients attended the
2nd phase of the clinical trial after 8 weeks. 8 patients showed 15±33% improvement, 5 patients
showed 35±60% improvement and 10 patients showed less than 25% improvement. Thus it was
concluded that 30% of the patients showed signi®cant improvement in development of
pigmentation. Slight itching and blister formation was reported in couple of cases but reduced
after discontinuing the treatment. Gastritis, dry mouth and headache were common complaints.
Liver function tests were performed on regular basis and it was concluded that the drug was free
from hepatotoxicity. In case of ef®cacy it was concluded that results shown by the herbal drug were
in comparison to Psoralia corylifolia and Ammi majus (sources of Psoralen and Xanthotoxin), but it
often failed to bring back complete normal color of the skin in depigmented area. Ficus carica is
important medicinal plant of Ayurveda and ®nds application in formulations fro the treatment of
leucoderma. Because of this further investigations into the active constituent of Ficus carica and
role in the treatment of vitiligo must be undertaken.
267
Uveal Melanoma ± Adjuvant Therapy with Interferon Alpha 2 b
E. Richtig, G. Schlemmer, K. MuÈllner, P. Bergthaler, G. Papaefthymiou, G. Langmann, and J.
Smolle
Graz, Austria
Uveal melanoma is a rare entity of malignant melanoma compared to cutaneous malignant
melanoma. It carries a signi®cant risk of recurrence and metastatic spread. We examined the
potential effects of adjuvant interferon a 2 b. 39 patients (23 male and 16 female patients, mean age
56.5 years, range 35±78 years) with uveal melanoma encountered between June 1996 and
December 2001 received adjuvant treatment with interferon a 2 b 3 million units 3 times a week
over a period of one year. All patients had therapy of the primary tumor before interferon
treatment: Twelve patients had enucleation, 13 patients had Leksell Gamma Knife radiosurgery,
nine patients had a Ruthenium 106 applicator, four patients had transpupillary thermotherapy
(TTT), and one patient had ruthenium applicator combined with transpupillary thermotherapy.
History, potential risk factors, clinical presentation, therapy side-effects and clinical course were
documented. Outcome was compared with that obtained in 72 patients with uveal melanoma (33
male and 39 female, mean age 64.7 years, range 40±92 years) encountered during the same period,
who did not receive adjuvant treatment. Among all patients, local recurrence occurred in 27
patients (24.3%), distant metastases in 20 patients (18.0%) and 17 patients (15.3%) died due to
disseminated melanoma during the study period. 5 years survival rate was 49% for the interferon-
treated group and 80% for the noninterferon-treated group (log rank test: not signi®cant). In a
multivariate approach, horizontal tumor diameter was the most signi®cant prognostic parameter.
Again, interferon therapy showed no signi®cant effect in multivariate analysis. There was,
however, a trend towards unfavourable outcome in the interferon-treated group. Our data show
no evidence for a protective effect of adjuvant interferon treatment in ocular melanoma. Though
the study was not randomised, the negative trend in the interferon-treated group in a multivariate
approach suggests that at the moment interferon treatment cannot be recommended for uveal
melanoma unless other clinical trials will reveal more favourable results.
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Treosulfan and Gemcitabine in Metastatic Uveal Melanoma: First Multicenter
Experience
C. PfoÈhler, S. Ugurel, I. A. Cree,* N. Plowman,² C. Kuwert, K. Neuber, N. Haass, W. Tilgen,
and U. Reinhold
The Saarland University Hospital, Homburg/Saar, Germany; *Queen Alexandra Hospital, Portsmouth,
UK; ²St. Bartholomew's Hospital, London, UK
Background: No effective treatment currently exists for metastatic uveal melanoma. However,
recent results obtained by an ATP-based tumor chemosensitivity assay (ATP-TCA) have shown
consistent activity of treosulfan + gemcitabine in 80% of tumor specimens tested. In this study we
compare ®rst clinical results observed with this drug combination at different European centers in
patients with metastatic uveal melanoma. Methods: The study was a clinical case series of patients
with metastatic uveal melanoma treated with treosulfan + gemcitabine at seven separate centers.
Fourteen patients, 13 previously untreated and 1 pretreated with chemoimmunotherapy, were
included in the study. Patients received treosulfan + gemcitabine in four different dose regimens.
The response rates, progression-free and overall survival, and toxicity were evaluated. Results: The
analysis of 14 patients revealed 1 complete response, 3 partial responses, and a stable disease in 8
cases. The objective response rate was 28.6 %, the median overall survival was 61 weeks (95 %
con®dence interval, 54 ± 133 weeks), the progression-free survival was 28.5 weeks (95%
con®dence interval, 13- 62 weeks), and the one-year survival rate was 80%. The drugs were well
tolerated. The most common side effect was leuko- and thrombocytopenia. Conclusions: These
preliminary results suggest the potential therapeutic bene®t of treosulfan + gemcitabine treatment
in metastatic uveal melanoma and warrant further controlled studies.
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In¯uence of Cladribine on Normal and Diseased Human Skin Fibroblasts and Human
Leukaemic Mast Cell Line
A. Zalewska, E. Robak, H. Urbanska-Rys, A. Sysa-Jedrzejowska, J. Dastych, J. Wyczolkowska,
and T. Robak
Lodz, Poland
Single clinical observations both in literature data and our own seem to be in favour of 2-
chlorodeoxyadenosine (2-CdA, cladribine) use in systemic mastocytosis patients. So, the aim of our
study was to examine susceptibility of human leukaemic mast cell line (HMC-1), skin ®broblasts
from the lesions of urticaria pigmentosa (UP), psoriasis vulgaris (PsV), scleroderma (Scl) and normal
skin towards 2-CdA. Cells, either HMC-1 line or skin ®broblasts from the third passage were
stimulated with different concentrations of 2-CdA (0.1; 1.0; 2.5; 5.0; 10.0 and 20.0 nM/ml) for 24
or 72 h. Proliferation assays were performed in quadruplicate. After 24- h-incubation, we observed
proliferation inhibition of all the studied cells in a dose dependent manner. HMC-1 cells were
slightly less susceptible than normal skin ®broblasts to 2-CdA inhibition (at 20.0 nM per ml ±
proliferation decrease by mean 52.0 vs. 60.2%, respectively). However, surprisingly in all studied
cultures, after a single dose of 2-CdA, followed by 72- h-incubation-period, considerable
proliferation increase, independent of 2-CdA dose, ranging from 49.1 to 136.8% was observed.
This effect was abolished when 2-CdA was added repeatedly to the cultures every 24 h. We
noticed that cladribine seems to be more cytotoxic towards normal skin ®broblasts than UP ones ±
at 20.0 nM per ml of 2-CdA ± proliferation decrease by mean 60.2 vs. 26.8%, respectively. Scl
®broblasts were much less sensitive to 2-CdA than normal, PsV and even UP ones ± at 20.0 nM
per ml of 2-CdA ± proliferation decrease by mean 20.5, 38.9, 26.8%, respectively. We conclude
that in order to suf®ciently suppress cell proliferation, repeated doses of 2-CdA, added to cell
cultures every 24 h are required. As for clinical application in systemic mastocytosis, this new
purine nucleoside analog should be carefully considered as regards risk-bene®t ratio.
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Skin Problems in Paediatric Transplant Recipients
S. Euvrard, J. Kanitakis, and A. Claudy
Department of Dermatology, Ed. Herriot Hospital, Lyon, France
Skin diseases are frequent in organ transplant recipients but studies about children are sparse.
Pediatric organ transplantation accounts for 5±10% of all transplantations. The aim of this work is
to present skin diseases in children after solid organ transplantation and to compare them with
lesions occurring in adult transplant patients. Our experience concerns 170 children out of a
registry of more than 2000 transplant patients referred to our department during the past 10 years
either for a systematic examination (all kidney graft recipients) or for a speci®c disorder (all the
nonkidney ones). They included 133 kidney, 17 liver and 20 heart transplant recipients. The mean
age at transplantation was 9 years and the majority of patients were under triple immunosuppressive
therapy comprising corticosteroids, azathioprine and cyclosporine. More then 40 children had also
one of the new immunosuppressive drugs (tacrolimus and/or mycophenolate mofetil) that were
introduced either initially or after switching. Transplanted children frequently present side-effects
of immunosuppressive drugs and infectious diseases. Steroid-induced striae distensae and acne were
seen only in adolescents. Severe cyclosporine-related side-effects were more frequent in younger
children. No speci®c side-effects were seen in patients taking tacrolimus and mycophenolate
mofetil. The commonest ®ndings were warts (55%), tinea versicolor (15%), herpes simplex/zoster
(10%), molluscum contagiosum (7%), impetigo contagiosum and folliculitis (6%). Other notable
disorders included a diffuse hyperpigmentation with a ``dirty'' appearance of the skin, pyogenic
granulomas, proliferation of melanocytic nevi and skin tags. Skin cancers were not observed in
children but developed in early adulthood. Three of 28 further adult patients who were
transplanted during childhood had squamous cell carcinomas. Most disorders are related to the age
of the patients rather than to the length of immunosuppression whereas others are due to the
reinforcement of immunosuppression.
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Basophil CD63 Surface Expression Assay ± A Useful Functional Method in Chronic
Urticaria
A. Szegedi, E. Gyimesi, B. HõÂdveÂgi, E. TemesvaÂri, S. Sipka, and J. Hunyadi
Debrecen and Budapest, Hungary
The aetiology of chronic urticaria is still unknown. Currently the concept has evolved that the
chronic idiopathic urticaria (CIU) group might be autoimmune in origin, since it has become clear
that 27±50% of these patients have functional autoantibodies directed against the a-chain of the
high af®nity IgE receptor (FceRIa). These antibodies are identi®ed by autologous serum skin
testing and con®rmed by histamine release studies, immunoblot or ELISA methods. Our purpose
was ®rst to measure the percentage of patients with autoimmune chronic urticaria with two
methods. We applied the autologous serum skin test and a new assay for the detection of the
surface expression of the activation marker CD63 on basophils. Finally we compared the results of
the 2 methods and were looking for correlation. Autologous serum skin testing were carried out
according to the literature. Surface expression of the basophil activation marker CD63 was
measured on buffy coat without any previous activation. Phycoerythrin-conjugated anti-CD63
and FITC-conjugated anti-IgE monoclonal antibodies and ¯ow cytometry was used. We measured
the percentage of CD63 positive cells within the IgE positive cell population. The buffy coat cells
were obtained from atopic donors with extrinsic atopic dermatitis and allergic rhinitis. 60.3% of the
sera were positive in the autologous serum skin test and 56.8% in the CD63 expression assay. We
obtained some correlation between the serum skin test results and the CD63 expression assay.
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Imiquimod for the Treatment of Cutaneous T Cell Lymphoma
A. K. Born, K. Schreiber, A. Lukowsky, S. Gellrich, W. Sterry, and J. M. Muche
ChariteÂ, Berlin, Germany
Cutaneous T cell lymphomas (CTCL) are de®ned as malignant clonal proliferation of skin-
in®ltrating T cells. In most CTCL, neoplastic cells express type 2 cytokines and are attacked by
type 1 cytokine expressing reactive lymphocytes. Immunmodulators which induce type 1
cytokines (i.e. IFN-a) have been shown to be effective in CTCL treatment. At this background,
imiquimod (1-(2-methylpropyl-)-1H-imidazol[4,5-c]-quinolin-4-amine), an immunmodulator
inducing IFN-a, IFN-g and IL-12 but down-regulating IL-4 and IL-5, has been applied as 5%
ointment for the treatment of CTCL and CTCL precursors in two phase 1/2 studies. Firstly, 7
patients suffering from mycosis fungoides (MF, n = 5) and parapsoriasis en plaques (PEP, n = 2)
were treated with alternating administration of imiquimod at 5 lesions located at different skin
regions. Application was carried out 5 times per week for at most 6 months with reduction to 3
times per week in case of local erosions. Outcome of the treatment was assessed by the overall
response. Complete remission (CR) was observed in 3 cases (PEP, n = 2; MF, n = 1), partial
remission (PR) was found in 3 MF patients, whereas 1 patient with tumour stage MF showed
progressive disease. In the second study, 10 patients suffering from MF stage IA-IIA were treated
by application of imiquimod at 1 lesion of 20 cm2. Administration was carried out 5 times per week
for 12 weeks with reduction to 3 times per week in case of local erosions. Outcome of the
treatment was assessed by the overall response and by evaluation of index lesions. Response was
observed in 2 cases (1 CR, 1 PR), whereas 5 patients showed stable or progressive disease. Therapy
was discontinued in the remaining 3 patients (withdrawal of consent in 2 cases, arrhythmia in 1
case). In contrast to the overall response, treated lesions disappeared completely in 4/7 patients.
Adverse effects included local irritation (n = 5) or erosion (n = 3), fever (n = 2), nausea (n = 2), and
arrhythmia (n01, study discontinuation). In summary, topical imiquimod can be successfully
applied in MF and PEP. This treatment is well tolerated and applicable in the outpatient care. Due
to an insigni®cant systemic effect, at least one lesion per skin region should be treated to attain a
suf®cient response in CTCL.
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Further Study of HHV6 Reactivation in Hypersensitivity Syndrome
M. Tohyama, Y. Shirakata, and K. Hashimoto
Ehime University School of Medicine, Ehime, Japan
Hypersensitivity syndrome is a severe adverse drug reaction caused by the speci®c drugs including
anticonvulsants, salazosulfapyridine and allopurinol. The clinical symptoms are high fever, multiple
lymphadenopathy, severe skin rash, mononucleosis, and multivisceral involvement, which appear
two to six weeks after the beginning of drug administration. Moreover, it is well known that
relapse of symptoms, such as fever, eruption, and hepatitis, is observed several weeks after
discontinuation of causative drug treatment in this syndrome. We presented that reactivation of
HHV-6 was signi®cantly associated with hypersensitivity syndrome at the 4th International
Congress on Cutaneous ADRs. We examined additional patients to further characterize the
hypersensitivity syndrome±HHV±6 interaction. To clarify the relationship between clinical
manifestations and HHV-6 reactivation, we performed quantitative real-time PCR assays of serial
serum and blood samples, as well as measurements of the anti-HHV-6 IgG titers. As a result, we
clearly demonstrated the recurrence or worsening of symptoms such as hepatitis and fever was
observed concurrently with HHV-6 reactivation. Our ®ndings suggest that severe hypersensitivity
syndrome is a complex pathological condition that involves both drug allergy and HHV-6
reactivation.
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Melanocortin 1 Receptor Accounts for 50% of Variation in Hair Melanin Eumelanin and
Phaemelanin in a Northern European Dataset
L. Naysmith, T. Ha, K. Waterston, Y. Bisset, A. Ray, N. F. lanagan, S. Ito, K. Wakamatsu, and J.
L. Rees
Systems Group, Department of Dermatology, University of Edinburgh, Scotland, UK
The melanocortin 1 receptor (MC1R) is a major determinant of physiological variation in
pigmentation in many world populations. Previous studies have used a simple Mendelian model to
relate genotype to phenotype. In the present study we have attempted to move beyond this simple
framework to approach the subject as a quantitative issue: what proportion of variation can be
explained by allelic changes at MC1R? What proportion of variation is unexplained and must be
determined by othe loci? We studied 79 individuals comprising 38 volunteers with red hair and 41
nonred headed subjects. MC1R status was determined using automated sequencing. Known
functionally signi®cant changes at codons 142, 151, 160, 294 and frameshifts were counted as
mutant: other changes were treated as wild-type/pseudo-wildtype. Hair melanins were assayed for
eumelanin (PTCA) and phaeomelanin (AHP) using HPLC methods, including a recent
modi®cation enabling more direct estimation of phaeomelanin (AHP)levels (in press). Hair
colour was classi®ed according to the L'Oreal hair colour standards chart, and by using trispace
L*a*b* scores, using a chromometer, were obtained. As expected, there was a decrease in red hair
colour and phaeomelanin products with age. Using ANOVA models we showed clear differences
between the groups with strong evidence for a MC1R heterozygote effect (p < 0.01) in
determining eumelanin and phaeomelanin amounts and the ratio of phaeoelanin to eumelanin.
MC1R gene status predicts hair colour and accounts for about 50% of the variation in this
particular data set. Our results, show for the ®rst time, that objective measures using Laboratory
colour, particularly the a* and b* index (p < 0.01) may well be preferable to classi®cations based on
subjective hair colour charts.
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A New Objective and Validated Method to Measure Itch in Children with Atopic
Dermatitis
J. L. Rees, K. Benjamin, K. Waterston, OScho®eld, M. Russell, and B. Diffey
Systems Group, Dermatology, University of Edinburgh
Itch is a major symptom of skin disease. We wished to develop an objective method for measuring
itch (as scratch) that could be useful in clinical trials and to monitor disease activity. Our strategy
has been to use wrist-worn accelerometers, and to validate the use of such accelerometers in
patients in their own homes against infrared videoing of people. We have studied 21 subjects (14
with atopic dermatitis and 7 controls, age range 2±9). We used accelerometers purchased from
Cambridge Neurotechnology, worn on each limb, and subsequently interfaced via a proprietary
reader to a PC for analysis. Ethograms of child behaviour were made from direct observation of
infrared videoing carried out in the patient's own house. Child scratching behaviours were highly
heterogeneous and comprise up to 5% of the time in bed (compared with 0.2% in controls, p
< 0.01). Scratching and restlessness, as operationally de®ned, show a high degree of covariance
(p < 0.01 r2 > 0.9). There were clear differences for most of the variables measured between atopic
children and controls. We developed a number of algorithms to analyse the digital output from the
accelerometers including counting epochs with no movement, or simple double integration of
scores. Whichever analysis was used, clear differences were evident between atopics and the
controls (p < 0.01). There were no systematic differences between left and right, and whereas there
is an interesting interaction between leg and arm scores, it is likely that only one limb
accelerometer may need to be used in future studies. Finally, we note that the objective scores did
not correlate with subjective parental VAS scores. In conclusion we have developed a new
objective measure of disease activity useful for studying children with atopic dermatitis that has a
clear role both in studying itch physiology and as an endpoint in clinical trials.
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Epidemiological and Clinicopathological Features of Basal Cell Carcinomas (BCC)
Developing in Organ-Graft Recipients (OGR)
J. Kanitakis, L. Alhaj-Ibrahim, S. Euvrard, and A. Claudy
Lyon, France
OGR are at increased risk for developing various cancers, namely cutaneous squamous cell
carcinomas (SCC). Although the incidence of BCC is also increased in comparison with the
general population, these tumors have not yet been extensively studied in OGR. We studied the
epidemiological and clinicopathological features of BCC developing in OGR (OGR-BCC) in
comparison with an equivalent number of BCC retrieved randomly from the ®les of our
Dermatopathology laboratory, obtained from a control group (C) of nonimmunosuppressed
patients (C-BCC). 145/2028 OGR seen in our clinic developed 170 BCC. 40/177 OGR who
developed over 600 SCC had also at least one BCC (SCC:BCC ratio 4.3:1). OGR-BCC appeared
on average 6.94 (6 4.7) year after transplantation. The men:women ratio was higher in OGR-
BCC than in C-BCC (4:1 vs 1.3:1, p<.001), and this predominance remained signi®cant (p<.001)
after adjustment for the overrepresentation of men (68%) in the group of OGR. The mean age at
diagnosis of BCC was signi®cantly lower in OGR as compared with the C (5561 vs 70611,5 yrs,
p<.01). BCC were predominantly located over the head & neck, more frequently on the ear in
OGR as compared with C (p<.05); moreover some unusual localisations (genitalia, wrist, hand)
were found in OGR. Histologically, the mean thickness (Breslow) of OGR-BCC (1.1 6 .8 mm)
did not differ signi®cantly from that of C-BCC (1.35 6 .9 mm). Super®cial type BCC were more
frequent in OGR (34%) than in the C (14%, p<.001). Epidermal ulceration was found in 51% of
OGR-BCC and 44% of C-BCC (NS). The density of the peritumoral cell in®ltrate (scored semi-
quantitatively) was signi®cantly lower in BCC-OGR as compared with C-BCC (p<.001). Our
data con®rm that in OGR, BCC appear at a younger age, affect predominantly men, and can be
observed in unusual localisations; histologically, they tend to be super®cial, probably because they
are diagnosed at an earlier stage. The reduced in¯ammatory peritumoral reaction in OGR-BCC is
probably due to the chronic immunosuppression.
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Is Lichen Myxoedematosus an IgG-Mediated Disease?
C. Pfeiffer, R. Aschoff, and U. Julius
University Hospital Carl Gustav Carus, Technical U, Dresden, Germany
Lichen myxoedematosus is a rare, slowly progressive disease characterised by dermal acid
mucopolysaccharide, predominantly hyaluronic acid deposits. Paraproteinemia is often observed.
Its pathogenetic signi®cance is however, not clear. We treated a patient with selective IgG ablation
by immunoapheresis to study the in¯uence of IgG in disease activity. We describe a 44-years-old
lady with a nine year-history of increasing papular lichenoid lesions on forearms, knees and face.
Histology revealed Lichen myxoedematosus. A monoclonal IgG (k) could be demonstrated on
serumelectrophoresis. A plasmocytoma could be excluded. As the patient did not agree to
melphalan therapy, we instituted plasmapheresis for eight cycles. This therapy induced a slight
improvement of the skin lesions. Immunoapheresis employing a Ig-speci®c-column (Ig-
TherasorbTM, Plasmaselect) was performed for 30 cycles at appr. one week intervals. Removal
of the IgG paraprotein was ef®cient. Before treatment the paraprotein formed a 17.9% fraction at a
total protein of 78 g per l, i.e. 13.96 g per L. Before the last immunoapheresis the paraprotein was
10.3% of 60.1 g per l, i.e. 6.19 g per L. We measured the skin relief at 10 standardised sites by
visiometer. The wrinkle depth increased from 0.1 mm to 0.3 mm 20 MHz-ultrasound
documentation of the skin structure demonstrated a decrease in the amorphous dermal in®ltrate.
While plasmapheresis removes a plethora of serum proteins, immunoapheresis with the applied
column removes IgG, as well as some IgM and IgA, but no other serum proteins. Thus the
treatment success in our patient supports the notion that the paraprotein commonly observed in
Lichen myxoedematosus has a pathogenetic role in this disease.
278
Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-
induced transcription of vascular endothelial growth factor (VEGF/VPF): contribution
of the PI-3 kinase/Akt and MEK1/2 signaling pathway
K. Reisinger, R. Kaufmann and J. Gille
Zentrum der Dermatologie, Klinikum der J.W. Goethe-UniversitaÈt, Frankfurt am Main, Germany.
Hepatocyte growth factor (HGF/SF)-induced expression of vascular endothelial growth factor
(VEGF/VPF) has been implicated in paracrine ampli®cation of angiogenesis, contributing to
angiogenic responses during in¯ammation, wound healing, collateral formation and tumor growth.
We have shown previously that HGF/SF-mediated VEGF/VPF expression by keratinocytes is
primarily dependent on transcriptional activation, mapping the HGF/SF-responsive element to a
GC-rich region between bp ±88 and ±65. Sp1-like factors bind to this element constitutively,
however the VEGF/VPF promoter is transactivated by HGF/SF in the absence of induced binding
activity. In experimental approaches to clarify molecular mechanisms of Sp1-dependent VEGF/
VPF gene transcription, neither HGF/SF-dependent changes in nuclear expression nor in relative
DNA binding activity of Sp family members to the indicated element were observed. Thus, HGF/
SF was hypothesized to induce VEGF/VPF gene transcription via increased transactivation activity
of Sp1 due to biochemical modi®cation. In immunoprecipitation studies, HGF/SF was found to
increase the amount of serine-phosphorylated Sp1, revealing a likely mechanism of HGF/SF-
induced VEGF/VPF expression, as phosphorylation may enhance of Sp1 transcriptional activity.
By the use of chemical inhibition, overexpression of kinase-de®cient signaling proteins, and
transfection of antisense oligonucleotides, we herein provide evidence that PI-3 kinase/Akt, PKC-
zeta, and MEK1/2 are essential for HGF/SF-induced VEGF/VPF promoter activation. Together,
our results elucidate a critical pathway of paracrine ampli®cation of angiogenesis, suggesting that
HGF/SF-induced Sp1 phosphorylation may activate VEGF/VPF promoter activity, requiring the
contribution of distinct pathways.
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Impaired Dihydropterin Reductase Activities (DHPR) in Patients with Vitiligo
S. Hasse and K. U. Schallreuter
University of Bradford, UK
The essential cofactor for the hydroxylation of the amino acids L-phenylalanine, L-tyrosine and L-
tryptophan is (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (6BH4). 6BH4 is synthesised de novo by
the conversion of GTP via GTP-cyclohydrolase I or by regeneration of the reduced 6BH4 via
pterin carbinolamine dehydratase (PCD) and DHPR. DHPR is an NADH dependent reductase
that converts quinonoid dihydropterin into 6BH4. The method for the determination of DHPR
activity in whole blood samples uses oxidised cytochrome C to produce reduced cytochrome C
that is measured at 550 nm. Our investigation compared DHPR activity in blood samples from
healthy controls and patients with the depigmentation disorder vitiligo. The results yielded
signi®cantly increased activities of DHPR in patients with vitiligo compared to controls. Since
there are two pathways for the supply of the essential cofactor 6BH4 it could be possible that the
recycling process contributes to the pool of reduced 6BH4. However, it has been shown that
patients with vitiligo have a pathological increased shortcut to quinonoid dihydropterin due to the
deactivation of PCD by hydrogen peroxide. Hence increased production of quinonoid
dihydropterin may induce DHPR explaining the elevated activity measured in this patient group.
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Treatment of Primary Cutaneous B-Cell Lymphoma with Intralesional Rituximabq
R. Fink-Puches, I. Zalaudek, H. Kerl, and L. Cerroni
Department of Dermatology, University of Graz, Graz, Austria
Rituximabq is a genetically engineered antibody directed against the CD20 antigen. Intravenous
administration of rituximabq has been used for the treatment of patients with low-, intermediate-,
and high-grade B-cell non-Hodgkin lymphomas, and is a registered treatment modality for this
indication. Treatment of cutaneous B-cell lymphoma (CBCL) with intralesionally applied
rituximabq has been described in a few cases. We report on 6 patients with CBCL (M:F = 3 : 3;
mean age: 64,7; range: 48±80; follicle center cell lymphoma-FCCL: 3, marginal zone lymphoma-
MZL: 3) that have been treated with intralesional administration of rituximabq. Rituximabq was
applied intralesionally according to the following scheme: each patient received 20±30 mg of
rituximabq/application, fractioned in one or more doses depending on the number of lesions
treated (minimal single dose: 10 mg). The applications were repeated 3 times over a period of one
week. A new cycle of treatment was repeated after 4 weeks if lesions failed to show complete
clinical response. Complete remission could be observed in 4 patients (FCCL: 2; MZL: 2) after 1,
2, 6, and 7 cycles of treatment, respectively. Clinical remission was veri®ed by histologic
examination. Two patients (FCCL: 1; MZL: 1) achieved only a partial remission after 4 cycles of
treatment, and are currently being treated. No severe side-effect occurred except for slight pain
during injection. FACS analysis of peripheral blood revealed complete disappearance of B-
lymphocytes for a period of few weeks after application, without clinical relevance. In conclusion,
intralesional rituximabq therapy is a well tolerated and effective treatment for CBCL. Response to
therapy, however, is different for different patients, and several cycles of treatment may be
necessary to achieve complete response.
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Comparative Time Courses of Blood Flow and Itch in Wheal-and-Flare Reactions
Induced by Histamine and Type I Allergens
C. M. Willis, S. J. Bantick, I. Tracey, R. Rukwied, F. McGlone, D. I. Orton, and J. D. Wilkinson
Amersham, Oxford and Port Sunlight, UK
As part of ongoing investigations into the perception of itch, we have conducted a clinical study to
more fully characterize the physiological response to skin prick testing. Cohorts of atopic and
nonatopic individuals (n = 14) underwent a standardized prick test procedure using histamine,
saline control and the relevant type I allergen (grass pollen/house dust mite; atopics only) during
the winter months. Skin blood ¯ow was measured continuously by laser Doppler ¯owmetry over a
20-min period, with the volunteers' concurrent perception of itch intensity being recorded using
an electronic visual analogue scale. Analysis of the data revealed signi®cant differences between the
responses to histamine and allergen in atopic subjects. Histamine induced a more rapid increase in
blood ¯ow, which occurred in parallel with the onset of itch. However, the magnitudes of both
blood ¯ow increase and itch intensity were signi®cantly greater following allergen administration
and, unlike the histamine-induced changes, were sustained at their maximum levels throughout the
20 min assessment period. Atopics and nonatopics exhibited similar responses to histamine. The
study lends support to the view that histamine is only one of a number of mediators responsible for
the allergen-induced wheal-and-¯are response, and also indicates that prick testing of sensitized
individuals with the appropriate allergen provides a better paradigm for the sensation of itch than
histamine alone.
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Alefacept Selectively Reduces Subpopulations of Memory CD4+ and CD8+ T Cells
J. G. Krueger, P. Gilleaudeau, T. Kikuchi, and E. Lee
The Rockefeller University, Laboratory for Investigative Dermatology, New York, New York, USA
Activated memory (CD45RO+) T cells are believed to mediate the in¯ammatory process in
psoriasis. Alefacept (human LFA-3/IgG1 fusion protein) has been shown to reduce circulating
levels of CD4+ and CD8+ memory T cells. An open-label study of patients with chronic plaque
psoriasis was designed to assess the mechanism of action of alefacept and its effects on
subpopulations of memory T cells. Alefacept 7.5 mg was administered once weekly by IV bolus for
12 weeks. Immunohistology and ¯ow cytometry were used to study T-cell populations in skin
lesion biopsies and peripheral blood. Data are available for 13 patients at this time. At week 13, 8
patients (62%) achieved histologic remission and were judged complete responders, with reversal of
K16 expression in the epidermis and reduction of epidermal hyperplasia; 5 patients were either
partial responders or nonresponders. Mean PASI in all patients was reduced from 21.2 at baseline to
8.45 at Week 13, representing a mean decrease of 61%. From baseline to Week 13, 5 of 13 patients
achieved > 75% PASI reduction; maximal PASI improvement occurred between Weeks 13 and
19, with 9/13 patients achieving this level of response. Mean epidermal thickness was signi®cantly
reduced in responders at week 13. In complete responders, there were mean reductions of 81% for
epidermal T cells, 70% for epidermal CD8+ cells, and 56% for epidermal CD103+ (epithelial
homing) cells. Thus, circulating CD8+ memory and CD8+ epithelial homing T cells are affected to
the largest extent by alefacept. These populations are major T-cell subsets found in the epidermis of
lesional psoriatic skin. At week 13, epidermal thickness was highly correlated (r = 0.87) with the
residual number of T cells in the epidermis of lesions. In responders, the reduction in epidermal T
cells (averaging 27 3 109 cells) far exceeded the reduction of circulating memory T cells (averaging
3.4 3 109). The reduction from baseline in IFNg-producing T cells in the circulation (57%)
exceeded that of the overall memory T-cell population (30%), supporting the selectivity of
alefacept for Type 1 T cells. These results establish selective effects of alefacept on disease-related T
cells with at least 8:1 therapeutic selectivity. These data are most consistent with selective depletion
as the relevant therapeutic mechanism of alefacept, though relative immune deviation may also
contribute to ef®cacy.
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Retreatment with Alefacept Improves Clinical Response: Results from Two Phase III
Trials
P. Van de Kerkhof, G. Wozel, M. de la Brassine, and R. Langley
University Hospital Nijmegen, the Netherlands; University Carl Gustav, Dresden, Germany; CHU Liege
Sart Tilman, Belgium; Dalhousie University, Halifax, Nova Scotia
The ef®cacy and safety of alefacept in patients with chronic plaque psoriasis has been evaluated in
two randomized, placebo-controlled phase III trials. Alefacept 7.5 mg was administered by 30-
second IV bolus in 1 trial and as a 15-mg intramuscular (IM) injection in the other. A course of
treatment was de®ned as once-weekly injections of alefacept for 12 weeks followed by 12 weeks of
observation. A single course of IV or IM alefacept provided statistically and clinically signi®cant
reductions in the symptoms and severity of psoriasis compared with placebo. Two courses of
alefacept provided greater bene®t in both studies. Patients who received two courses of alefacept
(7.5 mg IV or 15 mg IM) had a maximum reduction from ®rst-course baseline Psoriasis Area
Severity Index (PASI) of 54% at 6 weeks after the last IV dose and 45% at 12 weeks after the last IM
dose of the second course. The percentages of patients who achieved > 75% reduction in PASI
during the entire study period after a single course and after a second course were 28% and 40%,
respectively, for alefacept IV, and 33% and 43%, respectively, for alefacept IM. Corresponding
response rates for > 50% reduction in PASI were 56% and 71% for alefacept IV and 57% and 69%
for alefacept IM. The percentages of patients who achieved ``clear'' or ``almost clear'' by Physician
Global Assessment after two courses of therapy were 32% and 31% for IV and IM alefacept,
respectively. No rebound of disease or ¯ares were observed following treatment cessation in either
study. Notably, repeated courses of IV and IM alefacept were well tolerated, with similar adverse
event reports during Course 1 and Course 2. There was no evidence of a cumulative effect on
lymphocytes. In conclusion, two courses of IV or IM alefacept produce signi®cant clinical
improvements in psoriasis. The incremental effectiveness of a second course of alefacept provides
strong support for its use as an intermittent therapy.
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Skin Problems in Adult Organ Transplant Recipients
C. A. Harwood, I. M. Leigh, and C. M. Proby
Centre for Cutaneous Research, Barts and the London Queen Mary's School of Medicine and Dentistry,
University of London, UK
The number of organ allograft recipients worldwide is steadily increasing and the chronic
immunosuppressive therapy necessary for graft function frequently results in cutaneous side-effects.
In addition to the direct side-effects of drugs (e.g. acne vulgaris, hirsutism, skin atrophy, gum
hypertrophy), infections and malignancies are the most commonly encountered problems in adults.
Fungal and viral infections, particularly by the human papillomaviruses (HPV), may be extensive
and refractory to treatment. Non-melanoma skin cancers are the commonest post-transplant
malignancy, with the risk for SCC increased 50±100 fold and BCC up to 10-fold. These tumours
are often multiple, aggressive and have increased metastatic potential. Ultraviolet radiation and
reduced immunesurveillance clearly play a role in their pathogenesis, but there is mounting
evidence implicating an important cofactor role for HPV, particularly by viruses of the
epidermodysplasia verruciformis subgroup. Predisposing genetic factors such speci®c polymorph-
isms in p53 and GST may also be relevant. Malignant melanoma, cutaneous lymphoma and
Kaposi's sarcoma are over-represented and evidence is emerging that rarer appendageal tumours,
especially those of sebaceous gland origin, are also more common. The diverse spectrum and high
frequency of cutaneous malignancies observed in organ transplant recipients highlights the
importance of regular surveillance of this high-risk population and the need for well-designed
preventative and therapeutic management strategies.
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Eczematous Dermatitis During Treatment of Hepatitis C with Interferon a and
Ribavirinin
J. LuÈbbe, K. Kerl-Bullani, and F. Negro*
Departments of Dermatology and *Gastroenterology, HoÃpital cantonal universitaire, Geneva, Switzerland
Introduction: Interferon a (IFNa) and ribavirin combination therapy is currently considered the
most effective treatment for chronic hepatitis C. Both monotherapy with IFNa, and combination
treatment have been associated with an increased prevalence of in¯ammatory skin diseases.
Background: Cutaneous adverse effects may be an obstacle to adherence with long-term
combination therapy of chronic hepatitis C. A better characterization of cases is needed in order to
de®ne the role of a dermatologic approach in concerned patients. Observations: Between january
1999 and april 2002, 53 patients receiving combination treatment with ribavirin and interferon alfa
were followed prospectively. Eight patients developed de novo generalized eczematous dermatitis.
One of them had a personal history suggestive of atopic diathesis. A search for elevated speci®c IgE
(phadiatop°) was performed in 5 patients, and was positive in 3 patients. One patient noted an
aggravation of a preexistent eczematous dermatitis. One patient developed a localized nummular
eczematous plaque distant from IFNa injection sites. First symptoms appeared between a few days,
and 9 months after onset of treatment. Treatment with mid-potent topical corticosteroids and
emmolients was effective in most patients ; in no case had the combination therapy to be
interrupted. Discussion: The observations suggest that eczematous dermatitis is a frequent side
effect of combination therapy for chronic hepatitis C. At least a portion of cases is associated with
elevated speci®c IgE, but further studies are needed to determine the role of atopy as a predisposing
factor vs. a consequence of therapy with IFNa and ribavirin.
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Herpes Simplex History, Serology, and Symptomatic Infections in Patients Treated
with Topical Tacrolimus for Atopic Dermatitis
J. LuÈbbe
Departments of Dermatology and Venerology, Geneva University Hospital, Geneva, Switzerland
Introduction: Tacrolimus ointment is a new and effective treatment for atopic dermatitis. As a main
advantage over topical corticosteroids, this macrolide immunosuppressor does not induce
cutaneous atrophy. Topical tacrolimus ointment will therefore become a treatment of choice
for sensitive areas such as the head and neck, which is also a site of predilection for herpes simplex
infection. Background: Eczema herpeticatum is a potentially serious complication of herpes
simplex infection, and has been observed during treatment of atopic dermatitis with tacrolimus
ointment. Objective: To study symptomatic herpes simplex infections in a cohort of 52 patients
with atopic dermatitis that were treated with tacrolimus ointment. Results: Overall, 19% of
patients presented with symptomatic herpes simplex. None of the patients with a positive history
and/or recurrent herpes simplex suffered a complication, while all three patients with eczema
herpeticatum had a negative herpes simplex history. Discussion: Our observations suggest that
patients with a negative herpes simplex history may be more at risk for eczema herpeticatum than
patients with symptomatic recurrent herpes simplex. A speculative explanation for this apparent
paradoxon would be that patients with a negative herpes history have unrecognized symptomatic
herpes simplex infection, and thus might bene®t from targeted information about herpes simplex in
order to reduce the risk of treating herpetic lesions with topical tacrolimus.
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Helio (Photo) -thalassic Therapy and Bio-Stimulated Pigmentation in Psoriasis
A. Petrov, P. Bachevski, Gj Gocev, N. Petrova, and R. Ohrid
Skopje and Macedonia
Psoriasis is chronic disease with unclear etiology, genetic predisposition and unpredictable
evolution. Conventional therapy does not stop the relapses, has numerous side-effects, so it is
serious psychological stress for patients, who affect their quality of life, and leads to hospitalizem.
This is great challenge for developing new treatment strategy based on natural recourses. We tried
to promote the method of photo (helio)-thalassic therapy with biostimulated pigmentation in ideal
climate of Ohrid Lake and higher segment of near Galicica Mountain. This region with many
sunny days, in period from April to October, is particularly good for such treatment. We treated
group of 40 patients- volunteers (age from 5 to 39) where diagnosis psoriasis vulgaris was clinically
established and by histology con®rmed. Duration of the disease was between 3 months and
25 years. Ten percent (10%) of patients were psihologicaly traumatized by previous long-time
treatment. Weekly dynamics of therapy was, in mountain segment once a week between 8 and 11
a.m., in lake segment every day between 8 and 11 a.m., and 3±6 p.m. For stimulation of
pigmentation, 1 h before exposure to the sun locally was applied extracts from plants and bee
products. State Health Institute previously approved their use. Medium duration of treatment was
3 weeks, and 32 (80%) of patients had complete remission (compared with 30% spontaneous
remission of psoriasis) of the skin changes. These results are demonstrating and supporting bio-
stimulated pigmentation in psoriasis vulgaris as additional therapy to conventional treatment.
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The Targeted Mechanism of Alefacept Selectively Reduces Memory-Effector
(CD45RO+) T Cells and is Related to Clinical Improvements in Psoriasis
L. Dubertret, P. Altmeyer, and K. Gordon
HoÃpital St Louis, Paris, France; St Josef-Hospital, Bochum, Germany; North-western University, Chicago,
Illinois, USA
Alefacept is a fully human fusion protein consisting of the ®rst extracellular domain of LFA-3 fused
to the hinge, CH2, and CH3 sequences of IgG1. The LFA-3 segment binds CD2 on the surface of
T cells, while the Fc portion binds FcgRIII on accessory cells. These actions inhibit T-cell
activation and proliferation and induce selective apoptosis of memory-effector (CD4+CD45RO+
and CD8+CD45RO+) T cells. These T cells are preferentially reduced because they express higher
levels of CD2 than naõÈve (CD45RA+) T cells. Memory T cells make up the majority of T cells
found in psoriatic plaques and are thought to mediate disease activity in the skin. In randomized
phase III clinical trials of alefacept in chronic plaque psoriasis, the relationship between memory T-
cell reduction and clinical improvement was assessed. The magnitude of reduction in peripheral
memory T cells was measured by the area under the effect curve (EAUC), and then divided into
quartiles. Clinical response was measured by PASI and PGA. In a double-blind, international study
(n = 507), patients were randomized to alefacept 10 or 15 mg or placebo weekly by IM injection
for 12 weeks, followed by 12 weeks of observation. The percentages of alefacept-treated patients
(10 or 15 mg) who had > 75% PASI reduction from baseline at any time increased with increasing
effect on peripheral memory CD4+ T cells (21%, 28%, 33%, and 38% for EAUC quartiles 1±4,
respectively). Corresponding percentages of patients who achieved PGA of ``clear'' or ``almost
clear'' at any time were 13%, 16%, 29%, and 33%. Similar results were observed in a multicenter
study (n = 553) that consisted of two double-blind, 12-week treatment courses, each with 12 weeks
of treatment-free follow-up. Alefacept 7.5 mg and placebo were administered weekly by 30-
second IV bolus injection. The percentages of alefacept-treated patients who had > 75% PASI
reduction from baseline at any time in Course 1 increased with greater reductions in CD4+
memory T cells (16%, 20%, 32%, and 44% for EAUC quartiles 1±4, respectively). Of those
receiving two courses of alefacept, corresponding response rates at any time in Course 2 were 19%,
9%, 30%, and 62%. The relationship between the extent of memory T-cell reduction and clinical
ef®cacy supports a key role for this T-cell subset in disease pathology.
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The Role of Reactive Oxygen (ROS) and Nitrogen Species (RNS) in the Pathogenesis of
Warts: Hypothesis and Reality of Clinical Trial
C. De Luca, I. Deeva, U. Lancia, D. Fileccia, A. Luci, and L. Korkina
Rome, Italy and Moscow, Russia
The dozens of topical and systemic treatments of verruca vulgaris, hyperkeratosis caused by human
papillomavirus, include chemical, cryo-, thermal, and photo-destruction, in combination with
immunosensitization and topical application of pro-in¯ammatory agents. No treatment gives so far
entirely satisfactory results, due to high incidence of relapses or nonresponders, morbidity, adverse
effects, or low ef®cacy. In the last decade a ``double-edge sword'' role of ROS and RNS in the
pathogenesis of viral infections has been hypothesized. The viral-induced low intracellular levels of
ROS are triggers for nuclear transcription factor (NFkB), leading to increased proliferation of both
the host keratinocytes and virus itself, while higher levels of ROS and RNS cause in a
concentration-dependent manner either apoptotic or necrotic death of virus bearing cells, thus
limiting the spread of infection to neighboring tissue. Although by different mechanisms, all the
therapeutic agents used in the treatment of warts induce an increased production of ROS or/and
RNS. After thorough laboratory investigation, a nutraceutical formulation (Immugenq, IDI
Farmaceutici, Italy) containing inducers of intracellular ROS and RNS production (L-methionine
and soy phospholipids) to eliminate virus-bearing cells, and strong antioxidants to protect the host
cells against free radical destruction (a-tocopherol, ubiquinone, selenium aspartate) has been
chosen. We performed a double blind placebo- and case-controlled randomized clinical trial
(number of patients ±59, selected for the presence of at least 1 relapse after cryotherapy; duration of
treatment ±180 days; number of warts per patient ± > 10), comparing a combination of
cryodestruction and oral administration of Immugenq and cryosurgery + placebo. The study was
conducted with external monitoring, and in compliance to Good Clinical Practices. Results
showed the statistically signi®cant increase in total clearance of the virus (57% vs. 33% for placebo
group), lower incidence of relapses (25% vs. 50%), good tolerability and compliance, and the
absence of adverse effects. The interim analysis of results provides evidence that the administration
of pro-/antioxidants in combination with cryosurgery can be recommended for safe and successful
treatment of recurrent cutaneous warts.
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The Ef®cacy of 308 nm Excimer Laser in the Treatment of Psoriasis is Related to
Individual Clinical Subtypes
W. Gerber and H. M. Ockenfels
Department of Dermatology and Allergology, Klinikum Stadt Hanau, Germany
Objectives: The UV-light therapy of psoriasis using psoralen and UV-A (PUVA) or UV-B,
especially 311 nm, is one of the most used treatments inducing clearance of psoriatic leasions.
Recently, a successfully irradiation of psoriatic leasions with 308 nm Excimer Laser was described.
This new type of treatment allows to aime at involved areas without hitting normal skin and uses
more than 3-fold of the individual MED on the involed skin. Methods: To analize if all different
types of psoriasis bene®t to this new treatment and to standardize the therapy, a prospective study
was performed: 60 patients (33 men and 27 women, mean age 49 years) where included in the
study. The criterias of 1) persistance of psoriasis less or more one year, 2) the localization (e.g.
scalp), 3) the involved body surface and 4) the clinical type (e.g. pustulosa) where related to
number of Excimer laser treatments and the cumulative dosis of UV-B 308 nm until clearance was
measured and compared to traditionally used 311 nm. Clinical improvement and relapse was
documented by PASI over a time period of 4 months. Results: Patients with a short history of
psoriasis < 1 year, especially with guttate-type and/or with several plaques pro®t extremly of
Excimer laser treatment. In 36 patients who were treated 9,4 + 3.1 times with cumulative dosis
of 9.8 J per cm2 + 4,2 J per cm2 , PASI was reduced from 9.3 + 4,2 to 2.1 + 1.8 . In contrast, the
ef®cacy was less in patients with an involved body surface > 25% and with long history of thick
chronic plaques and hereby high dosages of UV-B radiation ( 31.3 J per cm2 + 6.7 J per cm2) and
many sessions 23.2 + 4.0 were necessary to reduce PASI from 15.3 + 3.1 to 8.3 + 2.7. The ef®cacy
for treating scalp psoriasis (n = 5) was not convincing, but pustulosa psoriasis (n = 5) was cleared in
15.6 + 3.7 treatments using 16,9 J per cm2 + 2.9 J per cm2. Conclusion: Excimer laser generated
308-nm UV-B radiation is one of the most effective treatment modalities for moderate forms of
psoriasis. Hereby cumulative UV-B dose is lower than seen in traditionally used 311 nm radiation.
When applied as a monotherapy, UV-B 308 nm Excimer Laser therapy is less suf®cient in the
treatment of severe psoriasis with thick stationary plaques.
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Cutaneous Field Stimulation of Sensory Nerve Fibers Reduces Itch But Has No Effect
on Experimental Delayed Reactions
J. Wallengren
Department of Dermatology, University Hospital, Lund, Sweden
A new technique, cutaneous ®eld stimulation (CFS), which electrically stimulates unmyelinated C-
®bers, is used to treat itch in skin disease. The aim of this study was to investigate how
experimental contact dermatitis responds to this treatment. Twelve patients with contact dermatitis
to nickel used CFS for one hour during four days. A ¯exible plate with electrodes was applied on
the test area on one upper arm and stimulated by a constant current (0.8 mA). On the ®fth day they
were provoked with nickel sulphate (allergic contact dermatitis) and benzalkonium chloride
(irritant contact dermatitis) epicutaneously and with tuberculine (delayed immunologic reaction)
intradermally. Twelve patients with type I allergy were treated with CFS on the lower arm for one
hour and then pricked with histamine and the allergen extracts (the volume of the weals being
measured) and tested with bensoic acid (nonimmunologic contact urticaria, closed test). Itch was
recorded. In addition, 10 patients used CFS for four days and the experiments were performed on
the ®fth day. The allergic prick test reactions were increased after a single CFS treatment, the itch
being signi®cantly reduced after both single and repeated CFS treatments. All other test reactions
remained unchanged. Repeated CFS seems to be a safe treatment of itch without adverse effects on
contact dermatitis.
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Adverse Cutaneous Reactions to Imatinib (STI571) in Philadelphia Chromosome-
Positive Leukemias: A Prospective Study of 54 Patients
L. Valeyrie, S. Bastuji-Garin,* J. Revuz, N. Bachot, J. Wechsler,² P. Berthaud,§ M. Tulliez,³ and
S. Giraudier³
Department of Dermatology, *Public Health, ²Pathology, ³Hematology, Henri-Mondor Hospital (AP-HP),
CreÂteil, France; §Novartis Laboratory
Background: Imatinib is a new major treatment in chronic myeloid leukemia. Objective: To study
the cutaneous reactions induced by imatinib. Methods: All in- and out-patients with Philadelphia
chromosome-positive leukemia, treated by imatinib were included in this prospective study.
Clinical features, pathological ®ndings, evolution of each case, and analysis of potential risk factors
were recorded. Results: 54 patients were included, 48 of whom experienced at least one cutaneous
reaction. These reactions consisted of 36 rashes, 35 edemas, and 22 pruritus. The rash was severe in
5 patients, resulting in temporary interruption of treatment in 3. Highly signi®cant relationships
were observed between the daily dose of imatinib and both rashes and edema. In a multivariate
analysis, female gender and the daily dose of imatinib were independent risk factors for the
development of rashes. Conclusion: Adverse cutaneous reactions induced by imatinib are frequent,
generally moderate and dose dependent.
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Severity of Drug Reaction with Eosinophiilia and Systemic Symtoms (DRESS)
E. P. Begon, N. Bachot, N. Beneton, H. Bocquet, J. Revuz, and J. C. Roujeau
Henri Mondor, CreÂteil, France
The short and long-term prognosis of DRESS is poorly known. This was evalauted in a
retrospective analysis of 55 patients hospitalized in a single center from 01 to 1995 to 06±2001. The
severity of the disease was evaluated on 3 criteria: a severity score at diagnosis, duration of
symptoms for more than 6 weeks, death. A diagnosis of DRESS was considered de®nite in 55 of 74
cases where this diagnosis had been proposed at discharge. The patients were 24 males and 31
females, the mean age was 45 years (range 15±84), 15/55 were of African ancestry (27%). The delay
between onset of treatment and reaction was 31 days as a mean (1±79). Medications that were more
often implicated were minocycline (11), carbamazepine (10), antibacterial sufonamides (8) and
allopurinol (7). The severity score at diagnosis was above 6 in 17 patients, including 12 with black
skin. (OR 28, 5.8±135) and 7 exposed to minocycline (0R 6, 1.4±24.5). The duration of the
disease exceeded 6 weeks in 13 patients (24%) including 7 with black skin (OR 5, 1.3±19) and 7
exposed to minocycline (OR 11, 2.5±50). Five patients died (9%), including 2 with black skin. and
3 with a prolonged disease. These results con®rm that DRESS is a severe disease with a high
percentage of chronic forms. Black ethnicity and exposition to minocycline are factors predisposing
to more severe and chronic disease.
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Thymic Index and Infantile Atopic Dermatitis: A Case-Control Study
F. Boralevi, P. Petit, J. F. Chateil, M. Brun, C. LeÂauteÂ-LabreÁze, C. Thestrup-Pedersen, and A.
TaõÈeb
Bordeaux, France and Marselisborg, Denmark
Atopic dermatitis has been hypothesized as the result of thymic dysmaturation. We studied thymic
size in a cohort of children aged from one month to two years to check whether morphologic
®ndings do support this hypothesis. Three groups of 20 children were enrolled: a group with atopic
dermatitis, a group at high risk of atopy (infants with a ®rst-degree parent suffering from atopic
disease) and a control group. For each infant, a physical examination was performed and the size of
the thymus was measured by sonography. In the group with atopic dermatitis, SCORAD index
was calculated and IgE levels were obtained. No statistical difference in thymic index was found
between the three groups. Within the atopic group, analysis of subgroups according to index of
severity indicated the same trend, i.e. the higher the SCORAD index, the lower the thymic index.
In this group, there was no relationship between IgE values and the thymic index. Confounders,
such as systemic effect of topical steroids and possible biases in measurement are limiting factors in
interpretation of these data. However, although these preliminary results need to be con®rmed, the
thymus may play a role in the pathophysiology of atopic dermatitis. The smaller size of the thymus
in severe cases suggests that excessive apoptotic material from the thymocytes could be involved in
the onset of atopic dermatitis.
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Validity of Self-Assessment of Melanoma Risk: Case-Control Study
A. Harbauer, M. Binder, H. Pehamberger, K. Wolff, and H. Kittler
Vienna, Austria
The aim of the study was to assess the validity of a risk strati®cation model for melanoma based on
self assessment of risk factors. In a case-control study melanoma patients (n = 202) and controls
(n = 202) matched by age and gender ®lled in a questionnaire including melanoma risk factors and
were examined by specially trained interviewers. For analysing the data we used odds ratios of risk
factors and compared a self-assessment based risk strati®cation model for melanoma with a model
based on physician assessment of risk factors (ROC analysis). Self-assessment and physician
assessment of risk factors identi®ed the number of naevi, skin phototype, and UV-damage of the
skin as independent risk factors for melanoma. ROC analysis showed no statistically signi®cant
difference between the accuracy of the self-assessment based risk model (area under the curve:0.73;
95% CI: 0.68±0.77) and the model based on physician assessment (area under the curve: 0.77, 95%
CI: 0.73±0.83; p = 0.10). A group de®ned as being at high risk of melanoma derived from the self
assessment based risk model and the physician based risk model included 39% (95% CI: 31%-48%)
and 42% (95% CI: 33%-52%) of the melanoma patients while excluding 90% of the controls. A
relatively simple risk strati®cation model based on self-assessment of risk factors is as accurate as a
model based on physician assessment and could be useful for identi®cation of a group of individuals
at high-risk for developing melanoma.
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The EuroSCAR study
J.-C. Roujeau
HoÃpital Henri Mondor, UniversiteÂ Paris XII, Dermatology, CreÂteil, France
A case control study of severe cutaneous reactions (SCAR) to drugs (Stevens±Johnson syndrome-
SJS, toxic epidermal necrolysis-TEN and acute generalized exanthematous pustulosis-AGEP) was
conducted in 7 european countries from September 1997 to December 2001. A total of 810
potential cases were collected prospectivelly. 443 cases of probable or de®nite SJS or TEN and 137
cases of probable or de®nite AGEP were enrolled together with 1589 controls. The results from
preliminary case-control analyses con®rmed that for SJS or TEN the drugs associated to the highest
risks were anticonvulsants, oxicam NSAIDs, antibacterial sulfonamides and allopurinol. Compared
with the results of a prior case-control study, the EuroSCAR study found a higher risk associated to
the use of allopurinol and pointed to very high risks linked to two recently released drugs:
lamotrigine and nevirapine. Lamotrigine, an anticonvulsant, was associated to a risk that was at least
as high as those related to phenytoin or carbamazepine. Nevirapine, an antiretroviral agent took the
place of sulfonamides as the main cause of SCARs in HIV infected persons. Concerning AGEP the
EuroSCAR study con®rmed the principal role of antibiotics as a cause of the reaction. Further
analyses will precise the respective role of infections and antibacterial medications in inducing
severe cutaneous reactions.
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Atopic Dermatitis and the Risk of Cancer
A. Braae Olesen, G. Engholm, H. H. Storm, and K. Thestrup-Pedersen
Aarhus and Copenhagen, Denmark
Both blood and skin lymphocytes from adults with severe atopic dermatitis show telomere erosion
and have increased telomerase activity similar to what is found in patients with lymphoma.
Treatments with immunosuppressive agents such as tar, UV therapy and corticosteroids may also
increase the risk of cancer. We therefore analyzed, if patients having severe atopic dermatitis have
an increased risk of cancer. All individuals admitted with a primary diagnosis of atopic dermatitis
during 1977±96 were identi®ed in the Danish National Hospital Register and followed up in the
Danish Cancer Register. A total of 6275 persons were admitted with atopic dermatitis during the
20-year period. Among 2030 adult patients an increased risk of cancer was observed; SMR = 1.5
(95%CI: 1.2±1.9). Half the excess cases of cancer was related to nonmelanoma skin cancer
diagnosed within the ®rst 10 years of discharge; SMR = 2.7 (95%CI = 1.6±4.3). Ten men
developed nonmelanoma skin cancer vs. 3.6 expected; SMR = 2.8 (95%CI: 1.3±5.1). No increased
risk of malignant melanoma nor lymphoma was observed and the cancer risk was not increased
among women or children (No. 4245; age < 18 years). In conclusion, male adult atopic dermatitis
patients had increased risk of nonmelanoma skin cancer but not other cancers. No increased cancer
risk was observed among women and children.
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Skin Care in Organ Transplant Patients (SCOP) ± Analysis of Risk factors,
Prophylactical Strategies and Therapeutical Options Basing on the International
Scop-Network
E. Stock¯eth, C. Ulrich, T. Schmook, and W. Sterry
ChariteÂ, Humboldt UniversitaÈt Berlin, Dermatology, Berlin, Germany
Background: Transplantation of solid organs has been a well established mode of therapy for the
treatment of various end-stage diseases for many years now. While in the ®rst year following
transplantation special emphasis is given to the prevention of viral, bacterial and fungal infections a
signi®cant increased incidence of non-melanoma skin cancer is paralleling the extended survival
rates of grafted patients. Against the background of lifelong immunosuppression risk factors such as
sun-exposure and infections with oncogene virus have to be discussed. Until now most of the
published data contains only small groups of patients making comprehensive risk-factor analysis still
dif®cult. Objective: The structure of an international, internet based, epidemiologic data-bank -
the SCOP-Network - is presented. Results: First results highlight the signi®cance of epidemiologic
research in transplant medicine and emphasize the importance of standardized interdisciplinary and
dermatological care in this ®eld. Our data indicates that 40% of the organ grafted patients show
premalignant or malignant lesions on their ®rst visit. Further on 22% develop SCC, 17% BCC,
12% Bowen's disease and nearly 5% malignant melanoma. Actinic keratoses are found in 43% of
these patients. 66% of the lesions are located on sun exposed areas of the skin. Various in¯uencable
riskfactors such as cumulative sun-exposure and the total immunosuppressive therapy burden are
quanti®ed and discussed against the innate individual susceptibility for skin cancer. Conclusion:
The SCOP-Network represents a new type of multi national cooperation in the ®eld of transplant-
dermatology. Besides a epidemiologic databank, the integration of basic research and the
exploration of new therapeutic options will provide effective strategies to ease the burden of skin
infections and cutaneous malignancies in these group of patients. New data on the incidence of
skin cancer related to the lifetime-sunexposure, the cumulative dose of immunosuppressive drugs
or the load of oncogenous human papilloma viruses (HPV) might lead towards new preventive
strategies.
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Accuracy of Drug Prescriptions and Risk of Toxic Epidermal Necrolysis
N. Bachot, M. Aigle, J. Revuz, and J. C. Roujeau
HoÃpital Henri Mondor, CreÂteil, France
One third of admissions for a drug adverse effect in an American hospital were secondary to an
inappropriate prescription. Our aim was to check whether this was also true for toxic epidermal
necrolysis (TEN) and Stevens Johnson Syndrome (SJS). In a retrospective series of 275 patients
hospitalized between 1987 and 2000, we selected the 132 cases who had clear data on: (1) causative
drug(s) belonging to the category of anticonvulsants, antibacterial sulfonamides, allopurinol, or
oxicam NSAIDs, and (2) indication for prescription of this causative drug. The prescription was
judged questionable when (1) indication was different from the designated use or (2) precautions or
contraindications were not respected, both as labelled in the 2001 formulary. According to the
2001 recommendations 76 prescriptions (58%) were questionable: 24/32 (75%) for trimethoprim-
sulfamethoxazole (mild urinary tract infection), 0/25 (0%) for sulfadiazine, 4/4 for sulfadoxine 9/
20 (45%) for carbamazepine (acute pain, including trigeminal neuralgia), 14/19 (74%) for
phenobarbital (tranquillizer), 13/17 (77%) for allopurinol (asymptomatic hyperuricemia), 11/12
(92%) for oxicams (®rst line treatment for acute rheumatologic disorders), and 1/3 for phenytoin.
These results con®rmed that in a majority of cases of SJS or TEN (58%) the prescription of ``high
risk drugs'' could have been avoided. A strict respect of present prescription rules for the main
drugs associated with high risk of TEN or SJS could decrease by 30% the incidence of TEN and
SJS.
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Adenosine Receptors as Mediators of Both Cell Proliferation and Cell Death of Cultured
Human Melanoma Cells
S. Merighi, P. Mirandola, K. Varani, S. Gessi, S. Dalla®na, K. N. Klotz, E. Leung, P. G. Baraldi,
and P. A. Borea
Ferrara, Italy, Wurzburg, Germany, Cary, USA
Adenosine displays contradictory effects on cell growth: it improves cell proliferation, but it may
also induce apoptosis and impair cell survival. Following the pharmacological characterisation of
adenosine receptor expression on the human melanoma cell line A375, we chose A375 as our
cellular model to de®ne how the extracellular adenosine signals are conveyed from each receptor.
By using selective adenosine receptor agonists or antagonists, we found that A2A stimulation
reduced cell viability and cell clone formation while at the same time it improved cell proliferation.
In support of this ®nding we demonstrate that the stimulation of A2A adenosine receptors stably
expressed in CHO cell clone reproduced deleterious effects observed in human melanoma cells. A3
stimulation counteracted A2A-induced cell death but also reduced cell proliferation. Furthermore,
we found that A3 stimulation ensures cell survival. We demonstrate that adenosine triggers a
survival signal via A3 receptor activation and it kills the cell through A2A receptor inducing a
signalling pathway that involves protein kinase C (PKC) and mitogen-activated protein kinases
(MAPKs).
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T-Flavanone(t-FN), a Novel Hair Growth Promotor, Suppresses Hair Loss Through
Reinforcing Hair Rooting
E. Wakisaka, A. Ouchi, S. Moriwaki, T. Nomura, H. Kidena, M. Hotta, and Y. Takema
Kao Co, Japan
This study aims at investigating the mechanism of hair growth promoting activity of t-FN(trans-
3,4¢-dimethyl-3-hydroxy¯avanone), a newly synthesized chemical derived from St John's Wort. A
double-blind usage test was performed on 84 healthy volunteers who had male pattern baldness.
The subjects were divided into three groups with equal average baldness. At the beginning of the
test, an evaluation area was set for each subject around the scalp where hair loss was prominent.
Each group used, twice a day for six-months, a vasodilator-containing hair lotion supplemented
either with 0% (control), 0.1%, or 0.3% t-FN. The ef®cacy of t-FN was evaluated in the set area, in
terms of the total hair number, the terminal hair number, the percentage of terminal hairs, and the
hair shaft diameter. At the end of the test period, the terminal hair tenacity was determined as an
average peak force required for plucking out a single hair in a nonbald area, with a digital force
gauge. In the six-month usage, the terminal hair number, a measure of growing-phase hair ratio,
showed a tendency of t-FN dose-dependent increase. This increase was signi®cant in the 0.3%
group (p = 0.02). The hair tenacity was also increased dose-dependently, being signi®cant in the
0.3% group (p = 0.03). This effect could be explained by stiff rooting of the hair in the scalp and/or
by mere thickening of the hair shafts. Previously we had demonstrated that t-FN did increase hair
shaft diameter. But, interestingly, even when hairs of the same diameter were compared, the
tenacity was signi®cantly increased in the 0.3% group (p = 0.01). We speculate that t-FN may
reinforce the hair rooting independent of the hair thickening. Taken together with our previous In
vitro studies showing that t-FN enhances the cell adhesion molecule expression in hair follicles, the
reinforcement of hair rooting can be a mechanism of the hair growth promotion by t-FN.
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The In¯uence of Chloroquine Treatment on Minimal Erythemal Dose Measurements in
Systemic Lupus Erythemaosus Patients
A. Wozniacka, E. Robak, A. Sysa-Jedrzejowska, and M. Zak-Prelich
Department of Dermatology, Medical University, Lodz, Poland
Antimalarials have been used in the treatment of systemic lupus erythematosus (SLE) for many
years. The mechanism by which they act is not well de®ned, however, their photoprotective
effects are well documented. It was also revealed that IL-6 and IL-18 levels are increased in SLE
patients. The aim of our study was to compare minimal erythemal dose (MED) in SLE patients
before (BT) and after (AT) prolonged use of chloroquine (CQ) and to investigate whether this
treatment may in¯uence the IL-6 and IL-18 sera concentrations in some SLE patients. The study
involved 18 patients (17 women and 1 men) aged 24±65 years (mean: 44 y). The diagnosis of SLE
was based on the revised criteria of the American College of Rheumatology. Patients included in
the study were in inactive phase of the disease, which was determined according to the systemic
lupus activity measure (SLAM). Corticosteroids and immunosuppressive drugs were ceased at least
1 month before phototesting and antimalarials at least 6 months. MED measurements were
performed typically before and after 3 months treatment with 250 mg of CQ daily. In statistical
analysis t-Student, Wilcoxon range and Cochran-Cox tests were used. In 6 patients also IL-6 and
IL-18 concentrations in sera were evaluated by ELISA. SLAM score decrease from 9 points (3±15)
to 3 (range 1±7) after CQ treatment. MED measurements were as follows: BT: 0.04±0.19 J per cm2
(mean: 0.10 J per cm2), AT: 0.07±1.15 J per cm2 (mean: 0.20 J per cm2). The differences were
highly statistically signi®cant (p < 0.001). IL-6 and IL-18 levels was measured in 6 patients and 17
controls. IL-6 concentrations were as follows: BT: mean: 3.5 pg per ml (range 0.8±7.6 pg per ml),
AT mean: 2,5 pg per ml (range: 0.9±5.0 pg per ml), Controls: mean: 0.7 pg per ml (0.1±2.0 pg
per ml). And in IL-18: 458 pg per ml (205±844 pg per ml), 363 pg per ml (184±530 pg per ml) and
221 pg per ml (72±496 pg per ml), respectively. The differences in IL-6 and IL-18 levels BT and
AT were not statistically signi®cant, however, there were statistically signi®cant differences
between both samples and the controls (p < 0.05). The results showed not only bene®cial (SLAM
score) but also signi®cant photoprotective effect of chloroquine treatment in SLE patients.
Although IL-6 and IL-18 levels decreased during the treatment with chloroquine, the differences
were not statistically signi®cant
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The In¯uence of Chloroquine Treatment on Cholesterol, Triglyceride and Glucose
Levels in Systemic Lupus Erythematosus Patients
M. Zak-Prelich, A. Sysa-Jedrzejowska, E. Robak, and A. Wozniacka
Department of Dermatology, Medical University, Lodz, Poland
Antimalarials have been used in the treatment of systemic lupus erythematosus (SLE) for many
years. It was revealed that among other bene®cial effects they can reduce cholesterol, trigliceryde
and glucose levels, although most studies were performed with hydroxychloroquine (HCQ). As
HCQ is not registered in Poland, the aim of the study was to investigate the in¯uence of low doses
of chloroquine (CQ) on cholesterol, HDL, LDL, triglyceride and glucose levels in SLE patients.
The study involved 16 patients (15 women and 1 men), aged 24±65 years (mean: 45 years). The
diagnosis of SLE was based on the revised criteria of the American College of Rheumatology.
Patients included in the study were in inactive phase of the disease which was determined
according to the systemic lupus activity measure (SLAM < 15) and they did not change their eating
habits during the study. Corticosteroids and immunosuppressive drugs were stopped at least
1 month before the study and antimalarials at least 6 months. The blood for laboratory
investigations was collected twice: before (BT) and after (AT) 3 months of the daily treatment
of 250 mg of CQ. In statistical analysis t-Student test was used. The cholesterol level decreases from
189 mg/% (range: 128±280 mg%) to 167 mg/% (range: 98±233 mg/%) (p < 0.02), the trigliceryde
level decreases from 147 mg/% (range: 62±267 mg/%) to 98 mg/% (range: 45±199 mg/%)
(p < 0.01). HDL levels were as follows: BT: 47 mg/% (range: 37±62 mg/%); AT: 45 mg% (range:
25±69 mg/%); (p = 0.056) and LDL levels BT: 122 mg/% (range: 71±195 mg/%); AT: 105 mg%
(range: 48±158 mg/%); p = 0.056. There were no statistically signi®cant differences in glucose
levels before and after the treatment. Our results revealed the in¯uence of chloroquine treatment
on lipid blood levels in SLE patients. Chloroquine can lower cholesterol and triglicerides levels in
SLE patients, which may be bene®cial in terms of risk of coronary artery disease especially during
corticosteroid treatment.
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Structure-Function Relation of Novel Members of the Efomycine Family
W.-H. Boehncke, T. Krahn,* M. SchoÈn, and M. P. SchoÈn
Departments of Dermatology, Universities of Frankfut and Magdeburg; *Bayer AG, Germany
We have recently described efomycine M, a speci®c small-molecule selectin inhibitor both In vitro
and in vivo. Since efomycine M is a synthetic derivative of a naturally occuring compound, we
were interested in further analysing related molecules and their antiadhesive properties In vitro.
Fermentation material of Streptomyces BS 1261 was analysed using FAB-MS spectroscopy and
reversed phase-HPLC. Following puri®cation of naturally occurring efomycines, chemical
modi®cations were carried out, and the resulting efomycines were used for cell adhesion assays.
The initial analysis of Streptomyces fermentation material revealed the presence of 4 major
compounds with molecular weights ranging from 1010 to 1052. These compounds were termed
efomycines G, E, A and B, representing 14, 68, 16 and 2% of the material, respectively. The most
abundant naturally occuring compound, efomycine E, served as the source for modi®cations
resulting in 6 synthetic efomycines: Efomycines N and O are mono-O-methylated and di-O-
methylated, efomycines L and M are mono-defucosylated and di-defucosylated. Macrolide-
cleavage of efomycine M resulted in efomycine S, and the peracetylated form was termed
efomycine T. The potential of these efomycines to inhibit adhesion was tested in experiments
assessing neutrophil adhesion to albumin-coated plastic ware, platelets, hypoxia-stimulated porcine
aortas, and human umbilical vein endothelial cells (HUVEC). Overall, while the antiadhesive
effects of various efomycines were heterogeneous when comparing different matrices, these
experiments strongly suggested that efomycines interfered with different selectin-mediated
adhesive functions. Thus, we have identi®ed structural motifs necessary for adhesion to certain
matrices. Molecular modeling revealed three H-bonding donor/acceptor groups in a de®ned
spatial arrangement which are shared between at least 3 of the efomycines (G, M, T) and the
naturally occuring selectin ligand, Sialyl-Lewisx. This motif is borne on the central macrolide ring
system and the rather rigid acyclic side chains. In conclusion, these studies identi®ed small-
molecule structural mimetics of selectin ligands which may be particularly amenable as a
therapeutic of in¯ammatory disorders.
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Curcuma longa Extract Combined with UVA or Visible Light Induces Apoptosis in
Human Keratinocytes
J. Dujic, S. Kippenberger, S. Simon, A. Ramirez Bosca, E. Quintanilla Almagro, J. Diaz-Alperi, J.
Bereiter-Hahn, R. Kaufmann, and A. Bernd
Frankfurt, Germany and Alicante, Spain
Curcuma longa Linn (Zingiberaceae) is a medical plant and spice widely cultivated in tropical
regions of Asia and central America. In the form of the herbal powder turmeric, it has been used as
an anti-in¯ammatory remedy in Asian medicine. We could show that Curcuma longa extract
(ZCL4) combined with both, UVA or visible light, induces strong growth inhibition in different
cell lines. Treatment of cultures of human keratinocytes (HaCaT) with ZCL4 (1±10 mg per ml) plus
UVA (1 J per cm2) inhibited the incorporation rate of BrdU without any detectable release of
cytoplasmic lactate dehydrogenase into the supernatant. Using a luciferase reporter assay we found
a ZCL4/UVA dependent repression of NF-kB which is thought to be the central regulator of
stress responses. Hoechst staining showed an concentration dependent increase of fractionated cell
nuclei after treatment with ZCL4/UVA. In addition, the release of cytochrome C from
mitochondria (ELISA) corresponded very well with the fragmentation of cell nuclei. Taken
together, we suppose the blocking of the NF-kB cell survival pathway and the induction of
apoptotic processes after the treatment of human keratinocytes with photo activated ZCL4 without
any sign of cell membrane damages up to 10 mg per ml ZCL4. Theses ®ndings could contribute to a
new photo therapeutic treatment strategy.
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Idiopathic Angioedema Associated with Estrogen-Containing Oral Contraceptives and
Hormonal Replacement Therapy
K. Bork, S. Barnstedt, and D. GuÈl
Mainz, Germany
Information about recurrent episodes of skin angioedema and abdominal pain attacks caused by
oral contraceptives or menopausal hormonal replacement therapy is limited to hereditary
angioedema due to C1 inhibitor de®ciency type 1 and type 2 and to hereditary angioedema type 3
occurring in females with normal C1 inhibitor. Because of spontaneous reports about an
exacerbation of idiopathic angioedema following the intake of oral contraceptives the data of 73
patients were analyzed who had idiopathic angioedema, i.e. recurrent angioedema without
urticaria which cannot be classi®ed into the angioedema disease entities known until now. Eight of
them were females in whom exogenous estrogens induced angioedema attacks within a latency of
3 days to 3 weeks after starting the medication. In 5 patients clinical symptoms occurred after the
intake of oral contraceptives, in 3 patients after starting hormonal replacement therapy. In 5
patients the symptoms occurred for the ®rst time, 3 patients experienced an exacerbation of a
previously existent idiopathic angioedema. In the 8 patients C1 inhibitor protein levels, C1
inhibitor function, C4 and C1q concentrations were found to be normal. Various biochemical tests
recorded no activation of the ®brinolysis or coagulation system. It is concluded that oral
contraceptives or hormonal replacement therapy may cause an induction or exacerbation of
nonhereditary idiopathic angioedema.
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In Vitro Diagnosis of Anticonvulsant Hypersensitivity Reaction by Flow Cytometric
Assessment of the Cell Cycle
A. Dorfmuller, C. N. Renn, W. Straff, J. M. Baron, F. K. Jugert, and H. F. Merk
Aachen, Germany
Anticonvulsants such as carbamazepine or phenytoine may cause the anticonvulsant hypersensi-
tivity syndrome presenting clinically with symptoms including generalised exanthema, Steven
Johnson's syndrome, toxic epidermal necrolysis as well as drug induced hepatitis. T-lymphocytes
and oxidising enzymes have been shown to contribute to the underlying pathophysiology of this
reaction. The polyclonal stimulation of peripheral T-lymphocytes (lymphocyte transformation test,
LTT) proved to be helpful in identifying the triggering agent and eventually diagnosing drug
allergy (Nyfeler, B., Pichler, WJ., Clin Exp Allergy, 1997) especially when both parent compounds
and their metabolites are taken into account (Hertl, M., Jugert, F., Merk, HF., Br J Dermatol.,
1995). However, the need for radioactive components to get a read out for this assay
(incorporation of 3H-thymidine during DNA-synthesis) prompted us to use nonradioactive read
out techniques. Among these determining the amount of drug induced IL-5 via ELISPOT or ¯ow
cytometric analysing of cell cycle phases are to note. We improved the conventional LTT by
several modi®cations: PBMC proliferation was determined by a ¯ow cytometric based technique
performing DNA staining in order to assess cell cycle phases. Cell cycle S-phase and G2/M-phase
turned out to be reliable read out parameters for PBMC proliferation. This method was compared
with both the conventional performed LTT and ELISPOT resulting in similar data with regard to
sensitivity and speci®city.
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Dimethylfumarate (DMF) Interferes with the Release of Perforin (Perf) Containing
Lytic Granules from Cytotoxic T Lymphocytes (CTLs) of Healthy Individuals In Vitro
D. KoÈnig, A. Ambach, B. Bonnekoh, and H. Gollnick
Magdeburg, Germany
Systemic therapy of psoriasis with fumaric acid esters is effective. Its molecular mode of action,
however, is not known in detail. CD8+ cells are major players in the immuno-pathology of
psoriasis dominating, e.g. the cellular in®ltrate in the lesional epidermis. In addition, as compared
to healthy individuals, peripheral blood CTLs of psoriasis patients express more Perf. Since the
effect of DMF on CD8+ CTLs is not known, we investigated the in¯uence of this drug on the
release of Perf-granules from CTLs In vitro. Ficoll isolated peripheral blood mononuclear cells of
healthy volunteers were preincubated for 1 h with 1, 4, 16, and 40 mmol DMF. Perf-granule release
was induced in the presence of DMF with ionomycin and phorbol 12-myristate 13-acetate (PMA).
Cells were ®xed in 2% formaldehyde after 0, 30, 60, 90, and 120 min, permeabilized with 0.2%
saponin, and stained over night with monoclonal antibodies against CD8 and Perf (HoÈlzel,
Cologne, Germany) at 4°C. The percentage of Perf+ CD8hi+ cells was quanti®ed by ¯ow
cytometry. Perf+ portion of CD8hi+ lymphocytes at time point zero was set for 100%. In all 4
individuals, DMF was found to inhibit Perf-granule release dose-dependently. At 30 min after
PMA/ionomycin stimulation, CD8hi+ lymphocytes treated with 4 mmol DMF contained a greater
portion of Perf+ cells (98 6 14%) as compared to DMF-untreated but PMA/ionomycin-stimulated
controls (56 6 4%; p < 0.01). This inhibitory effect was similar at 60 min: 75 6 11 of initial Perf+
lymphocytes treated with 4 mmol DMF still stained Perf+ as compared to 52 6 9% in unstimulated
controls (p < 0.05). Concentrations of 1, 16, and 40 mmol DMF did not in¯uence signi®cantly
Perf-granule release. However, an inhibitory trend was detected with 16 and 40 mmol DMF which
might reach signi®cance in larger study groups. Taken together, we report a dose-dependent
inhibitory effect of DMF on the PMA/ionomycin-stimulated Perf-granule release from CTLs In
vitro. This might contribute to the immunomodulatory potential of fumaric acid esters.
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Successful Treatment of Primitive Cutaneous CD30+ T Cell Lymphoma with Topical
Imiquimod
B. Didona, R. Benucci, F. Canzona, O. Rienzo, and R. Cavalieri
IDI-IRSS, Rome, Italy
Imiquimod, an imidazoquinoline amine, is an immune reponse modi®er drug, which has shown
potent antiviral and antitumoral properties in animal models. Although its mechanism of action is
little understood, imiquimod stimulates various types of cells to produce interferon alfa, IL12 and
other cytokines. On that account it has been initially successfully used topically in genital and
perianal warts and newly in the treatment of actinic keratosis, basal cell carcinoma, squamous cell
carcinoma, lentigo maligna, cutaneous metastasis of melanoma and Kaposi's sarcoma. Based on
these encouraging results and on well-known therapeutic effects of interferon a on cutaneous T
cell lymphoma, we decided to treat a 23-year-old male patient suffering from primitive cutaneous
CD30+ T cell lymphoma, arising in his right leg three months before our observation. Before
starting the treatment the patient was subjected to stadiation, which did not show any involvement
other than the skin. The immunohistological esamination disclosed a dermal in®ltrate of large
lymphocitic cells with CD3+,CD45RO+,CD30+,CD20± phenotype and gene rearrangement of
TCRg demonstrated a monoclonality of T cell population, making the diagnosis of primitive
cutaneous anaplastic large cell CD30+ T cell lymphoma. Imiquimod was applied as a 5% cream 3
times per week and 40days after the start of therapy the cutaneous lesion was completely healed:
the histological an immunological examination con®rmed the total vanishing of T cell in®ltrate.
The pharmacological properties of this drug, like the capability to stimulate the innate and acquired
immunity by the production of numerous cytokines, make it as a novel therapeutic approach to
cutaneous lymphoma.
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Comparative Effect of Reference Molecules for Alopecia Treatment in a Murine Model
of Hair Growth
N. Castex-Rizzi, S. Gratias, M. CharveÂron, and Y. Gall
Institut de Recherche Pierre Fabre ± CERPER, Laboratoire de Biologie Cellulaire CutaneÂe, Toulouse,
France
Hair growth stages have been widely studied in C57BL/6 and C3H mice. A feature of these mouse
models is that pigment production is exclusively associated to the hair growth so that assessment of
skin color allows the monitoring of anagen phase. Our aim was to evaluate the effect of two
reference molecules for alopecia treatment in this mouse model. Minoxidil is known to stimulate
the vascularization of the skin and ®nasteride acts as an antiandrogen through the inhibition of 5 a-
reductase enzyme. Therefore, minoxidil and ®nasteride effect was evaluated on hair growth.
Anagen phase was induced by wax depilation of the back skin of the two strain mice. Changes in
skin pigmentation were assessed by the melanin index meter, chromametry and photographs.
Melanin analysis showed that, topically applied once a day for 19 days, 2% minoxidil prolonged the
anagen stage by inducing by one day an earlier skin darkening in C57BL/6 mice. Chromametry
analysis displayed an effect of minoxidil on C3H mice. Topical (0.6%) but not oral (100 mg per kg)
treatment with ®nasteride once a day for 19 days mice signi®cantly decreased the ``a'' parameter of
chromametry measurement indicating a hair growth. Both molecules seemed not to affect the
duration of the cycle: catagen phase appeared at the same moment around day 21 after depilation.
Our results showed an ef®cacy of minoxidil on hair regrowth on the two strains of mice whereas
®nasteride was only effective in the C3H strain. The C57BL/6 strain can be suited for screening
molecules of minoxidil-like activity and the C3H strain, a sensitive strain for oestrogen, can be
predictive for assessing molecule exhibiting antiandrogen activity.
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Topical PPAR b/d and g Ligands in the Mouse Tail Model and Plaque Psoriasis Assay
S. Kuenzli, P. Carraux, and J. H. Saurat
University Hospital, Geneva, Switzerland
Ligands of nuclear hormone receptors such as glucocorticoid, retinoid, and vitamin D have proved
to be candidates in the development of antipsoriatic drugs. PPARs (peroxisome proliferator-
activated receptors), which belong to the nuclear hormone receptor superfamily, are pleitropic
regulators of immune response, growth, and differentiation in many cell types including the
keratinocytes. Several recent reports have dealt with the involvement of PPARa in epidermal
processes such as barrier development, proliferation, and differentiation. Little attention has been
given however, to the other PPAR subtypes. In the hyperproliferative psoriatic epidermis the
expression of both PPARa and PPARg is decreased, whereas the exact oppposite happens with
PPARb/d. Ligands of PPARg include the thiazolidinediones of which oral troglitazone has been
shown to be an effective treatment of chronic plaque psoriasis. Pro-differentiating activities and
profound antiproliferative action on keratinocytes, as well as critical roles in keratinocyte response
to in¯ammation of PPARb/d have been reported. The purpose of our study is to address the
effects of tetradecylthioacetic acid (TTA), a potent activator of PPARb/d, and rosiglitazone, a
speci®c ligand for PPARg, both in the mouse tail model in terms of morphological changes, and in
clinical trials of therapeutic ef®cacy on plaque psoriasis. The mouse tail is a relatively sensitive
method which allows the evaluation of the effects of antipsoriatic agents on cell differentiation by
quantifying the induction of granular layer in the interfollicular regions. Topical treatments of the
mouse tail with antipsoriatic drugs such as retinoic acid enhances the conversion of parakeratotic
into orthokeratotic cell differentiation (granular cell layer). This model also offers the possibility of
measuring the epidermal thickness. The increased antipsoriatic activity is often accompanied with
an increase in epidermal thickness, but both reactions are not necessarily related. Epidermal
thickness is better regarded as a parameter of skin irritation. The tails of C57BL/6 mice were
treated with vehicle (5% tween 80, 10% cetanol, 30% oleo arachidis hydrogenatum, 10%
propylenglycol, and 45% aqua conservans), rosiglitazone 0,5%, and TTA 0,5% twice daily over a
period of 14 days. Thereafter, longitudinal histological sections were prepared from the tails skin in
order to determine the activity on reduction of parakeratosis and epidermal thickness. In the
psoriasis plaque assay, eight individuals (5m/3f) suffering from psoriasis were treated twice daily for
30 days with vehicle (n: 14 plaque psoriasis), rosiglitazone 0,5% (n: 18), and TTA 0,5% (n: 18).
Assessment of PASI plaque score were carried out at days 0, 4, 7, 11, 14, and 30. In the mouse tail
model, neither rosiglitazone nor TTA affected the cell differentiation as no sign of granular layer
induction was observed. Although, a slight decrease was demonstrated with TTA (96% 6 3 SEM
compared to vehicle), only rosiglitazone is correlated with a statistically signi®cant decrease in
epidermal thickness (86% 6 2 SEM compared to vehicle). No signi®cant difference in the
reduction of PASI plaque score for total, scale, and in®ltration score between the examination
times for vehicle, rosiglitazone, and TTA has been observed. For the eythema score, signi®cant
differences were observed only at day 7 and 11 between rosiglitazone and TTA. Each treatment
was well tolerated by all the patients, with no skin irritation nor adverse drug-related symptoms and
dropouts. Although substantial In vitro and in vivo evidences tend to support the importance of
PPARs as critical regulators of disease characterized by hyperproliferation and aberrant
differentiation, our clinical observations failed to substantiate the ef®cacy of rosiglitazone and
TTA in an animal model as well in plaque psoriasis assay.
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Pharmacological Study of the Local Effects of a Soluble Oatmeal Extract on Histamine-
Induced In¯ammatory Reaction in the Skin of Human Healthy Volunteers In Vivo
M. Laurence, C. Christine,* J.-L. Francette, L. VeÂronique, D. Patrick,² and D. Louis
Institut de Recherche sur la Peau (IRP), INSERM U532, HoÃpital Saint-Louis, 75010 Paris, France;
²Pierre Fabre Research Institute, Vigoulet Auzil, Toulouse, France
This study aimed to quantitatively determine the effects of local administration of a soluble oatmeal
extract on the development of histamine-induced in¯ammatory reaction in vivo, in six healthy
human volunteers. The histamine±induced reaction was quanti®ed during 6 h and at the 24th h in
terms of vasopermeability and release of mediators, including neuropeptides (Substance P),
proteins, lipid mediator (prostaglandin (PG) E2) and cytokines (IL-8 et TNFa). The methodology
was based on the skin chamber technique: six skin blisters were created on the forearms of the
volunteers, epidermal roofs were removed and skin chambers applied on the denuded dermis.
One ml of Hanks' solution containing histamine dihydrochloride (1 mM) vs. one ml control Hanks'
medium were introduced into two skin chambers. The soluble extract was introduced at four
concentrations, 1%, 3%, 10% and 30% (w/v), in 1 mM histamine-containing solution in the
remaining chambers. Solutions were renewed hourly during 6 h and left until the 24th h. In the
collected samples, protein levels were quanti®ed by Lowry's method, mediators amounts by
commercial speci®c ELISA. The results clearly demonstrated the development of an in¯ammatory
reaction in response to histamine introduction into the chambers, as shown by the signi®cant
increase in protein extravasation and mediators during the ®rst hours as compared to control
medium. A signi®cant modulatory effect of the oatmeal extract at 1% and 3% was observed on the
time-dependent release of substance P according to a dose-dependent manner, with an area under
curve of 191.1 6 233.3 mg per cm2 and 12.9 6 22.3 mg per cm2, respectively, in comparison with
control histamine-induced reaction 937.3 6 455.1 mg per cm2 (mean 6 SD). However, the
highest concentration of oatmeal (30% and often 10%) induced some interference with substance
P. No major inhibitory effects were observed on proteins, cytokines and lipid mediator. To
conclude, the present results show a potent inhibitory effect of oatmeal extract on neurogenic
in¯ammation induced by histamine in healthy human skin.
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Experimental Basis for Bene®cial Effects of Pro-/Antioxidants in the Treatment of Viral
and Bacterial Skin Lesions
L. Korkina, E. Mikhal'chik, Z. Kharaeva, D. Fileccia, A. Luci, and C. De Luca
Rome, Italy and Moscow, Russia
The leading role of reactive oxygen (ROS) and nitrogen species (RNS) produced by
phagocytosing cells in nonspeci®c antibacterial immunity is well recognized. ROS, mainly
hypochlorite and hydroxyl radicals, as well as RNS peroxynitrite are known to kill bacteria
extracellularly and help to complete their digestion inside the phagocyte vacuole. The impact of
ROS/RNS in viral pathogenesis is unclear as yet. Various viruses, like bacteria, induce defensive
ROS/RNS production by both infected cells and by recruited phagocytes, with dual consequence:
(1) low intracellular levels of ROS are mitogenic for host cells and promote viral replication, via
nuclear transcription factor (NFkB); (2) higher levels of ROS/RNS cause, depending on
concentration, either apoptotic or necrotic death of virus bearing cells, thus limiting the spreading
of infection. In both bacterial and viral infections, excessive release of ROS/RNS inevitably leads
to free radical-mediated in¯ammatory damage to cells and tissues. Therefore, we suggested that up-
regulation of ROS and RNS production by enzyme-inducers and pro-oxidants enhances
antibacterial and antiviral immunity; on the other hand, limitation of oxidative damage by
antioxidants protects host against cellular death. The pro/antioxidant properties of Immugenq (IDI
Farmaceutici, Italy) and its components (ubiquinone, a-tocopherol, L-methionine, selenium
aspartate, soy phospholipids) were studied in both In vitro and ex vivo experiments using methods of
electron paramagnetic resonance, chemiluminescence, ¯uorescent probes, and spectrophotometry
that allowed us to distinguish and quantify different ROS/RNS. Results showed that both free
radical scavenging and antioxidant properties of ubiquinone and vitamin E were coupled with
prominent pro-oxidant and intracellular free radical-generating activity of methionine and soy
phospholipids. The former well correlated with production of antiviral cytokines by human
leukocytes, their phagocytosing and digestive capacity towards Staphylococcus aureus. Based on
these experimental results, a double blind placebo- and case-controlled randomised clinical trial
was conducted on 59 patients with recurrent skin warts, proving that cryotherapy and oral
administration of Immugenq for 180 days was indeed successful in the treatment of recurrent
verruca vulgaris with signi®cant improvement of total viral clearance and lower incidence of
relapses.
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Detection of RNase 7 Immunoreactivity in In¯ammatory Skin Diseases
M. Sticherling, F. Rastar, J. Harder, E. Christophers, E. Wandel, and J. SchroÈder
Leipzig, Germany, Kiel, Germany
The skin is the largest human organ and constantly exposed to various microbials. Therefore it is
surprising that the incidence of clinically manifest skin infections is rather low. There must be
potent mechanisms which protect the skin from microbial attacks. In recent studies antimicrobial
peptides have been described which are either constitutively expressed by epithelial cells or are
induced after contact with infectious agents. One of these peptides is RNase 7, a novel 18±20 kDa
cationic protein with antibiotic activity against staphylococcus aureus, pseudomonas aeruginosa,
propionibacterium acnes and candida albicans. To obtain antibodies against RNase 7, Balb/c mice
were immunized with natural protein puri®ed from psoriatic scales. One out of several monoclonal
antibodies raised showed distinct epidermal reactivity on both acetone ®xed cryostat sections and
formaldehyde ®xed, paraf®n embedded sections of human skin. In normal human skin, RNase 7
immunoreactivity was found in all epidermal layers. In chronic plaque type psoriasis signals were
detected in upper layers below and within parakeratotic layers around microabscesses. Eczema
showed a similar pattern whereas in foliculitis a diffuse epidermal staining was found. Surprisingly,
dermal vasculature is stained as well. These ®ndings support the idea of an important role of
antimicrobial peptides in skin disorders beside protection from infections.
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Vascular Function of Nonlesional Skin in Psoriasis
S. D. Platt, P. S. Friedmann, and G. F. Clough
Southampton, UK
The purpose of this study was to investigate the microvasculature status of uninvolved, nonlesional
skin of patients with psoriasis. Studies were performed in vivo in the skin of the forearm of eight
patients with psoriasis and their healthy, age and sex matched controls. Laser Doppler imaging
(Moor Instruments Ltd, UK) was used to assess skin blood ¯ux and cutaneous microdialysis to
measure tissue levels of NO and total protein using linear 5 kDaA and 3000 kDa molecular mass cut
off probes, respectively. The cutaneous vascular response to intradermal injection of substance P
(SP, 1 3 10±6 M) and histamine (9 3 10±6 M) was also investigated. Basal blood ¯ux was similar in
the nonlesional skin of psoriatics and healthy controls. NO in dialysate from psoriatic nonlesional
skin was 47% lower than that recovered from the control group (0.36 6 0.04 mM and
0.67 6 0.04 mM, respectively, p = 0.006). By contrast, basal protein levels were 27% higher in
psoriatic skin (245.5 6 6.4 mg per ml vs. 178.7 6 26.4 mg per ml, p = 0.02). The ¯are response to
intradermal SP in nonlesional psoriatic skin (8.4 6 1.4 cm2) was signi®cantly lower than that in
controls. (13.8 6 1.9 cm2) (p = 0.04) as was itch. There was no signi®acnt difference in the
histamine-induced ¯are or itch. Together, these data suggest that microvascular function is altered
in nonlesional skin of patients with psoriasis and that the cutaneous microvascular abnormalities
seen in psoriasis are not con®ned to psoriatic plaques.
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Clonality Detection in Cutaneous B-Cell Lymphomas Using Immunoglobulin Heavy
Chain Gene Rearrangement PCR and Fluorescence Fragment Analysis on Automated
DNA Sequencer
A. Lukowsky, M. Marchwat, S. Gellrich, W. Sterry, and J. M. Muche
Berlin, Germany
Detection of clonally expanded immunoglobulin heavy chain (Igh) gene rearrangements by PCR
and subsequent electrophoresis is increasingly used in the diagnosis of cutaneous B-cell lymphomas
(CBCL). To this end, primers for the three Igh framework regions (FR1,2,3), the leader sequence
and the Jh region are applied, all amplifying the highly variable Igh third complementary region
(CDR3). Recently, ¯uorescence PCR-fragment analysis on automated DNA sequencers
(GeneScan analysis, GSA), providing an exact sizing has been applied as appropriate separation
technique in this context. We have evaluated all Igh primers hitherto known by a PC primer
analysis program. Then, ¯uorescently labeled products generated from DNAs of 58 paraf®n
embedded and 5 frozen lesional skin biopsies of con®rmed CBCL cases, using the primer sets
selected, were analyzed by GSA on the ABI 310 Prism instrument. Single round or seminested
FR3/Jh-PCR showed clonal B-cells only in 32.6 or 37% of cases, respectively. This fraction was
increased to 54.3% including a nested FR1/Jh-PCR, and, to 60% applying a supplementary nested
FR2/Jh-PCR. However, false clonal results, indicated by peaks of varying sizes from repeated
PCR, have been received by nested PCR, mostly by FR2/Jh. Obviously due to their poor quality,
the Igh leader-PCR has not yielded ampli®cation products from paraf®n-derived DNAs. Our data
show that the FR3/Jh-PCR only is not suf®cient for detecting B-cell clonality in CBCL, but
following inclusion of additional Igh-PCR, a substantial number of cases still fail to show clonality.
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Histopathological and Ultrastructural Changes in Human Skin as a Result of Black Fly
Attack in Suburban Area of Warsaw, Poland
L. Chomicz, C. Kowalewski, Z. êwiderski, and M. Walski
Warsaw, Poland
Black ¯ies, cosmopolitan cattle ectoparasites from genus Simulium, are insects of great medical
importance because of their massive attack on humans; they represent vectors of onchocercosis and
probably anthrax. The aim of this study was to assess cutaneous changes in man caused by a severe
invasion of black ¯ies (Simulium sp.). Twelve men and women (19±62 years old) with the dermal
disorders caused by black ¯y bites were assessed clinically. Skin biopsy for the histopathological and
the transmission electron microscope examinations was taken from the man with the most serious
symptoms. All persons showed changes of various intensity situated mainly on lower limb skin.
Some of them had a local allergic reaction maintaining for up to two weeks. Small painful petechial
spots, swellings and pruritic blisters, and later greater erythematous changes around a few sites of
bites occurred. Blisters were bleeding profusely during a long time after scratching. The clinical
assessment showed that the cutaneous changes were healing fully when the antihistamine and
antibiotic treatments have been applied during seven weeks after the black ¯y invasion. The
histopathological examinations revealed the skin lesions, damages of the blood capillaries and
in¯ammatory process developing in sites of black ¯y bites. In®ltration consisted of different cells
and the oedema with extravasated blood occurred. Clear changes inside and outside the dermal
cells were found by means of TEM in skin biopsy material. Numerous macrophages ®lled with
phagolysosomes occurred in the extracellular dermal space. Conglomerations of the mast cells were
also found. Ultrastructure of the analysed material indicated advanced process of rebuilding in the
dermal cell region developing with the intensive neoangiogenesis. The above described skin
changes are connected with various adaptations of the mouthpart that enable ¯ies to feed the blood.
Contents of ¯y saliva and the toothed bladelike cutting mouthpart cause bite wounds with damages
of dermal cells and blood capillaries. Different personal susceptibility may in¯uence various
intensiveness these changes. Better knowledge of skin lesion types, caused by Simulium may be
useful for a proper diagnosis, treatment and for preventing of serious secondary infections.
318
Withdrawn
VOL. 119, NO. 3 SEPTEMBER 2002 ABSTRACTS 765
319
Skin Mapping Using Low Cost Stereo Vision
J. Smolle, G. Paar, A. Gerger, G. Lechner, and O. Sidla
Graz, Austria
In dermatology assessment of localization and extent of skin involvement is often a prerequisite for
therapy planning and evaluation of therapeutic effects. So far, this has largely been done by
subjective, semiquantitative scoring systems. Digital images, in contrast, can provide an objective
and comprehensive database, but they contain only two-dimensional information and are therefore
inappropriate when large areas of the body surface have to be considered. The reason for this are
the many occlusions and distortions introduced with a simple 2D imaging approach. Therefore
three-dimensional information has to be obtained so that a geometric recti®cation of skin surface
patches allows quantitative measurements. We propose two off-the-shelf digital cameras to acquire
a stereo data set from the skin surface. A ®rst image pair with random texture projected is used to
generate 3D information. One colour image of the skin texture completes the input data set for
stereo reconstruction. Dense stereo matching is performed, then the resulting point cloud is
overlaid with texture from the skin surface. This allows the expert to work on a geometrically
correct high-resolution virtual model of the patient's surface. Recognition of lesional skin is further
based on colour and texture analysis. A prototype system yielding two oblique views from the back
of the trunk was used to evaluate patients with multiple melanocytic lesions and patients with
plaque-type psoriasis. In using a texture based matching method designed to obtain a dense grid of
correspondences on fairly smooth surfaces (such as most patches on the human skin) stereo
reconstruction produces a three-dimensional view of the skin surface. Lesional skin was
automatically detected by means of tissue counter analysis, yielding quantitative data as to the
extent of skin involvement and as to the localization of individual lesions. The skin mapping
prototype described in this study is a ®rst step towards digital mapping of the entire skin. The ®nal
goal is a skin mapping equipment for follow-up examinations in pigmented lesion screening as well
as for an objective quantitative assessment of therapeutic effects in in¯ammatory dermatoses.
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Pseudopelade of Brocq: Immunohistochemical De®nition of Different In®ltrating
Patterns
S. Moretti, L. Amato, B. Bianchi, I. Gallerani, and P. Fabbri
Department of Dermatology, University of Florence, Florence, Italy
Twelve cases of clinically diagnosed Pseudopelade of Brocq (PB) were studied by immunohis-
tochemistry to evaluate antigenic features of the in®ltrate and the presence of ®brogenic and
anti®brogenic cytokines. On the basis of both histology and direct immuno¯uorescence, two cases
could be diagnosed as discoid lupus erythematosus (DLE), and 3 cases as lichen planopilaris (LPP).
The other 7 cases were classi®ed as ``non characterized pseudopelade'' (NCPP). By
immunohistochemistry the pattern of the in®ltrate was assessed. Two major patterns were
de®ned: (1) conspicuous periadnexal/interstitial in®ltrate of CD3+ cells with high CD4+/CD8+
ratio and a variable amount (always less than in®ltrating lymphocytes) of macrophages, mastocytes,
and ®broblasts; (2) unconspicuous periadnexal/interstitial in®ltrate of CD3+ cells with variable
CD4+/CD8+ ratio, and conspicuous amounts of macrophages, mastocytes and ®broblasts in
various proportions. The ®rst pattern was typical of the cases classi®ed as DLE or LPP, the second
pattern was representative of the cases classi®ed as NCPP. IL-4 was expressed by lymphocitic
in®ltrate nearly in all cases, IL-6 was observed on lymphocytes and macrophages in all cases, IFN-g
was found in LP in®ltrating lymphocytes, bFGF was always expressed on macrophages.
Immunohistochemistry of our PB cases allowed us to identify two different in®ltrating patterns
and to recognize the consistent presence of ®brogenic cytokines.
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Cd44 Expression in Mouse Epidermis After Topical Application of Retinoids and UVB
Irradiation
E. CË alyÂkolu, O. Sorg, P. Carraux, J.-H. Saurat, and G. Kaya
Departments of Dermatology, Fatih University Medical Faculty, Ankara, Turkey; DHURDV, University
Hospital of Geneva, Geneva, Switzerland
CD44 is a polymorphic transmembrane glycoprotein and the principal cell surface receptor of
hyaluronate (HA). Recently we have shown that the topical application of retinaldehyde (RAL)
resulted in an epidermal hyperplasia and a marked increase of CD44 expression in the follicular and
interfollicular epidermis in C57BL/6 and SKH1 hairless mice. In another study, we also showed
that CD44 expression was signi®cantly reduced in the membrane and became cytoplasmic 2 h after
UVA (10 j per cm2) or UVB (1 j per cm2) and reconstituted within 8 or 24 h for UVA and UVB,
respectively. In a previous study, we demonstrated that topical application of 0.05% RAL for 3 days
prevented the decrease of CD44 and HA in the epidermis induced by UVA and UVB irradiation.
In the present study, we aimed to explore the expression of CD44 in the epidermis of the back skin
of SKH1 hairless mice after UVB irradiation (1 j per cm2) which was previously treated with 0.05%
retinaldehyde (RAL), 0.05% retinoic acid (RA), and 0.05% retinol (ROL) topically for 7 days. For
this purpose, an immunohistochemical study was performed on the skin sections of mice by using
biotinylated anti-CD44 antibodies. Our results showed that all the retinoids increased the
expression of epidermal CD44. The CD44 expression was more strongly increased in mice treated
with RAL when compared to those treated with RA and ROL. In addition, RAL prevented the
decrease of CD44 induced by UVB irradiation more signi®cantly when compared to RA and
ROL.
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Association of hsp27 with Epidermal Structural Proteins and its Expression in
Keratinization Disorders
C. Jonak, G. Klosner, D. FoÈdinger, H. Traupe, D. Metze, H. HoÈnigsmann, and F. Trautinger
Vienna, Austria and MuÈnster, Germany
Hsp27 is a small heat shock protein, which is expressed in an ubiquitous and intracellular way. This
stress protein has been highly conserved during evolution. In human epidermis its expression is
associated with keratinocyte differentiation. Hsp27 functions as a molecular chaperone by binding
to other proteins, e.g. actin. Concerning the differentiation associated expression pattern of hsp27
the aim of this study was to provide evidence for a possible function of hsp27 as a molecular
chaperone in human keratincytes especially during the assembly of the CCE. We investigated the
expression- and colocalization pattern of hsp27 and ®laggrin, loricrin, transglutaminase 1, keratins,
and actin in normal human skin. Evaluation was done by confocal laser scan microscopy and
electron microscopy. Furthermore we investigated a panel of kerinization disorders for the
expression of hsp27 by immunohistochemistry. In more than 60% of the samples we could detect
subcorneal colocalization of hsp27 with loricrin, ®laggrin, transglutaminase 1, and keratins.
Colocalization with actin could not be revealed. For loricrin and ®laggrin we could show that
ultrastructurally the obtained colocalizations are caused by binding of these antigens to
tono®laments in close vicinity. Most of the keratinization discorders we investigated expressed
hsp27 in a regular pattern corresponding to normal skin. However, 3 out of 3 patients with
chondrodysplasia punctata (CDPX) lacked epidermal expression of hsp27. From these results we
conclude that hsp27 might serve as a molecular chaperone of tono®laments and of the corni®ed
cell envelope. Further studies will address the role of the lack of hsp27 in the pathophysiology of
CDPX.
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Pityriasis Lichenoides is a Polyclonal T Cell Disorder with a Variable Recruitment of the
Different Subpopulations of CD8+ Cytotoxic T-Cells along its Various Histological
Phases
D. Tomasini, C. Tomasini,* A. Cerri,² G. Palmedo,³ and H. Kutzner³
Department of Dermatology, Busto Arsizio Hospital, Busto Arsizio, Italy; *IInd Dermatologic Clinic,
University of Turin, Turin, It; ²IVth Dermatologic Clinic, University of Milan, Milan, Italy;
³Dermatopathologische Gemeinshaftspraxis, Friedrichshafen, Germany
Pityriasis lichenoides (PL) chronica and its acute form, pityriasis lichenoides et varioliformis acuta,
are skin diseases of unknown origin that probably represent an hypersensitivity reaction to an
infective agent. PL is a benign disorder but some authors, for the detection of monoclonal T-cell
populations both in the chronic and acute form, have suggested that PL might belong to the group
of primary CTCL. Other authors showed that the in¯ammatory in®ltrate in PL is composed by
CD8+ T-cells but they did not detect cytotoxic molecules. These data prompted us to evaluate in
60 cases of PL: (a) the T-cell receptor (TCR) g gene rearrangement; (b) cytotoxic proteins
expression like TIA-1 and Granzyme-B (Gr-B); (c) the apoptotic index by means of ``Tunel''
analysis and detection of activated caspase-3; (d) the phenotypical pro®le, by testing serial tissue
sections with monoclonal and polyclonal sera against CD2, CD3, CD4, CD8, CD45RA,
CD45RO, CD56. All the studies have been performed on formalin-®xed and paraf®n-embedded
materials. The cases analysed were further subdivided, according to speci®c histological parameters,
into early, fully developed and late lesions. Our results demonstrate that the in®ltrate in PL early
lesions is composed by CD2+, CD3+, CD8+, CD56±, T-cells, whereas CD8+ cytotoxic T-cells
with a phenotype indicative of the naõÈve (CD45RA+, CD8+, CD56±, TIA-1+), memory
(CD45RO+, CD8+, CD56±, TIA-1+) and effector populations (CD45RA+, CD8+, CD56±,
TIA-1+, Gr-B+) are quite exclusively observed in fully developed and late lesions. Gr-B is variably
expressed from case to case but both with a clear correlation with histological signs of acuteness and
of cytopathic damage, the more the signs the more the percentage of Gr-B+ cells, and with the
apoptotic index. Finally, TCR g gene rearrangement analysis gave a polyclonal signal in almost all
the analysed cases. In conclusion, data obtained so far suggest that PL is a polyclonal T-cell disorder
linked to CD8+ cytotoxic T-cell activity.
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CD40-CD154 Ligation Between Keratinocytes and T Cells in Psoriatic Lesion and
Keratinocyte Production of Chemokines by This Ligation In Vitro
M. C. Pasch, K. K. Timar, V. M. R. Heydendael, M. van Meurs, J. D. Laman, J. D. Bos, and S. S.
Asghar
Amsterdam and Rotterdam, the Netherlands
In psoriatic lesions, activated T cells and CD40+ keratinocytes are seen. We argued that some of
the activated T cells may be CD154+ cells which may ligate with CD40+ keratinocytes. This
ligation may induce the release of chemokines and complement by keratinocytes and alter their
expression of complement (C) regulatory proteins; abnormalities seen in psoriatic lesion. To test
this, we examined CD40-CD154 ligation in the lesion of 10 patients with psoriasis in situ. We also
studied, In vitro, the keratinocyte release of chemokines (IL-8, RANTES and MCP-1) and C
components (C3 and factor B) by ELISA and alteration of expression of C regulatory proteins
(DAF, MCP and CD59) by ¯ow cytometry in response to this ligation. For CD40-CD154 ligation
on keratinocytes, we ®rst treated keratinocytes with IFN-( in culture to up-regulate CD40
expression and then incubated them with CD154 transfected J558 cells or soluble CD154. In the
lesion, CD40+ keratinocytes were seen in all patients; in relatively larger clusters in stratum
spinosum, smaller clusters in stratum basale and occasionally in small clusters in stratum
granulosum. CD154+ T cells were seen exclusively in stratum spinosum in seven patients; in six in
juxtaposition to CD40+ keratinocytes. These results indicated CD40-CD154 ligation between
keratinocytes and T-cells in the lesion. In vitro, keratinocytes produced small amounts of IL-8,
RANTES and MCP-1 in culture medium but CD40-CD154 ligation on them greatly enhanced
the production of these chemokines (10-, 10-, and 3-fold, respectively) without inducing the
production of C3 and factor B and without altering the expression of MCP, DAF or CD59. Up-
regulation was time and dose dependent. Contact between CD154 transfected cell and CD40+
keratinocytes was essential for up-regulation of chemokine production as seen in a Transwell
system. An anti-CD40 monoclonal antibody almost completely blocked IL-8 induction in
response to this ligation. Interaction between CD154+ T cells and CD40+ keratinocytes in the
epidermis of psoriasis patients may play a role in the genesis of a local in¯ammatory process via
chemokine production by keratinocytes.
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Morphology of Sweat Glands and Periglandular Nerves in Hyperhidrotic Palms Before
and After Intradermal Botulinum Toxin
C. Swartling, H. Naver, I. Pihl-Lundin, E. Hagforsen, and A. Vahlquist
University Hospital, Uppsala, Sweden
Intradermal botulinum toxin (Btx) produces long-lasting relief of focal hyperhidrosis. Although
Btx blocks cholinergic transmission, its mechanism of action in hyperhidrosis is poorly understood.
Objective: To study the effect of Btx A on the size and innervation of sweat glands in patients with
palmar hyperhidrosis.
Palmar skin biopsy specimens from 20 hyperhidrotic patients and 11 controls were investigated.
Nine of the patients also underwent biopsy 2.5-6 months after Btx injections when no relapse of
sweating had yet occurred. Sweat gland morphology (diameters of the secretory tubule and tubular
lumen) was investigated by light microscopy after routine haematoxylin staining.
Immuno¯uorescence with antibodies to the neural marker protein gene product 9.5 (PGP 9.5)
and to vasoactive intestinal peptide (VIP) and calcitonin gene-related peptide (CGRP) was used to
analyse the periglandular innervation. Results: Tubular dimensions in patients with hyperhidrosis
after Btx treatment were similar to those in control subjects. The tubular lumen had diminished
(p<0.05) and a tendency to decreased PGP 9.5-like immunoreactivity (p=0.09) around the glands
was seen. No change in VIP or CGRP immunoreactivity was observed post-treatment.
Both the periglandular innervation and the sweat gland per se seem to be affected by intradermal
botulinum toxin.
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Morphometric Diagnosis of Histologic Sections of Melanocytic Skin Tumors in
Automated Image Analysis
A. Gerger and J. Smolle
Graz, Austria
In tissue counter analysis, digital images of tissue scenes are dissected into elements of equal size and
shape, and the contents of each element are evaluated by a set of grey level, color and texture
features. The aim of this study was to test the applicability of tissue counter analysis and CART
(Classi®cation and Regression Tree) to the diagnostic discrimination of a large series of histologic
sections of benign common nevi and malignant melanoma. Two hundred cases each of benign
nevi and malignant melanoma were consecutively sampled. After creation of datasets based on 10
cases each, CART analyses of background vs. tissue elements and cellular vs. other tissue elements
were performed. In a second step, a learning set of 120000 cellular elements obtained from 100
cases each was created. Based on the learning set, CART analysis was performed in order to
differentiate between benign and malignant cellular elements. For diagnostic assessment, only the
percentage of cellular elements suggestive for malignancy in each case was used. In the learning
sets, CART analysis led to a correct classi®cation of 99% of background vs. tissue elements, 96% of
cellular vs. other tissue elements and 79.1% of benign vs. malignant cellular elements. When the
percentage of cellular elements suggestive for malignancy in each case was evaluated it turned out
that a threshold level of 52.51% provides a correct classi®cation of 192 nevi and 186 melanoma out
of 200 each (speci®city 96%, sensitivity 93%, positive predictive value 95.9%). An overall
performance of 94.5% correctly classi®ed cases in a total of 400 histologic sections of melanocytic
skin tumors clearly suggests that tissue counter analysis combined with CART (Classi®cation and
Regression Tree) is a powerful tool for diagnostic purposes in histopathology.
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CD44 and Hyaluronate Expression in Follicular Mucinosis
G. Kaya, E. Augsburger, P. Chavaz, and J.-H. Saurat
Department of Dermatology, DHURDV, University Hospital of Geneva, Geneva, Switzerland
CD44 is a membrane glycoprotein and serves as the major cell surface receptor for hyaluronate
(HA). In a recent study we have demonstrated that the lack of CD44 expression in murine
keratinocytes leads to an abnormal HA accumulation in the super®cial dermis, indicating an
important role of CD44 in local HA metabolism in the mouse skin. We have also observed a
decrease in the expression of epidermal CD44 in patients of lichen sclerosus et atrophicus which is
potentially responsable for the dermal deposition of HA in this disease. Recently we have also
shown that HA accumulation was associated with decreased expression of CD44 in
trichofolliculoma-like epithelial proliferations in perifollicular solitary cutaneous myxoma. In this
study we examined the follicular expression of CD44 and HA in the skin biopsy specimens of
seven patients with follicular mucinosis by using CD44-speci®c monoclonal antibodies and
biotinylated HA-binding protein (HABP), respectively. No difference of CD44 expression was
observed in the follicular keratinocytes when compared with those of unaffected interfollicular
epidermis. The follicular zones of mucin deposition were strongly positive for HA. A weak
interkeratinocyte staining pattern for HA was also observed in the interfollicular epidermis.
However, HABP staining revealed a stronger reactivity in the follicular keratinocytes surrounding
the mucin-accumulated areas compared to the interfollicular keratinocytes, indicating an active
secretion of HA by follicle cells in follicular mucinosis.
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Amyloid Elastosis: A Rare Variant of Al Systemic Amyloidosis
I. MasouyeÂ, G. Vecchietti, D. Salomon, and L. Borradori
Department of Dermatology, DHURDV, University Hospital of Geneva, Geneva, Switzerland
A 56-year-old woman presented with polyneuropathy and yellowish coalescing macules in
intertriginous areas resembling pseudoxanthoma elasticum (PXE) or diffuse plane xanthomas. Two
lesional skin biopsies were obtained from the axilla and the thigh. Both specimens demonstrated
small globules of slightly basophilic amorphous material between collagen bundles throughout the
dermis. These deposits were PAS-positive and showed ¯uorescence with Thio¯avine-T. They
strongly stained with Congo red and showed the characteristic green birefringence of amyloid
substance when viewed under polarized light. Orcein stain revealed that amyloid was preferentially
deposited on elastic ®bers that appeared to be coated with a thick layer of unstained amyloid
substance. Immunostaining using monoclonal mouse antibody to amyloid A remained negative.
Electron microscopic studies con®rmed that the micro®brillar amyloid substance was closely
associated with elastic ®bers in the dermis. Amyloid was further detected in muscle, nerve, gastric,
duodenal and bone marrow biopsy specimens. The patient had medullary plasmocytosis with
lambda light chain restricted expression. She underwent autologous stem cell transplantation,
which resulted in progressive regression of cutaneous signs and stabilisation of the polyneuropathy.
Amyloid elastosis is a rare variant of systemic amyloidosis characterized by prominent amyloid
deposition on elastic ®bers, in close association with their micro®brils. Only 2 cases of amyloid
elastosis with PXE-like features and a rapid fatal outcome have been previously described.
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Penile Lichen Sclerosus and Carcinoma
D. Innocenzi
Dermatology and Plastic Surgery Department, University of Rome ``La Sapienza''- Italy
The relationship between penile lichen sclerosus (LS) and cancer development has not been clearly
assessed so far. In order to de®ne those histological features of LS that may indicate or precede a
malignant degeneration, 104 biopsy specimens from 86 patients with LS of the glans and from 9
patients with a penile malignancy arising on LS were reviewed. Three different histopathologic LS
patterns were identi®ed ± a ®rst pattern with a prominent lichenoid in¯ammatory in®ltrate in the
dermis (9%), a second pattern characterized by a band-like in®ltrate separated from the epidermis
by a band of dermal sclerosis (44%), and a third pattern showing prominent sclerosis with minimal
or absent in¯ammatory in®ltrate (9%). In 38% of cases we also found a fourth pattern, with
overlapping features between the ®rst and the third pattern, occasionally showing areas of
epidermal thickening, with loss of the normal keratinocyte cytoarchitectural differentiation,
mitoses and apoptotic cells. The histological features observed in the fourth pattern may be
interpreted as areas of disease reactivation within a chronic stage. Furthermore, 7 out of 9 cases of
penile cancer from our series (78%) were associated with this pattern of LS, suggesting that it may
correlate with a malignant degeneration.
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Ultrastructural and Genetic Studies in Patients with Autosomal Recessive Congenital
Ichthyoses
K. Becker, M. CsikoÂs, M. SaÂrdy, Zs Szalai, and S. KaÂrpaÂti
Budapest, Hungary
Skin ultrastructure and TGM1 mutations were studied in seven families with autosomal recessive
congenital ichthyosis (ARCI). Two patients with lamellar ichthyosis (LI) showed similar
rectangular clefts within the corneocytes (IC typeII). One of them was heterozygote for known
missense mutations (A3366G/V378L), the other one had a novel amino acid substitution R553P
within the TGM1 gene. Five patients ful®lled clinical criteria of congenital ichthyosiform
erythroderma (CIE), one of them, however, had had erythroderma only in childhood. We found
rectangular clefts in the horny cells in one CIE patient, who proved to have a V378L change on
one allele in TGM1. Here we diagnosed a CIE-like LI, possibly initiated by retinoid treatment.
Skin ultrastructure of the second patient detected thinner corni®ed cell envelopes and lipid droplets
in the corneocytes (IC type I). The patient was heterozygote for two novel TGM1 nonsense
mutations Y503X/S669X, resulting in a truncated TGase 1 molecule. The third patient, who
presented with mild scaling without erythema, was classi®ed as CIE because of a continous
erythroderma during his early childhood. Skin ultrastructure proved perinuclear membranous
structures in the granular and membranous bundles within the horny cells (IC III). No underlying
TGM1 mutations had been veri®ed. Ultrastructural features of the remaining two patients
displayed two unique features. They had no keratohyalin granules but had multiple vacuoles ®lled
with electrondense granular material within the granular and horny cells. Neither TGM1 gene
mutations, nor hairshaft abnormalities could have been detected.
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Giant Cell Lichenoid Dermatitis in a Patient with Baboon Syndrome
G. Kaya, M. Touati-Serraj, J. Perriard, J.-H. Saurat, and P. Chavaz
Department of Dermatology, DHURDV, University Hospital of Geneva, Geneva, Switzerland
Giant cell lichenoid dermatitis is a recently described pathological entity which can be seen as an
unusual lichenoid drug eruption, a manifestation of sarcoidosis or within herpes zoster scars.
Histopathological ®ndings include focal vacuolar alteration of the basal layer with cytoid bodies,
dermal and intraepidermal multinucleated giant cells, and a mixed chronic in¯ammatory in®ltrate
with a lichenoid pattern consisting of lymphocytes, histiocytes, eosinophils and plasma cells. Here
we report a giant cell lichenoid dermatitis in a 41-year-old male patient who developed, 3 days
after intravenous treatment with amoxicillin-clavulanic acid for erysipelas of the left leg, a clinical
picture suggesting a Baboon syndrome characterized by an erythematous and purpuric eruption on
the axillary, inguinal and popliteal areas and the anterior side of elbows. Histologically there was an
epidermal hyperplasia and atrophy with focal vacuolar alteration of the basal layer, exocytosis and
cytoid body formation. A band-like lichenoid in¯ammatory in®ltrate containing lymphocytes,
histiocytes, eosinophils, plasma cells and epidermotropic CD68+ multinucleate giant cells was
found at the dermoepidermal junction and in the super®cial dermis. This is the ®rst reported case
of giant cell lichenoid dermatitis in a patient with Baboon syndrome.
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Vasoactive Intestinal Polypeptide Receptor VPAC2: Localisation of mRNA-Expression
in Human Skin
D. A. Groneberg, P. Welker, and T. C. Fischer
Berlin, Germany
The bioactive peptide vasoactive intestinal polypeptide (VIP) is involved in the regulation of
various aspects of cutaneous cell differentiation. VIP is abundantly present in cutaneous autonomic
nerve ®bers where it acts as neuromodulator and participates in the regulation of regional blood
¯ow and pain transmission. We studied the distribution of the inducible receptor subtype VPAC2
mRNA in the human skin using a human speci®c VPAC2 cRNA probe. Non-isotopic in-situ-
hybridisation for the receptor mRNA was simultaneously combined with immunohistochemistry
for the ligand VIP. VPAC2 mRNA hybridisation signals were detected in a variety of cutaneous
cell types. There was marked staining of epidermal cells with most pronounced hybridisation
signals found in keratinocytes of the basal layer. In deeper regions, glandular cells surrounded by
VIP-immunoreactive nerve ®bers were positive for VPAC2 mRNA. Hair follicle cells next to
VIP-positive ®bers also exhibited hybridisation signals. Speci®c staining was also detected in
mononuclear cells. No signals were obtained in vascular smooth muscle myocytes and endothelium
and connective tissue. There was no difference in the pattern of distribution between biopsies of
different areas. In summary, VPAC2 mRNA is localised in keratinocytes, glandular, hair follicle
and immune cells of the skin but not in vascular smooth muscle indicating that the effects of VIP
on vasodilation may be mediated via a different receptor or by paracrine pathways.
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